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Abstract	  
Haemophilus	   influenzae	   is	   an	   important	   human	   pathogen,	   responsible	   for	  respiratory	  infections,	  such	  as	  otitis	  media,	  bronchitis	  and	  epiglottitis,	  as	  well	  as	  invasive	  disease.	  Despite	  being	   the	   first	   free-­‐living	  organism	  to	  have	   its	  whole	  genome	  sequenced,	  there	  have	  been	  only	  a	  few	  published	  studies	  investigating	  its	   transcriptional	   profile	   using	   next-­‐generation	   sequencing	   (NGS).	   The	   work	  presented	  in	  this	  thesis	  aimed	  to	  use	  NGS	  to	  improve	  the	  understanding	  of	  how	  
H.	   influenzae	   behaves	   during	   natural	   infection	   and	   to	   identify	   novel	   RNA	  structures	  with	  potentially	  important	  roles	  in	  pathogenesis.	  	  The	  whole	   transcriptome	   of	  H.	   influenzae	   during	   infection-­‐relevant	   conditions	  was	   analysed	   using	   high-­‐throughput	   RNA	   sequencing.	   For	   the	   first	   time,	   the	  transcriptional	  profile	  of	  H.	  influenzae	   during	   stationary	  phase	  and	  nutritional	  stress	  was	   determined	   on	   a	  whole-­‐genome	   scale.	  Differential	   gene	   expression	  analysis	   of	   an	   invasive	   strain,	   R2866,	   and	   a	   laboratory	   strain,	   Rd	   KW20,	  revealed	   differences	   in	   their	   transcriptional	   response,	   particularly	   during	  oxidative	  stress	  and	  iron	  starvation.	   Importantly,	  a	  new	  systematic	  and	  robust	  bioinformatic	   tool,	   "toRNAdo",	   was	   developed	   to	   identify	   non-­‐coding	   RNA	  elements	   from	   the	   bacterial	   transcriptomic	   data.	   It	   enabled	   discovery	   of	   a	  repertoire	   of	   novel	   putative	   intergenic	   and	   antisense	   non-­‐coding	   RNAs	   in	  H.	  
influenzae.	   In	   addition,	   the	   first	   fully	   sequenced	   genome	   of	   a	   free-­‐living	  organism,	   the	   Rd	   KW20	   strain	   of	   H.	   influenzae,	   was	   re-­‐sequenced	   and	   re-­‐annotated	  for	  the	  first	  time.	  This	  enabled	  identification	  of	  multiple	  nucleotide-­‐level	  differences	  between	  original	  and	  re-­‐sequenced	  genomes	  of	  Rd	  KW20.	  	  The	   work	   presented	   here	   facilitates	   future	   characterisation	   of	   novel	   RNA	  elements,	   with	   potentially	   important	   regulatory	   roles	   in	   pathogenesis	   in	   H.	  
influenzae,	   and	   has	   implications	   for	   defining	   a	   model	   bacterial	   strain.	  Importantly,	  the	  findings	  present	  significant	  insight	  into	  the	  pathogenic	  lifestyle	  of	  H.	  influenzae.	  They	  provide	   the	  basis	   for	   further	  work,	  where	  novel	  vaccine	  and	  antibiotic	  targets	  may	  get	  developed.	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Chapter	  1:	  Introduction	  
Haemophilus	   influenzae	   was	   the	   first	   free-­‐living	   organism	   to	   have	   its	   whole	  genome	   sequenced	   in	   1995,	   signifying	   the	   start	   of	   the	   genomic	   era	   in	  bacteriology	   (Fleischmann	   et	   al.,	   1995).	   Since	   then,	   the	   advances	   in	   next-­‐generation	   sequencing	   (NGS)	   technologies	   allowed	   researchers	   to	   study	  bacterial	  organisms	  on	  a	  whole-­‐genome	  scale,	   including	  the	  work	  presented	  in	  this	   thesis.	  H.	   influenzae	   is	   an	   important	   human	  pathogen,	  with	   historical	   and	  present-­‐day	  significance.	  This	  study	  aimed	  to	   investigate	   the	  behaviour	  of	   this	  organism	  during	   infection-­‐relevant	  conditions	  using	  NGS.	   It	  provides	   the	  most	  comprehensive	  repertoire	  of	  non-­‐coding	  RNAs	  (ncRNAs)	  in	  H.	  influenzae	  to-­‐date	  as	   well	   as	   explores	   implications	   of	   using	   old	   annotated	   genomes	   of	   model	  organisms.	   The	   findings	   presented	   in	   this	   work	   provide	   new	   insight	   into	   the	  pathogenesis	  of	  H.	  influenzae	  and	  lay	  important	  groundwork	  for	  future	  work	  on	  potentially	  important	  RNA	  elements	  in	  this	  organism.	  	  
1.1	  Haemophilus	  influenzae	  
1.1.1	  Haemophilus	  genus	  
Haemophilus	   is	  a	  genus	  of	  Gram-­‐negative,	  non-­‐motile	  coccobacilli,	  belonging	  to	  the	   Pasteurellaceae	   family	   of	   the	   phylum	  Proteobacteria.	  Haemophilus	   species	  are	   known	   to	   cause	   diseases	   in	   a	   range	   of	   hosts	   as	   well	   as	   behave	   as	   a	  commensal	   (Norskov-­‐Lauritsen,	   2014).	   These	   species	   share	   the	   growth	  requirement	  for	  at	  least	  one	  of	  blood-­‐associated	  growth	  factors:	  haemin	  (factor	  X)	  and	  nicotinamide	  adenine	  dinucleotide	  (NAD;	   factor	  V)	  (Norskov-­‐Lauritsen,	  2014).	  The	  most	  significant	  and	  extensively	  studied	  member	  of	  the	  Haemophilus	  genus	   is	  H.	   influenzae,	   capable	   of	   causing	   important	   infections	   in	   humans,	   as	  described	  below.	  A	  list	  of	  Haemophilus	  species	  specific	  to	  the	  human	  host,	  along	  with	  their	  clinical	  presentations,	  is	  presented	  in	  Table	  1.1.	  In	  addition,	  there	  are	  
Haemophilus	   species	   with	   different	   animal	   hosts,	   including	   Haemophilus	  
parasuis,	  Haemophilus	  paracuniculus	   and	  Haemophilus	   felis,	   isolated	   from	  pigs,	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Table	  1.1:	  List	  of	  Haemophilus	  species	  with	  human	  host	  specificity.	  
Haemophilus	  species	   Clinical	  presentation	   Reference	  
H.	  influenzae	  
Respiratory	  tract	  diseases,	  meningitis,	  bacteraemia,	  endocarditis	  
(Makela	  et	  al.,	  1992,	  Brouqui	  and	  Raoult,	  2001,	  Agrawal	  and	  Murphy,	  2011)	  
H.	  influenzae	  biogroup	  
aegyptius	   Acute	  conjunctivitis,	  Brazilian	  purpuric	  fever	   (Pittman	  and	  Davis,	  1950,	  Tondella	  et	  al.,	  1995)	  
Haemophilus	  
parainfluenzae	   Endocarditis	   (Brouqui	  and	  Raoult,	  2001)	  
Haemophilus	  
haemolyticus	  
Common	  commensal,	  rare	  invasive	  disease	   (Anderson	  et	  al.,	  2012)	  
Haemophilus	  
parahaemolyticus	   Pharyngitis,	  endocarditis	   (Pittman,	  1953)	  
Haemophilus	  
paraphrohaemolyticus	   Rare	  clinical	  presentation	   (Norskov-­‐Lauritsen	  et	  al.,	  2012)	  
Haemophilus	  ducreyi	   Chancroid	   (DiCarlo	  et	  al.,	  1995)	  
Haemophilus	  
pittmaniae	   Respiratory	  disease	   (Boucher	  et	  al.,	  2012)	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1.1.2	  Overview	  of	  H.	  influenzae	  
H.	  influenzae	  is	  a	  small-­‐celled	  (1	  µm	  x	  0.3	  µm),	  facultatively	  anaerobic,	  fastidious	  organism	  that	  has	  an	  absolute	  growth	  requirement	  for	  factors	  X	  and	  V.	  It	  forms	  pale	  grey	  colonies	  on	  chocolate	  agar	  and	  grows	  optimally	  at	  35-­‐37	  °C	  with	  5%	  CO2,	  mirroring	  its	  ability	  to	  colonise	  the	  human	  upper	  respiratory	  tract.	   It	  was	  initially	  described	  incorrectly	  as	  the	  causative	  agent	  of	  influenza,	  which	  explains	  the	   aetiology	   of	   the	   name	   of	   the	   species	   (Pfeiffer,	   1892).	   Originally	   called	  
Bacillus	   influenzae,	   it	   was	   not	   renamed	   H.	   influenzae	   until	   more	   than	   two	  decades	   later	   (Pfeiffer,	   1892,	   Winslow	   et	   al.,	   1920).	   H.	   influenzae	   was	   first	  identified	   as	   the	   cause	   of	   meningitis	   in	   1911,	   while	   the	   involvement	   of	  capsulated	  strains	   in	  clinical	  manifestation	  of	  meningitis	  was	  characterised	  20	  years	  later	  (Wollstein,	  1911,	  Pittman,	  1931).	  	  	  Human	  is	  the	  only	  natural	  host	  of	  H.	  influenzae,	  where	  it	  is	  generally	  present	  as	  a	  commensal.	  However,	  H.	  influenzae	   can	  also	  act	  as	  a	  pathogen	   in	  susceptible	  individuals,	   who	   include	   infants,	   the	   elderly	   and	   immunocompromised	   adults	  (van	  Wessel	   et	   al.,	   2011).	   In	   addition,	   viral	   infections	   as	  well	   as	   diseases	   like	  chronic	   obstructive	   pulmonary	   disorder	   (COPD)	   and	   cystic	   fibrosis	   also	  predispose	  patients	  to	  infection	  with	  H.	  influenzae	  (Smith	  et	  al.,	  1976,	  Murphy	  et	  al.,	  2004,	  Cardines	  et	  al.,	  2012).	  	  
1.1.3	  Classification	  of	  H.	  influenzae	  
The	  pathogenicity	  and	   type	  of	  diseases	   caused	  by	  H.	  influenzae	   are	  dependent	  on	   the	   presence	   or	   absence	   of	   a	   capsule.	   This	   is	   a	   polysaccharide	   structure	  present	   outside	   the	   cell	   wall	   and	   acts	   as	   an	   important	   virulence	   factor	   in	  H.	  
influenzae	  (see	  section	  1.1.7).	  All	  typeable	  H.	  influenzae	  strains	  are	  encapsulated	  and	  classified	  based	  on	  the	  capsule	  structure	  (serotypes	  a-­‐f),	  with	  type	  b	  being	  the	  most	  historically	   important	   as	   a	   common	  aetiological	   agent	  of	   an	   invasive	  disease	  (Pittman,	  1931,	  Makela	  et	  al.,	  1992).	  Non-­‐typeable	  H.	  influenzae	  (NTHi)	  strains	   lack	   a	   capsule	   and	   are	   most	   frequently	   found	   as	   respiratory	   tract	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commensals,	  but	  also	  have	  the	  potential	  to	  cause	  local	  and	  invasive	  disease	  (see	  section	  1.1.3.2).	  	  	  
1.1.3.1	  H.	  influenzae	  type	  b	  
H.	   influenzae	   type	   b	   (Hib)	   used	   to	   be	   the	   most	   common	   cause	   of	   bacterial	  meningitis	   in	   infants	   and	   young	   children,	   as	   well	   as	   an	   important	   causative	  agent	   of	   diseases	   like	   epiglottitis,	   septic	   arthritis,	   pneumonia	   and	   generalised	  bacteraemia,	   before	   the	   introduction	   of	   an	   effective	   capsular	   polysaccharide	  vaccine	   (Makela	   et	   al.,	   1992).	   The	   initiation	   of	   Hib	   vaccine	   in	   the	   developed	  world	  in	  the	  late	  1980s	  and	  early	  1990s	  has	  resulted	  in	  a	  significant	  decrease	  in	  Hib	   carriage	   and	   the	   prevalence	   of	   Hib	   infections	   (Hargreaves	   et	   al.,	   1996,	  Agrawal	  and	  Murphy,	  2011).	  Routine	  Hib	  vaccination	  began	  in	  the	  UK	  in	  1992,	  which	  resulted	  in	  a	  decrease	  in	  over	  96%	  of	  confirmed	  cases	  of	  Hib	  infections	  in	  children	   by	   1999	   (Heath	   et	   al.,	   2000,	   Ladhani,	   2012).	   While	   there	   was	   an	  increase	   of	   Hib	   disease	   cases	   in	   the	   following	   few	   years,	   an	   improved	  vaccination	   programme	   resulted	   in	   the	   number	   of	   documented	   cases	   of	   the	  invasive	   Hib	   disease	   being	   reduced	   to	   30	   in	   England	   and	   Wales	   in	   2010	  (Ladhani,	  2012).	  	  In	   addition	   to	   the	  near	  elimination	  of	  Hib	  disease,	   there	  has	  been	  a	   change	   in	  those	  in	  the	  population	  who	  are	  most	  at	  risk	  of	  it:	  adults	  with	  comorbidities,	  as	  opposed	   to	   infants	   and	   young	   children,	   are	   now	   most	   commonly	   presenting	  with	   Hib	   infection	   in	   England	   and	   Wales,	   though	   the	   prevalence	   is	   very	   low	  (Collins	  et	  al.,	  2013).	  The	  Hib	  vaccine	  has	  also	  been	  increasingly	   introduced	  in	  the	  developing	  world,	  with	   similar	   successful	  outcomes	   (Lee	  et	   al.,	   2008).	  Hib	  still	  remains	  an	  important	  pathogen	  in	  the	  countries	  where	  Hib	  vaccination	  was	  never	   established,	   contributing	   to	   subsequent	   debilitating	   sequelae	   and	   high	  mortality	  rates	  (Ahmed	  et	  al.,	  2013).	  Other	  serotypes	  of	   typeable	  H.	  influenzae	  as	   well	   as	   non-­‐typeable	   strains	   can	   also	   cause	   invasive	   disease	   (Shuel	   et	   al.,	  2011,	  Golebiewska	  et	  al.,	  2016,	  Tsang	  et	  al.,	  2016).	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1.1.3.2	  NTHi	  NTHi	  is	  a	  common	  commensal	   in	  humans	  with	  the	  carriage	  rate	  reaching	  over	  60%	   in	   children	   and	   remaining	   high	   in	   adulthood	   (Farjo	   et	   al.,	   2004).	   The	  presence	  of	  a	  number	  of	  virulence	  factors	  allows	  it	  to	  cause	  disease	  in	  humans,	  though	  the	  exact	  mechanisms	  of	  the	  transition	  from	  commensal	  to	  a	  pathogenic	  state	  are	  still	  poorly	  understood	  (see	  section	  1.1.7).	  NTHi	  is	  a	  frequent	  causative	  agent	  of	  otitis	  media	  in	  infants	  and	  children,	  especially	  after	  the	  introduction	  of	  pneumococcal	   vaccination	   (Casey	   and	  Pichichero,	   2004,	  Agrawal	   and	  Murphy,	  2011).	  Otitis	  media	  is	  a	  very	  common	  disease	  in	  young	  children	  and,	  whilst	  the	  mortality	   is	   low,	   the	   possible	   sequelae	   make	   it	   a	   disease	   with	   a	   significant	  socioeconomic	   burden	   (Monasta	   et	   al.,	   2012).	   NTHi	   is	   also	   associated	   with	  respiratory	  tract	  infections	  (bronchitis	  and	  pneumonia)	  in	  infants,	  children	  and	  adults,	  and	  is	  linked	  to	  exacerbations	  of	  COPD	  (King,	  2012).	  	  	  NTHi	  is	  capable	  of	  causing	  invasive	  disease;	  high	  levels	  of	  invasive	  NTHi	  disease	  were	   observed	   in	   prematurely	   born	   infants	   and	   older	   adults	   (>65	   year	   old)	  (Dworkin	  et	  al.,	  2007,	  van	  Wessel	  et	  al.,	  2011).	  Small	  nosocomial	  outbreaks	  of	  virulent	   NTHi	   have	   also	   been	   reported,	   particularly	   among	   elderly	   patients	  (Yang	   et	   al.,	   2010,	   Andersson	   et	   al.,	   2015).	   It	   remains	   unclear	   whether	   the	  introduction	  of	   the	  Hib	  vaccine	  has	   lead	  to	  an	   increase	   in	   the	  number	  of	  NTHi	  cases	  as	  well	  as	  a	  shift	  towards	  NTHi	  causing	  more	  invasive	  disease,	  as	  several	  studies	  give	  conflicting	  evidence	  on	  this	  matter	  (O'Neill	  et	  al.,	  2003,	  McConnell	  et	  al.,	  2007,	  Kalies	  et	  al.,	  2009,	  Agrawal	  and	  Murphy,	  2011).	  This	  suggests	  that	  a	  more	   careful	   monitoring	   of	   the	   potentially	   increasing	   clinical	   threat	   of	   NTHi	  must	  be	  undertaken.	  	  	  
1.1.4	  Antibiotic	  resistance	  
A	   significant	   contribution	   to	   the	   clinical	   importance	   of	   H.	   influenzae	   is	   its	  resistance	   to	   various	   antibiotics,	   particularly	   to	  beta-­‐lactams.	  They	   are	  broad-­‐range	   antibiotics	   that	   possess	   a	   beta-­‐lactam	   ring,	   which	   act	   by	   inhibiting	  bacterial	  cell	  wall	  synthesis.	  A	  large	  number	  of	  H.	  influenzae	  strains	  containing	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ROB-­‐1	   and	   TEM	   beta-­‐lactamases	   have	   been	   identified	   (Scriver	   et	   al.,	   1994).	  These	  are	  enzymes	  that	  hydrolyse	  the	  beta-­‐lactam	  ring	  and	  thereby	  deactivate	  beta-­‐lactam	   antibiotics.	   High	   rates	   of	   beta-­‐lactamase	   negative	   ampicillin	  resistant	   (BLNAR)	   strains,	  with	   a	   different	   beta-­‐lactam	   resistance	  mechanism,	  have	  also	  been	  reported	   in	  USA	  and	   Japan	  (Hasegawa	  et	  al.,	  2004,	  Shuel	  et	  al.,	  2011).	   BLNAR	   strains	   are	   resistant	   to	   beta-­‐lactam	   antibiotics	   due	   to	   the	  modification	   of	   their	   penicillin-­‐binding	   proteins	   rather	   than	   an	   enzymatic	  action.	   Some	   strains	   have	   been	   shown	   to	   possess	   both	   mechanisms	   of	   beta-­‐lactam	   resistance	   and	   are	   termed	   beta-­‐lactamase-­‐positive	   amoxicillin-­‐clavulanate-­‐resistant	  (BLPACR)	  (Matic	  et	  al.,	  2003).	  	  	  Resistance	  to	  quinolones,	  which	  act	  to	  inhibit	  DNA	  replication	  via	  binding	  to	  the	  DNA	  gyrase	  or	  topoisomerase	  IV,	  is	  rare	  in	  H.	  influenzae	  and	  yet	  highly	  resistant	  strains	  have	  been	  reported	  (Rodriguez-­‐Martinez	  et	  al.,	  2006).	  Both	  intrinsic	  and	  mobile	  genetic	  element-­‐encoded	  resistance	  to	  chloramphenicol,	  macrolides,	  and	  tetracyclines	   (that	   inhibit	   protein	   synthesis	   via	  different	  modes	  of	   action)	  has	  been	   described	   as	   well,	   although	   not	   to	   the	   same	   extent	   as	   to	   beta-­‐lactam	  antibiotics	  (Tristram	  et	  al.,	  2007).	  	  	  Multi-­‐drug	   resistant	   H.	   influenzae	   are	   consistently	   identified	   among	   clinical	  isolates,	   posing	   significant	   threat	   to	   current	   treatment	   strategies	   (Reis	   et	   al.,	  2002,	  Pfeifer	  et	  al.,	  2013,	  Skaare	  et	  al.,	  2014).	  Mobile	  genetic	  elements,	  such	  as	  integrative	  and	  conjugative	  elements	  (ICE),	  have	  in	  particular	  contributed	  to	  the	  increased	   spread	   of	   antibiotic	   resistance	   in	   naturally	   competent	  H.	   influenzae	  (Campos	   et	   al.,	   2003,	   Mohd-­‐Zain	   et	   al.,	   2004).	   The	   transfer	   of	   genetic	  information	   can	   also	   occur	   between	  H.	   influenzae	   and	   closely-­‐related	   species,	  such	   as	   Haemophilus	   haemolyticus	   and	   Haemophilus	   parainfluenzae,	  emphasising	   the	   need	   for	   an	   effective	   control	   of	   the	   transfer	   of	   antibiotic	  resistance	   among	  bacterial	   populations	   (Scheifele	   et	   al.,	   1982,	   Takahata	   et	   al.,	  2007,	  Sondergaard	  et	  al.,	  2015).	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1.1.5	  Rd	  KW20	  and	  R2866	  strains	  of	  H.	  influenzae	  
As	   of	   March	   2016,	   there	   are	   123	   whole-­‐genome	   sequences	   of	   H.	   influenzae	  strains,	  including	  16	  complete	  (without	  gaps	  in	  the	  sequence)	  genomes,	  on	  the	  National	   Centre	   for	   Biotechnology	   Information	   (NCBI)	   database	  (http://www.ncbi.nlm.nih.gov/genome/).	  These	  include	  strains	  of	  H.	  influenzae	  that	  have	  been	  extensively	  used	   for	   laboratory	  research	   in	   the	  past.	  Rd	  KW20	  (henceforward	  referred	  to	  as	  Rd),	  one	  of	  the	  two	  strains	  of	  H.	  influenzae	  used	  in	  this	   study,	   was	   isolated	   in	   mid-­‐1940s	   by	   culturing	   a	   type	   d	   strain	   of	   H.	  
influenzae	   and	   selecting	   a	   mutant	   that	   had	   lost	   the	   capsule	   (Alexander	   and	  Leidy,	  1951).	  Since	  then	  it	  has	  been	  propagated	  as	  a	  standard	  laboratory	  strain	  and	  was	   used	   as	   the	   representative	   strain	   of	  H.	   influenzae	   for	   whole-­‐genome	  sequencing	   in	   1995	   (Fleischmann	   et	   al.,	   1995).	   Rd	  was	   also	   the	   source	   of	   the	  first	  type	  II	  restriction	  enzyme	  HindII	  -­‐	   the	  work,	   for	  which	  Hamilton	  O.	  Smith	  was	  awarded	  the	  Nobel	  prize	  in	  1978	  (Smith	  and	  Wilcox,	  1970,	  Linn,	  1978).	  The	  other	  strain	  of	  H.	  influenzae	  used	  in	  this	  study,	  R2866,	  was	  isolated	  in	  1996	  from	  the	  blood	  of	  a	  30-­‐month	  old	  child	  with	  meningitis	  and	  has	  since	  been	  used	  as	  an	  exemplar	  of	  an	  invasive	  NTHi	  strain	  (Nizet	  et	  al.,	  1996).	  	  	  
1.1.5.1	  Phenotypic	  differences	  between	  Rd	  and	  R2866	  R2866,	  an	  invasive	  NTHi	  isolate,	  has	  significant	  phenotypic	  differences	  to	  Rd,	  a	  classic	   laboratory	   strain.	   The	   major	   difference	   is	   an	   increased	   resistance	   of	  R2866	  to	  the	  human	  serum	  (Erwin	  et	  al.,	  2005).	  This	  has	  been	  attributed	  to	  the	  expression	   of	   a	   glycosyltransferase	   gene,	   lgtC,	   responsible	   for	  modulating	   the	  composition	  of	  lipooligosaccharide	  (LOS)	  (see	  section	  1.1.7)	  (Erwin	  et	  al.,	  2006).	  The	   ability	   of	   R2866	   to	   circumvent	   the	   complement	   cascade	   by	   delaying	   the	  deposition	  of	  the	  C3	  component	  has	  also	  been	  linked	  to	  an	  increased	  survival	  in	  the	   human	   serum	   (Williams	   et	   al.,	   2001).	   In	   addition,	   different	   growth	   rates	  have	  been	  observed	  for	  Rd	  and	  R2866	  grown	  at	  pH	  6.8,	  7.0	  and	  8.0	  (Ishak	  et	  al.,	  2014).	   Comparing	   the	   transcriptional	   response	   to	   iron	   starvation	   has	   also	  revealed	   differences	   in	   the	   iron-­‐regulated	   genes	   between	   these	   two	   strains	  (Whitby	  et	  al.,	  2009).	  	  
	  	   9	  
1.1.5.2	  Genetic	  differences	  between	  Rd	  and	  R2866	  The	  availability	  of	  whole-­‐genome	  sequencing	  provides	  the	  basis	  for	  determining	  genetic	   evidence	   for	   phenotypic	   differences.	   Rd	   and	   R2866	   differ	   in	   their	  genome	   size	   by	   0.1	   Mb,	   as	   inferred	   from	   the	   NCBI	   database	   (see	   Table	   1.2).	  Consequently,	   these	   strains	   also	   have	   a	   different	   number	   of	   genome	   features,	  with	   Rd	   having	   1,610	   and	   R2866	   having	   1,796	   protein-­‐coding	   genes.	  Interestingly,	  despite	  having	  a	  smaller	  genome,	  Rd	  is	  found	  to	  possess	  a	  larger	  number	  of	  pseudogenes	  than	  R2866.	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Table	  1.2:	  Whole-­‐genome	  sequence	   features	  of	  Rd	  and	  R2866	   strains,	   as	  
inferred	  from	  the	  NCBI	  database.	  
Genome	  feature	   Rd	   R2866	  Genome	  size	  (Mb)	   1.83	   1.93	  GC	  content	  (%)	   38.2	   38.1	  Number	  of	  genes	   1,765	   1,900	  Number	  of	  protein-­‐coding	  genes	   1,610	   1,796	  Number	  of	  pseudogenes	   67	   22	  Number	  of	  ribosomal	  RNAs	  (rRNAs)	   19	   19	  Number	  of	  transfer	  RNAs	  (tRNAs)	   58	   59	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1.1.5.2.1	  Core	  and	  accessory	  genomes	  of	  Rd	  and	  R2866	  The	  accessory	  genome	  of	  a	  set	  of	  bacterial	  strains	  or	  species	  represents	  genes	  that	   are	   present	   in	   some	   members	   of	   that	   set,	   but	   not	   in	   others.	   This	   is	   in	  contrast	  to	  the	  core	  genome,	  which	  is	  a	  subset	  of	  genes	  present	  in	  all	  compared	  strains	  or	  species.	  Core	  and	  accessory	  genomes	  were	  previously	  calculated	  for	  13	   strains	   of	  H.	   influenzae	   in	   a	   pairwise	  manner	   (Hogg	   et	   al.,	   2007).	   The	   core	  genome	  of	  Rd	  and	  R2866	  was	  found	  to	  contain	  1,576	  genes.	  The	  Rd	  strain	  was	  shown	   to	   possess	   extra	   134	   genes,	   while	   R2866	   had	   extra	   259	   genes.	   Rd	  contains	  a	  urease	  locus,	  which	  in	  the	  R2866	  strain	  is	  replaced	  by	  mtrF	  -­‐	  a	  gene	  linked	   to	   antimicrobial	   resistance	   (Veal	   and	   Shafer,	   2003,	   Erwin	   et	   al.,	   2005).	  R2866,	   unlike	   Rd,	   possesses	   a	   tryptophanase	   locus,	   which	   is	   responsible	   for	  indole	   production	   and	   has	   been	   used	   for	   biotyping	   of	   H.	   influenzae,	   due	   its	  association	  with	  an	  invasive	  phenotype	  (Kilian,	  1976,	  Martin	  et	  al.,	  1998).	  	  	  A	  general	   feature	  of	  any	  accessory	  genome	  is	  the	  abundance	  of	  mobile	  genetic	  elements	   (Kung	   et	   al.,	   2010,	   Jackson	   et	   al.,	   2011).	   This	   provides	   the	   bacterial	  species	  with	  a	  pool	  of	  available	  genes	  for	  the	  transfer	  between	  different	  strains,	  potentially	   conferring	  new	  advantages,	   such	  as	   antibiotic	   resistance	   (Elwell	   et	  al.,	  1975).	  The	  presence	  of	  a	  53-­‐kb	  ICE,	  homologous	  to	   ICEHin1056,	  as	  well	  as	  bacteriophage	   HP2	   has	   been	   described	   in	   the	   R2866	   strain,	   but	   not	   in	   Rd	  (Williams	  et	  al.,	  2002,	  Hogg	  et	  al.,	  2007,	  Juhas	  et	  al.,	  2007).	  	  
1.1.6	  H.	  influenzae	  as	  a	  model	  organism	  
Due	   to	   its	   relatively	   small	   genome,	   genetic	   manipulability	   and	   close	  phylogenetic	  distance	  to	  Escherichia	  coli,	  H.	  influenzae	  has	  been	  a	  popular	  model	  organism	   for	   various	   microbiology	   studies	   (Evers	   et	   al.,	   1998,	   Kolker	   et	   al.,	  2003).	  The	  availability	  of	  a	   complete	  genome	  sequence	   for	   the	  Rd	  strain	   from	  the	  mid-­‐1990s	  made	  H.	  influenzae	   an	  even	  more	  attractive	  model	   for	  genomic	  studies	   (Fleischmann	   et	   al.,	   1995).	   However,	   the	   original	   isolation	   of	   the	   Rd	  strain	  in	  the	  mid-­‐1940s	  and	  its	  subsequent	  propagation	  in	  different	  laboratories	  over	   several	   decades	   might	   have	   lead	   to	   its	   significant	   genetic	   divergence	  (Alexander	  and	  Leidy,	  1951).	  Current	  descendants	  of	  the	  original	  Rd	  strain	  have	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likely	   accumulated	   a	   number	   of	   mutations,	   leading	   to	   small	   but	   possibly	  relevant	  changes	  in	  the	  behaviour	  of	  this	  strain.	  It	  is	  possible	  that	  the	  Rd	  strain,	  originally	   sequenced	   in	   1995,	   is	   genetically	   and	   phenotypically	   different	   to	  other	  Rd	  descendants	  present	   in	  other	   laboratories	  (Fleischmann	  et	  al.,	  1995).	  The	  phenotypic	  differences	  in	  the	  same	  strain	  from	  different	  laboratories	  have	  been	   documented	   previously	   in	   E.	   coli,	   highlighting	   the	   accumulation	   of	  variations	  within	  the	  same	  strain	  over	  time	  (Soupene	  et	  al.,	  2003).	  	  	  
1.1.7	  Virulence	  of	  H.	  influenzae	  
Virulence	   factors	   are	   pathogen-­‐produced	   products,	   which	   facilitate	   the	  establishment	   and	   progression	   of	   disease.	   Both	   typeable	   and	   non-­‐typeable	  H.	  
influenzae	   strains	   contain	   virulence	   factors	   that	   promote	   infection.	   The	  presence	   of	   a	   capsule,	   especially	   in	   type	   b	   strains,	   significantly	   contributes	   to	  the	   ability	   of	   typeable	   strains	   to	   invade	   and	   persist	   in	   the	   bloodstream,	   by	  increasing	  bacterial	  resistance	  to	  the	  action	  of	  complement	  (Moxon	  and	  Vaughn,	  1981,	   Sutton	   et	   al.,	   1982).	   NTHi	   strains	   have	   also	   been	   shown	   to	   invade	   the	  bloodstream	   and	   cause	   invasive	   disease,	   meaning	   that	   they	   utilise	   different	  virulence	  factors	  to	  achieve	  this	  (O'Neill	  et	  al.,	  2003).	  	  	  In	  order	  to	  cause	  invasive	  or	  localised	  disease,	  H.	  influenzae	  needs	  to	  be	  able	  to	  circumvent	   mucosal	   barriers,	   evade	   host	   immune	   response	   and	   successfully	  adhere	  to	  the	  host	  epithelium.	  For	  that	  purpose,	  H.	  influenzae	  produces	  different	  virulence	   factors,	   aiding	   in	   establishment	   and	   development	   of	   disease,	   which	  are	   summarised	   in	   Table	   1.3.	   Novel	   virulence	   factors	   still	   continue	   to	   be	  discovered	  in	  H.	  influenzae,	  such	  as	  msf,	  a	  recently	  characterised	  gene	  associated	  with	  an	  intracellular	  survival	  in	  macrophages	  (Kress-­‐Bennett	  et	  al.,	  2016).	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Table	  1.3:	  Summary	  of	  major	  virulence	  factors	  in	  H.	  influenzae.	  
Virulence	  factor	   Role	  in	  H.	  influenzae	   Reference	  
Polysaccharide	  capsule	   Invasion,	  persistence	  in	  the	  bloodstream,	  competence	  evasion	   (Moxon	  and	  Vaughn,	  1981,	  Sutton	  et	  al.,	  1982)	  
LOS	   Adhesion,	  invasion,	  immune	  evasion,	  damage	  to	  host	   (Johnson	  and	  Inzana,	  1986,	  Swords	  et	  al.,	  2000)	  
Pili	  (fimbriae)	   Adherence	  to	  nasopharyngeal	  tissue	  and	  respiratory	  mucus	   (Loeb	  et	  al.,	  1988,	  Kubiet	  et	  al.,	  2000)	  
High	  molecular	  weight	  adhesins	  HMW1	  and	  HMW2	   Adherence	  to	  host	  epithelium	   (St	  Geme	  et	  al.,	  1993)	  
Protein	  E	   Adherence	  to	  components	  of	  the	  extracellular	  matrix	  (ECM)	   (Singh	  et	  al.,	  2010)	  
Proteins	  P2	  and	  P5	   Adherence	  to	  respiratory	  mucus	   (Reddy	  et	  al.,	  1996)	  
Autotransporter	  Hia	   Adherence	  to	  host	  epithelium	   (Barenkamp	  and	  St	  Geme,	  1996,	  St	  Geme	  and	  Cutter,	  2000)	  
Autotransporter	  Hap	   Adherence	  to	  host	  epithelium	  and	  components	  of	  the	  ECM	   (St	  Geme	  et	  al.,	  1994,	  Fink	  et	  al.,	  2002)	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H.	   influenzae	   was	   among	   the	   first	   bacteria	   where	   simple	   sequence	   repeats	  (SSRs),	   associated	   with	   phenotype	   switching	   of	   cell	   surface	   structures,	   were	  reported	  (Weiser	  et	  al.,	  1989).	  They	  are	  1-­‐8	  base	  pair	  (bp)	   long	  hypermutable	  tandem	  repeats;	  regions	  containing	  them	  have	  been	  defined	  as	  simple	  sequence	  contingency	   loci	   (Bayliss	   et	   al.,	   2001).	   SSRs	   contribute	   to	   virulence	   through	  facilitating	   phase	   variation	   -­‐	   a	   process	   of	   reversible	   phenotypic	   change.	   SSRs	  appear	   in	   open	   reading	   frames	   and	   promoter	   regions	   of	   important	   virulence-­‐associated	  contigency	   loci	   in	  H.	  influenzae.	  These	   include	  several	  genes	  coding	  for	  pilin	  subunits,	  adhesins	  HMW1	  and	  HMW2,	  several	  LOS-­‐associated	  genes	  as	  well	  as	  a	  restriction-­‐modification	  gene,	  mod	  (Weiser	  et	  al.,	  1989,	  van	  Ham	  et	  al.,	  1993,	  Dawid	  et	  al.,	  1999,	  De	  Bolle	  et	  al.,	  2000).	  The	  phase	  variation	  of	  the	  latter	  gene	  induces	  global	  changes	  in	  gene	  expression	  in	  H.	  influenzae	  (Srikhanta	  et	  al.,	  2005).	   Ability	   to	   switch	   between	   different	   phenotypes	   provides	  H.	   influenzae	  with	  a	  more	  effective	  niche	  colonisation	  and	  persistence,	  thus	  contributing	  to	  its	  pathogenesis.	  	  
1.1.8	  Stress	  response	  in	  H.	  influenzae	  
H.	  influenzae	   is	   likely	   to	  encounter	  a	  variety	  of	  stresses	  during	   infection	  of	   the	  host,	   including	   nutrient	   limitation	   and	   host	   immune	   response.	   Bacterial	  adaptation	   to	   these	   stresses	   ensures	   successful	   colonisation	   and	   subsequent	  disease	   progression.	   When	   DNA	   damage	   is	   inflicted,	   bacteria	   respond	   by	  inducing	   their	   "SOS"	   regulon,	   which	   largely	   contains	   genes	   involved	   in	   DNA	  repair	  (Radman,	  1975).	  The	  SOS	  response	  has	  been	  described	  in	  H.	  influenzae	  as	  well,	  mediated	  by	   the	   transcriptional	   repressor	  LexA	   (Sweetman	  et	   al.,	   2005).	  The	  expression	  of	  five	  genes	  recA,	  recN,	  recX,	  ruvA	  and	   lexA,	  with	  roles	  in	  DNA	  repair	  and	  recombination,	  was	  induced	  as	  part	  of	  this	  response	  in	  H.	  influenzae	  (Sweetman	   et	   al.,	   2005).	   Other	   important	   stress	   response	   pathways	   in	   H.	  
influenzae	  are	  discussed	  below.	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1.1.8.1	  Oxidative	  stress	  Reactive	  oxygen	  species	  (ROS)	  are	  generated	  as	  part	  of	  normal	  cell	  metabolism	  in	   living	   cells	   and	   cause	   damage	   to	   DNA,	   proteins	   and	   other	   biomolecules	  (Gonzalez-­‐Flecha	  and	  Demple,	  1995,	  Tamarit	  et	  al.,	  1998,	  O'Rourke	  et	  al.,	  2003).	  
H.	   influenzae	   has	   evolved	   to	   deal	   with	   this	   oxidative	   stress	   in	   a	   variety	   of	  mechanisms,	  as	  it	  needs	  to	  combat	  ROS	  generated	  by	  the	  host	  immune	  system,	  its	   own	   aerobic	   respiration	   and	   co-­‐pathogens,	   such	   as	   Streptococcus	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1.1.8.1.1	  Regulation	  of	  oxidative	  stress	  response	  OxyR	   has	   been	   described	   as	   a	   major	   bacterial	   regulator	   of	   oxidative	   stress	  response	   (Zheng	  et	   al.,	   2001).	   In	   the	  H.	  influenzae	  strain	  86-­‐028NP,	  OxyR	  was	  shown	  to	  regulate	  the	  expression	  of	  11	  genes,	  most	  of	  which	  play	  a	  role	  in	  the	  defence	   against	   oxidative	   stress	   (Harrison	   et	   al.,	   2007).	   Mutation	   of	   the	   oxyR	  gene	   in	  H.	  influenzae	   resulted	   in	   increased	  sensitivity	   to	  hydrogen	  peroxide	  as	  well	  as	  decreased	  fitness	  and	  virulence	  in	  a	  rat	  model	  of	  H.	  influenzae	  infection	  (Whitby	  et	  al.,	  2012).	  	  	  The	   two-­‐component	  system	  ArcAB	   is	  another	   regulator	   that	   is	   involved	   in	   the	  response	   to	   oxidative	   stress	   in	   H.	   influenzae,	   particularly	   during	   anaerobic	  growth	  (Wong	  et	  al.,	  2007).	  It	  was	  shown	  to	  regulate	  the	  expression	  of	  the	  dps	  gene,	  encoding	  a	  ferritin-­‐like	  protein,	  which	  protects	  against	  oxidative	  stress	  by	  sequestering	   free	   ferrous	   iron	   (see	   section	   1.1.8.2)	   (Wong	   et	   al.,	   2007).	  Interestingly,	  dps	  is	  also	  part	  of	  the	  OxyR	  regulon	  in	  H.	  influenzae	  and	  is	  known	  to	  bind	  DNA	  protecting	  it	  from	  oxidative	  damage	  in	  E.	  coli	  (Martinez	  and	  Kolter,	  1997,	   Harrison	   et	   al.,	   2007).	   The	   importance	   of	   dps	   in	   the	   defence	   against	  oxidative	   stress	   was	   further	   demonstrated	   by	   an	   increased	   sensitivity	   of	   H.	  
influenzae	   to	   hydrogen	   peroxide	   in	   a	   dps	   knockout	   mutant	   (Harrison	   et	   al.,	  2015).	  	  	  The	   ArcAB	   system	   has	   been	   found	   to	   be	   protective	   against	   the	   bactericidal	  activity	   of	   the	   human	   serum	   by	   regulating	   resistance	   to	   complement,	   which	  highlights	   its	   role	   in	   the	   survival	   of	  H.	   influenzae	   within	   the	   human	   host	   (De	  Souza-­‐Hart	  et	  al.,	  2003,	  Wong	  et	  al.,	  2011).	  The	  fumarate-­‐nitrate	  transcriptional	  regulator	  (FNR)	  has	  also	  been	  shown	  to	  play	  a	  role	  in	  defence	  against	  oxidative	  stress,	  with	  manganese-­‐associated	   superoxide	   dismutase	   (SOD)	   likely	   being	   a	  part	  of	  its	  regulon	  (Kroll	  et	  al.,	  1993,	  Jiang	  et	  al.,	  2016a).	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1.1.8.1.2	  SOD	  SOD	   is	   the	   main	   enzyme	   for	   protecting	   the	   cell	   against	   superoxide-­‐related	  stress,	  which	  is	  an	  unavoidable	  consequence	  of	  aerobic	  respiration.	  Out	  of	  four	  known	  types	  of	  SODs,	  H.	  influenzae	  has	  only	  been	  shown	  to	  possess	  a	  functional	  manganese-­‐associated	   SOD	   (Kroll	   et	   al.,	   1993).	   The	   gene	   sodC,	   coding	   for	  copper-­‐zinc	   SOD,	   is	   present	   in	   some	   capsulated	   H.	   influenzae,	   although	   the	  enzyme	  itself	   is	  not	   functional	  (Kroll	  et	  al.,	  1991).	  Neither	  nickel	  nor	   iron	  SOD	  has	  been	  identified	  in	  H.	  influenzae	  to-­‐date.	  	  	  
1.1.8.1.3	  Catalase	  Catalase	   is	   a	   key	   enzyme	   responsible	   for	   scavenging	   hydrogen	   peroxide	   from	  the	  cell.	  In	  H.	  influenzae	  it	  is	  encoded	  by	  the	  hktE	  gene,	  which	  is	  part	  of	  the	  OxyR	  regulon	  (Harrison	  et	  al.,	  2007).	  Catalase	  activity	  in	  H.	  influenzae	  was	  found	  to	  be	  lower	   during	   stationary	   growth	   phase	   when	   compared	   to	   exponential	   phase,	  which	  is	  contrary	  to	  catalase	  activity	  in	  E.	  coli	  (Loewen	  and	  Triggs,	  1984,	  Bishai	  et	   al.,	   1994).	   It	  was	   also	   the	  most	   up-­‐regulated	   gene	   in	   response	   to	   hydrogen	  peroxide	   in	   the	  86-­‐028NP	  strain	  (Harrison	  et	  al.,	  2007).	   It	  has	  been	  suggested	  that	   catalase	   is	   more	   effective	   when	   dealing	   with	   high	   concentrations	   of	  hydrogen	  peroxide,	  whereas	  other	  antioxidants,	  such	  as	  PgdX,	  are	  more	  efficient	  at	   scavenging	   low	   concentrations	   (Vergauwen	   et	   al.,	   2001,	   Vergauwen	   et	   al.,	  2003a,	  Pauwels	  et	  al.,	  2004).	  	  	  
1.1.8.1.4	  PgdX	  and	  glutathione	  PgdX	  is	  a	  glutathione-­‐dependent	  peroxiredoxin-­‐glutaredoxin	  and	  it	  was	  shown	  to	   play	   an	   important	   role	   in	   protecting	  H.	   influenzae	   against	   oxidative	   stress	  during	  stationary	  phase,	  when	  catalase	  is	  being	  down-­‐regulated	  (Pauwels	  et	  al.,	  2004).	   Interestingly,	   a	  PgdX	  mutant	  was	  more	   resistant	   to	  hydrogen	  peroxide	  stress	   due	   to	   an	   increased	   activity	   of	   catalase,	   highlighting	   the	   evolved	  compensatory	  oxidative	  stress	  control	  mechanisms	  in	  H.	  influenzae	  (Pauwels	  et	  al.,	   2004,	   Harrison	   et	   al.,	   2015).	   Both	   PgdX	   and	   catalase	   are	   the	   two	   major	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scavengers	  of	  hydrogen	  peroxide	   in	  H.	  influenzae	   as	   shown	  by	   the	  diminished	  resistance	  of	  double	  mutants	  to	  hydrogen	  peroxide	  (Vergauwen	  et	  al.,	  2006).	  	  	  The	   activity	   of	   PgdX	   is	   reliant	   on	   the	   presence	   of	   glutathione,	   which	   was	  demonstrated	  by	  the	  sensitivity	  of	  a	  catalase	  mutant	  of	  H.	  influenzae	  to	  oxidative	  stress	  when	  grown	  in	  a	  medium	  lacking	  glutathione	  (Vergauwen	  et	  al.,	  2003a).	  Glutathione	   is	   a	   thiol	   molecule	   involved	   in	   the	   protection	   against	   hydrogen	  peroxide	   in	   both	   prokaryotes	   and	   eukaryotes.	   H.	   influenzae	   lacks	   the	   gene	  encoding	   glutathione,	   but	   possesses	   genes	   required	   for	   the	   import	   of	  extracellular	   glutathione	   and	   its	   subsequent	   metabolism	   (Vergauwen	   et	   al.,	  2003b).	   The	   presence	   of	   a	   large	   number	   of	   genes	   directly	   involved	   in	   the	  protection	   against	   oxidative	   stress	   in	   a	   relatively	   small	  H.	   influenzae	   genome	  emphasises	   the	   importance	   of	   these	   overlapping	   defence	  mechanisms	   for	   the	  organism.	  	  	  
1.1.8.2	  Iron-­‐mediated	  oxidative	  stress	  
H.	   influenzae	   has	   a	   growth	   requirement	   for	   haem,	   which	   is	   produced	   by	  ferrochelatase	  enzyme	  combining	   iron	  and	  protoporphyrin	   IX	   (PPIX)	   (Granick	  and	   Gilder,	   1946).	   However,	   H.	   influenzae	   does	   not	   have	   enzymes	   for	   the	  biosynthesis	  of	  PPIX,	  meaning	  that	  the	  haem	  requirement	  must	  be	  satisfied	  by	  other	   means	   (White	   and	   Granick,	   1963).	   For	   that	   purpose,	   H.	   influenzae	   has	  evolved	   different	   mechanisms	   to	   salvage	   extracellular	   haem,	   PPIX	   and	   iron	  molecules.	  Iron	  uptake	  must	  be	  carefully	  controlled	  by	  H.	  influenzae,	  as	  there	  is	  a	  clear	  link	  between	  oxidative	  stress	  and	  free	  intracellular	  ferrous	  iron	  (Touati,	  2000).	   Ferrous	   iron	   interacts	   with	   hydrogen	   peroxide	   and	   generates	   free	  hydroxyl	  radicals	  through	  the	  Fenton	  reaction	  (see	  Figures	  1.1;	  1.2).	  Thus	   it	   is	  critical	   for	   bacteria	   like	  H.	   influenzae	   to	   carefully	   balance	   the	   necessary	   iron	  uptake	  against	  harmful	  oxidative	  effects.	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Figure	  1.2:	  A	  schematic	  of	  the	  Fenton	  reaction,	  induced	  by	  oxidative	  stress	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1.1.8.2.1	  Regulation	  of	  iron	  homeostasis	  The	   Ferric	   Uptake	   Regulator	   (Fur)	   is	   a	   transcriptional	   repressor	   of	   genes	  responsible	  for	  iron	  uptake	  into	  the	  cell.	  In	  E.	  coli	  it	  is	  regulated	  by	  OxyR,	  which	  highlights	  the	  close	  relationship	  between	  iron	  homeostasis	  and	  oxidative	  stress	  (Zheng	  et	  al.,	  1999).	  Despite	  not	  being	  part	  of	  OxyR	  regulon	  in	  H.	  influenzae,	  Fur	  still	  plays	  an	  important	  role	  in	  the	  defence	  against	  oxidative	  stress.	  Fur	  mutants	  were	  shown	  to	  have	  increased	  sensitivity	  to	  hydrogen	  peroxide	  (Harrison	  et	  al.,	  2015).	  This	  can	  be	  explained	  by	  the	  Fur-­‐related	  loss	  of	  iron	  homeostasis,	  which	  leads	   to	   increased	   intracellular	   levels	   of	   ferrous	   iron	   and	   generation	   of	  more	  hydroxyl	  radicals	  through	  the	  Fenton	  reaction	  (see	  Figure	  1.2).	  	  	  Interestingly,	   several	   iron	   uptake	   genes	   were	   up-­‐regulated	   upon	   hydrogen	  peroxide	   treatment	   in	   the	   86-­‐028NP	   strain	   (Harrison	   et	   al.,	   2007).	   This	   could	  possibly	  be	  due	  to	  the	  need	  to	  repair	  proteins	  containing	  iron-­‐sulphur	  clusters	  damaged	  by	  oxidative	  stress,	  revealing	  the	  complexity	  of	  the	  interplay	  between	  iron	  homeostasis	  and	  oxidative	  stress	  defence	   (Flint	  et	  al.,	  1993).	  Ferritin	  and	  transferrin-­‐like	   proteins	   are	   responsible	   for	   iron	   sequestration,	   and	   thus	   can	  protect	   the	   cell	   from	   accumulating	   free	   ferrous	   iron.	   Genes	   encoding	   such	  proteins	  have	   indeed	  been	  found	  to	  be	  up-­‐regulated	  during	  oxidative	  stress	   in	  
H.	  influenzae	  (Harrison	  et	  al.,	  2007).	  Double	  mutants	  of	  Fur	  and	  ferritin-­‐like	  Dps	  in	   H.	   influenzae	   also	   showed	   very	   high	   sensitivity	   to	   hydrogen	   peroxide	  treatment,	  again	  emphasising	  a	  critical	  role	  that	  iron	  homeostasis	  plays	  during	  oxidative	  stress	  (Harrison	  et	  al.,	  2015).	  	  
1.1.8.3	  Iron-­‐starvation	  stress	  
H.	   influenzae	   is	   likely	   to	   reside	   within	   an	   iron-­‐restricted	   environment	   during	  colonisation	   and	   infection	   of	   the	   human	   host,	   hence	   it	   needs	   to	  maximise	   its	  ability	   to	   acquire	   any	   available	   iron.	  H.	   influenzae	  has	   a	   range	   of	   overlapping	  mechanisms	  for	  iron	  uptake,	  the	  majority	  of	  which	  are	  regulated	  by	  Fur.	  The	  Fur	  regulon	  was	  described	  in	  the	  86-­‐028NP	  strain	  of	  H.	  influenzae	  and	  contains	  73	  proteins	   (Harrison	   et	   al.,	   2013).	   These	   include	   HitABC	   and	   HfeABCD	   iron	  transport	  systems,	  heme-­‐binding	  proteins	  HxuABC,	  transferrin-­‐binding	  proteins	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TbpA	   and	   TbpB,	   a	   hemoglobin-­‐haptoglobin	   binding	   protein	   HgpB,	   and	   a	  transmembrane	  protein	  TonB.	  The	  latter	  in	  particular	  plays	  a	  critical	  part	  in	  the	  iron	  uptake	  in	  H.	  influenzae	  as	  many	  of	  the	  surface-­‐bound	  receptors,	  which	  are	  responsible	   for	   iron	   transport,	   function	   via	   a	   TonB-­‐dependent	   mechanism	  (Postle,	   1990,	   Jarosik	   et	   al.,	   1994,	   Jarosik	   et	   al.,	   1995).	   In	   addition,	   the	  expression	   of	   an	   fhu	   operon	   allows	  H.	   influenzae	   to	   acquire	   iron	   through	   the	  utilisation	  of	  extracellular	  siderophores,	  which	  are	  small	   iron-­‐binding	  proteins	  secreted	  by	  other	  bacteria	  (Morton	  et	  al.,	  2010).	  	  	  Several	   transcriptomic	   studies	   using	   microarrays	   have	   been	   performed	   to	  determine	  the	  response	  of	  H.	  influenzae	   to	   iron-­‐starvation.	   In	   fact,	  a	  core	   iron-­‐responsive	   regulon	   has	   been	   identified	   in	   five	   strains	   of	   H.	   influenzae	   -­‐	   Rd,	  10180,	  R2866,	  R2846	  and	  86-­‐028NP	  (Whitby	  et	  al.,	  2006,	  Whitby	  et	  al.,	  2009,	  Whitby	   et	   al.,	   2013).	   The	   latter	   two	   strains	   were	   more	   sensitive	   to	   iron-­‐starvation	   than	   others	   (Whitby	   et	   al.,	   2013).	   As	   expected,	   core	   regulon	   genes	  that	   were	   up-­‐regulated	   during	   iron-­‐starvation	   stress	   encoded	   the	  aforementioned	   proteins	   with	   important	   roles	   in	   iron	   acquisition:	   HitABC,	  HxuABC,	  TbpAB	  and	  TonB.	  A	  similar	  gene	  expression	  pattern	  was	  observed	   in	  
H.	   influenzae	   in	   a	   chinchilla	   otitis	  media	  model,	   indicating	   an	   analogous	   iron-­‐starved	  environment	  (Whitby	  et	  al.,	  2013).	  There	  were	  also	  a	   large	  number	  of	  iron-­‐responsive	  non-­‐core	  genes	  specific	  to	  each	  H.	  influenzae	  strain,	  suggesting	  that	   these	   strains	   possess	   different	   affinities	   and	   adaptation	   techniques	   to	  environments	  within	  the	  human	  host.	  	  
1.1.9	  H.	  influenzae	  infection	  of	  human	  cells	  
H.	  influenzae	  is	  able	  to	  colonise	  and	  cause	  localised	  disease	  in	  a	  variety	  of	  niches	  within	  the	  human	  host,	  including	  the	  nasopharynx,	  middle	  ear	  and	  lung	  tissues.	  In	   addition,	   H.	   influenzae	   is	   capable	   of	   causing	   invasive	   disease	   after	  translocating	  across	  the	  epithelium	  and	  endothelium	  into	  the	  bloodstream.	  Cell	  culture	  models	  have	  been	  extensively	  used	   to	   study	  H.	   influenzae	   colonisation	  and	   infection	  processes.	  H.	  influenzae	  adheres	   to	  a	  number	  of	  different	  human	  cell	   types	   in	   vitro,	   including	   lung	   bronchial	   and	   alveolar	   epithelium,	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oropharyngeal	   epithelium,	   conjunctival	   epithelium	   and	   brain	   microvascular	  endothelium	  (St	  Geme	  and	  Falkow,	  1990,	  Holmes	  and	  Bakaletz,	  1997,	  Daines	  et	  al.,	  2003,	  Morey	  et	  al.,	  2011,	  Singh	  et	  al.,	  2016).	  	  	  
H.	  influenzae	  has	  been	  shown	  to	   invade	  both	  epithelial	  and	  endothelial	  human	  cell	  types,	  a	  process	  mediated	  by	  the	  human	  cytoskeleton	  (St	  Geme	  and	  Falkow,	  1990,	   Daines	   et	   al.,	   2003).	   Upon	   invasion,	  H.	   influenzae	   resides	   inside	   human	  cells	   in	   a	  non-­‐replicative	   state	  within	   endosome-­‐like	   compartments	   (Morey	  et	  al.,	   2011).	   The	   process	   of	   invasion	   likely	   has	   a	   significant	   contribution	   to	  persistence	  of	  H.	  influenzae	  during	  disease,	  aiding	   the	  evasion	  of	  host	   immune	  cells.	  	  	  There	   are	   notable	   differences	   in	   pathogenesis	   between	   typeable	  H.	   influenzae	  and	  NTHi,	  with	  the	  former	  being	  a	  lot	  more	  effective	  at	  causing	  invasive	  disease.	  In	   typeable	   strains	   the	   capsule	   is	   required	   to	   avoid	   phagocytosis	   by	  macrophages	  and	  resist	   the	  action	  of	  complement	   (Sutton	  et	  al.,	  1982,	  Noel	  et	  al.,	  1992).	   It	  has	  been	  proposed	  that	  the	   level	  of	  encapsulation	  changes	  during	  colonisation	  process,	  with	  the	  absence	  of	  capsule	   linked	  to	   increased	  adhesion	  and	   invasion,	   due	   to	   enhanced	   interaction	   of	   surface-­‐bound	   ligands	  with	   host	  receptors	   (St	  Geme	  and	  Falkow,	  1991,	  St	  Geme	  and	  Cutter,	  1996).	  This	  means	  that	   the	   capsule	   serves	   both	   as	   an	   asset	   and	   a	   hindrance	   to	   typeable	   H.	  
influenzae,	   proving	   that	   a	   careful	   modulation	   of	   encapsulation	   is	   required	  during	  infection.	  	  	  Due	   to	   complete	   absence	   of	   the	   capsule,	   NTHi	   strains	   are	   more	   efficient	   at	  adhesion	   and	   invasion	   than	   typeable	   strains.	   Despite	   NTHi	   primarily	   causing	  localised	   disease,	   its	   ability	   to	   adhere	   and	   invade	   human	   endothelial	   cells	  indicates	   its	  capacity	   to	  cause	   invasive	  disease	  through	  potential	   translocation	  into	   the	   bloodstream	   (Daines	   et	   al.,	   2004).	   The	   NTHi	   strain	   R2866	   has	   been	  reported	  to	  transcytose	  human	  epithelium,	  i.e.	  traverse	  across	  the	  interior	  of	  the	  cell	   and	   emerge	   on	   the	   opposite	   side	   to	   its	   entry	   (VanWagoner	   et	   al.,	   2016).	  There	   is	   also	  evidence	   for	  H.	  influenzae	   undergoing	  paracytosis	   -­‐	   a	  process	  by	  which	  bacteria	  pass	  between	  cells	  across	  the	  cell	   layer	  (van	  Schilfgaarde	  et	  al.,	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1995).	   This	   shows	   that	   typeable	   and	   non-­‐typeable	   H.	   influenzae	   strains	   all	  possess	   a	   variety	   of	   mechanisms	   to	   cause	   a	   diverse	   range	   of	   diseases	   in	   the	  human	  host.	  Interestingly,	  even	  the	  Rd	  strain,	  propagated	  in	  the	  laboratory	  for	  several	  decades,	  is	  still	  capable	  of	  adherence	  and	  invasion	  of	  both	  epithelial	  and	  endothelial	   cell	   types,	   suggesting	   its	   suitability	   as	   a	   model	   for	   H.	   influenzae	  virulence	  (Daines	  et	  al.,	  2003).	  	  	  
1.1.10	  Gene	  expression	  in	  H.	  influenzae	  
Gene	   expression	   in	   prokaryotes	   is	   controlled	   through	   transcriptional	   and	  translational	   regulation	   pathways	   in	   response	   to	   environment	   (Nogueira	   and	  Springer,	  2000,	  Balleza	  et	   al.,	   2009).	   Studying	  gene	  expression	   in	  bacteria	   can	  therefore	  shed	  light	  on	  their	  pathogenesis	  and	  potentially	  lead	  to	  the	  discovery	  of	  novel	  treatment	  strategies.	  A	  number	  of	  different	  methods	  have	  been	  used	  to	  explore	  gene	  expression	  in	  H.	  influenzae.	  Whole-­‐genome	  microarrays	  were	  used	  to	   investigate	   genes	   involved	   in	   iron	   homeostasis	   (Whitby	   et	   al.,	   2009).	   Real-­‐time	  quantitative	  polymerase	  chain	  reaction	  (RT-­‐qPCR)	  was	  utilised	  to	  explore	  the	   differential	   gene	   expression	   of	   H.	   influenzae	   and	   S.	   pneumoniae	   in	   a	   co-­‐culture	  as	  compared	  to	  monocultures	  (Cope	  et	  al.,	  2011).	  Northern	  blotting	  was	  used	   to	   study	   the	   effect	   of	   the	   presence	   of	   a	   glpTQ	   intergenic	   region	   on	   the	  expression	  of	  the	  flanking	  genes	  in	  H.	  influenzae	  (Song	  and	  Janson,	  2003).	  	  	  Since	   the	   advent	   of	   NGS,	   and	   RNA	   sequencing	   (RNA-­‐Seq)	   in	   particular,	   there	  have	   been	   several	   studies	   to-­‐date	   investigating	   the	  whole	   transcriptome	  of	  H.	  
influenzae	  (see	  section	  1.3.2)	  (Baddal	  et	  al.,	  2015).	  RNA-­‐Seq	  was	  used	  to	  study	  the	  response	  of	  strains	  Rd	  and	  86-­‐028NP	  to	  the	  changes	  in	  oxygen	  levels	  in	  the	  growth	   medium	   (Jiang	   et	   al.,	   2016a,	   Jiang	   et	   al.,	   2016b).	   The	   transcriptional	  responses	   of	   H.	   influenzae	   to	   glucocorticosteroid	   treatment	   and	   intracellular	  nickel	  were	  also	  determined	  (Earl	  et	  al.,	  2015,	  Tikhomirova	  et	  al.,	  2015a).	  Whole	  transcriptomes	   of	   Rd	   and	   otitis	   media	   strains	   of	  H.	   influenzae	   were	   explored	  during	  co-­‐culture	  with	  S.	  pneumoniae	  (Tikhomirova	  et	  al.,	  2015b).	  Finally,	  RNA-­‐Seq	  was	  used	  to	  describe	  the	  transcriptional	  response	  of	  R2846	  and	  a	  Hib	  strain	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to	   increased	   pH	   levels	   in	   the	   growth	   medium	   (Ishak	   et	   al.,	   2014).	   Further	  applications	   of	   RNA-­‐Seq	   to	   the	   study	   of	   the	   whole	   transcriptome	   of	   H.	  
influenzae,	   including	   the	   identification	   of	   small	   regulatory	   RNAs	   across	   the	  whole	   genome,	   would	   allow	   a	   deeper	   insight	   into	   genes	   and	   the	   regulatory	  network	   involved	   in	   the	   pathogenesis	   of	  H.	   influenzae	   and	   its	   adaption	   to	   the	  changes	  in	  the	  environment.	  	  
1.2	  Small	  RNAs	  in	  bacteria	  The	   first	   regulatory	   RNAs	   were	   identified	   in	   prokaryotes	   over	   three	   decades	  ago,	  although	  the	  actual	  complexity	  and	  significance	  of	  this	  regulatory	  system	  in	  bacteria	   has	   only	   begun	   to	   be	   appreciated	   in	   recent	   years	   (Tomizawa	   et	   al.,	  1981,	   Mizuno	   et	   al.,	   1984).	   These	   short,	   non-­‐coding,	   highly-­‐structured	   RNA	  transcripts	   (~50-­‐300	   nucleotides),	   termed	   small	   RNAs	   (sRNAs),	   are	  increasingly	   shown	   to	   have	   important	   regulatory	   and	   housekeeping	   roles	  (Waters	  and	  Storz,	  2009).	  The	  majority	  of	  sRNAs	  are	  non-­‐coding,	  though	  some	  encode	   small	   proteins.	   For	   example,	   RNA	   III,	   which	   is	   a	   functional	   sRNA	   in	  
Staphylococcus	  aureus,	  was	   also	   shown	   to	  possess	   a	  delta-­‐hemolysin-­‐encoding	  region	   (Benito	  et	  al.,	  2000).	  The	   first	   identified	  chromosomally-­‐encoded	  sRNA	  was	  MicF	   in	  E.	  coli,	  which	   silences	   the	   expression	   of	  ompF	   -­‐	   a	   porin-­‐encoding	  gene	  (Mizuno	  et	  al.,	  1984).	  A	  large	  number	  of	  sRNAs	  have	  been	  identified	  since	  then,	  with	   research	   efforts	   stimulated	   by	   the	   advent	   of	  RNA-­‐Seq	   (Mann	   et	   al.,	  2012).	  	  	  
1.2.1	  Types	  of	  sRNAs	  
There	  are	  several	  types	  of	  regulatory	  sRNAs,	  classified	  based	  on	  the	  method	  of	  regulatory	  function.	  Small	  RNAs	  may	  associate	  with	  complementary	  nucleic	  acid	  sequences	   in	   a	   base-­‐pairing	   manner	   either	   in	   cis	   or	   trans	   (see	   Figure	   1.3).	  Antisense	   transcripts	   that	   target	   the	  messenger	   RNA	   (mRNA)	   of	   genes	   in	   the	  same	  position	  but	  on	  the	  opposite	  strand	  of	  DNA	  are	  called	  cis-­‐sRNAs,	  whereas	  
trans-­‐sRNAs	   target	   the	  mRNA	  of	   genes	   that	   are	  elsewhere	   in	   the	  genome.	  Cis-­‐
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Figure	   1.3:	   The	   mechanisms	   of	   action	   of	   cis-­‐	   and	   trans-­‐acting	   bacterial	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Binding	  of	  base-­‐pairing	  sRNAs	   to	   the	   ribosomal	  binding	  site	  of	  mRNA	  directly	  interferes	   with	   the	   initiation	   of	   the	   translation	   process,	   as	   was	   originally	  proposed	   for	   the	   MicF	   sRNA	   in	   E.	   coli	   (Mizuno	   et	   al.,	   1984).	   In	   some	   cases,	  sRNAs	  positively	  affect	  mRNA	  translation	  by	  changing	  the	  secondary	  structure	  of	  the	  mRNA	  molecule	  and	  uncovering	  the	  ribosomal	  binding	  site,	  as	  was	  shown	  for	  RNA	  III	  in	  S.	  aureus	  (Morfeldt	  et	  al.,	  1995).	  Alternatively,	  base-­‐pairing	  sRNAs	  can	  bind	   in	   the	  protein-­‐coding	   region	  of	   the	  mRNA,	   leading	   to	   its	  degradation	  (Pfeiffer	   et	   al.,	   2009).	   Some	   sRNAs	   even	   associate	  with	   proteins	   and	   regulate	  their	  activity.	  A	  good	  example	  of	  this	  is	  6S	  RNA.	  It	  regulates	  gene	  expression	  in	  
E.	   coli	   via	   interaction	   with	   the	   sigma-­‐70	   holoenzyme	   of	   RNA	   polymerase	  (Wassarman	   and	   Storz,	   2000).	   In	   addition,	   some	   sRNAs	   are	   able	   to	   sequester	  proteins	   through	   direct	   binding,	   as	   is	   the	   case	   with	   the	   CsrB	   sRNA,	   which	  inhibits	  the	  effects	  of	  the	  CsrA	  protein	  on	  the	  gene	  expression	  in	  E.	  coli	  (Liu	  et	  al.,	  1997).	  	  	  
1.2.2	  Different	  roles	  of	  sRNAs	  
Many	   studies	   have	   been	   carried	   out	   on	   the	   roles	   of	   sRNAs	   in	   bacterial	  pathogenesis	  and	  stress	   responses.	   IsrM,	  an	  sRNA	  encoded	  on	  a	  pathogenicity	  island	   in	   Salmonella	   enterica,	   was	   identified	   as	   a	   virulence	   factor,	   as	  demonstrated	  by	  reduced	  intracellular	  replication	  inside	  macrophages	  by	  IsrM	  deletion	  mutants,	  along	  with	  their	  attenuated	  killing	  of	  mice	  (Gong	  et	  al.,	  2011).	  OxyS	   was	   one	   of	   the	   first	   sRNAs	   shown	   to	   be	   involved	   in	   the	   response	   to	  oxidative	  stress,	  by	  regulating	  the	  expression	  of	  as	  many	  as	  40	  genes	   in	  E.	  coli	  (Altuvia	  et	  al.,	  1997).	  Another	  sRNA	  involved	  in	  multiple	  gene	  targeting	  is	  RyhB,	  which	  is	  a	  regulator	  of	  iron	  homeostasis	  in	  E.	  coli	  (Masse	  and	  Gottesman,	  2002).	  Its	   targets	   included	   genes	   coding	   for	   a	   superoxide	   dismutase	   and	   two	   iron-­‐sequestering	   proteins.	   MicC	   is	   a	   good	   example	   of	   a	   single	   sRNA	   regulating	  responses	  to	  different	  stresses,	  namely	  changes	  in	  temperature	  and	  osmolarity,	  via	   interaction	  with	   just	  one	   target	  mRNA,	  encoding	   the	  OmpC	  porin	   in	  E.	  coli	  (Chen	  et	  al.,	  2004).	  	  	  
	  	   29	  
The	  RNA	  chaperone	  Hfq	  has	  been	  studied	  in	  many	  bacteria	  and	  was	  shown	  to	  be	  involved	   in	   a	   variety	   of	   processes	   including	   virulence	   and	   stress	   response,	  through	  facilitating	   interactions	  between	  sRNAs	  and	  their	  targets	  (Sittka	  et	  al.,	  2007,	  Kulesus	  et	  al.,	  2008).	  A	  recent	  study	  showed	  the	  importance	  of	  Hfq	  in	  H.	  
influenzae	  in	  haem	  acquisition	  and	  the	  ability	  to	  cause	  disease	  in	  animal	  models	  (Hempel	  et	  al.,	  2013).	  Hfq	  associating	  with	  sRNAs	  in	  other	  bacteria	  suggests	   it	  may	  also	  do	  so	  in	  H.	  influenzae.	  	  	  
1.3	  High-­‐throughput	  sequencing	  The	   sequencing	   of	   the	   first	   bacterial	   whole	   genome,	   the	   Rd	   strain	   of	   H.	  
influenzae,	  was	  performed	  using	  Sanger	  methodology,	  which	  relies	  on	  the	  DNA	  chain	   termination	   approach	   using	   dideoxynucleotides	   (Sanger	   et	   al.,	   1977,	  Fleischmann	  et	  al.,	  1995).	  A	  decade	  later,	  the	  genomic	  field	  was	  revolutionised	  with	   the	   advent	   of	   high-­‐throughput	   sequencing	   (HTS)	   technologies,	   which	  employ	   massively	   parallelised	   sequencing	   of	   millions	   of	   fragmented	   DNA	  molecules	   (Loman	  et	  al.,	  2012).	  These	   technologies	  provide	  a	  much	   faster	  and	  cheaper	  approach	  to	  sequencing	  compared	  to	  the	  conventional	  Sanger	  method,	  with	  completion	  of	  the	  sequencing	  within	  hours	  instead	  of	  months.	  In	  addition,	  the	   development	   of	   benchtop	   sequencers	   now	   makes	   HTS	   a	   feasible	  undertaking	  in	  a	  standard	  laboratory.	  	  	  
1.3.1	  Illumina	  HTS	  platform	  
Illumina	   is	   the	   current	   leader	   among	   HTS	   platforms,	   which	   also	   include	   Life	  Technologies,	  Pacific	  Biosciences	  and	  Oxford	  Nanopore	  Technologies	  (Reuter	  et	  al.,	   2015).	   The	   Illumina	   platform	   relies	   on	   sequencing	   by	   synthesis,	   using	  modified	   deoxynucleotides	   (dNTP)	   as	   reversible	   terminators	   (Bentley	   et	   al.,	  2008).	   In	   this	   approach,	   millions	   of	   clonally	   amplified	   DNA	   fragments	   are	  attached	   to	   a	   flow	   cell	   surface	   and	   serve	   as	   templates	   for	   the	   synthesis	   of	   a	  complementary	  DNA	  (cDNA	  strand	  (see	  Figure	  1.4).	  Polymerisation	  of	  cDNA	  is	  temporarily	   terminated	   after	   each	   addition	   of	   a	   fluorescently	   labelled	   dNTP.	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Figure	   1.4:	   A	   simplified	   schematic	   of	   the	   Illumina	   "sequencing	   by	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The	  Illumina	  platform	  is	  recognised	  for	   low	  error	  rates,	   the	  ability	  to	  generate	  paired-­‐end	   reads	   (by	   sequencing	   both	   ends	   of	   a	   DNA	   fragment)	   and	   its	   user-­‐friendly	  workflow	  (Loman	  et	  al.,	  2012).	  The	  Illumina	  HiSeqTM	  series	  instruments	  are	  used	  for	  large-­‐scale	  sequencing	  experiments,	  whereas	  the	  Illumina	  MiSeqTM,	  MiniSeqTM	  and	  NextSeqTM	  are	  all	  established	  benchtop	  sequencers.	  The	  Illumina	  MiSeqTM	  currently	  allows	  for	  up	  to	  50	  million	  paired-­‐end	  reads	  per	  single	  data	  output,	   with	   sequencing	   run	   times	   as	   short	   as	   4	   hours	  (http://www.illumina.com/systems.html).	  This	  makes	   it	  a	  particularly	   feasible	  tool	   for	   sequencing	   of	   prokaryotic	   genomes,	   which	   has	   already	   been	  successfully	  applied	  for	  research	  in	  microbiology	  (Eyre	  et	  al.,	  2012).	  	  	  
1.3.2	  RNA-­‐Seq	  
The	  study	  of	  bacterial	  gene	  expression	  provides	  the	  means	  of	  identifying	  genes	  potentially	   involved	   in	   important	   processes	   related	   to	   pathogenesis	   and	  persistence	   in	   the	   host.	   The	   advent	   of	   high-­‐throughput	   RNA	   sequencing	   has	  contributed	   significantly	   to	   gene	   expression	   studies.	   Prior	   to	   RNA-­‐Seq,	  microarrays	  used	  to	  be	  the	  technique	  of	  choice	  for	  the	  study	  of	  large	  scale	  gene	  expression	   (Hitzemann	   et	   al.,	   2013).	   They	   enable	   gene	   profiling	   by	   the	  complementary	   hybridisation	   of	   isolated	  RNA	   to	  DNA	   probes.	   In	   recent	   years	  there	   has	   been	   a	   shift	   in	   gene	   expression	   studies	   from	   microarrays	   towards	  RNA-­‐Seq	   and	   it	   has	   been	   proposed	   that	   RNA-­‐Seq	   should	   replace	  microarrays	  entirely	  (Hitzemann	  et	  al.,	  2013).	  	  	  RNA-­‐Seq	   offers	   significant	   advantages	   over	   microarrays,	   including	   single-­‐nucleotide	   resolution,	   lower	   background	   noise	   and	   the	   ability	   to	   detect	   low-­‐level	   and	   short	   transcripts.	   Importantly,	   no	   prior	   knowledge	   of	   the	   gene	   or	  reference	   sequence	   is	   required.	   This	   means	   that	   RNA-­‐Seq	   can	   be	   used	   to	  discover	   novel	   transcripts,	   including	   ncRNAs	   (Mann	   et	   al.,	   2012).	   In	   addition,	  enrichment	   of	   primary	   transcripts	   from	   total	   RNA	   using	   differential	   RNA-­‐Seq	  (dRNA-­‐Seq)	  approach	  allows	  for	  the	  identification	  of	  transcriptional	  start	  sites	  (Sharma	  et	  al.,	  2010).	  RNA-­‐Seq	  has	  already	  become	  the	  technique	  of	  choice	  for	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simple	   differential	   gene	   expression	   studies	   as	   well	   as	   complex	   transcriptome	  analyses	  and	  has	  been	   successfully	   applied	   to	   study	  bacterial	   gene	  expression	  (Kumar	  et	  al.,	  2012,	  Spaniol	  et	  al.,	  2013,	  Baddal	  et	  al.,	  2015).	  	  	  
1.4	  Research	  aims	  and	  objectives	  Studying	   how	  H.	   influenzae	   behaves	   during	   natural	   infection	   is	   important	   for	  understanding	  the	  processes	  involved	  in	  its	  pathogenesis,	  which	  can	  potentially	  lead	  to	  the	  discovery	  of	  novel	  vaccine	  and	  antibiotic	  targets.	  Therefore,	  the	  main	  research	  aim	  of	  this	  project	  was	  to	  use	  the	  NGS	  technology	  in	  order	  to	  expand	  the	   current	   knowledge	   of	   the	   behaviour	   of	   H.	   influenzae	   under	   infection-­‐relevant	  conditions.	  In	  addition,	  as	  ncRNAs	  have	  been	  largely	  understudied	  in	  H.	  
influenzae,	   this	   study	   also	   aimed	   to	   utilise	   bioinformatic	   tools	   in	   order	   to	  identify	   these	   potentially	   important	   elements.	   The	   robust	   discovery	   of	   novel	  ncRNAs	   may	   provide	   a	   deeper	   insight	   into	   important	   regulatory	   processes	  during	  the	  host	  infection	  by	  H.	  influenzae.	  	  	  The	  overall	  objectives	  of	  this	  study	  were:	  
• To	   identify	   any	   nucleotide-­‐level	   variants	   between	   published	   and	   re-­‐sequenced	  whole	  genomes	  of	  Rd	  and	  R2866	  strains	  of	  H.	  influenzae.	  
• To	   carry	   out	   an	   in-­‐depth	   analysis	   of	   the	   accessory	   genome	   of	   Rd	   and	  R2866	  strains.	  
• To	  develop	  and	  optimise	  an	   in	  vitro	   invasion	  assay	  in	  order	  to	  establish	  the	  ability	  of	  Rd	  and	  R2866	  strains	  from	  this	  laboratory	  to	  invade	  human	  epithelial	  cells.	  
• To	  characterise	  the	  transcriptional	  response	  of	  Rd	  and	  R2866	  strains	  to	  infection-­‐relevant	   conditions	   on	   a	  whole-­‐genome	   scale,	   using	   the	  RNA-­‐Seq	  method.	  
• To	  develop	  a	  robust	  bioinformatic	  tool	  for	  the	  discovery	  of	  novel	  putative	  ncRNA	  elements	  from	  bacterial	  RNA-­‐Seq	  data.	  
• To	   identify	   and	   characterise	   a	   repertoire	   of	   putative	   intergenic	   and	  antisense	  ncRNAs	  in	  Rd	  and	  R2866	  strains	  of	  H.	  influenzae.	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Chapter	  2:	  Materials	  and	  Methods	  
2.1	  Media	  and	  solutions	  Recipes	  for	  media	  and	  solutions	  used	  in	  this	  study	  are	  presented	  in	  Appendix	  A.	  	  
2.2	  H.	  influenzae	  
2.2.1	  Strains	  
Two	  strains	  of	  H.	  influenzae	  were	  used	  in	  this	  study	  -­‐	  Rd	  and	  R2866.	  Rd	  is	  a	  non-­‐encapsulated	   standard	   laboratory	   strain,	   first	   isolated	   in	   the	   mid-­‐1940s	  (Alexander	  and	  Leidy,	  1951).	  R2866	  is	  an	  invasive	  non-­‐typeable	  strain,	  isolated	  from	  the	  blood	  of	  a	  child	  with	  meningitis	  (Nizet	  et	  al.,	  1996).	  	  
2.2.2	  Optical	  density	  
The	   optical	   density	   (OD)	   of	   bacterial	   broth	   cultures	   was	   measured	   on	   a	  spectrophotometer,	   using	   the	   wavelength	   of	   600	   nm.	   The	   medium	   without	  bacterial	  cultures	  was	  used	  as	  a	  blank.	  	  
2.2.3	  Growth	  and	  storage	  conditions	  
H.	   influenzae	   was	   routinely	   grown	   on	   chocolate	   agar	   at	   37	   °C	   in	   a	   5%	   CO2	  incubator,	  for	  24-­‐48	  hours.	  A	  single	  bacterial	  colony	  was	  picked	  each	  time	  and	  inoculated	   in	   brain-­‐heart	   infusion	   (BHI)	   medium	   (Oxoid,	   UK),	   supplemented	  with	   15	   μg/ml	   haemin	   (Sigma,	   UK)	   and	   15	   μg/ml	   NAD	   (Sigma,	   UK).	   Broth	  cultures	   were	   grown	   overnight	   in	   supplemented	   BHI	   (sBHI)	   in	   50	   ml	   Falcon	  tubes	   at	   37	   °C	   with	   shaking	   at	   200	   revolutions	   per	   minute	   (rpm).	   Overnight	  broth	  cultures	  were	  diluted	  to	  a	  starting	  OD600	  of	  0.05	  in	  fresh	  sBHI.	  Growth	  was	  continued	   in	   125	  ml	   sterile	   glass	   flasks	   or	   50	  ml	   Falcon	   tubes	   at	   37	   °C	   with	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shaking	   at	   200	   rpm.	  H.	   influenzae	   strain	   stocks	  were	   stored	   at	   -­‐70	   °C	   in	   15%	  glycerol	  in	  sBHI.	  	  
2.2.4	  Standard	  growth	  curve	  
Standard	   growth	   curves	   were	   set	   up	   with	   a	   starting	   OD600	   of	   0.05.	   Broth	  cultures	  were	  grown	  at	  37	  °C	  with	  shaking	  at	  200	  rpm	  and	  OD600	  was	  measured	  every	   hour.	   Growth	   measurements	   were	   stopped	   when	   OD600	   started	  decreasing.	  	  
2.2.5	  Growth	  in	  medium	  IV	  
Broth	  cultures	  were	  grown	  overnight	  in	  sBHI	  medium,	  centrifuged	  at	  4,000	  rpm	  for	   10	   minutes,	   washed	   once	   in	   chemically-­‐defined	   medium	   IV	   (MIV),	  centrifuged	   again	   and	  diluted	   in	  MIV	   to	  OD600	   of	   0.05.	   Standard	   growth	   curve	  measurements	  were	  then	  carried	  out.	  	  	  
2.2.6	  Oxidative	  stress	  
Oxidative	  stress	  was	  induced	  in	  H.	  influenzae	  by	  growing	  broth	  cultures	  in	  sBHI	  until	  mid-­‐exponential	  phase	  and	  treating	  them	  with	  hydrogen	  peroxide	  (Sigma,	  UK)	  (Wong	  et	  al.,	  2007).	  For	  an	  RNA	  sample	  acquisition,	  broth	  cultures	  at	  mid-­‐exponential	  phase	  were	  treated	  with	  hydrogen	  peroxide	  for	  10	  minutes.	  Control	  cultures	  had	  an	  equal	  volume	  of	  sBHI	  medium	  added	  to	  them.	  	  	  
2.2.7	  Iron-­‐starvation	  stress	  
Iron-­‐starvation	   stress	  was	   induced	   in	  H.	   influenzae	   by	   growing	   broth	   cultures	  until	   mid-­‐exponential	   phase	   and	   treating	   them	   with	   2,2-­‐bipyridine	   (VWR	  International,	  UK),	  which	  is	  an	  iron-­‐chelating	  agent	  (Harrison	  et	  al.,	  2013).	  For	  an	   RNA	   sample	   acquisition,	   broth	   cultures	   at	   mid-­‐exponential	   phase	   were	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treated	  with	  2,2-­‐bipyridine	  for	  1	  hour.	  Control	  cultures	  had	  an	  equal	  volume	  of	  100%	  ethanol	  added	  to	  them.	  	  
2.3	  DNA	  extraction	  DNeasy®	  Blood	  &	  Tissue	  kit	  (QIAGEN,	  UK)	  was	  used	  to	  extract	  DNA	  from	  Rd	  and	  R2866	   strains,	   according	   to	  manufacturer's	   instructions.	   1	  ml	   of	   an	   overnight	  broth	   culture	   was	   centrifuged	   at	   5,000	   g	   for	   10	   minutes	   and	   the	   pellet	   was	  resuspended	   in	   180	   μl	   of	   kit	   buffer	   ATL.	   20	   μl	   of	   Proteinase	   K	   was	   added,	  samples	  were	  vortexed	  and	  then	  placed	   in	  a	   thermomixer	  at	  1,000	  rpm,	  56	  °C	  for	  40	  minutes.	  After	  vortexing	   samples	   for	  5	   seconds,	  200	  μl	  of	  kit	  buffer	  AL	  and	  200	  μl	  of	  100%	  ethanol	  were	  added.	  Samples	  were	  briefly	  vortexed,	   then	  pipetted	  onto	  a	  DNeasy®	  Mini	  spin	  column	  and	  centrifuged	  at	  8,000	  rpm	  for	  1	  minute.	  The	   flow-­‐through	  was	  discarded	   and	  500	  μl	   of	   kit	   buffer	  AW1	  added.	  Samples	  were	   then	   centrifuged	   for	   3	  minutes	   at	   8,000	   rpm,	   the	   flow-­‐through	  discarded,	   and	   500	   μl	   of	   kit	   buffer	   AW2	   added.	   Samples	   were	   further	  centrifuged	   at	   13,500	   rpm	   for	   3	   minutes	   to	   remove	   all	   ethanol	   from	   the	  membrane	  of	  the	  spin	  column.	  DNA	  was	  eluted	  twice	  in	  100	  μl	  of	  kit	  buffer	  AE	  by	   incubating	   the	   spin	   column	   at	   room	   temperature	   (RT)	   for	   1	   minute	   and	  centrifuging	  at	  8000	  rpm	  for	  1	  minute.	  	  	  
2.4	  Quality	  control	  
2.4.1	  Qubit®	  2.0	  Fluorometer	  assay	  
The	   Qubit®	   2.0	   Fluorometer	   assay	   kit	   (Life	   Technologies,	   UK)	   was	   routinely	  used	  to	  quantify	  DNA	  and	  RNA	  in	  studied	  samples,	  according	  to	  manufacturer's	  instructions.	  The	  reagent	  mix	  was	  prepared	  by	  diluting	  Qubit®	  reagent	  1:200	  in	  Qubit®	   buffer	   and	   briefly	   vortexing.	   1-­‐10	   μl	   of	   RNA	   or	   DNA	   sample	   was	  combined	  with	  190-­‐199	  μl	   of	   the	   reagent	  mix,	   vortexed	  briefly	   and	   incubated	  for	  2	  minutes	  before	  using	  the	  Qubit®	  Fluorometer.	  The	  RNA	  BR	  (broad	  range;	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1-­‐1,000	   ng/μl)	   assay	   kit	   was	   used	   to	   quantify	   all	   RNA	   samples.	   The	   DNA	   HS	  (high	  sensitivity;	  0.01-­‐100	  ng/μl)	  assay	  kit	  was	  used	  to	  measure	  concentrations	  of	   DNA	   and	   cDNA	   libraries	   in	   sequencing	   experiments.	   DNA	   BR	   (0.1-­‐1,000	  ng/μl)	   kit	   was	   used	   for	   all	   other	   DNA	   measurements.	   The	   fluorometer	   was	  calibrated	  each	  time	  using	  appropriate	  nucleic	  acid	  standards.	  	  	  
2.4.2	  Agilent	  2100	  Bioanalyzer	  
The	  Agilent	  2100	  Bioanalyzer	   (Agilent,	  UK)	   instrument	  was	  used	   to	   check	   the	  quality	  of	  RNA	  (RNA	  6000	  Pico	  kit)	  and	  DNA	  (DNA	  High	  Sensitivity	  kit)	  samples,	  according	   to	  manufacturer's	   instructions.	  All	  kit	   reagents	  were	  equilibrated	   to	  RT	  for	  30	  minutes	  before	  use.	  Agilent	  Bioanalyzer	  chips	  contain	  micro-­‐channels	  that	  connect	  sample	  and	  reagent	  wells	  on	  a	  single	  chip.	  Bioanalyzer	  electrodes	  drive	   electrophoresis	   of	   DNA	   or	   RNA	  molecules,	  which	   are	   separated	   by	   size.	  The	  data	  are	  presented	  in	  electropherogram	  images.	  	  	  The	  RNA	  6000	  Pico	  gel	  was	  prepared	  by	  centrifuging	  550	  μl	  of	  the	  gel	  matrix	  in	  a	  spin	  column	  at	  1,500	  g	  for	  10	  minutes.	  The	  dye	  concentrate	  was	  vortexed	  for	  10	  seconds	  and	  1	  μl	  was	  mixed	  with	  65	  μl	  of	  filtered	  gel	  matrix.	  The	  gel-­‐dye	  mix	  was	  centrifuged	  at	  13,000	  g	  for	  10	  minutes	  before	  use.	  	  The	  High	  Sensitivity	  DNA	  dye	  concentrate	  was	  vortexed	  for	  10	  seconds	  and	  15	  μl	  was	  added	   to	   the	  supplied	  gel	  matrix.	  The	  gel-­‐dye	  mix	  was	  vortexed	   for	  10	  seconds	  and	  centrifuged	  at	  2,300	  g	  for	  10	  minutes	  before	  use.	  	  The	   chip	  was	   placed	   on	   the	   chip	   priming	   station	   and	   9	   μl	   of	   gel-­‐dye	  mix	  was	  pipetted	   into	   an	   indicated	  well.	   The	   syringe	  plunger	  was	  pushed	  down	   for	  30	  seconds	   (RNA	  6000	  Pico	  kit)	   or	  1	  minute	   (High	  Sensitivity	  DNA	  kit)	   and	   then	  released.	  9	  μl	  of	  gel-­‐dye	  mix	  was	  pipetted	  into	  remaining	  gel	  wells.	  When	  using	  the	  RNA	  6000	  Pico	   kit,	   9	   μl	   of	   the	   conditioning	   solution	  was	   pipetted	   into	   an	  indicated	  well	  and	  RNA	  samples	  were	  denatured	  at	  70	  °C	  for	  2	  minutes	  prior	  to	  loading	  on	  the	  chip.	  1	  μl	  of	  the	  DNA	  or	  RNA	  sample	  was	  combined	  with	  5	  μl	  of	  the	  marker	   in	   each	   sample	  well	   on	   the	   chip.	   1	   μl	   of	   the	   supplied	   ladder	  was	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combined	  with	  5	  μl	  of	  the	  marker	  in	  the	  ladder	  well.	  The	  chip	  was	  vortexed	  at	  2,400	  rpm	  in	  an	  IKA	  vortex	  mixer	  for	  1	  minute	  and	  then	  run	  on	  the	  instrument	  within	  5	  minutes.	  	  
2.5	  Polymerase	  chain	  reaction	  Standard	   polymerase	   chain	   reaction	   (PCR)	   was	   set	   up	   using	   GoTaq®	   Green	  Master	  mix	  (Promega,	  UK).	  For	  a	  50	  μl	  reaction,	  the	  components	  used	  were	  12.5	  μl	  of	  Master	  mix,	  1	  μl	  of	  each	  PCR	  primer,	  2-­‐3	  μl	  of	  sample,	  7.5-­‐8.5	  μl	  of	  sterile	  water.	   A	   negative	   control	   was	   included	   in	   every	   PCR	   reaction.	   Specific	   PCR	  conditions	  are	  described	  in	  each	  relevant	  section.	  	  
2.5.1	  Agarose	  gel	  electrophoresis	  
Agarose	   gels	   (0.8-­‐2%)	   were	   prepared	   by	   dissolving	   agarose	   in	   Tris-­‐Acetate-­‐Ethylenediaminetetraacetate	  (TAE)	   buffer.	   SYBR®	   Green	   I	   nucleic	   acid	   stain	  (Thermo	  Fisher	  Scientific,	  UK)	  was	  diluted	  1:10,000	  in	  the	  gel.	  10	  μl	  of	  the	  PCR	  product	  and	  appropriate	  size	  marker	  were	  pipetted	   into	  wells	  on	   the	  gel.	  Gels	  were	  run	  in	  TAE	  buffer	  at	  100	  V	  for	  45	  minutes	  and	  visualised	  under	  UV	  light.	  	  
2.6	  Whole-­‐genome	  sequencing	  
2.6.1	  Genomic	  DNA	  library	  preparation	  
The	  Nextera®	  XT	  kit	  (Illumina,	  UK)	  was	  used	  to	  prepare	  genomic	  DNA	  libraries	  for	  whole-­‐genome	  sequencing,	  according	  to	  manufacturer's	  instructions.	  1	  ng	  of	  DNA	   in	   5	   μl	   volume	  was	   used	   as	   starting	  material.	   DNA	   samples	  were	  mixed	  with	  10	  μl	  of	  kit	  buffer	  TD	  and	  5	  μl	  of	  kit	  reagent	  ATM,	  centrifuged	  at	  280	  g	  for	  1	  minute	  and	  incubated	  at	  55	  °C	  for	  5	  minutes.	  5	  μl	  of	  kit	  buffer	  NT	  was	  added	  to	  stop	   the	   reaction	   and	   samples	   were	   vortexed	   at	   280	   g	   for	   1	   minute.	   After	  incubation	  at	  RT	  for	  5	  minutes,	  15	  μl	  of	  kit	  reagent	  NPM	  and	  5	  μl	  of	  each	  Index	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adapter	  (i5	  and	  i7)	  were	  added.	  Samples	  were	  centrifuged	  at	  280	  g	  for	  1	  minute	  and	  placed	  on	  a	  thermocycler	  with	  the	  following	  settings:	  	  1.	  72	  °C	  for	  3	  minutes	  2.	  95	  °C	  for	  30	  seconds	  	  3.	  95	  °C	  for	  10	  seconds	  4.	  55	  °C	  for	  30	  seconds	  5.	  72	  °C	  for	  30	  seconds	  6.	  Repeat	  steps	  3-­‐5	  11	  times	  7.	  72	  °C	  for	  5	  minutes	  	  DNA	   libraries	   were	   purified	   using	   Agencourt®	   AMPure®	   XP	   magnetic	   beads	  (Beckman	   Coulter,	   UK),	   which	   had	   been	   equilibrated	   to	   RT	   for	   at	   least	   30	  minutes.	  25	  μl	  of	  beads	  were	  mixed	  with	  each	  sample	  and	  incubated	  at	  RT	  for	  5	  minutes.	   Tubes	   were	   placed	   on	   a	   magnetic	   rack	   for	   2	   minutes	   and	   the	  supernatant	  was	  carefully	  removed.	  Beads	  were	  then	  washed	  twice	  with	  200	  μl	  of	  80%	  ethanol	  for	  30	  seconds	  on	  the	  magnetic	  rack.	  Beads	  were	  left	  to	  air-­‐dry	  for	   15	   minutes	   before	   being	   resuspended	   in	   52.5	   μl	   of	   Resuspension	   buffer.	  Samples	  were	   incubated	  at	  RT	   for	  2	  minutes	  and	  placed	  on	   the	  magnetic	   rack	  for	   2	  minutes.	   50	   μl	   of	   supernatant,	   containing	   the	   purified	   DNA	   library,	  was	  transferred	   to	   a	   new	   tube.	   The	   DNA	   concentration	   was	   measured	   with	   the	  Qubit®	  DNA	  HS	  assay	  kit	  (see	  section	  2.4.1).	  DNA	  fragment	  size	  in	  each	  sample	  was	   determined	   using	   the	   Bioanalyzer	   High	   Sensitivity	   DNA	   kit	   (see	   section	  2.4.2).	  	  
2.6.2	   Whole-­‐genome	   sequencing	   on	   the	   Illumina	  
MiSeqTM	  
The	  molar	  concentration	  of	  each	  DNA	  library	  sample	  was	  determined	  using	  the	  formula	  below:	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Molar	  concentration	  (M)	  =	  Concentration	  (g/l)	  /	  (DNA	  fragment	  size	  (bp)	  *	  650)	  	  5	  μl	  of	  the	  pooled	  library,	  diluted	  to	  4	  nM,	  was	  mixed	  with	  5	  μl	  of	  0.2	  M	  sodium	  hydroxide.	  Samples	  were	  briefly	  vortexed,	  centrifuged	  at	  300	  g	  for	  1	  minute	  and	  incubated	  at	  RT	   for	  5	  minutes.	  990	  μl	  of	   the	   ice-­‐cold	  hybridisation	  buffer	  was	  added	  and	  the	   library	  was	   further	  diluted	   in	   the	  hybridisation	  buffer	   to	  10-­‐12	  pM.	   600	   μl	   of	   denatured	  DNA	   library	  was	   loaded	   onto	   the	  MiSeqTM	   (Illumina,	  UK).	  The	  paired-­‐end	  2x250	  bp	  kit	  was	  used	  for	  the	  whole-­‐genome	  sequencing.	  	  
2.7	  RNA	  extraction	  Prior	   to	   any	   RNA-­‐related	  work,	   all	  materials	   and	   designated	  RNA	   space	  were	  cleaned	  with	  70%	  ethanol	  and	  sprayed	  with	  RNaseZap®.	  	  
2.7.1	  Collection	  and	  preservation	  of	  bacterial	  cultures	  
Bacterial	   cells	   at	   0.4-­‐0.6	   OD	   were	   taken	   for	   RNA	   extraction	   each	   time.	   The	  RNAprotect®	   reagent	   (QIAGEN,	   UK)	   was	   used	   to	   stabilise	   and	   preserve	   RNA	  samples	   for	   RNA	   extraction	   on	   a	   separate	   day.	   Bacteria	   were	   first	   grown	   in	  broth	   cultures	   (see	   sections	   2.2.4-­‐2.2.7)	   and	   mixed	   with	   2x	   volume	   of	  RNAprotect®.	   Cultures	   in	   RNAprotect®	   were	   vortexed	   immediately	   for	   5	  seconds,	  incubated	  for	  5	  minutes	  at	  RT	  and	  centrifuged	  for	  5	  minutes	  at	  5,000	  g.	  The	  supernatant	  was	  then	  removed	  and	  pellets	  were	  stored	  at	  -­‐70	  °C.	  	  For	  RNA	  extraction	  on	  the	  same	  day,	  bacterial	  broth	  cultures	  were	  centrifuged	  at	  4,000	  rpm	  for	  10	  minutes	  and	  pellets	  were	  resuspended	   in	  1	  ml	  of	  QIAzol®	  reagent	  from	  miRNeasy	  Mini	  kit	  (QIAGEN,	  UK).	  RNA	  extraction	  was	  then	  carried	  out	  using	  miRNeasy	  Mini	  kit	  per	  manufacturer's	  instructions	  (see	  section	  2.7.2).	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2.7.2	  miRNeasy	  Mini	  kit	  
RNA	   extraction	  was	   performed	  with	  miRNeasy	  Mini	   kit	   (QIAGEN,	   UK),	   which	  enables	  purification	  of	  total	  RNA,	  including	  mRNA	  and	  small	  (<200	  nucleotides)	  RNA	   transcripts.	   This	   method	   utilised	   phenol	   and	   guanidine	   thiocyanate	  (QIAzol®	  reagent)	  for	  sample	  lysis	  and	  a	  silica	  membrane-­‐based	  procedure	  for	  RNA	  extraction.	  	  	  Following	  the	  preservation	  in	  RNAprotect®,	  samples	  were	  treated	  with	  100	  μl	  of	  1	  mg/ml	  lysozyme	  in	  Tris-­‐Ethylenediaminetetraacetate	  (TE)	  buffer	  (pH	  8.0)	  and	  20	  μl	  of	  Proteinase	  K	  (QIAGEN,	  UK)	  to	  facilitate	  the	  breakdown	  of	  the	  bacterial	  cell	   wall.	   Samples	   were	   vortexed	   for	   5	   seconds	   and	   incubated	   at	   RT	   for	   5	  minutes,	  vortexing	  for	  10	  seconds	  every	  2	  minutes.	  1	  ml	  of	  QIAzol	  reagent	  was	  added	  and	  samples	  were	  vortexed	  for	  3	  minutes	  before	  being	   incubated	  at	  RT	  for	  5	  minutes.	  200	  μl	  of	   chloroform	  was	  added,	   tubes	  were	  shaken	  vigorously	  for	  15	  seconds	  and	  incubated	  at	  RT	  for	  3	  minutes.	  Samples	  were	  centrifuged	  at	  12,000	   g	   for	   15	  minutes	   at	   4	   °C	   and	   the	   resulting	   upper	   aqueous	   phase	   was	  transferred	  to	  RNase-­‐free	  2	  ml	  tubes.	  1.5x	  volume	  of	  100%	  ethanol	  was	  added	  and	  the	  solution	  mixed	  by	  pipetting.	  	  700	  μl	  of	  the	  sample	  was	  added	  to	  the	  spin	  column,	  which	  was	  then	  centrifuged	  for	  15	  seconds	  at	  10,000	  rpm,	  with	   the	   flow-­‐through	  discarded.	  This	  step	  was	  repeated	  for	  the	  remainder	  of	  the	  sample.	  80	  μl	  of	  DNase	  I	  (diluted	  1:8	  in	  RDD	  buffer)	  was	  pipetted	  directly	  onto	  the	  top	  of	  the	  silica	  membrane	  and	  left	  for	  15	  minutes	  at	  RT.	  350	  μl	  of	  Buffer	  RWT	  was	  added	  to	  the	  column	  and	  samples	  were	  centrifuged	   at	   10,000	   rpm	   for	   15	   seconds,	   with	   the	   flow-­‐through	   discarded.	  DNase	   I	   treatment	  was	   repeated	   again,	   to	   ensure	   the	   efficient	   degradation	   of	  genomic	   DNA,	   which	   would	   otherwise	   interfere	   with	   sensitive	   downstream	  applications,	  RNA-­‐Seq	  experiments	  in	  particular.	  	  	  500	   μl	   of	   RPE	   buffer	   was	   added	   to	   the	   spin	   column	   and	   samples	   were	  centrifuged	  for	  15	  seconds	  at	  10,000	  rpm,	  with	  the	  flow-­‐through	  discarded.	  500	  μl	  of	  RPE	  buffer	  was	  added	  again	  and	  samples	  were	  centrifuged	  for	  2	  minutes	  at	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10,000	   rpm.	   The	   spin	   column	   was	   centrifuged	   for	   1	   minute	   at	   full	   speed	   to	  remove	   any	   residual	   ethanol.	   RNA	   was	   subsequently	   eluted	   with	   20-­‐40	   μl	  RNase-­‐free	  water	  by	  centrifuging	  at	  10,000	  rpm	  for	  1	  minute.	  The	  elution	  step	  was	   performed	   twice	   to	   increase	   the	   overall	   RNA	   yield.	   The	   total	   volume	   of	  eluted	  RNA	  was	  40-­‐60	  μl	  and	  it	  was	  stored	  at	  -­‐70	  °C.	  	  
2.7.3	  PCR	  to	  check	  for	  the	  genomic	  DNA	  contamination	  
RNA	   samples	   for	   RNA-­‐Seq	   experiments	   were	   checked	   for	   genomic	   DNA	  contamination	  using	  standard	  PCR	  of	  the	  16S	  rRNA	  gene.	  Genomic	  Rd	  DNA	  was	  used	  as	  a	  positive	  control.	  PCR	  primers	  for	  16S	  rRNA	  were:	  AGAGTTTGATCMTGGCTCAG	  (forward)	  CGGTTACCTTGTTACGACTT	  (reverse).	  	  	  PCR	  conditions	  were:	  1.	  Initial	  denaturation	  at	  94	  °C	  for	  3	  minutes	  2.	  Denaturation	  at	  94	  °C	  for	  30	  seconds	  3.	  Annealing	  at	  55	  °C	  for	  30	  seconds	  4.	  Extension	  at	  68	  °C	  for	  1	  minute	  5.	  Repeat	  steps	  2-­‐4	  29	  times	  6.	  Final	  extension	  at	  68	  °C	  for	  5	  minutes	  	  Absence	   of	   detectable	   16S	   rRNA	   PCR	   products	   was	   used	   to	   signify	   lack	   of	  genomic	  DNA	  contamination.	  	  
2.8	  RNA-­‐Seq	  
2.8.1	  Depletion	  of	  rRNA	  
The	   Ribo-­‐ZeroTM	   rRNA	   Removal	   kit	   for	   bacteria	   (Illumina,	   UK)	   was	   used	   to	  remove	   most	   rRNA	   from	   total	   bacterial	   RNA,	   according	   to	   manufacturer's	  instructions.	  Ribo-­‐ZeroTM	  bead	  preparation	  was	  as	  follows.	  225	  μl	  of	  beads	  were	  equilibrated	  at	  RT	  for	  30	  minutes,	  placed	  on	  the	  magnetic	  rack	  for	  1	  minute	  and	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the	  supernatant	  removed.	  Beads	  were	  washed	  twice	  with	  225	  μl	  of	  RNase-­‐free	  water	   by	   placing	   them	   for	   1	  minute	   on	   the	  magnetic	   stand	   and	   removing	   the	  supernatant.	  Magnetic	  beads	  were	   then	  resuspended	   in	  65	  μl	  of	  Resuspension	  solution	  and	  1	  μl	  of	  RiboGuard	  RNase	  inhibitor	  (100	  U/μl)	  was	  added.	  	  1-­‐5	   μg	   of	   total	   extracted	   RNA	   was	   used	   and	   samples	   were	   topped	   up	   with	  RNase-­‐free	  water	  to	  28	  μl.	  4	  μl	  of	  Ribo-­‐ZeroTM	  Reaction	  buffer	  and	  8	  μl	  of	  Ribo-­‐ZeroTM	   rRNA	   Removal	   solution	  were	   added	   to	   each	   sample.	   The	  mixture	  was	  incubated	   at	   68	   °C	   for	   10	  minutes	   and	   then	   cooled	   for	   5	  minutes	   at	   RT.	   The	  solution	   was	   mixed	   well	   with	   pre-­‐prepared	   Ribo-­‐ZeroTM	   beads	   by	   repeated	  pipetting	  and	  vortexing	  for	  10	  seconds.	  Tubes	  were	  incubated	  for	  5	  minutes	  at	  RT	   and	   vortexed	   again	   at	   50°C	   for	   5	  minutes.	   Tubes	  were	   then	  placed	   on	   the	  magnetic	  rack	  and	  the	  supernatant,	  containing	  rRNA-­‐free	  RNA,	  was	  transferred	  to	  a	  new	  RNase-­‐free	  tube.	  	  	  Ethanol	  precipitation	  was	  used	  to	  purify	  RNA.	  RNA	  samples	  were	  topped	  up	  to	  180	  μl	  with	  RNase-­‐free	  water.	  18	  μl	  of	  3	  M	  sodium	  acetate,	  2	  μl	  of	  glycogen	  (10	  mg/ml)	  and	  600	  μl	  of	  ice-­‐cold	  100%	  ethanol	  were	  added	  to	  each	  sample.	  Tubes	  were	  vortexed	  and	  incubated	  at	  -­‐20	  °C	  for	  at	  least	  1	  hour	  before	  centrifuging	  at	  full	  speed	  for	  30	  minutes.	  RNA	  pellets	  were	  washed	  twice	  with	  350	  μl	  of	  ice-­‐cold	  70%	  ethanol	  and	  centrifuged	  at	  14,000	  rpm	  for	  5	  minutes	  each	  time.	  After	  air-­‐drying	   the	   pellets,	   they	  were	   resuspended	   in	   5.5	   μl	   of	   RNase-­‐free	  water.	   The	  efficiency	  of	  rRNA	  depletion	  was	  checked	  using	  the	  Bioanalyzer	  RNA	  6000	  Pico	  kit	  (see	  section	  2.4.2).	  	  
2.8.2	  Generation	  of	  the	  cDNA	  library	  
A	  modified	  TruSeqTM	  Stranded	  mRNA	  sample	  preparation	  protocol	  was	  used	  to	  prepare	   cDNA	   libraries	   for	   sequencing.	   All	   steps	  were	   carried	   out	   in	   sealable	  sterile	  96-­‐well	  plates.	  	  
	  	   44	  
5	  μl	  of	  rRNA-­‐depleted	  RNA	  was	  mixed	  with	  13	  μl	  of	  TruSeqTM	  Fragment,	  Prime,	  Finish	  mix	  and	  incubated	  at	  94	  °C	  for	  8	  minutes.	  The	  96-­‐well	  plate	  was	  briefly	  centrifuged	   at	   280	   g,	   incubated	   for	   5	  minutes	   at	   RT	   and	   17	   μl	   of	   the	   sample	  transferred	   to	   a	   new	   well	   on	   the	   same	   plate.	   0.1x	   volume	   of	   Superscript	   II	  (Fisher,	  UK)	  was	  mixed	  with	  0.9x	  volume	  of	  TruSeqTM	  First	  Strand	  Synthesis	  Act	  D.	  8	  μl	  of	  this	  mix	  was	  added	  to	  each	  sample	  and	  the	  plate	  was	  incubated	  at	  25	  °C	  for	  10	  minutes,	  42	  °C	  for	  15	  minutes	  and	  70	  °C	  for	  15	  minutes.	  	  	  5	  μl	  of	  TruSeqTM	  End	  Repair	  Control,	  diluted	  1:50	   in	  Resuspension	  buffer,	  and	  20	   μl	   of	   TruSeqTM	   Second	   Strand	   Marking	   Master	   mix	   were	   added	   to	   each	  sample	  and	  incubated	  at	  16	  °C	  for	  1	  hour.	  A	  purification	  step	  was	  performed	  by	  adding	  90	  μl	  of	  Agencourt®	  AMPure®	  XP	  magnetic	  beads,	  incubating	  the	  plate	  at	  RT	  for	  15	  minutes	  and	  then	  placing	   it	  on	  a	  magnetic	  rack	  for	  5	  minutes	  at	  RT.	  The	  supernatant	  was	  discarded	  and	  the	  beads	  were	  washed	  twice	  with	  200	  μl	  of	  80%	  ethanol,	  by	  incubating	  for	  30	  seconds	  on	  the	  magnetic	  rack	  and	  discarding	  the	   supernatant.	   Beads	   were	   air-­‐dried	   for	   15	   minutes	   and	   17.5	   μl	   of	  Resuspension	  buffer	  was	  added	  to	  each	  sample.	  The	  plate	  was	  incubated	  at	  RT	  for	   2	   minutes,	   placed	   on	   the	   magnetic	   rack	   for	   5	   minutes	   and	   15	   μl	   of	   the	  supernatant,	  containing	  double-­‐stranded	  cDNA,	  was	  transferred	  to	  a	  new	  well.	  	  2.5	  μl	  of	  TruSeqTM	  A-­‐Tailing	  Control,	  diluted	  1:100	  in	  Resuspension	  buffer,	  and	  12.5	   μl	   of	   TruSeqTM	   A-­‐Tailing	  mix	  were	   added	   to	   each	   sample.	   The	   plate	  was	  incubated	  at	  37	  °C	   for	  30	  minutes	  and	  70	  °C	   for	  5	  minutes.	  2.5	  μl	  of	  TruSeqTM	  Ligation	   Control,	   diluted	   1:100	   in	   Resuspension	   buffer,	   2.5	   μl	   of	   TruSeqTM	  Ligation	  mix	  and	  2.5	  μl	  of	  Index	  adapter	  were	  added	  to	  each	  sample.	  The	  plate	  was	  centrifuged	  at	  280	  g	  for	  1	  minute	  and	  then	  incubated	  at	  30	  °C	  for	  1	  hour.	  5	  μl	  of	  TruSeqTM	  Stop	  Ligation	  buffer	  was	  added	  to	  stop	  the	  reaction.	  	  The	  second	  purification	  step	  with	  42	  μl	  of	  Agencourt®	  AMPure®	  XP	  beads	  was	  carried	   out	   as	   described	   previously:	   beads	   were	   washed	   with	   80%	   ethanol,	  resuspended	   in	  52.5	  μl	  of	  Resuspension	  buffer	  and	  50	  μl	  was	   transferred	   to	  a	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new	   well.	   The	   third	   purification	   step	   with	   50	   μl	   of	   Agencourt®	   AMPure®	   XP	  beads	  was	  performed	  immediately	  after:	  beads	  were	  washed	  with	  80%	  ethanol,	  resuspended	   in	  22.5	  μl	  of	  Resuspension	  buffer	  and	  20	  μl	  was	   transferred	   to	  a	  new	  well.	  	  5	  μl	   of	  PCR	  Primer	  Cocktail	   and	  25	  μl	   of	  PCR	  Master	  mix	  were	  added	   to	   each	  well	  and	  the	  following	  PCR	  reaction	  was	  set	  up:	  1.	  Initial	  denaturation	  at	  98	  °C	  for	  30	  seconds	  2.	  Denaturation	  at	  98	  °C	  for	  10	  seconds	  3.	  Annealing	  at	  60	  °C	  for	  30	  seconds	  4.	  Extension	  at	  72	  °C	  for	  30	  seconds	  5.	  Repeat	  steps	  2-­‐4	  14	  more	  times	  6.	  Final	  extension	  at	  72	  °C	  for	  5	  minutes	  	  The	  final	  purification	  step	  was	  performed	  with	  50	  μl	  of	  Agencourt®	  AMPure®	  XP	  beads	   as	   described	   previously:	   beads	   were	   washed	   with	   80%	   ethanol	   and	  resuspended	   in	   32.5	   μl	   of	   Resuspension	   buffer.	   30	   μl	   of	   Resuspension	   buffer,	  containing	   completed	   cDNA	   library,	  was	   then	   transferred	   to	   a	   new	  well.	   DNA	  concentration	  was	  measured	   using	   the	   Qubit®	   High	   Sensitivity	   DNA	   assay	   kit	  (see	  section	  2.4.1).	  DNA	  fragment	  size	  of	  each	  library	  was	  determined	  using	  the	  Bioanalyzer	  High	  Sensitivity	  DNA	  kit	  (see	  section	  2.4.2).	  	  
2.8.3	  RNA-­‐Seq	  on	  the	  Illumina	  MiSeqTM	  
Libraries	   of	   cDNA	   were	   pooled	   and	   prepared	   for	   sequencing	   as	   previously	  described	  (see	  section	  2.6.2).	  The	  paired-­‐end	  2x75	  bp	  kit	  was	  used	  for	  RNA-­‐Seq	  on	  the	  Illumina	  MiSeqTM.	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2.9	  Northern	  blot	  
2.9.1	  Primer	  design	  and	  PCR	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Table	  2.1:	  List	  of	  primers	  used	  to	  design	  RNA	  probes	  for	  northern	  blotting.	  T7	  polymerase	  promoter	  sequence	  is	  depicted	  in	  bold.	  
Target	   Forward	  primer	  sequence	  (5'-­‐3')	   Reverse	  primer	  sequence	  (5'-­‐3')	  R2866_101	   ccttagttggtttaggttgct	   ctaatacgactcactatagggagactagataagcggcttttatatg	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Standard	  GoTaq®	   (Promega,	  UK)	  PCR	  was	   set	  up	   as	   a	  50	  μl	   reaction,	   using	  H.	  
influenzae	   strain	   R2866	   genomic	   DNA	   as	   the	   template.	   The	   PCR	   conditions	  were:	  1.	  Initial	  denaturation	  at	  95	  °C	  2.	  Denaturation	  at	  95	  °C	  for	  30	  seconds	  3.	  Annealing	  at	  51	  °C	  for	  30	  seconds	  4.	  Extension	  at	  72	  °C	  for	  15	  seconds	  5.	  Repeat	  steps	  2-­‐4	  34	  times	  6.	  Final	  extension	  at	  72	  °C	  for	  5	  minutes	  	  PCR	  products	  were	  checked	  on	  2%	  agarose	  gel	  (see	  section	  2.5.1).	  	  	  
2.9.2	  PCR	  purification	  
PCR	  products	  were	  purified	  with	   the	   illustraTM	  GFXTM	  PCR	  DNA	  and	  Gel	  Band	  Purification	   kit	   (GE	   Healthcare,	   UK).	   500	   μl	   of	   kit	   Capture	   buffer	   type	   3	   was	  mixed	  with	  40	  μl	  of	  PCR	  product,	   transferred	   to	  a	   spin	  column,	   centrifuged	  at	  16,000	  g	  for	  30	  seconds	  and	  the	  flow-­‐through	  discarded.	  The	  centrifugation	  step	  was	  repeated	  by	  adding	  500	  μl	  of	  kit	  Wash	  buffer	  type	  1.	  The	  spin	  column	  was	  centrifuged	  at	  16,000	  g	  for	  30	  seconds	  to	  remove	  any	  residual	  ethanol.	  DNA	  was	  eluted	  in	  17.5	  μl	  of	  kit	  Elution	  buffer	  type	  4	  (10	  mM	  Tris,	  pH	  8.0)	  by	  centrifuging	  at	  16,000	  g	   for	  1	  minute.	  The	  elution	  step	  was	  repeated	   for	  a	   total	  of	  35	  μl	  of	  purified	  PCR	  product.	  	  	  
2.9.3	  Generating	  the	  biotin-­‐labelled	  RNA	  probe	  
The	  purified	  PCR	  product	  was	   used	   as	   a	   template	   for	  making	   the	  RNA	  probe.	  First,	   the	   nucleoside	   triphosphate	   (NTP)	  mix	  was	   prepared	   by	  mixing	   2	   μl	   of	  adenosine	   triphosphate	   (ATP),	   2	   μl	   of	   guanosine	   triphosphate	   (GTP),	   2	   μl	   of	  cytidine	  triphosphate	  (CTP),	  0.5	  μl	  of	  uridine	  triphosphate	  (UTP)	  (100	  mM	  stock	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each)	   and	   15	   μl	   of	   biotin-­‐labelled	   UTP	   (10	   mM	   stock).	   Subsequently,	   RNA	  transcription	   was	   set	   up	   by	   mixing	   12	   μl	   of	   the	   DNA	   template	   (previously	  purified	  PCR	  product),	  2	  μl	  of	  NTP	  mix,	  4	  μl	  of	  5x	   transcription	  buffer,	  2	  μl	  of	  dithiothreitol	  (100	  mM	  stock),	  2	  μl	  of	  T7	  RNA	  polymerase	  and	  1	  μl	  of	  RNasin®.	  All	  reagents	  were	  purchased	  from	  Promega,	  UK.	  The	  reaction	  was	  incubated	  for	  2	   hours	   at	   37	   °C	   in	   a	   water	   bath.	   2	   μl	   of	   0.2	   M	   ethylenediaminetetraacetate	  (EDTA)	  was	  added	  to	  stop	  transcription.	  	  	  RNA	  was	  precipitated	  by	  adding	  4.5	  μl	  of	  4	  M	  lithium	  chloride	  and	  75	  μl	  of	  100%	  ethanol	  and	   incubating	   for	  2	  hours	  at	   -­‐20	  °C.	  The	  precipitated	  RNA	  probe	  was	  centrifuged	  for	  10	  minutes	  at	  12,000	  g	  and	  the	  RNA	  pellet	  was	  washed	  with	  200	  μl	  of	  70%	  ethanol	  by	   centrifuging	  at	  12,000	  g	   for	  10	  minutes.	  The	  RNA	  pellet	  was	   dissolved	   in	   100	   μl	   of	   RNAse-­‐free	  water	   and	  1	   μl	   of	   RNasin®	  was	   added.	  RNA	  probes	  were	  stored	  at	  -­‐70	  °C.	  	  
2.9.4	  Denaturing	  RNA	  gel	  
A	  2%	  denaturing	  RNA	  gel	  was	  prepared	  by	  dissolving	  agarose	   in	  MOPS	  (3-­‐(N-­‐morpholino)propanesulfonic	   acid)	   buffer	   and	   tempering	   at	   56	   °C	   for	   30	  minutes.	   17.5	   ml	   of	   34%	   formaldehyde	   solution	   was	   added	   to	   83	   ml	   of	   the	  denaturing	  RNA	  gel	  and	  mixed	  thoroughly,	  before	  pouring	  into	  the	  gel	  cast.	  	  	  10	   μg	   of	   each	   RNA	   sample	   and	   biotin-­‐labelled	   RNA	   ladder	   was	   run	   on	   the	  denaturing	   RNA	   gel.	   The	   volumes	   of	   RNA	   samples	   and	   RNA	   ladder	   were	  adjusted	   to	   20	   μl	   with	   RNAse-­‐free	   water,	   mixed	   with	   10	   μl	   of	   RNA	   sample	  loading	  buffer,	  denatured	  at	  70	  °C	  for	  5	  minutes	  and	  immediately	  put	  on	  ice.	  20	  μl	  from	  each	  sample	  was	  carefully	  loaded	  into	  a	  well	  of	  the	  denaturing	  RNA	  gel.	  The	  gel	  was	  run	  for	  2	  hours	  and	  15	  minutes	  at	  100	  V	  in	  MOPS	  buffer	  to	  ensure	  sufficient	  separation	  of	  RNA	  size	  markers.	  	  	  The	   gel	  was	   stained	   in	   a	   DiamondTM	  Nucleic	   Acid	   dye	   (Promega,	   UK),	   diluted	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1:10,000	   in	  MOPS	   buffer,	   in	   the	   dark	   on	   a	   rocking	   platform	   at	   50	   rpm	   for	   30	  minutes.	   The	  quality	   of	  RNA	  was	  determined	  by	   the	  presence	  of	   16S	   and	  23S	  rRNA	  bands,	  when	  viewed	  under	  UV	  light.	  	  
2.9.5	  Capillary	  blotting	  
Capillary	  blotting	  apparatus	  was	  assembled	  by	  placing	  the	  lid	  of	  a	  medium-­‐sized	  box	  at	  a	  90°	  angle	  on	  top	  of	  the	  box	  filled	  with	  Transfer	  buffer.	  A	   long	  strip	  of	  standard	  filter	  paper	  was	  cut	  and	  soaked	  in	  Transfer	  buffer,	  before	  being	  placed	  on	  top	  of	  the	  lid,	  with	  the	  ends	  dipped	  in	  Transfer	  buffer.	  A	  25	  ml	  sterile	  pipette	  was	  used	  to	  roll	  across	  the	  filter	  paper	  to	  make	  it	  flat.	  The	  RNA	  gel	  was	  cut	  with	  a	  scalpel	   to	   the	  desired	  size	  and	  placed	  on	   top	  of	   the	   filter	  paper	  on	   the	   lid.	  A	  Hybond®-­‐N+	   nitrocellulose	   membrane	   (GE	   Healthcare,	   UK)	   was	   cut	   slightly	  larger	  than	  the	  gel	  and	  floated	  on	  the	  surface	  of	  RNase-­‐free	  water	  for	  5	  minutes.	  The	   membrane	   was	   submerged	   in	   RNase-­‐free	   water	   and	   then	   soaked	   for	   5	  minutes	  in	  Transfer	  buffer,	  before	  being	  placed	  on	  top	  of	  the	  gel.	  Another	  25	  ml	  sterile	   pipette	   was	   rolled	   across	   to	   exclude	   air	   bubbles.	   Two	   pieces	   of	   filter	  paper	  were	  cut	  and	  placed	  on	  top	  of	  the	  membrane,	  rolling	  across	  with	  a	  25	  ml	  sterile	   pipette	   each	   time.	   Strips	   of	   Parafilm	   M®	   were	   used	   to	   seal	   the	   area	  around	  the	  gel	  to	  prevent	  the	  bypassing	  of	  the	  capillary	  action.	  A	  large	  stack	  of	  paper	  tissues,	  with	  a	  heavy	  weight	  on	  top,	  was	  placed	  on	  the	  filter	  paper.	  This	  ensured	  that	  RNA	  would	  transfer	  from	  the	  gel	  onto	  the	  nitrocellulose	  membrane	  due	   to	   capillary	   action.	   The	   capillary	   blotting	   apparatus	   was	   incubated	  overnight	  in	  order	  to	  allow	  complete	  RNA	  transfer.	  	  
2.9.6	  Hybridisation	  
Following	   an	   overnight	   incubation,	   the	   blotting	   apparatus	   was	   disassembled	  and	   the	   nitrocellulose	   membrane	   removed	   from	   the	   top	   of	   the	   gel.	   RNA	  was	  fixed	  to	  the	  membrane	  by	  UV	  crosslinking	  at	  120,000	  mJ	  for	  2	  minutes	  and	  then	  soaked	  for	  10	  minutes	  in	  Neutralisation	  solution.	  Subsequently,	  the	  membrane	  was	  placed	  inside	  a	  hybridisation	  tube,	  with	  the	  RNA	  side	  facing	  inwards.	  20	  ml	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of	  pre-­‐warmed	  pre-­‐hybridisation	  solution	  was	  added	  to	  the	  hybridisation	  tube,	  which	  was	  then	  placed	  on	  rotation	   in	  a	  hybridisation	  oven	  for	  1	  hour	  at	  58	  °C	  (20	  °C	  below	  the	  melting	  temperature	  of	  the	  probe).	  In	  the	  meantime,	  900	  ng	  -­‐	  1	  μg	   of	   the	  RNA	  probe	  was	  mixed	  with	   10	  ml	   of	   pre-­‐warmed	  pre-­‐hybridisation	  solution,	   denatured	   at	   65	   °C	   for	   15	   minutes	   in	   a	   water	   bath	   and	   then	  immediately	   placed	   on	   ice.	   After	   a	   one-­‐hour	   incubation	   at	   58	   °C,	   the	   pre-­‐hybridisation	  solution	  was	  discarded	  from	  the	  hybridisation	  tube.	  10	  ml	  of	  the	  denatured	   RNA	   probe	   was	   added	   to	   the	   hybridisation	   tube	   with	   the	  nitrocellulose	  membrane,	  which	  was	  then	  placed	  on	  rotation	  in	  a	  hybridisation	  oven	  overnight	  at	  58	  °C.	  	  
2.9.7	  Detection	  of	  biotin-­‐labelled	  RNA	  
All	  wash	  and	  detection	  steps	  were	  carried	  out	  with	  the	  nitrocellulose	  membrane	  placed	  inside	  a	  black	  Incubation	  box	  (LI-­‐COR,	  UK).	  The	  membrane	  was	  washed	  twice	  with	   50	  ml	   of	  Wash	   solution	   I	   for	   5	  minutes.	   It	  was	   then	  washed	   three	  times	   for	  15	  minutes	  with	  50	  ml	  of	  Wash	  solution	   II	  at	  58	   °C	   in	  a	  water	  bath.	  Subsequently,	   the	   membrane	   was	   washed	   with	   30	   ml	   of	   Wash	   buffer	   for	   5	  minutes	  on	  a	  rocking	  platform	  at	  100	  rpm	  and	  incubated	  in	  15	  ml	  of	  Odyssey®	  Blocking	  buffer	   (LI-­‐COR,	  UK)	   for	  30	  minutes	  on	  a	   rocking	  platform	  at	  50	  rpm.	  1.5	   μl	   of	   IRDye®	   800CW	   Streptavidin	   (LI-­‐COR,	   UK)	  was	   added	   directly	   to	   the	  blot	  submerged	   in	  the	  Odyssey®	  blocking	  buffer.	  The	  membrane	  was	   left	   for	  a	  further	  30	  minutes	  at	  50	  rpm.	  Finally,	  the	  membrane	  was	  washed	  twice	  with	  30	  ml	  of	  Wash	  buffer	   for	  30	  minutes.	  Northern	  blots	  were	  visualized	  using	  IR740	  Module	  lighting	  and	  LY800	  filter,	  with	  a	  ten-­‐minute	  exposure.	  	  
2.10	  Cell	  culture	  
2.10.1	  Maintenance	  
The	  human	  alveolar	  epithelial	  cell	   line	  A549	  was	  kindly	  provided	  by	  Dr	  Meera	  Unnikrishnan.	  Cells	  were	  routinely	  grown	  in	  T75	  flasks	  in	  a	  5%	  CO2	  incubator	  at	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37	   °C.	   The	   cell	   culture	  medium	   used	   was	   Dulbecco's	   Modified	   Eagle	  medium	  (DMEM),	   supplemented	   with	   10%	   fetal	   bovine	   serum	   (FBS)	   and	   1	   U/ml	  penicillin/streptomycin.	   A549	   stocks	   were	   stored	   at	   -­‐70	   °C	   in	   the	   freezing	  medium:	  50%	  DMEM,	  40%	  FBS,	  10%	  dimethyl	  sulphoxide	  (DMSO).	  	  
2.10.2	  Passage	  
Cells	  were	   passaged	   upon	   reaching	   90%-­‐100%	   confluence.	   Briefly,	   cells	  were	  washed	   twice	  with	  warm	  phosphate-­‐buffered	   saline	   (PBS)	   and	  detached	   from	  the	   surface	   of	   the	   flask	   by	   incubating	   in	   1.5-­‐2	   ml	   of	   trypsin/EDTA	   for	   4-­‐5	  minutes	  at	  37	  °C.	  10	  ml	  of	  warm	  cell	  culture	  medium	  was	  then	  added	  to	  the	  cells	  and	   they	  were	   centrifuged	   at	   1,000	   rpm	   for	   5	  minutes.	   The	   supernatant	  was	  removed	  and	  cells	  were	  resuspended	  in	  warm	  cell	  culture	  medium.	  If	  required,	  A549	   cells	  were	   quantified	   by	   pipetting	   10	   μl	   of	   the	   cell	   suspension	   onto	   the	  haemocytometer	  and	  counting	  viable	  cells	  under	  the	  light	  microscope.	  	  
2.10.3	  Infection	  with	  H.	  influenzae	  
A549	  cells	  in	  the	  media	  without	  antibiotics	  were	  seeded	  at	  the	  concentration	  of	  4x105	  cells/ml	  in	  6-­‐well	  or	  24-­‐well	  plates	  and	  grown	  overnight	  to	  a	  confluence	  of	   80-­‐90%.	   Bacterial	   cultures	   were	   grown	   to	   mid-­‐exponential	   phase,	  centrifuged	  at	  7,000	  rpm	  for	  7	  minutes,	  washed	   in	  warm	  PBS	  and	  centrifuged	  again	  at	  7,000	  rpm	  for	  7	  minutes.	  Bacterial	  cells	  were	  resuspended	  in	  infection	  medium	   without	   antibiotics	   and	   were	   used	   to	   infect	   A549	   cells	   at	   a	   set	  multiplicity	  of	  infection	  (MOI).	  	  	  
2.10.4	  Invasion	  of	  A549	  cells	  
H.	  influenzae	   invasion	  was	   studied	  by	   infecting	  A549	  cells	   for	   a	   set	   amount	  of	  time	  and	  quantifying	   intracellular	  bacterial	  numbers.	  Optimisation	  of	   infection	  time	  is	  described	  in	  section	  4.2.1.1.	  Extracellular	  bacteria	  were	  killed	  by	  treating	  the	   infected	   monolayer	   with	   infection	   medium	   containing	   200	   μg/ml	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gentamicin	   for	   1	   hour.	   Cells	  were	   then	  washed	   several	   times	  with	  warm	  PBS	  and	   lysed	   either	  with	   0.025%	   saponin	   (VWR	   International,	   UK)	   in	   PBS	   for	   10	  minutes	  at	  37	  °C	  or	  with	  0.5%	  TritonTM	  X-­‐100	   in	  PBS	   for	  10	  minutes	  at	  37	  °C.	  Viable	  cell	  counts	  were	  performed	  as	  described	  below	  (see	  section	  2.10.5).	  	  
2.10.5	  Growth	  of	  H.	  influenzae	  in	  the	  infection	  medium	  
The	   effect	   of	   the	  FBS	  on	   the	   viability	   of	  H.	   influenzae	   in	   the	   infection	  medium	  was	   tested	   as	   follows.	   Bacterial	   broth	   cultures	   were	   grown	   in	   sBHI	   to	   mid-­‐exponential	  phase,	  centrifuged	  at	  7,000	  rpm	  for	  7	  minutes,	  washed	  in	  warm	  PBS	  and	   centrifuged	   again	   at	   7,000	   rpm	   for	   7	   minutes.	   The	   supernatant	   was	  removed	   and	   bacteria	   were	   resuspended	   in	   warm	   infection	   medium	   without	  antibiotics.	  The	  infection	  medium	  was	  either	  without	  FBS	  or	  with	  2%,	  5%	  and	  10%	   FBS.	   Bacterial	   cultures	   were	   diluted	   to	   OD600	   of	   0.1	   and	   growth	   was	  measured	  at	  1.5	  and	  3	  hours.	  For	  viable	  cell	  counts,	  100	  μl	  of	  bacterial	  cultures	  were	   serially	   diluted,	   pipetted	   onto	   sBHI	   agar	   plates	   and	  distributed	   over	   the	  agar	  surface	  using	  sterile	  colony	  spreaders.	  Agar	  plates	  were	  kept	  in	  a	  5%	  CO2	  incubator	  at	  37	  °C	  and	  single	  H.	  influenzae	  colonies	  were	  counted	  the	  following	  day.	  	  
2.10.6	  Fluorescence	  staining	  of	  infected	  cells	  
For	  fluorescence	  staining,	  A549	  cells	  were	  seeded	  at	  the	  concentration	  of	  4x105	  cells/ml	   in	   a	   sterile	   4-­‐well	   NuncTM	   Lab-­‐TekTM	   II	   Chamber	   SlideTM	   (Thermo	  Fisher	  Scientific,	  UK).	  1	  hour	  and	  30	  minutes	  before	  infection	  with	  H.	  influenzae,	  A549	   cells	   were	   stained	   for	   45	   minutes	   with	   5	   μg/ml	   FM®	   4-­‐64	   lipophilic	  membrane	   dye,	   diluted	   in	   the	   cell	   culture	   medium	   (Vida	   and	   Emr,	   1995).	  Subsequently,	  cells	  were	  washed	  twice	  in	  warm	  PBS	  and	  grown	  for	  another	  45	  minutes,	  before	  proceeding	  with	  H.	  influenzae	  infection	  as	  described	  previously	  (see	  section	  2.10.4).	  Cells	  were	  fixed	  with	  1	  ml	  of	  4%	  paraformaldehyde	  (PFA)	  for	  10	  minutes	  at	  RT,	  washed	  twice	   in	  PBS	  and	  stained	  for	  5	  minutes	  with	  the	  nuclear	  counterstain,	  4',6-­‐diamidino-­‐2-­‐phenylindole	  (DAPI),	  diluted	  in	  PBS	  to	  a	  concentration	  of	  250	  ng/ml.	  The	  chamber	  and	   the	  gasket	  were	   removed	   from	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the	  Chamber	  SlideTM	  and	  images	  of	  fluorescent	  cells	  were	  taken	  on	  a	  Leica	  DMi8	  inverted	  fluorescence	  microscope	  at	  100x	  magnification	  with	  oil	  immersion.	  	  	  
2.11	  RNA	  extraction	  from	  infected	  human	  cells	  The	  infected	  monolayer	  of	  A549	  cells	  was	  directly	  treated	  with	  1	  ml	  of	  QIAzol®	  reagent	   and	  RNA	  was	   subsequently	   extracted	   using	   the	  miRNeasy	  Mini	   kit	   as	  described	  previously	  (see	  section	  2.7.2).	  	  
2.11.1	  Enrichment	  of	  bacterial	  RNA	  
MicrobEnrichTM	   kit	   (Thermo	   Fisher	   Scientific,	   UK)	   was	   used	   to	   deplete	  eukaryotic	   RNA	   from	   a	   mixed	   sample	   containing	   bacterial	   and	   human	   RNA,	  according	  to	  manufacturer's	  instructions.	  MicrobEnrichTM	  Oligo	  MagBeads	  were	  placed	   in	   an	   RNase-­‐free	   tube	   on	   a	   magnetic	   rack	   for	   3	   minutes	   and	   the	  supernatant	  was	  removed.	  Beads	  were	   then	  washed	  once	   in	  RNase-­‐free	  water	  and	  once	  in	  MicrobEnrichTM	  Binding	  buffer	  by	  incubating	  them	  on	  the	  magnetic	  rack	   for	   3	   minutes	   and	   removing	   the	   supernatant.	   Beads	   were	   stored	   on	   ice	  until	  required.	  	  27	  μg	  of	  total	  RNA	  in	  30	  μl	  was	  combined	  with	  300	  μl	  of	  MicrobEnrichTM	  Binding	  buffer	  and	  12	  μl	  of	  MicrobEnrichTM	  Capture	  Oligo	  mix.	  RNA	  was	  then	  denatured	  at	   70	   °C	   for	   10	  minutes	   and	   the	   samples	  were	   incubated	   at	   37	   °C	   for	   1	   hour.	  They	  were	   then	  mixed	  with	  MicrobEnrichTM	  Oligo	  MagBeads	  and	   incubated	  at	  37	  °C	  for	  15	  minutes.	  Tubes	  were	  placed	  on	  the	  magnetic	  rack	  for	  3	  minutes	  and	  the	  supernatant,	  containing	  enriched	  RNA,	  transferred	  to	  a	  new	  tube.	  The	  beads	  were	   resuspended	   in	   100	   μl	   of	   pre-­‐warmed	   MicrobEnrichTM	   Wash	   solution,	  incubated	  at	  37	   °C	   for	  5	  minutes	  and	  placed	  again	  on	   the	  magnetic	   rack	   for	  3	  minutes.	  The	  supernatant,	  containing	  any	  remaining	  enriched	  RNA,	  was	  pooled	  with	  the	  previously	  kept	  supernatant.	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RNA	   was	   precipitated	   for	   1	   hour	   at	   -­‐20	   °C	   with	   0.1x	   volume	   of	   3	   M	   sodium	  acetate,	   4	   μl	   glycogen	   (5	   mg/ml)	   and	   2.5x	   volume	   of	   ice-­‐cold	   100%	   ethanol.	  Samples	  were	   centrifuged	   at	   13,000	   rpm	   for	   30	  minutes	   and	   the	   supernatant	  discarded.	   RNA	   pellets	   were	   washed	   twice	   with	   750	   μl	   of	   70%	   ethanol	   by	  centrifuging	   at	   13,000	   rpm	   for	  5	  minutes.	   Tubes	  were	  briefly	   centrifuged	   and	  any	  remaining	  supernatant	  was	  carefully	  removed.	  RNA	  pellets	  were	  air-­‐dried	  for	  5	  minutes	  and	  resuspended	  in	  50	  μl	  of	  RNase-­‐free	  water.	  	  
2.12	  Bioinformatic	  data	  analysis	  
2.12.1	  H.	  influenzae	  genome	  sequences	  
Whole-­‐genome	   reference	   sequences	   of	   Rd	   and	   R2866	   strains	   were	   available	  from	   the	   NCBI	   database	   (http://www.ncbi.nlm.nih.gov).	   Accession	   numbers	  were	  NC_000907	  for	  Rd	  and	  CP002277	  for	  R2866.	  	  
2.12.2	  Whole-­‐genome	  assembly	  
SPAdes	  software	  was	  used	  to	  assemble	  sequencing	  reads	  into	  joined	  contiguous	  sequences	   (contigs)	   (Bankevich	   et	   al.,	   2012).	   "Careful"	   mode	   was	   selected	   to	  reduce	   the	   number	   of	   mismatches	   as	   well	   as	   short	   insertions	   and	   deletions	  (indels).	   QUAST,	   included	   in	   SPAdes	   software,	   was	   used	   to	   assess	   the	  whole-­‐genome	   assembly	   properties	   (Gurevich	   et	   al.,	   2013).	   Contigs	  were	   removed	   if	  they	   were	   shorter	   than	   200	   bp	   and	   the	   read	   coverage	   was	   lower	   than	   10x.	  Mauve	  was	  used	  to	  align	  contigs	  to	  the	  appropriate	  reference	  genome	  sequence	  from	  the	  NCBI	  database	  (Darling	  et	  al.,	  2004).	  The	  Mauve	  Contig	  Mover	  module	  was	   subsequently	   used	   to	   reorder	   contigs	   based	   on	   Rd	   or	   R2866	   reference	  genome	   (see	   section	   2.12.1)	   (Rissman	   et	   al.,	   2009).	   Ordered	   contigs	   were	  concatenated	   into	  one	   complete	   sequence	  with	   the	  EMBOSS	  union	  online	   tool	  (http://www.bioinformatics.nl/cgi-­‐bin/emboss/union).	   Qualimap	   was	   used	   to	  determine	  read	  coverage	  of	  each	  assembled	  genome	  after	  mapping	  sequencing	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reads	  against	  the	  assembled	  genome	  (see	  section	  2.12.5)	  (Garcia-­‐Alcalde	  et	  al.,	  2012).	  	  	  
2.12.3	  Whole-­‐genome	  annotation	  
Prokka	  was	  used	  to	  annotate	  sequenced	  whole	  genomes	  of	  H.	  influenzae	  Rd	  and	  R2866	   strains	   (Seemann,	   2014).	   It	   was	   important	   to	   retain	   the	   original	  annotation	  of	  genome	  sequences	  of	  these	  strains.	  Hence,	  the	  makeblastdb	  (part	  of	   BLAST+	   package)	   command-­‐line	   tool	   was	   used	   to	   create	   a	   genus	   database	  from	   the	   reference	   genome	   sequences	   (Camacho	   et	   al.,	   2009).	   The	   genus	  database	  was	  used	  during	  Prokka	  annotation	  of	  sequenced	  genomes.	  	  
2.12.4	  Sequence	  comparison	  and	  visualisation	  
Whole-­‐genome	   and	   RNA-­‐Seq	   data	   were	   visualised	   in	   the	   Artemis	   genome	  browser	   (Rutherford	   et	   al.,	   2000).	   The	   Artemis	   Comparison	   Tool	   (ACT)	   was	  used	  to	  compare	  the	  genomes	  of	  Rd	  and	  R2866	  strains	  (Carver	  et	  al.,	  2005).	  For	  this	   purpose,	   comparison	   files	   were	   generated	   with	   an	   online	   tool	   WebACT	  (http://www.webact.org/WebACT/home)	   using	   the	   BLASTn	   algorithm	   with	  default	  parameters.	  The	  average	  nucleotide	  identity	  (ANI)	  was	  calculated	  using	  best	  hit	  and	  reciprocal	  best	  hit	  methods	  (http://enve-­‐omics.ce.gatech.edu/ani/)	  (Goris	  et	  al.,	  2007).	  	  
2.12.5	  Mapping	  and	  processing	  sequencing	  reads	  
Paired-­‐end	  reads	  from	  RNA-­‐Seq	  experiments	  were	  in	  the	  opposite	  orientation:	  the	   first	   read	  was	   reverse	   (3'-­‐5')	   and	   the	   second	   read	  was	   forward	   (5'-­‐3').	   In	  order	  to	  visualize	  mapped	  RNA-­‐Seq	  reads	  in	  Artemis,	  they	  needed	  to	  be	  of	  the	  same	   orientation.	   Hence,	   the	   first	   read	   was	   reverse	   complemented	   using	   the	  seqtk	   command-­‐line	   tool,	   so	   that	   both	   reads	  were	   in	   the	   forward	   orientation.	  This	  was	  not	  required	  for	  whole-­‐genome	  sequencing	  reads.	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The	  reference	  genome	  was	   indexed	  using	  bowtie2-­‐build	  command	  (Langmead	  and	  Salzberg,	  2012).	  Sequencing	  reads	  were	  mapped	   to	   the	  reference	  genome	  using	   bowtie2	   software	   (Langmead	   and	   Salzberg,	   2012).	   Read	   alignment	   data	  was	   generated	   in	   SAM	   (sequence	   alignment/map)	   file	   format.	   SAMtools	   was	  used	   to	   convert	   alignment	   data	   to	   BAM	   (binary	   alignment/map)	   file	   format,	  which	   is	   a	   binary	   version	   of	   SAM	   file	   format	   (Li	   et	   al.,	   2009).	   SAMtools	   was	  subsequently	  used	  to	  sort	  and	  index	  BAM	  files.	  	  	  
2.12.6	  Genome	  variant	  calling	  
The	   SAMtools	   command	   "mpileup"	  was	   used	   to	   generate	   a	   pileup	   format	   file	  from	  a	  sorted	  BAM	  file	  and	  a	  FASTA	  file	  of	  the	  reference	  genome	  (Li	  et	  al.,	  2009).	  This	  was	  used	  as	  input	  for	  VarScan2	  software,	  which	  identifies	  single	  nucleotide	  polymorphisms	   (SNP)	   and	   indels	   present	   between	   two	   genome	   sequences	  (Koboldt	  et	  al.,	  2012).	  The	  minimum	  read	  coverage	  was	  set	  to	  20.	  The	  minimum	  number	   of	   reads	   needed	   to	   support	   SNP	   or	   an	   indel	   was	   chosen	   as	   15.	   The	  minimum	   quality	   for	   a	   bp	   was	   set	   to	   30.	   The	   minimum	   allele	   frequency	  threshold	   was	   0.9.	   Finally,	   the	   minimum	   allele	   frequency	   to	   be	   called	   a	  homozygote	  was	  set	  to	  0.9.	  	  
2.12.7	  Differential	  gene	  expression	  analysis	  
The	  R	  package	  DESeq2	  uses	  a	  negative	  binomial	  distribution	  model	   to	   test	   for	  the	  differential	  expression	  in	  RNA-­‐Seq	  data	  (Love	  et	  al.,	  2014).	  Sorted	  BAM	  and	  GFF	  (general	  feature	  format)	  files	  were	  used	  as	  input	  for	  the	  coverageBed	  tool,	  outputting	   a	   text	   file	  with	   read	   coverage	   information	   for	   every	   feature	   in	   the	  genome.	   These	   text	   files,	   one	   per	   biological	   replicate,	   were	   used	   as	   input	   for	  DESeq2.	   P-­‐values	   were	   adjusted	   for	   a	   false	   discovery	   rate	   at	   5%	   using	   the	  Benjamini-­‐Hochberg	   method	   (Benjamini	   and	   Hochberg,	   1995).	   Data	   were	  further	  filtered	  by	  applying	  a	  standard	  cut-­‐off	  of	  2	  for	  the	  fold	  change	  and	  0.05	  for	  adjusted	  p-­‐value	  (Baddal	  et	  al.,	  2015).	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2.12.8	  Analysis	  of	  enriched	  functional	  groups	  
DAVID	  (Database	   for	  Annotation,	  Visualization,	  and	   Integrated	  Discovery) was	  used	   to	   identify	   gene	   ontology	   (GO)	   terms	   and	  Kyoto	   Encyclopaedia	   of	   Genes	  and	   Genomes	   (KEGG)	   pathways	   that	   were	   enriched	   in	   lists	   of	   differentially	  expressed	   genes	   (Huang	   da	   et	   al.,	   2009a,	   Huang	   da	   et	   al.,	   2009b).	   Reference	  Sequence	   (RefSeq)	  protein	   identifiers	   for	   every	   gene	   from	  a	   list	  were	  used	   as	  input.	   KEGG	   pathway	   diagrams	   were	   generated	   using	   KEGG	   Mapper	  (http://www.kegg.jp/kegg/tool/map_pathway2.html).	  	  
2.12.9	  TPM	  normalisation	  
For	  absolute	  expression	  analysis,	  RNA-­‐Seq	  data	  was	  manually	  normalised	  using	  the	  Transcripts	  per	  Million	  (TPM)	  method	  (Wagner	  et	  al.,	  2012).	  	  
2.12.10	  BLAST	  
All	   BLAST	   searches	   were	   performed	   online	   on	   the	   BLAST	   server	  (http://blast.ncbi.nlm.nih.gov)	   or	   using	   the	  BLAST+	   package	   on	   the	   command	  line	  (Camacho	  et	  al.,	  2009).	  Homology	  search	  of	  ncRNAs	  was	  carried	  out	  using	  the	  E-­‐value	  cut-­‐off	  of	  1e-­‐05.	  	  
2.12.11	  Identification	  of	  ncRNAs	  
Sorted	  BAM	  files	  and	  a	  GFF	  file,	  containing	  coordinates	  of	  the	  coding	  sequences,	  were	   used	   as	   input	   for	   coverageBed	   and	   genomeCoverageBed	   command-­‐line	  tools,	   which	   are	   both	   part	   of	   the	   BEDTools	   suite	   (Quinlan	   and	   Hall,	   2010).	  CoverageBed	   was	   used	   to	   produce	   read	   coverage	   information	   for	   each	  nucleotide	   that	   is	   present	   in	   every	   coding	   sequence	   in	   a	   genome.	  GenomeCoverageBed	  was	  used	  to	  produce	  read	  coverage	   information	  for	  each	  nucleotide	  in	  the	  genome:	  on	  both	  strands	  and	  for	  each	  strand	  separately.	  These	  files	   were	   used	   as	   input	   for	   a	   Python	   script,	   which	   was	   written	   in-­‐house	   to	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identify	   ncRNA	   sequences	   from	   RNA-­‐Seq	   data.	   See	   Chapter	   5	   for	   a	   detailed	  description	  of	  the	  script.	  	  
2.12.12	  RNA	  and	  protein	  family	  analysis	  
Protein	  domain	  and	  family	  analysis	  was	  carried	  out	  using	  the	  InterPro	  database	  (Mitchell	  et	  al.,	  2015).	  The	  Rfam	  database	  was	  used	  to	  identify	  homologues	  from	  known	  RNA	  families	  (Griffiths-­‐Jones	  et	  al.,	  2003,	  Nawrocki	  et	  al.,	  2015).	  	  
2.12.13	  RNA	  secondary	  structure	  and	  gene	  targets	  
Secondary	   RNA	   structure	   was	   predicted	   using	   the	   RNAfold	   web	   server	  (Hofacker	  and	  Stadler,	  2006).	  Homologues	  of	  ncRNAs	  were	  identified	  using	  the	  GLASSgo	   online	   tool,	   using	   the	   "very	   high	   specificity"	   option	  (http://rna.informatik.uni-­‐freiburg.de).	   Five	   homologous	   sequences	  were	   then	  used	   to	   predict	   potential	   gene	   targets	   using	   CopraRNA	   (Wright	   et	   al.,	   2013,	  Wright	  et	  al.,	  2014).	  Potential	  target	  sequences	  were	  analysed	  75	  bp	  around	  the	  start	  codon	  of	  each	  gene.	  	  
2.12.14	  Figure	  generation	  and	  statistical	  analysis	  
Microsoft	   Excel	   was	   used	   to	   produce	   simple	   graphs	   of	   numeric	   data.	   False	  colour	   heatmaps	   were	   generated	   in	   R	   using	   the	   "heatmap.2"	   function	   of	   the	  "gplots"	   package.	   The	   Circos	   tool	  was	   used	   to	   visualize	   the	   genomic	   data	   in	   a	  circularized	   layout	   (Krzywinski	   et	   al.,	   2009).	   Venn	   diagrams	   were	   generated	  with	   the	   online	   tool	   Venny	   (http://bioinfogp.cnb.csic.es/tools/venny/).	   Image	  analysis	  was	  performed	  using	  the	  Fiji	   image	  processing	  package	  (Schindelin	  et	  al.,	  2012).	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Chapter	  3:	  Whole-­‐genome	  analysis	  and	  
comparison	  of	  Rd	  and	  R2866	  strains	  of	  H.	  
influenzae	  
3.1	  Introduction	  The	   accumulation	   of	   small	   genetic	   variations	   in	   descendants	   of	   the	   original	  bacterial	   strain	   can	   result	   in	  phenotypic	  differences	  between	   the	   same	  strains	  present	   in	   different	   laboratories,	   as	   described	   in	   section	   1.1.6.	   The	   use	   of	  original	  whole	  genome	  sequences	  of	  H.	  influenzae	  strains	  to	  infer	  the	  behaviour	  of	   other	   descendants	   of	   the	   same	   strain	   could	   therefore	   introduce	   potential	  inaccuracies	  in	  generated	  data.	  Hence	  one	  of	  the	  major	  aims	  of	  this	  chapter	  was	  to	  re-­‐sequence	  whole	  genomes	  of	  Rd	  and	  R2866	  strains	  of	  H.	  influenzae	  and	  to	  explore	   any	   potential	   nucleotide-­‐level	   variants	   between	   re-­‐sequenced	   and	  original	   published	   whole	   genome	   sequences.	   This	   was	   also	   relevant	   for	  subsequent	   RNA-­‐Seq	   experiments,	   where	   an	   accurate	   reference	   genome	   was	  required	   for	   mapping	   sequencing	   reads,	   in	   order	   to	   correctly	   deduce	   the	  transcriptional	   landscape	   of	  H.	   influenzae	  during	   infection-­‐relevant	   conditions	  (see	  Chapter	  4).	  	  Genome	   annotation	   methods	   are	   being	   constantly	   improved,	   due	   to	  development	  of	   superior	  gene	  prediction	  algorithms	  as	  well	  as	  new	  published	  functional	  data	   (Stothard	  and	  Wishart,	  2006).	  Therefore,	   it	   is	  advantageous	   to	  use	   the	   most	   recent	   genome	   annotations,	   to	   ensure	   up-­‐to-­‐date	   information	  about	  protein-­‐coding	  sequences.	  Still,	  automated	  genome	  annotation	  tools	  also	  pose	   some	   caveats,	   including	   inconsistent	   annotation	   of	   homologous	   regions	  and	   abundance	   of	   hypothetical	   proteins	   (Richardson	   and	   Watson,	   2013).	   In	  addition,	  sequencing	  errors	  could	  result	  in	  mis-­‐annotation	  of	  a	  subset	  of	  genes.	  Therefore,	   whole-­‐genome	   re-­‐sequencing	   and	   re-­‐annotation	   of	   Rd	   and	   R2866	  strains	   in	   this	   study	   was	   used	   to	   infer	   any	   previous	   annotation	   issues.	  Furthermore,	  an	  up-­‐to-­‐date	  genome	  re-­‐annotation	  also	  ensured	  inclusion	  of	  the	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latest	   bacterial	   genome	   features,	   which	   was	   again	   relevant	   for	   subsequent	  differential	  gene	  expression	  analysis	  (see	  Chapter	  4).	  	  The	   availability	   of	   whole-­‐genome	   sequences	   for	   different	   bacterial	   strains	  enables	   characterisation	   of	   their	   important	   genetic	   features,	   such	   as	   core	   and	  accessory	  genomes	  (see	  section	  1.1.5.2.1).	  The	  accessory	  genome	   in	  particular	  can	  help	  to	  explain	  strain-­‐specific	  phenotypes,	  as	  it	  may	  contain	  genes	  required	  for	   survival	   in	   certain	   environments.	   Thus	   the	   knowledge	   of	   differential	  presence	   of	   accessory	   genes	   is	   important	   in	   order	   to	   understand	   different	  behaviours	   of	   bacterial	   strains	   under	   a	   variety	   of	   growth	   conditions	   and	  stresses.	   The	   second	   major	   aim	   of	   this	   chapter	   was	   therefore	   to	   use	   whole-­‐genome	   sequencing	   to	   characterise	   the	   accessory	   genome	   of	   Rd	   and	   R2866	  strains	  and	   to	  use	   that	   to	   infer	  possible	  phenotypic	  differences	  between	   these	  strains.	  In	  addition,	  the	  description	  of	  the	  accessory	  genome	  was	  again	  relevant	  for	   subsequent	   RNA-­‐Seq	   experiments,	   where	   accessory	   genes	   were	   likely	   to	  help	   to	   explain	   some	   of	   the	   differences	   in	   the	   response	   of	   Rd	   and	   R2866	   to	  infection-­‐relevant	  conditions	  (see	  Chapter	  4).	  	  	  
3.2	  Results	  
3.2.1	   Whole-­‐genome	   re-­‐sequencing	   of	   Rd	   and	   R2866	  
strains	  
Assembly	  properties	  of	  re-­‐sequenced	  whole	  genomes	  of	  Rd	  and	  R2866	  strains	  are	  displayed	  in	  Table	  3.1.	  N50	  is	  a	  standard	  statistical	  measure	  of	  the	  size	  and	  quality	  of	   the	  assembly,	  where	  at	   least	  half	  of	  all	  nucleotides	   in	  the	  assembled	  genome	   belong	   to	   the	   contig	   of	   size	   N50	   or	   larger.	   High	   N50	   values	   are	  indicative	  of	   a	   good	  assembly	  quality,	  which	  was	   true	   for	  both	  Rd	  and	  R2866	  strains	   (>100,000).	   Filtering	   assembled	   contigs	  by	   their	   length	   (>200	  bp)	   and	  coverage	  (>10x)	  reduced	  the	  total	  number	  of	  contigs	  from	  125	  to	  26	  for	  Rd	  and	  from	  147	  to	  29	  for	  R2866.	  Filtered	  contigs	  were	  ordered	  based	  on	  the	  original	  published	   sequence	   and	   then	   concatenated	   into	   one	   contiguous	   sequence,	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which	   was	   used	   for	   all	   subsequent	   analyses.	   Both	   strains	   had	   high	   genome	  coverage	  values,	  with	  411x	  for	  the	  R2866	  strain	  and	  509x	  for	  the	  Rd	  strain.	  In	  addition,	   prior	   to	   calling	   nucleotide-­‐level	   genome	   variants,	   reads	   of	   re-­‐sequenced	   genomes	   were	   mapped	   to	   original	   whole	   genomes.	   Mapping	  properties	  are	  described	  in	  Table	  3.1	  as	  well.	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Table	   3.1:	   Whole-­‐genome	   assembly	   and	   mapping	   properties	   for	   re-­‐
sequenced	  Rd	  and	  R2866	  strains.	  	  
Assembly	  and	  mapping	  features	   Rd	   R2866	  Total	  number	  of	  reads	   3,876,150	   3,334,598	  Total	  number	  of	  contigs	   125	   147	  Largest	  contig	  length	  (bp)	   513,049	   629,744	  N50	   128,059	   362,305	  Number	  of	  filtered	  contigs	  (>200	  bp	  length;	  >10x	  coverage)	   26	   29	  Genome	  size	  (bp)	   1,798,888	   1,909,348	  GC	  content	  (%)	   38.0	   38.0	  Genome	  coverage	   509x	   411x	  Percentage	  of	  reads	  mapped	  to	  original	  reference	  genome	  (%)	   99.37	   98.79	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3.2.2	   Comparison	   of	   original	   and	   re-­‐sequenced	   whole	  
genomes	  of	  Rd	  and	  R2866	  
3.2.2.1	  Identification	  of	  SNPs	  SNPs	  are	  a	   form	  of	  nucleotide-­‐level	  genetic	  variation,	   each	  one	   representing	  a	  difference	   in	   a	   single	   nucleotide	   between	   two	   DNA	   sequences.	   In	   this	   study,	  SNPs	   were	   identified	   between	   the	   original	   and	   re-­‐sequenced	   Rd	   and	   R2866	  whole	   genomes.	   The	   original	   genome	   was	   used	   as	   a	   reference	   for	   detecting	  SNPs,	  while	  the	  re-­‐sequenced	  genome	  was	  a	  query.	  	  	  While	  no	  SNPs	  were	  discovered	  for	  the	  R2866	  strain,	  122	  SNPs	  were	  originally	  identified	  for	  Rd.	  However,	  37	  of	  these	  were	  called	  SNPs	  by	  the	  software	  due	  to	  the	   presence	   of	   an	   "N"	   nucleotide	   in	   the	   original	   published	   sequence,	   which	  meant	   that	   it	   could	   be	   any	   of	   the	   four	   nucleotides.	   Therefore,	   these	  were	   not	  true	   SNPs	   and	   were	   subsequently	   filtered	   out.	   In	   addition,	   there	   were	  ambiguous	   nucleotides	   present	   in	   the	   reference	   genome,	   representing	   any	   of	  the	  two	  possible	  nucleotides.	  If	  a	  query	  nucleotide	  was	  part	  of	  the	  possible	  pair	  of	  the	  ambiguous	  nucleotide	  in	  a	  reference,	  it	  was	  further	  filtered	  out.	  The	  final	  number	  of	  SNPs	  was	  41,	  of	  which	  14	  were	  present	  in	  intergenic	  regions.	  	  	  A	   list	  of	  27	  SNPs	   identified	  only	   in	   the	  coding	  sequences	   is	  displayed	   in	  Table	  3.2.	   The	   majority	   of	   SNPs	   were	   non-­‐synonymous,	   meaning	   that	   there	   was	   a	  change	  in	  the	  amino	  acid	  sequence	  of	  a	  protein.	  Only	  three	  SNPs	  were	  definitely	  synonymous	  (no	  changes	   in	   the	  amino	  acid	  sequence),	  while	   three	  more	  SNPs	  were	   undetermined,	   due	   to	   the	   ambiguity	   of	   the	   reference	   nucleotide.	   Most	  genes	   contained	   only	   one	   SNP,	   with	   the	   exception	   of	   HI0635,	   coding	   for	   a	  hemoglobin-­‐binding	  protein,	  which	  contained	   three	  non-­‐synonymous	  SNPs,	   as	  well	  as	  gene	  oppA,	  coding	  for	  an	  oligopeptide	  ABC	  transporter	  substrate-­‐binding	  protein,	  with	  two	  non-­‐synonymous	  SNPs.	  There	  were	  six	  SNPs	  present	  in	  genes	  coding	  for	  iron-­‐associated	  proteins.	  SNPs	  were	  also	  located	  in	  a	  mutS	  gene	  and	  a	  
vacB	   gene,	  which	   are	   associated	  with	   increased	  mutation	   rates	   and	   virulence	  respectively	  (Tobe	  et	  al.,	  1992,	  LeClerc	  et	  al.,	  1996).	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Table	   3.2:	   Strand-­‐specific	   SNPs	   present	   in	   coding	   sequences	   of	   the	   Rd	  
strain.	   The	   original	   (reference;	   Ref)	   and	   re-­‐sequenced	   (query;	   Que)	   genomes	  were	  compared.	  
Coordinate	  
(bp)	   Ref	   Que	   Gene	   Gene	  product	  
Amino	  acid	  
substitution	  29688	   T	   A	   lipB	   Lipoate-­‐protein	  ligase	  B	   V	  to	  D	  120631	   G/T	   A	   hemR	   Haemin	  receptor	   L	  to	  Q	  /	  R	  to	  Q	  153123	   A/G	   T	   dnaQ	   DNA	  polymerase	  III	  subunit	  epsilon	   C	  to	  F	  /	  Y	  to	  F	  224090	   C/T	   A	   dam	   DNA	  adenine	  methylase	   V	  to	  E	  /	  A	  to	  E	  318285	   C	   G	   menD	   2-­‐succinyl-­‐5-­‐enolpyruvyl-­‐6-­‐hydroxyl-­‐3-­‐cyclohexene-­‐1-­‐carboxylate	  synthase	   L	  to	  V	  597898	   T	   G	   fusA	   Elongation	  factor	  G	   Y	  to	  D	  673657	   C	   T	   HI0634	   tRNA-­‐dihydrouridine	  synthase	  A	   Y	  677077	   A	   T	   HI0635	   Hemoglobin-­‐binding	  protein	   R	  to	  S	  677154	   A	   G	   HI0635	   Hemoglobin-­‐binding	  protein	   I	  to	  V	  677157	   A	   G	   HI0635	   Hemoglobin-­‐binding	  protein	   I	  to	  V	  705310	   C	   G	   oapA	   Hemoglobin-­‐binding	  protein	   N	  to	  K	  753312	   T	   G	   mutS	   DNA	  mismatch	  repair	  protein	  MutS	   S	  to	  A	  760386	   T	   C	   HI0712	   Hemoglobin-­‐binding	  protein	   N	  765944	   G	   C	   nusG	   Transcription	  antitermination	  protein	  NusG	   M	  to	  I	  785858	   T	   A	   HI0730	   Organic	  solvent	  tolerance	  protein	   V	  to	  D	  911339	   G/T	   C	   vacB	   Virulence-­‐associated	  protein	   H	  /	  Q	  to	  H	  932583	   A/C	   G	   rplU	   50S	  ribosomal	  protein	  L21	   L	  to	  V	  /	  M	  to	  V	  991151	   G/T	   A	   eno	   Phosphopyruvate	  hydratase	   E	  /	  D	  to	  E	  1072736	   A	   T	   ispH	   4-­‐hydroxy-­‐3-­‐methylbut-­‐2-­‐enyl	  diphosphate	  reductase	   E	  to	  D	  1073376	   G/T	   A	   HI1008	   Hypothetical	  protein	   A	  to	  T	  /	  S	  to	  T	  1135980	   T	   A	   hrpA	   ATP-­‐dependent	  RNA	  helicase	  HrpA	   V	  to	  E	  1191409	   A	   G	   oppA	   Oligopeptide	  ABC	  transporter	  substrate-­‐binding	  protein	   T	  to	  A	  
1191430	   A	   G	   oppA	   Oligopeptide	  ABC	  transporter	  substrate-­‐binding	  protein	   T	  to	  A	  1473587	   C/T	   A	   sbcB	   Exonuclease	  I	   A	  to	  E	  /	  V	  to	  E	  1474924	   A/C	   T	   phoR	   Phosphate	  regulon	  sensor	  protein	  PhoR	   F	  /	  L	  to	  F	  1495274	   T	   C	   fumC	   Fumarate	  hydratase	   V	  to	  A	  1725283	   T	   C	   nrdA	   Ribonucleotide-­‐diphosphate	  reductase	  subunit	  alpha	   N	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3.2.2.2	  Identification	  of	  indels	  Indels,	  like	  SNPs,	  are	  a	  form	  of	  nucleotide-­‐level	  genetic	  variation,	  where	  there	  is	  either	   a	   deletion	   or	   an	   insertion	   of	   any	   number	   of	   nucleotides	   in	   a	   reference	  DNA	  sequence	  when	  compared	  to	  a	  query	  DNA	  sequence.	  Indels	  were	  identified	  between	  the	  original	  and	  re-­‐sequenced	  Rd	  and	  R2866	  whole	  genomes.	  As	  with	  SNPs,	   the	  original	   genome	  was	  used	   as	   a	   reference	   for	  detecting	   indels,	  while	  the	  re-­‐sequenced	  genome	  was	  a	  query.	  	  	  A	  total	  of	  226	  indels	  were	  detected	  for	  the	  Rd	  strain.	  Of	  these,	  93	  were	  present	  in	   intergenic	   regions	   and	   the	   remaining	   133	  were	   located	   in	   genes.	   61	   indels	  were	  identified	  in	  45	  genes	  that	  were	  annotated	  as	  pseudogenes	  in	  the	  original	  published	   Rd	   genome	   sequence	   (see	   Table	   3.3).	   The	  majority	   of	   these	   indels	  were	  present	   in	   the	  coding	  sequence	   in	  a	  way	  that	   they	  corrected	   frameshifts,	  which	   were	   most	   likely	   responsible	   for	   the	   annotation	   of	   the	   gene	   as	   a	  pseudogene.	  Only	  three	  indels,	  present	  in	  HI0247,	  HI1099a	  and	  HI1268	  genes,	  did	  not	  have	  an	  obvious	  correction	  of	  the	  frame.	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Table	   3.3:	   Indels	   present	   in	   pseudogenes	   in	   the	   Rd	   strain.	   The	   original	  (reference;	  Ref)	  and	  re-­‐sequenced	  (query;	  Que)	  genomes	  were	  compared.	  	  
Coordinate	  
(bp)	   Ref	   Que	   Pseudogene	  
	   Coordinate	  
(bp)	   Ref	   Que	   Pseudogene	  108367	   A	   AG	   HI0101	   	   1195324	   TG	   T	   HI1126.1	  130905	   AT	   A	   HI0116	   	   1195695	   C	   CA	  166073	   A	   AT	   HI0148.1	   	   1249451	   G	   GC	   HI1183	  170592	   C	   CT	   dcuB	   	   1257711	   TA	   T	  
HI1191	  265439	   TC	   T	   HI0234	   	   1257768	   TG	   T	  266933	   G	   GT	   perM	   	   1257775	   TG	   T	  277114	   TAA	   T	   HI0247	   	   1257781	   TG	   T	  313016	   AG	   A	   HI0279m	   	   1307904	   T	   TA	   HI1235	  354945	   G	   GC	   HI0326	   	   1330978	   AG	   A	   HI1254	  369921	   G	   GC	   napF	   	   1331102	   C	   CT	  370788	   GC	   G	   napA	   	   1331439	   C	   CT	  576723	   GA	   G	   devB	   	   1347623	   C	   CA	   HI1268	  607968	   G	   GC	   HI0585	   	   1377957	   T	   TG	   dgt	  654433	   GC	   G	   HI0620.1	   	   1476596	   TC	   T	   pstB	  787178	   T	   TAA	   HI0732	   	   1523755	   GC	   G	   HI1434.2	  787337	   A	   AT	   	   1525290	   GT	   G	   thiI	  787392	   A	   AT	   	   1541685	   G	   GA	   HI1458m	  892480	   A	   AG	   HI0842	   	   1569019	   G	   GC	   mor	  921808	   AG	   A	   HI0869	   	   1580044	   G	   GC	   HI1506	  922034	   CA	   C	   	   1607054	   GT	   G	   HI1534	  929031	   CA	   C	   pepB	   	   1608081	   G	   GC	  1014632	   AG	   A	   HI0956	   	   1634585	   TC	   T	   HI1565m	  1034913	   T	   TA	   HI0976	   	   1637524	   G	   GC	   HI1570	  1082187	   T	   TG	   HI1018	   	   1648801	   A	   AT	   HI1581	  1127714	   G	   GT	   HI1063	   	   1662092	   A	   AG	   ftsK	  1128978	   T	   TC	   	   1662266	   AT	   A	  1128980	   T	   TC	   	   1662939	   AC	   A	  1144510	   CG	   C	  
pnuC	  
	   1687060	   TG	   T	   HI1619	  1144973	   AC	   A	   	   1734148	   G	   GC	   HI1666	  1161063	   C	   CA	   HI1099a	   	   1789588	   GC	   G	   HI1718	  1195317	   TG	   T	   HI1126.1	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The	  remaining	  71	  indels	  were	  detected	  in	  51	  coding	  sequences	  (see	  Table	  3.4).	  The	  majority	  of	   these	   indels	  were	   located	  either	   towards	   the	  very	  start	  or	   the	  very	  end	  of	   a	   gene,	   therefore	  not	   greatly	   altering	  gene	   length.	   Six	   indels	  were	  present	  in	  the	  coding	  sequences	  that	  were	  split	  across	  two	  coding	  frames	  in	  the	  original	  genome,	  therefore	  correcting	  the	  frameshift.	  Seven	  indels	  were	  located	  in	   the	  middle	   of	   the	   coding	   sequences	  without	   any	   effect	   on	   the	   gene	   length.	  There	   were	   only	   three	   indels	   that	   were	   present	   in	   the	   middle	   of	   the	   coding	  sequences	  and	  resulted	  in	  a	  significantly	  truncated	  gene.	  The	  distribution	  of	  all	  indels	  and	  SNPs	  in	  the	  Rd	  genome	  is	  depicted	  in	  Figure	  3.1.	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Table	   3.4:	  Indels	   identified	   in	  protein-­‐coding	   genes	   in	   the	  Rd	   strain.	  The	  original	   (reference;	   Ref)	   and	   re-­‐sequenced	   (query;	   Que)	   genomes	   were	  compared.	  	  
Coordinate	  
(bp)	   Ref	   Que	   Gene	   Gene	  product	   Comments	  52066	   C	   CA	   HI0050m	   Integral	  membrane	  protein	  transporter	   Start	  of	  gene	  77924	   A	   AT	   ppnK	   Inorganic	  polyphosphate/ATP-­‐NAD	  kinase	   End	  of	  gene	  104315	   A	   AG	   hitA	   Iron-­‐utilisation	  periplasmic	  protein	  hFbpA	   Corrects	  frameshift	  142122	   TG	   T	  
fbpC	   Ferric	  transporter	  ATP-­‐binding	  protein	   End	  of	  gene	  
142152	   TA	   T	  142169	   TC	   T	  142202	   GC	   G	  142225	   TC	   T	  142237	   GC	   G	  143334	   G	   GCA	   afuB	   Ferric	  transport	  system	  permease-­‐like	  protein	   End	  of	  gene	  162571	   G	   GCA	   HI0147	   Hypothetical	  protein	   End	  of	  gene	  162605	   G	   GA	  201555	   AG	   A	  
tatA	   Sec-­‐independent	  protein	  secretion	  pathway	  component	  TatA	   Start	  of	  gene	  201574	   AG	   A	  391547	   AG	   A	   HI0367	   Hypothetical	  protein	   End	  of	  gene	  401967	   AC	   A	   HI0380.2	   tRNA-­‐Lys	   Start	  of	  gene	  511410	   CA	   C	   aphA	   Acid	  phosphatase/phosphotransferase	   Corrects	  frameshift	  560060	   GC	   G	   ureH	   Urease	  accessory	  protein	   End	  of	  gene	  579334	   A	   AT	   HI0559.1	   Hypothetical	  protein	   End	  of	  gene	  588149	   AG	   A	   tex	   Transcription	  accessory	  protein	   End	  of	  gene	  608500	   GC	   G	   pepE	   Peptidase	  E	   End	  of	  gene	  620939	   G	   GT	   ccrB	   Camphor	  resistance	  protein	  CrcB	   Possibly	  true	  706625	   TC	   T	   oapA	   Hemoglobin-­‐binding	  protein	   Start	  of	  gene	  721475	   G	   GT	   HI0680	   RarD	  protein	   End	  of	  gene	  850970	   A	   AG	   rpsM	   30S	  ribosomal	  protein	  S13	   End	  of	  gene	  926774	   G	   GA	   HI0874	   Hypothetical	  protein	   End	  of	  gene	  989395	   A	   AT	   HI0930	   Hypothetical	  protein	   Start	  of	  gene	  1036342	   TG	   T	  
prmA	   Ribosomal	  protein	  L11	  methyltransferase	   Middle	  of	  gene,	  no	  effect	  	  1036357	   AT	   A	  1036363	   GA	   G	  1068024	   GC	   G	   HI1004	   Peptidyl-­‐propyl	  cis-­‐trans	  isomerase	   Corrects	  frameshift	  1104427	   C	   CT	   ureF	   Urease	  accessory	  protein	   Start	  of	  gene	  1229388	   TC	   T	   HI1159m	   Thioredoxin	  domain-­‐containing	  protein	   Corrects	  frameshift	  1231800	   T	   TCCGC	   HI1162	   Hypothetical	  protein	   Start	  of	  gene	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Coordinate	  
(bp)	   Ref	   Que	   Gene	   Gene	  product	   Comments	  1244068	   TG	   T	   HI1174	   Opacity	  protein	   Start	  of	  gene	  1277863	   A	   AG	  
lysS	   Lysyl-­‐tRNA	  synthetase	   Middle	  of	  gene;	  no	  effect	  	  1277877	   GA	   G	  1290107	   CA	   C	  
cmk	   Cytidylate	  kinase	   End	  of	  gene	  1290126	   TC	   T	  1300566	   TC	   T	   lpdA	   Dihydrolipoamide	  dehydrogenase	   End	  of	  gene	  1370921	   A	   AGC	   truB	   tRNA	  pseudouridine	  synthase	  B	   End	  of	  gene	  1375515	   CG	   C	   HI1296	   Nuclease	   End	  of	  gene	  1375546	   A	   AT	  1394146	   TC	   T	   HI1317	   Hypothetical	  protein	   Start	  of	  gene	  1394184	   TC	   T	  1449975	   AT	   A	   HI1364	   Transcriptional	  regulator	   End	  of	  gene	  1449988	   TG	   T	  1449998	   GT	   G	  1480065	   G	   GA	   pstS	   Phosphate	  ABC	  transporter	  substrate-­‐binding	  protein	   Corrects	  frameshift	  1505885	   G	   GC	   HI1410	   Terminase	  large	  subunit-­‐like	  protein	   Start	  of	  gene	  1509059	   G	   GC	   HI1418	   Hypothetical	  protein	   End	  of	  gene	  1527279	   G	   GCAC	   ispA	   Geranyltranstransferase	   End	  of	  gene	  1564858	   C	   CG	  
muB	   DNA	  transposition	  protein	   End	  of	  gene	  1564863	   G	   GC	  1570070	   T	   TG	   HI1493	   Hypothetical	  protein	   Possibly	  true	  1571863	   CG	   C	   HI1498.1	   Hypothetical	  protein	   End	  of	  gene	  1587908	   A	   AG	   HI1516m	   Unannotated	   Possibly	  true	  1617702	   CA	   C	   HI1546	   Hypothetical	  protein	   End	  of	  gene	  1621283	   G	   GA	   bioD	   Dithiobiotin	  synthetase	   End	  of	  gene	  1647894	   CA	   C	  
lpp	   15	  kDa	  peptidoglycan-­‐associated	  lipoprotein	   End	  of	  gene	  1647913	   CA	   C	  1647920	   CA	   C	  1675969	   G	   GT	   tyrS	   Tyrosyl-­‐tRNA	  synthetase	   End	  of	  gene	  1689811	   AT	   A	   HI1625	   Hypothetical	  protein	   End	  of	  gene	  1691975	   C	   CA	   HI1629	   Hypothetical	  protein	   End	  of	  gene	  1691994	   T	   TA	  1697887	   A	   AT	  
purR	   DNA-­‐binding	  transcriptional	  repressor	  PurR	   Middle	  of	  gene;	  no	  effect	  	  1697907	   TG	   T	  1718873	   A	   AG	   tldD	   Hypothetical	  protein	   Corrects	  frameshift	  1738448	   G	   GC	   HI1670	   Solute/DNA	  competence	  effector	   End	  of	  gene	  1775364	   ATC	   A	   HI1704	   Hypothetical	  protein	   End	  of	  gene	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Figure	   3.1:	  Positions	   of	   indels	   and	   SNPs	   in	   the	  Rd	   genome.	   The	   genomic	  locations	   of	   indels	   and	   SNPs	   are	   shown	   in	   two	   concentric	   circles.	   The	   outer	  circle	   shows	   the	  positions	  of	  all	   identified	   indels,	  while	   the	   inner	  circle	   shows	  the	  positions	  of	  all	  identified	  SNPs.	  	  	  	  	  	  	  	  
Rd	  
	  	   72	  
Only	  one	  indel	  was	  present	  in	  the	  R2866	  strain	  at	  the	  953,610	  bp	  coordinate	  in	  the	   original	   genome.	   It	  was	   located	   in	   an	   intergenic	   region	   containing	   several	  tetranucleotide	  repeats.	  The	  indel	  itself	  constituted	  a	  single	  GCAA	  repeat,	  which	  was	   present	   in	   the	   original	   R2866	   genome,	   but	   absent	   in	   the	   re-­‐sequenced	  genome.	  	  
3.2.3	  Comparison	  of	  Rd	  and	  R2866	  genome	  sequences	  
In	   order	   to	   begin	   evaluating	   the	   genetic	   differences	   between	   Rd	   and	   R2866	  strains,	   their	   re-­‐sequenced	   genomes	  were	   aligned	   and	   visualised	   in	   ACT	   (see	  Figure	   3.1).	   Several	   genome	   regions	   were	   clearly	   present	   in	   only	   one	   of	   the	  strains,	   forming	   their	   accessory	   genome	   (see	   section	   3.2.3.1).	   ANI	   is	   another	  method	   to	   infer	   genetic	   relatedness	   between	   bacterial	   strains	   (Goris	   et	   al.,	  2007).	  In	  this	  study,	  ANI	  between	  Rd	  and	  R2866	  strains	  was	  found	  to	  be	  97.4%,	  which	  was	  the	  mean	  value	  from	  the	  two	  methods	  commonly	  used	  to	  calculate	  it	  (see	  Table	  3.5).	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Figure	   3.2:	   ACT	   view	   of	   the	   alignment	   of	   Rd	   and	   R2866	   re-­‐sequenced	  
genomes.	  The	  Rd	  genome	  is	  shown	  at	  the	  top,	  while	  the	  R2866	  genome	  is	  at	  the	  bottom.	   Blue	   and	   red	   lines	   show	   homologous	   sequences	   between	   the	   two	  strains.	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Table	  3.5:	  ANI	  between	  Rd	  and	  R2866	  re-­‐sequenced	  genomes.	  The	  best-­‐hit	  value	   was	   determined	   by	   using	   the	   Rd	   genome	   as	   a	   query	   and	   the	   R2866	  genome	  as	  a	  reference	  in	  a	  BLASTn	  comparison.	  Reciprocal	  best-­‐hit	  method	  was	  a	   two-­‐way	   BLASTn	   comparison,	  where	   Rd	   and	   R2866	   genomes	  were	   used	   in	  turn	  both	  as	  a	  query	  and	  a	  reference.	  	  
ANI	  calculation	  method	   ANI	  value	  (%)	  Best-­‐hit	   97.3	  Reciprocal	  best-­‐hit	   97.5	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Table	   3.6:	   Genes	   unique	   to	   the	   Rd	   strain	   when	   compared	   to	   R2866.	  Adjacent	  genes	  with	   the	   same	  annotation	  as	  well	   as	  major	  gene	  clusters	  were	  grouped	  together.	  	  
Gene	  name	   Gene	  coordinates	  (bp)	   Gene	  product	  PROKKA_00088	   94807	  -­‐	  95238	   PemK-­‐like	  protein	  PROKKA_00173	   177022	  -­‐	  177318	   Chloride	  channel	  protein	  PROKKA_00289	   288703	  -­‐	  289233	   Transposase	  PROKKA_00499	   490791	  -­‐	  491309	   Ribosomal-­‐protein-­‐alanine	  N-­‐acetyltransferase	  
hindIIR	   575625	  -­‐	  576401	   Type	  II	  restriction	  endonuclease	  
hindIIM	   576398	  -­‐	  577954	   Modification	  methylase	  
ureABCEFGH	   607479	  -­‐	  612940	   Urease	  locus	  PROKKA_00630	   622672	  -­‐	  623214	   Transposase	  PROKKA_00631	   623339	  -­‐	  623578	   Putative	  membrane	  protein	  PROKKA_00668	   662731	  -­‐	  664260	   TRAP	  transporter,	  DctM	  subunit	  
arcC	   664365	  -­‐	  665297	   Carbamate	  kinase	  PROKKA_00727	   716328	  -­‐	  717242	   Putative	  permease,	  DMT	  superfamily	  PROKKA_00749	   742135	  -­‐	  742431	   Bifunctional	  antitoxin/transcriptional	  repressor	  RelB	  
yafQ	   742431	  -­‐	  742739	   mRNA	  interferase	  YafQ	  
ansB	   782627	  -­‐	  783676	   L-­‐asparaginase	  II	  
anmK	   796479	  -­‐	  797627	   Anhydro-­‐N-­‐acetylmuramic	  acid	  kinase	  
murQ	   797637	  -­‐	  798548	   N-­‐acetylmuramic	  acid-­‐6-­‐phosphate	  etherase	  
tbp2_1	   1009658	  -­‐	  1010527	   Transferrin-­‐binding	  protein	  2	  PROKKA_01018	   1010591	  -­‐	  1011697	   TPR	  repeat-­‐containing	  protein	  precursor	  PROKKA_01060	   1059948	  -­‐	  1060295	   Putative	  cyclase	  PROKKA_01067-­‐01074	   1068768	  -­‐	  1076420	   L-­‐ascorbate	  utilisation	  locus	  PROKKA_01075	   1076614	  -­‐	  1077402	   Transcriptional	  regulator	  
ureF_2	   1083828	  -­‐	  1084796	   Urease	  accessory	  protein	  PROKKA_01083	   1084793	  -­‐	  1085707	   Modification	  methylase	  PROKKA_01302	   1327053	  -­‐	  1327589	   Iron	  chelatin	  ABC	  transporter	  permease	  PROKKA_01303	   1327606	  -­‐	  1328370	   ABC	  transporter	  ATP-­‐binding	  protein	  
yidK	   1371852	  -­‐	  1372142	   Putative	  symporter	  YidK	  
hindIIIM	   1464800	  -­‐	  1465729	   Modification	  methylase	  
hindIIIR	   1465710	  -­‐	  1466612	   Type	  II	  restriction	  endonuclease	  PROKKA_01423	   1467153	  -­‐	  1467575	   Zeta	  toxin	  
holC	   1467796	  -­‐	  1468230	   DNA	  polymerase	  III	  subunit	  chi	  
yhxB_2	   1473006	  -­‐	  1473515	   Tail	  fiber	  protein/phosphomannomutase	  PROKKA_01439	   1480491	  -­‐	  1481012	   Phage	  regulatory	  protein,	  Rha	  family	  PROKKA_01444	   1482865	  -­‐	  1483533	   Putative	  phage-­‐encoded	  protein	  PROKKA_01445	   1483894	  -­‐	  1484193	   Putative	  addiction	  module	  killer	  protein	  PROKKA_01446	   1484190	  -­‐	  1484483	   Putative	  addiction	  module	  antidote	  protein	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Gene	  name	   Gene	  coordinates	  (bp)	   Gene	  product	  PROKKA_01451	   1486093	  -­‐	  1487007	   Integrase/recombinase	  
fiu	   1519017	  -­‐	  1519562	   TonB-­‐dependent	  receptor	  Fiu	  
fhuA	   1520182	  -­‐	  1521219	   Ferric	  hydroxamate	  uptake	  PROKKA_01496	   1521278	  -­‐	  1523047	   ABC	  transporter	  ATP-­‐binding	  protein	  PROKKA_01498	   1523438	  -­‐	  1523785	   Molybdate	  ABC	  transporter	  periplasmic	  molybdate-­‐binding	  protein	  PROKKA_01499-­‐01501	   1523795	  -­‐	  1526604	   molABC	  locus	  
modD	   1526672	  -­‐	  1527517	   Molybdenum	  transport	  protein	  ModD	  PROKKA_01503	   1527527	  -­‐	  1528126	   ABC	  transporter	  ATP-­‐binding	  protein	  PROKKA_01504	   1528128	  -­‐	  1528367	   Molybdate	  ABC	  transporter	  permease	  protein	  PROKKA_01505-­‐01550	   1528715	  -­‐	  1561534	   Mu-­‐like	  prophage,	  FluMu	  PROKKA_01551	   1562193	  -­‐	  1563038	   Adenine-­‐specific	  DNA	  methylase	  
cysT	   1563102	  -­‐	  1563536	   Sulfate	  transport	  system	  permease	  protein	  CysT	  PROKKA_01553	   1563592	  -­‐	  1564329	   Molybdate-­‐binding	  periplasmic	  protein	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Table	   3.7:	   Genes	   unique	   to	   the	   R2866	   strain	   when	   compared	   to	   Rd.	  Adjacent	  genes	  with	   the	   same	  annotation	  as	  well	   as	  major	  gene	  clusters	  were	  grouped	  together.	  	  
Gene	  name	   Gene	  coordinates	  (bp)	   Gene	  product	  PROKKA_00017	   17532	  -­‐	  18215	   GTPase	  Era	  PROKKA_00019	   20558	  -­‐	  23287	   Type	  I	  restriction	  enzyme	  EcoKI	  subunit	  R	  PROKKA_00020	   23624	  -­‐	  23965	   Transcriptional	  repressor	  DicA	  PROKKA_00021	   24335	  -­‐	  24727	   Putative	  transcriptional	  regulator	  PROKKA_00022	   24752	  -­‐	  25429	   Putative	  cation	  efflux	  protein	  PROKKA_00050	   52856	  -­‐	  53302	   CRISPR	  associated	  protein	  Cas2	  
mtrF	   63686	  -­‐	  65257	   Antimicrobial	  resistance	  membrane	  protein	  MtrF	  
icsA	   145675	  -­‐	  147600	   Outer	  membrane	  protein	  IcsA	  autotransporter	  precursor	  PROKKA_00233	   236619	  -­‐	  237755	   Putative	  transposase	  
rep1	   285322	  -­‐	  286140	   Putative	  replicase	  protein	  PROKKA_00287	   286307	  -­‐	  286459	   DNA	  binding	  domain,	  excisionase	  family	  PROKKA_00292	   288551	  -­‐	  288985	   Putative	  transcriptional	  regulator	  
intA	   289022	  -­‐	  290233	   Putative	  integrase	  PROKKA_00389	   390171	  -­‐	  391112	   Abortive	  infection	  bacteriophage	  resistance	  protein	  
ahpC	   487938	  -­‐	  488540	   Peroxiredoxin	  
hsdR2	   509752	  -­‐	  512772	   Putative	  type	  I	  restriction	  modification	  system,	  restriction	  enzyme	  component	  HsdR2	  
hsdS2	   512873	  -­‐	  514174	   Putative	  type	  I	  restriction	  modification	  system,	  specificity	  component	  HsdS2	  PROKKA_00509	   514346	  -­‐	  515809	   Divergent	  AAA	  domain	  protein	  
hsdM2	   515938	  -­‐	  518310	   Putative	  type	  I	  restriction	  modification	  system,	  methylase	  component	  HsdM2	  PROKKA_00530-­‐00568	   539690	  -­‐	  569387	   Bacteriophage	  HP2	  PROKKA_00570-­‐00631	   570441	  -­‐	  623099	   ICE,	  homologous	  to	  ICEHin1056	  PROKKA_00644	   630888	  -­‐	  632012	   Putative	  peptidase	  
yjiG	   632026	  -­‐	  632496	   Inner	  membrane	  protein	  YjiG	  PROKKA_00646	   632498	  -­‐	  633130	   Sporulation	  integral	  membrane	  protein	  YlbJ	  
hia	   733204	  -­‐	  736494	   Adhesin	  Hia	  PROKKA_00912	   929171	  -­‐	  929626	   Putative	  5'(3')-­‐deoxyribonucleotidase	  PROKKA_00913	   929610	  -­‐	  930320	   Putative	  NAD-­‐dependent	  protein	  deacetylase	  
doc	   930369	  -­‐	  931367	   Death	  on	  curing	  protein	  PROKKA_00916	   931783	  -­‐	  932607	   Putative	  NAD-­‐dependent	  protein	  deacetylase	  PROKKA_00986-­‐01004	   993853	  -­‐	  1004502	   Putative	  bacteriophage	  PROKKA_01006	   1004954	  -­‐	  1005919	   P63C	  domain	  protein	  PROKKA_01007	   1006277	  -­‐	  1006918	   Putative	  prophage	  antirepressor	  protein	  PROKKA_01078	   1091522	  -­‐	  1091761	   DNA	  (cytosine-­‐5-­‐)-­‐methyltransferase	  PROKKA_01113	   1128571	  -­‐	  1129230	   Putative	  TPR	  repeat	  protein	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Gene	  name	   Gene	  coordinates	  (bp)	   Gene	  product	  PROKKA_01115	   1129418	  -­‐	  1129864	   Putative	  TPR	  repeat	  protein	  PROKKA_01117	   1130052	  -­‐	  1130711	   Putative	  TPR	  repeat	  protein	  PROKKA_01119	   1130899	  -­‐	  1131345	   Putative	  TPR	  repeat	  protein	  
hicAB;	  hifABCDE	   1178066	  -­‐	  1184978	   Pilus	  assembly	  locus	  PROKKA_01542	   1577809	  -­‐	  1578645	   Putative	  lipooligosaccharide	  biosynthesis	  protein	  
losAB2	   1579139	  -­‐	  1580841	   LOS	  biosynthesis	  los2	  locus	  
fpg2	   1580844	  -­‐	  1581656	   Formamidopyrimidine-­‐DNA-­‐glycosylase	  2	  PROKKA_01546	   1581705	  -­‐	  1582430	   Putative	  ABC	  transport	  system,	  periplasmic	  component	  PROKKA_01547	   1582440	  -­‐	  1583180	   Putative	  ABC	  transport	  system,	  ATPase	  component	  PROKKA_01548-­‐01549	   1583177	  -­‐	  1584189	   Putative	  ABC	  transporter	  permease	  protein	  PROKKA_01550	   1584204	  -­‐	  1584890	   Iron-­‐dicitrate	  transporter	  substrate-­‐binding	  subunit	  
lex2AB	   1680397	  -­‐	  1681483	   LOS	  biosynthesis	  lex2	  locus	  PROKKA_01720-­‐01767	   1747866	  -­‐	  1779744	   Bacteriophage	  
tnaAB	   1800781	  -­‐	  1803518	   Tryptophanase	  locus	  
mod2	   1808282	  -­‐	  1811182	   Putative	  Type	  III	  restriction-­‐modification	  system	  enzyme	  Mod	  
res2	   1811184	  -­‐	  1812830	   Putative	  Type	  III	  restriction-­‐modification	  system	  enzyme	  Res	  PROKKA_01849	   1865976	  -­‐	  1867274	   Archaeal	  ATPase	  PROKKA_01851	   1869130	  -­‐	  1870020	   Putative	  LysR-­‐family	  transcriptional	  regulator	  
rimO	   1870839	  -­‐	  1872176	   Ribosomal	  protein	  S12	  methylthiotransferase	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As	   expected,	   several	  mobile	   genetic	   elements	  were	   identified	   in	   the	   accessory	  genome	  of	  Rd	  and	  R2866	  strains,	  some	  of	  which	  have	  been	  previously	  described	  in	  other	  studies	  (see	  Tables	  3.6,	  3.7).	  The	  33-­‐kb	  Mu-­‐like	  prophage,	  FluMu,	  was	  present	  in	  Rd,	  but	  not	  in	  R2866	  (Morgan	  et	  al.,	  2002).	  R2866	  possessed	  the	  30-­‐kb	  bacteriophage,	  HP2,	  and	  another	  11-­‐kb	  putative	  bacteriophage.	  (Williams	  et	  al.,	  2002).	  As	  mentioned	  previously,	  the	  53-­‐kb	  ICE,	  homologous	  to	  ICEHin1056,	  was	  present	  in	  the	  R2866	  strain	  only	  (Juhas	  et	  al.,	  2007).	  The	  possession	  of	  this	  ICE	  has	  clinical	  significance	  for	  R2866,	  due	  to	  the	  presence	  of	  a	  bla	  gene,	  which	  encodes	  a	  beta-­‐lactamase	  precursor	  and	  confers	   resistance	   to	  ampicillin.	  Both	  strains	  also	  contained	  a	  number	  of	  other	  genes	  that	  were	  annotated	  as	  part	  of	  mobile	  genetic	  elements,	  but	  did	  not	  seem	  to	  form	  specific	  gene	  clusters.	  	  	  A	  number	  of	  pathogenicity-­‐related	  genes	  were	  identified	  as	  unique	  to	  either	  Rd	  or	  R2866	  strain.	  As	  described	  previously,	  a	  urease	  locus,	  ureABCEFGH,	  was	  only	  present	  in	  the	  Rd	  strain	  (see	  Table	  3.6).	  This	  locus	  was	  thought	  to	  be	  associated	  with	   an	   increased	   survival	   of	   H.	   influenzae	   in	   the	   acidic	   environment	   of	   the	  human	  respiratory	  tract	  as	  well	  as	  circumventing	  lower	  pH	  inside	  intracellular	  vesicles	  (Murphy	  and	  Brauer,	  2011).	  In	  addition,	  Rd	  possessed	  a	  gene	  encoding	  a	  putative	  transferrin-­‐binding	  protein,	  with	  a	  possible	  role	  in	  the	  survival	  within	  iron-­‐restricted	   environments	   inside	   the	   human	   host.	   A	   putative	   hemoglobin-­‐binding	  protein,	  encoded	  by	  the	  oapA_3	  gene,	  was	  also	  present	  in	  Rd	  only.	  Gene	  
oapA	   has	   been	   described	   in	  H.	   influenzae	   as	   playing	   an	   important	   role	   in	   the	  adhesion	  process	  (Weiser	  et	  al.,	  1995,	  Prasadarao	  et	  al.,	  1999).	  	  	  Aside	  from	  the	  aforementioned	  ICE,	  responsible	   for	  the	  antibiotic	  resistance,	  a	  number	  of	  other	  pathogenicity-­‐related	  accessory	  genes	  were	  unique	   to	  R2866	  when	  compared	   to	   the	  Rd	   strain.	  As	  described	  previously,	  R2866	  possessed	  a	  tryptophanase	   locus	   and	   the	  mtrF	   gene,	   their	   roles	   associated	  with	   virulence	  and	  antibiotic	  resistance	  respectively	  (see	  Table	  3.7)	  (Kilian,	  1976,	  Martin	  et	  al.,	  1998,	  Veal	  and	  Shafer,	  2003,	  Erwin	  et	  al.,	  2005).	  Gene	  icsA,	  identified	  in	  R2866,	  encoded	   a	   protein	   homologous	   to	   a	   family	   of	   virulence-­‐associated	  autotransporters	  (Davis	  et	  al.,	  2001).	  R2866,	  unlike	  Rd,	  also	  possessed	  two	  loci	  involved	  in	  the	  modification	  of	  LOS	  -­‐	  lex2AB	  and	  losAB2	  (Deadman	  et	  al.,	  2009,	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Hood	  et	  al.,	  2010).	  They	  are	  responsible	  for	  adding	  sugar	  moieties	  to	  LOS,	  thus	  contributing	  to	   its	  structural	  alteration	  between	  different	  H.	  influenzae	  strains,	  leading	   to	   variations	   in	   the	   fitness	  of	   this	  bacterium.	  Directly	  upstream	  of	   the	  
losAB2	   locus	  was	   a	   putative	   LOS	   biosynthesis	   gene,	  hgt1,	   encoding	   a	   putative	  glycosyltransferase	  with	  a	  possible	  role	  in	  LOS	  modification	  (Hood	  et	  al.,	  2010).	  	  	  A	  pilus-­‐assembly	  locus	  was	  found	  to	  be	  present	  in	  R2866,	  but	  absent	  in	  Rd	  (see	  Table	   3.7).	   Pili	   have	   been	   shown	   to	   promote	   the	   adhesion	   of	  H.	   influenzae	   to	  specific	   cell	   types	   (Gilsdorf	   et	   al.,	   1996).	   Gene	  ahpC	   encoding	   a	   peroxiredoxin	  was	  also	  unique	  to	  R2866	  when	  compared	  to	  Rd.	  It	  is	  homologous	  to	  a	  tsaA	  gene	  in	  the	  86-­‐028NP	  strain	  of	  H.	  influenzae.	  Despite	  its	  homologue	  in	  E.	  coli	  having	  an	   important	   role	   in	   scavenging	   endogenous	   hydrogen	   peroxide,	   it	   was	   not	  responsive	   to	   the	   hydrogen	   peroxide	   treatment	   in	   the	   86-­‐028NP	   strain,	  suggesting	   an	   alternative	   function	   (Seaver	   and	   Imlay,	   2001,	   Harrison	   et	   al.,	  2007).	  R2866	  also	  possessed	  a	  gene	  encoding	  an	  important	  adhesin,	  Hia,	  which	  belongs	   to	  an	  autotransporter	   family	  and	  mediates	   the	  adhesion	  process	  of	  H.	  
influenzae	  to	  several	  human	  cell	  types	  (Barenkamp	  and	  St	  Geme,	  1996,	  St	  Geme	  and	  Cutter,	  2000).	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Various	   metabolism-­‐related	   genes	   and	   gene	   clusters	   were	   identified	   in	   the	  accessory	  genome	  of	  Rd	  and	  R2866	  as	  well	  (see	  Tables	  3.6,	  3.7).	  A	  molybdate-­‐uptake	   locus,	  molABC,	  was	  present	   in	  Rd	   and	  not	   in	  R2866	   (Tirado-­‐Lee	   et	   al.,	  2011).	   Rd	   also	   contained	   an	   L-­‐ascorbate	   utilisation	   locus,	   comprised	   of	   seven	  genes	  and	  involved	  in	  an	  anaerobic	  catabolism	  of	  L-­‐ascorbate	  as	  an	  alternative	  carbon	   source	   (see	   Figure	   3.4)	   (Yew	   and	   Gerlt,	   2002).	   Other	  metabolic	   genes	  present	   only	   in	   Rd	   were	   L-­‐asparaginase,	   carbamate	   kinase	   as	   well	   as	   genes	  involved	   in	   the	   metabolism	   of	   anhydro-­‐N-­‐acetylmuramic	   acid.	   Interestingly,	  secretion	   of	   L-­‐asparaginase	   II	   has	   been	   previously	   implicated	   in	   promoting	  virulence	   of	   S.	   enterica	   (Kullas	   et	   al.,	   2012).	   In	   addition	   to	   metabolism-­‐associated	   genes,	   other	   noteworthy	   accessory	   features	   included	   a	   putative	  toxin-­‐antitoxin	  system	  in	  Rd	  as	  well	  as	  several	  restriction-­‐modification	  system	  genes	  present	  in	  both	  Rd	  and	  R2866	  strains.	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3.3	  Discussion	  The	  data	  presented	  in	  this	  chapter	  were	  used	  to	  describe	  potentially	  important	  differences	  in	  the	  genome	  composition	  of	  H.	  influenzae	  between	  and	  within	  two	  different	   strains.	   First,	   the	   availability	   of	   Rd	   and	   R2866	   whole-­‐genome	  sequences	   enabled	   detailed	   characterisation	   of	   the	   accessory	   genome	   of	   both	  strains.	   Second,	   re-­‐sequencing	   of	   the	   Rd	   genome	   established	   the	   genetic	  variance	  between	  two	  descendants	  of	  the	  original	  Rd	  strain.	  These	  findings	  have	  implications	  for	  the	  use	  of	  the	  Rd	  strain	  as	  a	  model	  organism	  as	  well	  as	  setting	  the	  scene	  for	  the	  subsequent	  chapters,	  as	  discussed	  below.	  	  The	  presence	   of	  multiple	   repetitive	   regions	   that	   are	   longer	   than	   raw	   Illumina	  sequencing	   reads	   (250	   bp)	   creates	   gaps	   during	   the	   de	   novo	   assembly	   of	   a	  genome	   (Treangen	   and	   Salzberg,	   2012).	   This	   results	   in	   a	   fragmented,	   contig-­‐based	  draft	  genome	  sequence,	  as	  opposed	  to	  a	  complete	  whole	  genome,	  where	  gaps	  between	  contigs	  have	  been	  closed	  using	  additional	  techniques,	  such	  as	  PCR	  (Rogers	  et	  al.,	  2005).	  The	   inability	   to	   identify	  gaps	  between	  contigs	  as	  well	   as	  contig	  filtering	  steps	  leads	  to	  inevitable	  loss	  of	  some	  of	  the	  genome	  information.	  For	  this	  reason	  the	  re-­‐sequenced	  genomes	  of	  both	  Rd	  and	  R2866	  strains	  were	  shorter	  by	  20-­‐30	  kb	  when	  compared	  to	   the	  original	  published	  genomes	  of	   the	  same	  strains.	  However,	  despite	  being	  draft	  versions	  of	  complete	  genomes,	  they	  still	  carry	  reliable	  genetic	   information	  about	  particular	  strains	  at	  a	  nucleotide-­‐level,	  and	  thus	  can	  be	  used	  to	  infer	  changes	  between	  original	  and	  re-­‐sequenced	  strains,	  as	  discussed	  later	  in	  this	  section.	  	  The	  number	  of	  unique	  accessory	  genes	  identified	  in	  each	  strain	  was	  very	  similar	  to	  what	  was	  previously	  described	  for	  these	  two	  strains	  in	  a	  study	  by	  Hogg	  et	  al.	  (Hogg	   et	   al.,	   2007).	   Small	   differences	   can	   be	   attributed	   to	   the	   genome	  annotation	   and	   disparate	   statistical	   methods	   for	   identifying	   the	   accessory	  genome.	  R2866	  was	  originally	  isolated	  from	  the	  blood	  of	  a	  sick	  patient	  (Nizet	  et	  al.,	  1996).	  Therefore,	  its	  possession	  of	  a	  larger	  number	  of	  virulence	  factors	  than	  Rd	   is	   not	   unexpected,	   as	   these	   factors	   likely	   contribute	   to	   an	   invasive	  phenotype.	   Pathogenicity-­‐associated	   accessory	   genes	   in	   R2866	   were	   well-­‐
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characterised	   and	   had	   distinct	   roles	   in	   infection-­‐relevant	   processes,	   such	   as	  adhesion,	   modification	   of	   surface	   molecules,	   antibiotic	   resistance	   and	   the	  response	   to	   oxidative	   stress.	   Together,	   these	   pathogenicity-­‐related	   factors	  establish	  R2866	  as	  a	  more	  effective	  pathogen	   than	  Rd.	  The	  only	  characterised	  pathogenicity-­‐associated	  gene	  cluster	   in	  Rd	  was	   the	  urease	   locus,	  whereas	   the	  rest	  had	  only	  putative	  roles	  in	  virulence.	  	  	  All	   identified	   accessory	   metabolic	   gene	   clusters	   were	   only	   present	   in	   the	   Rd	  strain.	  This	  higher	  metabolic	  versatility	  may	  contribute	  to	  an	  increase	  in	  fitness	  of	  Rd	  during	  growth	   in	  different	  environments,	   though	  that	  still	  remains	  to	  be	  investigated.	   In	   addition,	   the	   identified	   accessory	   putative	   toxin-­‐antitoxin	  system	  in	  Rd	  has	  homology	  to	  known	  toxin-­‐antitoxin	  systems	  in	  E.	  coli,	  involved	  in	   the	   regulation	   of	   protein	   synthesis	   and	   bacterial	   growth	   (Christensen	   and	  Gerdes,	  2003,	  Prysak	  et	  al.,	  2009).	  Several	  accessory	  genes,	  part	  of	  restriction-­‐modification	  systems,	  were	   found	   in	  both	  Rd	  and	  R2866,	  representing	  diverse	  mechanisms	  of	  defence	  against	  foreign	  DNA	  as	  well	  as	  possible	  different	  roles	  in	  generating	  genetic	  diversity	  (Vasu	  and	  Nagaraja,	  2013).	  	  	  Re-­‐sequencing	   of	   a	   reference	   genome	   has	   been	   previously	   applied	   to	  Bacillus	  
subtilis,	  where	   a	   large	   number	   of	   small	   variations	   between	   two	   genomes	  was	  observed	   (Barbe	   et	   al.,	   2009).	   In	   addition,	   re-­‐annotation	   of	   the	   re-­‐sequenced	  genome	  of	  B.	  subtilis	  using	  up-­‐to-­‐date	  databases	  allowed	  them	  to	  identify	  novel	  putative	   functions	   for	   a	   number	   of	   genes.	   This	   highlights	   the	   benefit	   of	   re-­‐sequencing	   reference	   genomes	   in	   an	   attempt	   to	   improve	   the	   annotation	   and	  correct	  previous	  sequencing	  errors.	  In	  this	  study,	  the	  whole	  genome	  of	  a	  model	  
H.	  influenzae	  strain	  Rd	  was	  re-­‐sequenced	  for	  the	  first	  time	  and	  compared	  to	  the	  original	   published	   sequence,	   resulting	   in	   identification	   of	   41	   SNPs	   and	   226	  indels.	  	  	  The	  majority	  of	  SNPs	  identified	  in	  genes	  in	  Rd	  were	  non-­‐synonymous,	  meaning	  that	   they	   could	   result	   in	   the	   loss	  of	  protein	   function	   (see	  Table	  3.7).	   Six	   SNPs	  were	  found	  in	  genes	  coding	  for	  iron-­‐associated	  proteins,	  with	  putative	  roles	  in	  survival	   within	   the	   human	   host.	   One	   SNP	   was	   also	   identified	   in	   a	   vacB	   gene	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encoding	  a	  virulence-­‐associated	  protein,	  though	  the	  ambiguity	  of	  the	  reference	  nucleotide	   means	   it	   could	   be	   a	   synonymous	   mutation.	   Since	   Rd	   has	   been	  propagated	   as	   a	   laboratory	   strain	   for	   several	   decades	   it	   is	   not	   surprising	   that	  the	  loss	  of	  function	  could	  occur	  in	  genes	  involved	  in	  the	  process	  of	  colonisation	  of	   its	  original	  niche	  and	  infection	  of	  the	  human	  host.	  These	  null	  mutations	  can	  actually	  be	  advantageous	  to	  bacteria,	  increasing	  their	  fitness	  during	  adaptation	  to	   new	   environments	   (Hottes	   et	   al.,	   2013).	   Of	   particular	   interest	   was	   a	   SNP	  identified	  in	  a	  mutS	  gene,	  which	  is	  part	  of	  a	  mismatch	  repair	  system	  in	  bacteria	  and	  has	  been	  known	  to	  be	  associated	  with	  increased	  mutation	  rates	  (LeClerc	  et	  al.,	  1996).	  However,	  the	  exact	  amino	  acid	  substitution	  in	  mutS	  identified	  in	  this	  study	  has	  not	  been	  described	  in	  the	  literature,	  making	  it	  hard	  to	  judge	  whether	  the	  SNP	  had	  any	  effect	  on	  the	  mutation	  rate	  of	  Rd.	  	  	  	  While	  any	  of	  the	   identified	  SNPs	  in	  the	  Rd	  strain	  could	  be	  true	  mutations,	   it	   is	  also	  possible	  that	  some	  or	  even	  most	  of	  these	  SNPs	  originated	  due	  to	  errors	  in	  the	  original	  reference	  or	  re-­‐sequenced	  genomes.	  The	  inherent	  errors	  present	  in	  the	  Illumina	  sequencing	  chemistry	  arise	  mainly	  due	  to	  inverted	  repeats	  and	  GGC	  sequences	  in	  the	  sequenced	  DNA,	   leading	  to	  SNP-­‐associated	  errors	  (Nakamura	  et	   al.,	   2011).	   However,	   these	   errors	   are	   largely	   based	   on	   poor-­‐quality	  nucleotides,	   which	   were	   filtered	   during	   SNP	   identification	   in	   this	   study.	  Therefore,	  it	  is	  unlikely	  to	  be	  the	  cause	  of	  SNP-­‐related	  errors	  here.	  The	  original	  Sanger	  sequencing	  produced	  longer	  and	  more	  accurate	  reads	  than	  the	  Illumina	  sequencing	   chemistry	   (Shendure	   and	   Ji,	   2008).	   However,	   since	   the	   original	  whole	  genome	  of	  Rd	  was	  the	  first	  to	  be	  sequenced	  over	  two	  decades	  ago,	  it	  can	  be	  expected	  that	  it	  would	  contain	  sequencing	  and	  assembly	  errors	  that	  can	  now	  be	   identified	  and	  corrected	  via	  re-­‐sequencing	  of	   the	  same	  strain,	  coupled	  with	  existing	  computational	  methods	  (Fleischmann	  et	  al.,	  1995).	  	  	  Nearly	  half	  of	  all	  identified	  indels	  in	  Rd	  were	  located	  in	  intergenic	  regions	  and,	  along	  with	  SNPs	  present	  in	  intergenic	  regions	  as	  well,	  could	  possibly	  contribute	  to	   changes	   in	   promoter	   sequences,	   which	   would	   affect	   the	   expression	   of	  downstream	   genes.	   Six	   indels	   were	   identified	   in	   genes	   that	   were	   split	   at	   a	  frameshift	   across	   two	   coding	   frames	   in	   the	   original	   genome.	   These	   indels	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corrected	  the	  split	  in	  the	  gene	  by	  joining	  two	  coding	  frames.	  This	  clearly	  meant	  that	   the	   original	   frameshift	  was	   present	   as	   a	   sequencing	   error	   in	   the	   original	  genome.	  Most	  other	   indels	  were	   located	  at	   the	  very	   start	  or	   the	  very	  end	  of	  a	  gene,	   without	   a	   large	   effect	   on	   the	   gene	   length.	   Only	   three	   indels	   caused	  significant	   truncation	   of	   a	   gene,	   meaning	   that	   they	   could	   be	   either	   true	  mutations	  or	  a	  result	  of	  Illumina	  sequencing	  errors.	  	  	  An	   interesting	   finding	   was	   the	   presence	   of	   a	   large	   number	   of	   indels	   in	  pseudogenes	   in	   the	   original	   published	   Rd	   genome.	   These	   pseudogenes	  contained	   one	   or	   more	   frameshifts,	   which	   resulted	   in	   significantly	   truncated	  coding	  sequences.	  Indels,	  identified	  in	  this	  study,	  corrected	  frameshifts	  in	  a	  way	  that	   pseudogenes	   were	   no	   longer	   truncated.	   This	   makes	   it	   likely	   that	  frameshifts	  were	  a	  result	  of	  previous	  sequencing	  errors	  and	  that	  these	  specific	  pseudogenes	   were	   in	   fact	   functioning	   genes.	   Correcting	   the	   number	   of	  pseudogenes	  in	  the	  original	  Rd	  sequence	  would	  reduce	  it	  from	  67	  to	  22,	  which	  is	   also	   the	   number	   of	   pseudogenes	   present	   in	   the	   original	   published	   R2866	  genome,	  further	  highlighting	  the	  falsehood	  of	  the	  majority	  of	  pseudogenes	  in	  the	  original	  Rd	  genome	  (see	  Table	  1.2).	  Nevertheless,	  there	  were	  three	  pseudogenes	  in	  Rd,	  where	   indels	  did	  not	   correct	   the	   coding	   frame.	  Therefore,	   it	   is	   possible	  that	   these	   particular	   mutations	   were	   indeed	   true.	   Furthermore,	   some	   of	   the	  frameshifts	   could	   have	   originated	   as	   true	   mutations	   due	   to	   generation	   of	   a	  genomic	   library	   in	   E.	   coli,	   as	   part	   of	   the	   original	   sequencing	   protocol	  (Fleischmann	  et	  al.,	  1995).	  	  The	  only	  genomic	  variant	  identified	  in	  R2866	  was	  a	  tetranucleotide	  repeat	  in	  an	  intergenic	   region.	  This	   SSR	  has	  been	  previously	  described	  as	  being	  associated	  with	   the	   phase	   variation	   of	   genes	   involved	   in	   LOS	   biosynthesis	   (Jarosik	   and	  Hansen,	  1994).	  The	  presence	  of	   this	  SSR	   in	   the	   intergenic	   region	  could	  signify	  phase-­‐variable	   gene	   expression	   of	   an	   upstream	   gene,	   coding	   for	   a	   putative	  sigma	   factor.	   The	   overall	   lack	   of	   variations	   between	   R2866	   original	   and	   re-­‐sequenced	  genomes	  could	  be	  attributed	  to	  a	  more	  recent	  common	  ancestor	  of	  the	   two	   R2866	   descendants.	   Additionally,	   the	   original	   R2866	   genome	   was	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sequenced	  in	  2010	  using	  HTS	  technologies,	  possibly	  contributing	  to	  a	  lower	  rate	  of	  sequencing	  and	  assembly	  errors	  than	  in	  the	  original	  published	  Rd	  genome.	  	  While	   it	   is	  possible	   that	  some	  of	  SNPs	  and	   indels	   identified	   in	   this	  study	  are	  a	  result	   of	   Illumina	   sequencing	   errors,	   the	   correction	   of	   a	   large	   number	   of	  frameshifts	   within	   pseudogenes	   in	   the	   original	   Rd	   genome	   implies	   that	   the	  majority	  of	  indels	  and,	  possibly,	  SNPs	  originated	  due	  to	  errors	  in	  the	  original	  Rd	  sequence.	  This	  is	  further	  supported	  by	  some	  of	  the	  indels	  correcting	  the	  coding	  frames	  of	  genes	  in	  Rd.	  The	  fact	  that	  R2866	  only	  had	  one	  variation,	  as	  opposed	  to	  267	  in	  Rd,	  signifies	  the	  improbability	  of	  Rd	  variations	  originating	  from	  Illumina	  sequencing	  errors.	  Despite	  the	  inability	  to	  reliably	  determine	  the	  exact	  source	  of	  most	  SNPs	  and	  indels	  in	  Rd,	  their	  presence	  still	  addresses	  a	  couple	  of	  important	  issues	  regarding	  the	  use	  of	  a	  model	  organism.	  First,	  it	  is	  necessary	  to	  be	  aware	  that	  the	  descendants	  of	  the	  same	  model	  strain	  could	  potentially	  have	  different	  genotypes	  and	  phenotypes.	  Second,	  using	  the	  old	  published	  genome	  sequence	  of	  a	  model	  strain	  could	  potentially	  introduce	  inaccuracies	  in	  the	  data	  analysis	  and	  experimental	  design,	  as	  demonstrated	   in	   this	   study	  by	   the	  presence	  of	  a	   large	  number	  of	  likely	  erroneous	  pseudogenes	  in	  the	  original	  Rd	  genome.	  	  	  The	  data	  presented	  here	   lays	   important	  groundwork	   for	   subsequent	  chapters,	  where	   re-­‐sequenced	   genomes	   of	   Rd	   and	   R2866	   were	   used	   as	   references	   for	  building	   the	   transcriptional	  profile	  of	   these	   two	  strains.	  The	  knowledge	  of	   the	  accessory	  genome	  is	  also	  relevant	   for	  subsequent	  work,	  where	  the	  differential	  gene	  expression	  during	  several	   infection-­‐relevant	  conditions	  will	  be	  examined	  in	  Rd	  and	  R2866.	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Chapter	  4:	  The	  response	  of	  H.	  influenzae	  
during	  infection-­‐relevant	  conditions	  
4.1	  Introduction	  
4.1.1	  Invasion	  of	  the	  host	  by	  H.	  influenzae	  
A	   recent	   dual	   RNA-­‐Seq	   study	   by	   Baddal	   et	   al.	   explored	   the	   transcriptional	  response	   of	   the	   host	   and	   bacteria	   during	   general	   cell-­‐association	   with	   H.	  
influenzae,	   without	   distinguishing	   between	   adhesion	   and	   invasion	   processes.	  (Baddal	   et	   al.,	   2015).	   A	   more	   targeted	   approach,	   where	   either	   process	   is	  investigated	   separately,	   would	   reduce	   the	   potential	   transcriptional	   noise	  resulting	   from	   the	   mixture	   of	   both	   adherent	   and	   internalised	   H.	   influenzae.	  Therefore,	   the	   first	  major	  goal	  of	   this	  study	  was	  to	  optimise	  an	   invasion	  assay	  using	  an	  A549	  human	  alveolar	  epithelial	  cell	  culture	  model,	  which	  could	  then	  be	  used	   to	   isolate	   RNA	   from	   both	   the	   host	   and	   intracellular	   bacteria	  simultaneously.	  	  	  While	  both	  Rd	  and	  R2866	   strains	  have	  previously	  been	   shown	   to	   infect	  A549	  cells,	  the	  same	  strains	  from	  different	  laboratories	  could	  have	  varied	  phenotypes	  due	  to	  potential	  accumulated	  genetic	  differences	  (Daines	  et	  al.,	  2003,	  Soupene	  et	  al.,	  2003,	  Tsao	  et	  al.,	  2012).	  Small	  genetic	  variations	  were	  indeed	  observed	  for	  the	  Rd	  strain	  used	  in	  this	  study,	  when	  compared	  to	  another	  descendant	  of	   the	  original	   Rd	   strain	   (see	   Chapter	   3).	   Therefore,	   the	   ability	   of	   Rd	   and	   R2866	  strains,	  used	  in	  this	  laboratory,	  to	  infect	  A549	  cells	  was	  also	  characterised.	  This	  then	   informed	   subsequent	   RNA-­‐Seq	   experiments,	   where	   infection-­‐relevant	  conditions	  were	  investigated.	  	  
4.1.1.1	  Eukaryotic	  cell	  lysis	  methods	  TritonTM	   X-­‐100	   and	   saponin	   are	   detergents	   that	   are	   used	   as	   standard	   lysis	  methods	   in	  bacterial	   invasion	  assays.	  TritonTM	  X-­‐100	  works	  by	  non-­‐selectively	  permeabilising	   the	   lipid	   bilayer	   of	   eukaryotic	   cells	   (Koley	   and	   Bard,	   2010).	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Saponin	  creates	  pores	  in	  the	  eukaryotic	  plasma	  membrane	  by	  interacting	  with	  cholesterol	  molecules	  (Seeman	  et	  al.,	  1973).	  Sterile	  cold	  water	  can	  also	  be	  used	  to	  recover	  intracellular	  bacteria	  through	  the	  hypotonic	  lysis	  of	  eukaryotic	  cells.	  All	   three	   of	   these	   lysis	  methods	   have	   been	   previously	   successfully	   applied	   in	  bacterial	   invasion	   assays	   (Nair	   et	   al.,	   2000,	   Swords	   et	   al.,	   2000,	   Raffel	   et	   al.,	  2013).	  However,	  their	  potential	  bactericidal	  and	  bacteriostatic	  effects	  may	  vary	  between	  different	  bacterial	  species	  and	  need	  to	  be	  investigated	  for	  the	  specific	  bacteria	  used	  in	  the	  assay	  (Edwards	  and	  Massey,	  2011).	  	  	  
4.1.1.2	  Enrichment	  of	  bacterial	  RNA	  Simultaneous	  transcriptome	  profiling	  of	  host-­‐pathogen	  interactions	  poses	  some	  caveats.	  Bacterial	  RNA	  makes	  up	  a	  very	  small	  proportion	  of	  a	  mixed	  prokaryotic	  and	  eukaryotic	  RNA	  sample.	  In	  the	  study	  by	  Baddal	  et	  al.	  the	  mixed	  RNA	  sample	  only	   contained	   <1.5%	   of	   bacterial	   RNA	   (Baddal	   et	   al.,	   2015).	   Studying	   the	  transcriptome	   of	   a	   subset	   of	   infecting	   bacteria,	   i.e.	   differentiating	   between	  adhering	   and	   invading	   microorganisms,	   would	   reduce	   this	   ratio	   even	   more.	  Only	   high-­‐end	   genome	   sequencers,	   like	   the	   Illumina	   HiSeqTM,	   are	   suitable	   for	  such	  studies,	  since	  a	  high	  read	  depth	  needs	  to	  be	  achieved	  in	  order	  to	  recover	  any	   significant	   information	  of	  bacterial	   transcriptome	   (Humphrys	   et	   al.,	   2013,	  Westermann	   et	   al.,	   2016).	   Bacterial	   mRNA	   enrichment	   kits,	   such	   as	  MicrobEnrichTM	   (Thermo	   Fisher	   Scientific,	   UK),	   are	   available	   in	   order	   to	  increase	  the	  ratio	  of	  bacterial	  RNA	  in	  the	  mixed	  sample	  at	  the	  expense	  of	  losing	  eukaryotic	  data.	  The	  MicrobEnrichTM	  kit	  was	  used	   in	   this	   study	   for	  a	  proof-­‐of-­‐principle	  enrichment	  of	  bacterial	  RNA	  from	  a	  mixed	  host	  and	  H.	  influenzae	  RNA	  sample.	  	  
4.1.2	  H.	  influenzae	  during	  infection-­‐relevant	  conditions	  
Throughout	   the	   onset	   and	   course	   of	   both	   colonisation	   and	   infection	   of	   the	  human	   host,	   H.	   influenzae	   encounters	   a	   number	   of	   different	   stresses	   and	  environmental	   changes.	   Variations	   in	   the	   nutrient	   availability	   can	   lead	   to	  nutritional	   stress,	   forcing	  H.	   influenzae	   to	   scavenge	   any	   available	   nutrients	   in	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order	   to	   survive.	  Nutrient	   limitation	   is	   also	   likely	   to	   lead	   to	   bacteria	   entering	  and	  persisting	  in	  stationary	  growth	  phase	  during	  natural	  infection	  (Kolter	  et	  al.,	  1993).	  Oxidative	  stress	  is	  another	  major	  obstacle	  for	  survival	  of	  H.	  influenzae	  in	  a	  colonised	  niche.	  It	  is	  primarily	  mediated	  by	  the	  activity	  of	  the	  human	  immune	  system	   as	   well	   as	   bacterial	   respiratory	   by-­‐products	   and	   co-­‐pathogens	   like	   S.	  
pneumoniae	   (see	   section	   1.1.8.1).	   To	   overcome	   this,	  H.	   influenzae	   has	   evolved	  various	  defence	  mechanisms,	  as	  discussed	  earlier	  (see	  section	  1.1.8.1).	  	  	  
H.	   influenzae	   is	   likely	   to	   experience	   iron-­‐limiting	   conditions	   during	   the	  colonisation	  and	  infection	  process	  and	  is	  therefore	  required	  to	  acquire	  iron	  and	  maintain	   iron	   homeostasis.	   High	   intracellular	   iron	   concentration	   can	   lead	   to	  oxidative	   stress	   through	   the	   Fenton	   reaction,	   whereas	   iron-­‐starvation	   has	   a	  detrimental	   effect	   on	   bacterial	   growth	   (see	   sections	   1.1.8.2;	   1.1.8.3).	   It	   is	  important	   to	   study	   how	   H.	   influenzae	   responds	   to	   these	   stresses,	   as	   it	   may	  improve	   our	   understanding	   of	   its	   pathogenesis	   and	   help	   to	   identify	   novel	  strategies	  for	  disease	  prevention.	  	  The	   second	  major	   aim	   of	   this	   chapter	  was	   to	   use	   the	   RNA-­‐Seq	   technology	   to	  characterise	   the	   transcriptional	   response	   of	   Rd	   and	   R2866	   strains	   during	  infection-­‐relevant	   conditions.	   Differential	   gene	   expression	   of	   these	   strains	  during	   oxidative	   and	   iron-­‐starvation	   stresses	   was	   examined	   in	   this	   study	   via	  treatment	   of	   bacterial	   cultures	  with	   appropriate	   agents.	   The	   nutrient-­‐limiting	  MIV	   medium	   was	   used	   in	   this	   study	   to	   test	   nutritional	   stress	   response.	   This	  medium	  was	  originally	  developed	  to	  induce	  competence	  in	  H.	  influenzae	  during	  starvation	   conditions	   (Herriott	   et	   al.,	   1970).	   The	   final	   infection-­‐relevant	  condition	   investigated	   in	   this	   study	   was	   the	   growth	   of	   H.	   influenzae	   during	  stationary	   phase	   in	   the	   standard	   rich	  medium,	   as	   compared	   to	   the	   growth	   at	  mid-­‐exponential	  phase.	  The	   transcriptional	   response	  of	  a	   laboratory	  Rd	  strain	  was	  compared	  to	  an	  invasive	  R2866	  strain,	  in	  order	  to	  shed	  light	  on	  what	  makes	  the	  latter	  a	  successful	  pathogen.	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4.1.3	   Important	   considerations	   for	   transcriptome	  
profiling	  
4.1.3.1	  Depletion	  of	  rRNA	  In	  contrast	  to	  whole	  genome	  sequencing,	  where	  DNA	  is	  expected	  to	  be	  present	  at	  constant	  levels	  across	  the	  genome,	  the	  whole	  transcriptome	  contains	  a	  wide	  range	  of	  differentially	   expressed	  gene	   transcripts.	   In	  order	   to	  detect	   low-­‐level	  transcripts,	  enough	  read	  depth	  needs	  to	  be	  acquired.	  95-­‐99%	  of	  total	  bacterial	  RNA	   consists	   of	   rRNA,	   hence	   removing	   rRNA	   transcripts	   before	   cDNA	   library	  preparation	   significantly	   increases	   the	   read	   depth	   for	   mRNA	   (Peano	   et	   al.,	  2013).	  The	  Ribo-­‐Zero™	  kit	  (Illumina,	  Inc.)	  has	  been	  reported	  to	  leave	  as	  little	  as	  <1%	   of	   rRNA,	   as	   compared	   to	   several	   other	   commercially	   available	   rRNA	  removal	  kits	  and	  methods	  (Giannoukos	  et	  al.,	  2012).	  It	  was	  used	  in	  this	  study	  to	  deplete	  rRNA	  in	  H.	  influenzae	  samples	  prepared	  for	  RNA-­‐Seq	  experiments.	  	  
4.1.3.2	  The	  use	  of	  replicates	  in	  transcriptome	  studies	  The	   use	   of	   biological	   replicates	   in	   RNA-­‐Seq	   experiments	   is	   important	   for	  downstream	  statistical	  inferences,	  such	  as	  differential	  gene	  expression	  analysis.	  Replicates	   help	   to	   identify	   outliers	   and	   improve	   the	   accuracy	   of	   data	  measurements.	  Importantly,	  the	  inclusion	  of	  replicates	  helps	  to	  account	  for	  the	  variation	   in	   gene	   expression	   between	   samples	   of	   the	   same	   origin.	   However,	  there	  is	  also	  inherent	  variation	  in	  RNA-­‐Seq	  data	  itself.	   In	  addition	  to	  biological	  variation,	   between-­‐sample	   variation	   also	   comes	   from	   a	   different	   number	   of	  sequencing	   reads	   per	   sample.	  Within-­‐sample	   variation	   originates	   from	   longer	  genes	   having	  more	   reads	  mapped	   to	   them.	   To	   account	   for	   inherent	   RNA-­‐Seq	  variation	   and	   to	   make	   gene	   expression	   comparable	   within	   and	   between	  samples,	  RNA-­‐Seq	  data	  needs	  to	  be	  normalised	  first,	  as	  described	  below.	  	  
4.1.3.3	  Normalisation	  methods	  Reads	   per	   kilobase	   per	   million	   reads	   (RPKM)	   has	   been	   one	   of	   the	   most	  commonly	  used	  methods	  to	  normalise	  RNA-­‐Seq	  data	  (Mortazavi	  et	  al.,	  2008).	  It	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is	  calculated	  as	  the	  ratio	  of	  reads	  per	  gene	  length	  and	  the	  total	  number	  of	  reads.	  However,	   using	   the	   latter	   for	   normalisation	   creates	   a	   bias,	   as	   it	   does	   not	  represent	   the	   total	   number	   of	   transcripts	   (Wagner	   et	   al.,	   2012).	   Superior	  alternative	  normalisation	  methods	  include	  quartile,	  median	  and	  TPM	  (Dillies	  et	  al.,	   2013).	  The	   latter	  method	   is	   a	  modification	  of	  RPKM	  and	  has	  been	  used	   to	  normalise	  prokaryotic	  whole-­‐transcriptome	  data	  (Wagner	  et	  al.,	  2012,	  Kroger	  et	  al.,	  2013).	   It	   is	  based	  on	  the	  total	  number	  of	   transcripts	   in	  RNA-­‐Seq	  data,	   thus	  eliminating	  the	  bias	  present	  in	  the	  RPKM	  method.	  The	  TPM	  normalisation	  was	  used	  in	  this	  work	  to	  determine	  the	  absolute	  expression	  of	  genome	  features	  of	  H.	  
influenzae.	  	  A	   commonly	   used	   tool	   for	   the	   differential	   gene	   expression	   analysis	   of	  prokaryotic	  RNA-­‐Seq	  data	  is	  DESeq2.	  (Love	  et	  al.,	  2014).	  It	  is	  implemented	  in	  R	  and	  is	  an	  advanced	  version	  of	  its	  predecessor	  DESeq,	  with	  added	  new	  features	  and	   improved	   statistical	   methodologies	   (Anders	   and	   Huber,	   2010).	   DESeq2	  models	  RNA-­‐Seq	  data	  based	  on	  the	  negative	  binomial	  distribution	  and	  uses	  the	  aforementioned	   median	   normalisation	   method,	   which	   relies	   on	   calculating	   a	  median	   value	   of	   geometric	   mean	   ratios	   (Anders	   and	   Huber,	   2010).	   Robust	  statistical	  methodologies	   and	   extensive	   use	   of	   the	   software	   in	   other	   bacterial	  transcriptomic	   studies	  make	  DESeq2	  one	  of	   the	  best	   currently	   available	   tools	  for	  prokaryotic	  differential	  gene	  expression	  analysis	  (Bent	  et	  al.,	  2015,	  Jiang	  et	  al.,	   2016b).	   For	   these	   reasons,	   DESeq2	   was	   used	   in	   this	   study	   to	   analyse	  differential	   gene	   expression	   in	   Rd	   and	   R2866	   strains	   of	  H.	   influenzae	   during	  infection-­‐relevant	  conditions.	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4.2	  Results	  
4.2.1	  Development	  of	  a	  eukaryotic	  cell	  invasion	  assay	  
4.2.1.1	  Optimisation	  of	  the	  invasion	  assay	  Several	   aspects	   of	   the	   invasion	   assay	  were	   first	   optimised,	   including	   the	  MOI,	  eukaryotic	  cell	   lysis	  and	  infection	  time.	  The	  MOI	  represents	  an	  initial	  bacterial	  inoculum	   and	   is	   defined	   as	   the	   number	   of	   bacteria	   per	   single	   host	   cell.	   The	  standard	   MOI	   used	   in	   infection	   assays	   ranges	   from	   1:1	   to	   100:1;	   a	   lower	   or	  higher	  MOI	  could	  potentially	  skew	  the	  data	  (Letourneau	  et	  al.,	  2011).	  MOI	  of	  1:1,	  10:1,	  50:1	  and	  100:1	  were	  tested	  for	  the	  Rd	  strain.	  A549	  cells,	  infected	  with	  Rd	  at	  different	  MOI,	  were	  incubated	  for	  two	  hours	  prior	  to	  a	  one-­‐hour	  gentamicin	  treatment.	   TritonTM	   X-­‐100	  was	   used	   to	   lyse	   infected	   A549	   cells.	   There	   was	   a	  trend	  of	   a	   larger	  number	   of	   intracellular	   bacteria	   being	   recovered	   as	   the	  MOI	  increased,	   with	   50:1	   and	   100:1	   resulting	   in	   the	   highest	   numbers	   (see	   Figure	  4.1).	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The	  effect	  of	  TritonTM	  X-­‐100,	  sterile	  cold	  water	  and	  saponin	  on	  the	  recovery	  of	  intracellular	   H.	   influenzae	   was	   tested	   after	   infecting	   A549	   cells	   with	   the	   Rd	  strain	  for	  two	  hours	  at	  the	  MOI	  of	  100:1	  (see	  Figure	  4.2).	  Saponin	  lysis	  of	  A549	  cells	  resulted	  in	  the	  highest	  counts	  of	   intracellular	  bacteria,	  with	  over	  twice	  as	  much	  recovery	  as	  with	  TritonTM	  X-­‐100.	  The	  recovery	  of	   invading	  bacteria	  with	  sterile	   cold	  water	  was	   only	   slightly	   higher	   than	  with	   TritonTM	   X-­‐100.	   Saponin	  was	   therefore	   selected	   as	   a	   preferred	   eukaryotic	   cell	   lysis	   method	   for	   all	  subsequent	  invasion	  experiments.	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  










Figure	   4.2:	   The	   effect	   of	   different	   eukaryotic	   cell	   lysis	   methods	   on	   the	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In	  order	  to	  determine	  the	  optimal	  MOI	  for	  the	  R2866	  strain,	  four	  different	  MOI	  were	  again	  tested	  -­‐	  1:1,	  10:1,	  50:1	  and	  100:1	  (see	  Figure	  4.3).	  A549	  cells	  were	  incubated	   for	   two	  hours	  prior	   to	   the	  one-­‐hour	   gentamicin	   treatment.	   Saponin	  was	  used	  as	  a	  eukaryotic	  cell	  lysis	  method,	  based	  on	  the	  previous	  optimisation.	  The	   same	   pattern	   of	   increasing	   intracellular	   bacterial	   numbers	  with	   a	   higher	  MOI	   was	   observed.	   Since	   one	   of	   the	   aims	   of	   this	   assay	   was	   to	   maximise	   the	  number	   of	   invading	   bacteria,	   the	   optimal	   MOI	   was	   chosen	   as	   100:1.	   It	   was	  henceforth	  used	  in	  all	  infection	  experiments	  for	  both	  Rd	  and	  R2866.	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The	   optimisation	   of	   infection	   time	   for	   Rd	   and	   R2866	   strains	  was	   carried	   out	  next.	  The	  initial	  bacterial	  inoculum	  (at	  MOI	  of	  100:1)	  was	  incubated	  with	  A549	  cells	  for	  2-­‐5	  hours,	  before	  proceeding	  with	  the	  gentamicin	  treatment	  in	  order	  to	  kill	   any	   remaining	   extracellular	   bacteria.	   For	   both	   Rd	   and	   R2866	   strains,	   the	  number	  of	  recovered	  intracellular	  bacteria	  increased	  at	  3	  hours	  compared	  to	  2	  hours,	  but	  then	  decreased	  again	  at	  4	  hours	  (see	  Figure	  4.4).	  However,	  there	  was	  another	  increase	  in	  the	  number	  of	  invading	  bacteria	  at	  5	  hours,	  particularly	  for	  the	   Rd	   strain.	   The	   optimal	   infection	   time	   was	   selected	   as	   3	   hours,	   due	   to	   a	  subsequent	  decrease	  in	  the	  number	  of	  intracellular	  bacteria	  at	  4	  hours.	  A	  larger	  number	  of	  recovered	  intracellular	  bacteria	  was	  observed	  at	  3	  hours	  for	  the	  Rd	  strain	  compared	  to	  R2866	  with	  the	  same	  MOI	  of	  100:1.	  The	  bacterial	  recovery	  at	  3	  hours	  was	  8.47	  x	  104	  CFU/ml	  for	  Rd	  and	  4.97	  x	  103	  CFU/ml	  for	  R2866.	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4.2.1.2	  Effect	  of	  serum	  in	  the	  infection	  medium	  on	  the	  bacterial	  
viability	  In	  order	   to	  understand	  the	  effect	  of	   the	   infection	  medium,	  specifically	   the	  FBS	  component,	  on	  the	  viability	  of	  Rd	  and	  R2866,	  both	  strains	  were	  grown	  in	  DMEM	  either	  without	  FBS	  or	  with	  2%,	  5%	  and	  10%	  FBS.	  Bacteria	  were	  quantified	  at	  1.5	  and	  3	  hours	  post-­‐inoculation.	  As	  the	  FBS	  concentration	  in	  DMEM	  increased,	  the	  CFU/ml	  values	  rose	  for	  both	  Rd	  and	  R2866	  (see	  Figure	  4.5).	  When	  no	  FBS	  was	  present	  in	  DMEM,	  the	  viability	  of	  both	  Rd	  and	  R2866	  decreased	  over	  time.	  Using	  2%	  and	  5%	  FBS	  resulted	  in	  an	  increase	  of	  Rd	  and	  R2866	  numbers	  at	  1.5	  hours,	  compared	  to	  0	  hours.	  This	  was	   followed	  by	  a	  reduction	   in	  viability	  at	  3	  hours	   for	  both	   strains.	  The	   same	  growth	  pattern	  was	  observed	   for	   the	  R2866	  strain	  at	  10%	  FBS,	  though	  Rd	  continued	  to	  grow	  at	  3	  hours.	  The	  growth	  in	  10%	  FBS	  (corresponding	  to	  the	  infection	  medium	  used	  in	  this	  study)	  resulted	  in	  the	  highest	  CFU/ml	  values	  for	  both	  Rd	  and	  R2866	  strains.	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Figure	  4.5:	  The	  effect	  of	  the	  FBS	  in	  the	  infection	  medium	  on	  the	  viability	  of	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4.2.1.3	   Fluorescence	   microscopy	   of	   H.	   influenzae	   invasion	   of	  
A549	  cells	  Fluorescence	  imaging	  of	  infected	  A549	  cells	  was	  carried	  out	  in	  order	  to	  confirm	  the	  invasion	  of	  these	  cells	  by	  Rd	  and	  R2866	  strains.	  The	  optimal	  MOI	  of	  100:1	  and	  infection	  time	  of	  3	  hours	  were	  used	  for	  the	  infection,	  prior	  to	  the	  one-­‐hour	  gentamicin	   treatment.	   Following	   that,	   a	   lipophilic	   dye	   FM®	   4-­‐64	  was	   used	   to	  stain	   the	   invading	   bacteria	   and	   eukaryotic	   vesicles,	   while	   cell	   nuclei	   were	  visualised	  using	  a	  standard	  DAPI	  stain	  (Vida	  and	  Emr,	  1995).	  Non-­‐infected	  A549	  cells	   were	   used	   as	   control.	   Fluorescence	   imaging	   confirmed	   the	   presence	   of	  invading	  H.	  influenzae	   in	  A549	  cells	  for	  both	  Rd	  and	  R2866	  strains	  (see	  Figure	  4.6).	  This	  was	  determined	  by	  observing	  the	  morphological	  differences	  between	  stained	  vesicles	  in	  a	  control	  sample	  and	  rod-­‐shaped	  bacteria	  in	  infected	  cells.	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Figure	  4.6:	  Fluorescence	  imaging	  of	  A549	  cells	  infected	  with	  Rd	  and	  R2866	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4.2.1.4	  RNA	  extraction	  from	  infected	  cells	  As	  proof	  of	  principle,	  RNA	  was	  extracted	  from	  A549	  cells	   infected	  with	  the	  Rd	  strain	   using	   the	   optimised	   invasion	   assay	   conditions.	   The	   Bioanalyzer	  electropherogram	  images	  showed	  clear	  peaks	  of	  the	  human	  18S	  and	  28S	  rRNA	  as	  well	   as	   lower	   peaks	   of	   smaller	   fragment	   size,	   representing	   5S	   rRNA,	   tRNA	  and	   other	   sRNAs	   (see	   Figure	   4.7A).	   There	   was	   no	   trace	   of	   bacterial	   rRNA.	  Following	   the	   enrichment	   of	   the	   bacterial	   RNA	   with	   the	   MicrobEnrichTM	   kit	  within	   the	   same	   mixed	   RNA	   sample,	   18S	   and	   28S	   rRNA	   peaks	   were	   absent,	  highlighting	  the	  efficiency	  of	   the	  removal	  of	  eukaryotic	  RNA	  (see	  Figure	  4.7B).	  The	  largest	  peaks	  of	  the	  enriched	  RNA	  likely	  represented	  small	  eukaryotic	  RNAs	  (5S	   rRNA	   and	   tRNA).	   There	  were	   small	   peaks	   present	   of	   the	   higher	   fragment	  size	  as	  well,	  but	   it	  was	  not	  possible	  to	   interpret	  whether	  they	  represented	  the	  remaining	   human	   rRNA	   or	   indeed	   the	   enriched	   bacterial	   16S	   or	   23S	   rRNA,	  which	  would	  be	  expected	  to	  make	  up	  the	  majority	  of	  the	  bacterial	  RNA	  sample.	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Figure	   4.7:	   Quality	   control	   of	   the	   enrichment	   of	   bacterial	   RNA	   from	   a	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4.2.2	  RNA-­‐Seq	   analysis	   of	   the	   transcriptional	   response	  
of	   Rd	   and	   R2866	   strains	   during	   infection-­‐relevant	  
conditions	  
4.2.2.1	  RNA	  sample	  acquisition	  and	  preparation	  for	  RNA-­‐Seq	  
4.2.2.1.1	   Growth	   of	   Rd	   and	   R2866	   strains	   in	   rich	   and	   nutrient-­‐
limiting	  media	  Having	  established	  the	  ability	  of	  Rd	  and	  R2866	  strains	   from	  this	   laboratory	  to	  infect	  human	  cells,	  the	  optimisation	  of	  infection-­‐relevant	  conditions	  was	  carried	  out	  next.	   First,	   it	  was	  necessary	   to	   characterise	   the	  growth	  kinetics	  of	  Rd	  and	  R2866	   in	   relevant	   media.	   That	   would	   then	   inform	   the	   acquisition	   of	   RNA	  samples	  at	  appropriate	  growth	  phases.	  Firstly,	  Rd	  and	  R2866	  were	  grown	  in	  the	  rich	  sBHI	  medium	  for	  nine	  hours	  and	  a	  growth	  curve	  was	  plotted	  for	  each	  strain	  after	   measuring	   OD600	   at	   one-­‐hour	   intervals	   (see	   Figure	   4.8).	   Rd	   and	   R2866	  exhibited	  very	  similar	  growth,	  with	  mid-­‐exponential	  phase	  being	  at	  OD600	  of	  0.3-­‐0.5.	  Late	  stationary	  phase,	  when	  OD600	  was	  no	  longer	  increasing,	  was	  at	  9	  hours	  for	  both	  strains.	  The	  transcriptional	  profile	  of	  H.	  influenzae	  would	  be	  compared	  between	  stationary	  and	  mid-­‐exponential	  growth	  phases	  (see	  section	  4.2.2.4.1).	  Therefore,	  bacteria	  were	  collected	  at	  these	  growth	  phases	  in	  the	  sBHI	  medium	  for	  the	  stationary	  phase	  RNA-­‐Seq	  experiment.	  	  	  The	   growth	   of	   Rd	   and	   R2866	   in	   the	   nutrient-­‐limiting	   MIV	   medium	   was	   also	  tested,	   in	   order	   to	   inform	   RNA	   sample	   acquisition	   for	   the	   nutritional-­‐stress	  RNA-­‐Seq	   experiment.	   As	   expected,	   Rd	   grew	   less	  well	   in	  MIV	   than	   in	   the	   sBHI	  medium,	  with	  mid-­‐exponential	   phase	   being	   at	   an	  OD600	   of	   0.1-­‐0.2	   (see	   Figure	  4.8).	   Rd	   reached	   late	   stationary	   phase	   in	   the	   MIV	   medium	   at	   9.5	   hours.	   The	  R2866	  strain	  did	  not	  grow	  in	  MIV.	  For	  a	  nutritional	  stress	  RNA-­‐Seq	  experiment,	  Rd	   broth	   cultures	   were	   collected	   at	   mid-­‐exponential	   phase	   during	   growth	   in	  sBHI	   and	   MIV	  media.	   Nutritional	   stress	   was	   not	   tested	   for	   R2866,	   due	   to	   its	  inability	  to	  grow	  in	  the	  MIV	  medium.	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4.2.2.1.2	   Optimisation	   of	   oxidative	   and	   iron-­‐starvation	   stresses	   for	  
Rd	  and	  R2866	  strains	  	  Hydrogen	   peroxide	   has	   been	   previously	   used	   as	   an	   agent	   for	   oxidative	   stress	  induction	   in	   H.	   influenzae	   (Wong	   et	   al.,	   2007).	   The	   effect	   of	   three	   different	  concentrations	  of	  hydrogen	  peroxide	  (1	  mM,	  5	  mM	  and	  15	  mM)	  was	  tested	  on	  the	  growth	  of	  Rd	  and	  R2866	  strains	  in	  this	  study.	  Hydrogen	  peroxide	  was	  added	  to	   sBHI	   broth	   cultures	   at	  mid-­‐exponential	   phase	   and	   OD600	   was	  measured	   at	  one-­‐hour	  intervals.	  The	  R2866	  strain	  was	  more	  sensitive	  to	  hydrogen	  peroxide	  treatment	  than	  Rd	  (see	  Figure	  4.9).	  An	  appropriate	  concentration	  of	  hydrogen	  peroxide	  for	  the	  use	  in	  an	  oxidative	  stress	  RNA-­‐Seq	  experiment	  was	  determined	  as	  5	  mM	  for	  both	  Rd	  and	  R2866	  strains:	  it	  had	  an	  inhibitory	  effect	  on	  bacterial	  growth,	  yet	  did	  not	  result	   in	  a	  subsequent	  drop	   in	  OD600	  as	  observed	  with	   the	  higher	  concentration	  of	  15	  mM.	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Figure	   4.9:	  The	   growth	   response	   of	   Rd	   and	   R2866	   strains	   to	   oxidative	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An	   iron	   chelator	   2,2-­‐bipyridine	   has	   been	   previously	   used	   to	   induce	   iron-­‐starvation	   in	  H.	  influenzae	   (Harrison	  et	   al.,	   2013).	  The	  effect	  of	   three	  different	  concentrations	   of	   2,2-­‐bipyridine	   (1	  mM,	   2	  mM	   and	   5	  mM)	  was	   tested	   on	   the	  growth	   of	   Rd	   and	   R2866.	   OD600	  measurements	  were	   carried	   out	   hourly	   after	  addition	  of	  2,2-­‐bipyridine	   to	  sBHI	  broth	  cultures.	  As	  with	  oxidative	  stress,	   the	  R2866	   strain	   was	   also	   more	   sensitive	   to	   iron-­‐starvation	   than	   Rd	   (see	   Figure	  4.10).	  It	  was	  also	  noted	  that	  the	  effect	  of	  2,2-­‐bipyridine	  on	  the	  growth	  was	  not	  noticeable	  in	  R2866	  30	  minutes	  after	  addition	  of	  the	  chelator,	  but	  was	  apparent	  after	  1	  hour.	  This	  was	  in	  addition	  to	  the	  liquid	  broth	  colour	  changing	  to	  dark	  red	  within	  1	  hour	   after	   treatment.	  An	   appropriate	   concentration	  of	   2,2-­‐bipyridine	  for	  use	  in	  an	  iron-­‐starvation	  RNA-­‐Seq	  experiment	  was	  deemed	  as	  5	  mM	  for	  both	  Rd	  and	  R2866	  strains.	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Figure	   4.10:	   The	   growth	   response	   of	   Rd	   and	   R2866	   strains	   to	   iron-­‐
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4.2.2.2	   Quality	   control	   of	   RNA	   extraction,	   rRNA	   depletion	   and	  
cDNA	  library	  preparation	  For	  each	  RNA-­‐Seq	  experiment,	  Rd	  and	  R2866	  strains	  were	  grown	   in	   triplicate	  and	   bacterial	   samples	   were	   collected	   at	   an	   appropriate	   growth	   phase	   or	  following	  a	  specific	   treatment,	  as	  described	  above.	  During	  RNA	  extraction	  and	  cDNA	   library	  preparation,	   several	  RNA	  and	   cDNA	  quality	   control	   checks	  were	  carried	  out	  using	  the	  Bioanalyzer.	  Figure	  4.11	  shows	  representative	  Bioanalyzer	  electropherogram	   images	   for	   Rd	   and	   R2866	   after	   RNA	   extraction,	   rRNA	  depletion	   and	   cDNA	   library	   preparation.	   Following	   RNA	   extraction,	   Rd	  contained	   two	  clear	  16S	  and	  23S	  rRNA	  bands,	  while	   there	  were	  multiple	  RNA	  bands	   present	   in	   the	   R2866	   strain.	   Depletion	   of	   rRNA	   was	   evident	   from	   the	  absence	  of	  clear	  rRNA	  bands	  and	  enrichment	  of	  mRNA.	  The	  cDNA	  Bioanalyzer	  electropherogram	  image	  represented	  amplified	  cDNA	  fragments	  and	  was	  used	  to	   quantify	   average	   cDNA	   fragment	   size,	   which	   was	   required	   for	   sequencing.	  RNA	   and	   cDNA	   samples	   used	   in	   all	   RNA-­‐Seq	   experiments	   had	   equivalent	  Bioanalyzer	   electropherogram	   traces	   as	   shown	   in	   Figure	   4.11.	   The	   cDNA	  libraries,	  prepared	  using	  TruSeqTM	  Stranded	  mRNA	  kit,	  were	  then	  sequenced	  on	  the	  Illumina	  MiSeqTM	  platform	  (see	  sections	  2.8.2;	  2.8.3).	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Figure	  4.11:	  Bioanalyzer	  electropherogram	  images	  representative	  of	  RNA	  
extraction,	   rRNA	   depletion	   and	   cDNA	   library	   preparation	   for	   Rd	   and	  
R2866	  strains.	  The	  triangular	  arrow	  points	  to	  a	  cDNA	  peak	  used	  to	  quantify	  the	  average	  fragment	  size	  of	  a	  cDNA	  library.	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4.2.2.3	  RNA-­‐Seq	  data	  processing	  and	  quality	  control	  Tables	  4.1	  and	  4.2	  show	  the	  number	  of	  RNA-­‐Seq	  reads	  generated	  for	  every	  Rd	  and	  R2866	  RNA-­‐Seq	  sample	  as	  well	  as	  the	  percentage	  of	  RNA-­‐Seq	  reads	  mapped	  to	  respective	  re-­‐sequenced	  reference	  genomes.	  Each	  sample	  had	  over	  3	  million	  reads,	   with	   the	  maximum	   number	   of	   reads	   being	   over	   30	  million	   for	   two	   Rd	  samples.	   99%	   or	   more	   of	   the	   generated	   RNA-­‐Seq	   reads	   were	   mapped	   to	  reference	   genomes	   for	   all	   RNA-­‐Seq	   samples.	   Next,	   the	   similarity	   between	  replicates	  from	  each	  RNA-­‐Seq	  experiment	  was	  examined	  using	  the	  hierarchical	  clustering	   method.	   Replicates	   from	   the	   same	   condition	   in	   each	   RNA-­‐Seq	  experiment	   indeed	   clustered	   together,	   apart	   from	   one	   R2866	   replicate	   in	   the	  oxidative	  stress	  experiment	  (see	  Figures	  4.12;	  4.13).	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Table	  4.1:	  Generation	  and	  processing	  of	  RNA-­‐Seq	  reads	  for	  the	  Rd	  strain.	  
RNA-­‐Seq	  
experiment	   Sample	  group	   Replicate	   Total	  number	  of	  reads	   Percentage	  of	  reads	  mapped	  to	  reference	  (%)	  
Stationary	  
phase	  
Mid-­‐exponential	  phase	   1	   8,513,820	   99.73	  2	   8,460,966	   99.71	  3	   8,054,466	   99.71	  
Stationary	  phase	   1	   9,577,404	   99.67	  2	   7,739,026	   99.61	  3	   6,922,290	   99.69	  
Oxidative	  
stress	  
-­‐	  H2O2	   1	   9,865,746	   99.28	  2	   8,554,276	   99.09	  3	   9,956,172	   99.25	  




-­‐	  2,2-­‐bipyridine	   1	   8,465,004	   99.69	  2	   9,407,392	   99.65	  3	   8,395,522	   99.66	  
+	  2,2-­‐bipyridine	   1	   11,748,542	   99.62	  2	   12,553,076	   99.54	  3	   9,969,430	   99.41	  
Nutritional	  
stress	  
sBHI	  medium	   1	   30,430,040	   99.57	  2	   13,007,846	   99.72	  3	   13,214,318	   99.69	  
MIV	  medium	   1	   33,644,884	   99.60	  2	   18,747,718	   99.73	  3	   15,066,398	   99.70	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Table	   4.2:	   Generation	   and	   processing	   of	   RNA-­‐Seq	   reads	   for	   the	   R2866	  
strain.	  
RNA-­‐Seq	  
experiment	   Sample	  group	   Replicate	  
Total	  number	  of	  
reads	  
Percentage	  of	  




Mid-­‐exponential	  phase	   1	   9,352,464	   99.71	  2	   10,588,010	   99.69	  3	   9,166,440	   99.69	  
Stationary	  phase	   1	   9,615,326	   99.61	  2	   9,387,932	   99.64	  3	   12,085,666	   99.48	  
Oxidative	  
stress	  
-­‐	  H2O2	   1	   9,016,922	   99.79	  2	   8,098,468	   99.05	  3	   10,954,020	   99.75	  




-­‐	  2,2-­‐bipyridine	   1	   4,157,900	   99.41	  2	   4,822,644	   99.45	  3	   4,111,496	   99.38	  
+	  2,2-­‐bipyridine	   1	   4,158,598	   99.38	  2	   4,318,270	   99.00	  3	   3,878,952	   99.08	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Figure	   4.12:	   Quality	   control	   of	   Rd	   replicates	   used	   in	   the	   RNA-­‐Seq	  
experiment.	   Samples	   were	   clustered	   based	   on	   the	   euclidean	   distance	  calculated	   based	   on	   the	   log2-­‐transformed	   gene	   expression	   data	   from	   each	  sample.	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Figure	   4.13:	   Quality	   control	   of	   R2866	   replicates	   used	   in	   the	   RNA-­‐Seq	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4.2.2.4	   Differential	   gene	   expression	   of	   H.	   influenzae	   during	  
infection-­‐relevant	  conditions	  Following	   sequencing	  and	  mapping	  of	  RNA-­‐Seq	   reads,	  differentially	  expressed	  genes	  were	  identified	  for	  each	  infection-­‐relevant	  condition.	  As	  it	  is	  not	  possible	  to	  cover	  all	  genes	  in	  the	  dataset,	  the	  following	  sections	  will	  focus	  on	  important	  findings,	   with	   the	   emphasis	   on	   characterised	   and	   putative	   gene	   clusters	   and	  operons	  as	  well	  as	  genes	  with	  known	  and	  predicted	  roles	  in	  stress	  response	  and	  pathogenesis.	   Differentially	   expressed	   genes	   were	   also	   analysed	   for	   the	  enrichment	   of	   functional	   groups	   (GO	   terms	   and	   KEGG	   pathways),	   the	   most	  important	  of	  which	  will	  be	  presented	  in	  the	  following	  sections.	  	  
4.2.2.4.1	  Transcriptional	  behaviour	  of	  Rd	  and	  R2866	  strains	  during	  
stationary	  growth	  phase	  A	  total	  of	  661	  genes	  were	  differentially	  expressed	  in	  the	  Rd	  strain	  at	  stationary	  phase	   in	   the	   sBHI	   medium	   when	   compared	   to	   mid-­‐exponential	   phase	   (see	  Appendix	   B).	   Of	   these,	   324	  were	   up-­‐regulated	   and	   337	  were	   down-­‐regulated.	  Similarly,	   709	   genes	   were	   differentially	   expressed	   in	   the	   R2866	   strain	   at	  stationary	   phase,	   356	   of	   which	   were	   up-­‐regulated	   and	   353	   were	   down-­‐regulated.	   As	   described	   in	   detail	   below,	   there	   was	   induction	   of	   various	  metabolic	   pathways,	   oxidative	   stress	   response	   and	   iron	   acquisition.	   In	  particular,	   up-­‐regulation	   of	   amino	   acid	   synthesis,	   coupled	   with	   reduction	   in	  protein	  biosynthesis	  and	  respiratory	  pathways,	  suggests	  that	  a	  classic	  stringent	  response	   was	   induced	   in	   both	   strains	   during	   stationary	   phase	   (Durfee	   et	   al.,	  2008).	  	  
4.2.2.4.1.1	  Metabolic	  response	  	  Multiple	   genes	   associated	  with	  metabolic	   pathways	  were	   up-­‐regulated	   during	  stationary	  phase	  in	  both	  Rd	  and	  R2866.	  This	  was	  also	  evident	  from	  the	  majority	  of	  enriched	  functional	  groups	  being	  associated	  with	  metabolism	  in	  both	  strains	  (see	  Figures	  4.14;	  4.15).	  There	  was	  increase	  in	  expression	  of	  genes	  involved	  in	  pentose	  and	  hexose	  sugar	  metabolism,	  including	  the	  L-­‐fucose	  operon,	  fucAIKPU,	  the	   D-­‐ribose	   transport	   and	   utilisation	   locus,	   rbsABCDKR	   as	  well	   as	   a	   putative	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galactose	  metabolism	  locus,	  galKMT	  (see	  Appendix	  B).	  Other	  up-­‐regulated	  genes	  involved	   in	   sugar	   and	   amino	   acid	   metabolism	   were	   a	   putative	   glycogen	  biosynthesis	   and	   processing	   locus,	   glgABCX,	   as	   well	   as	   several	   genes	   with	  predicted	   roles	   in	   glycerol	   metabolism.	   The	   whole	   putative	   histidine	  biosynthesis	  operon	  was	  up-­‐regulated	  in	  Rd,	  though	  only	  some	  members	  of	  this	  operon	  were	  induced	  in	  R2866	  (see	  Figure	  4.16).	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Figure	  4.14:	  Functional	  group	  enrichment	  analysis	  of	  up-­‐regulated	  genes	  
in	  the	  Rd	  strain	  during	  growth	  at	  stationary	  phase,	  compared	  to	  growth	  at	  
mid-­‐exponential	  phase.	  Groups	  were	  ordered	  from	  top	  to	  bottom	  based	  on	  the	  decreasing	  adjusted	  p-­‐value.	  The	  x-­‐axis	  displays	  the	  percentage	  of	  up-­‐regulated	  genes	  that	  belonged	  to	  each	  functional	  group.	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Figure	  4.15:	  Functional	  group	  enrichment	  analysis	  of	  up-­‐regulated	  genes	  
in	   the	   R2866	   strain	   during	   growth	   at	   stationary	   phase,	   compared	   to	  
growth	  at	  mid-­‐exponential	  phase.	  Groups	  were	  ordered	  from	  top	  to	  bottom	  based	  on	  the	  decreasing	  adjusted	  p-­‐value.	  The	  x-­‐axis	  displays	  the	  percentage	  of	  up-­‐regulated	  genes	  that	  belonged	  to	  each	  functional	  group.	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Several	  amino	  acid	  and	  sugar	  transport	  genes	  were	  also	  induced,	  including	  oppA	  and	  oppB	  genes,	  encoding	  oligopeptide	  transporter	  proteins,	  and	  a	  transporter	  system,	   afuABC	   (see	   Appendix	   B).	   Despite	   being	   annotated	   as	   a	   ferric	   uptake	  system	  in	  Rd	  and	  R2866,	  the	  highly	  conserved	  bacterial	  gene	  locus	  afuABC	  was	  recently	  shown	  to	  be	  responsible	   for	   the	  transport	  of	  sugar-­‐phosphates	  (Sit	  et	  al.,	   2015).	   The	   L-­‐ascorbate	   utilisation	   locus,	   absent	   from	   R2866,	   was	   also	  induced	   in	   the	  Rd	   strain.	   In	   addition,	   there	  was	  up-­‐regulation	  of	   the	  atoABDE	  operon,	  homologues	  of	  which	  encode	  proteins	  responsible	  for	  the	  catabolism	  of	  short-­‐chain	  fatty	  acids	  in	  E.	  coli	  (Pauli	  and	  Overath,	  1972).	  	  A	   gene	   in	   R2866	  with	   the	   highest	   level	   of	   up-­‐regulation	   (over	   123-­‐fold)	   was	  another	  metabolic	  gene	  tnaA,	  encoding	  a	  tryptophanase	  enzyme	  (see	  Table	  4.3).	  The	   tnaB	   gene,	   encoding	   a	   tryptophan	   permease	   protein,	   was	   the	   third	  most	  highly	   up-­‐regulated	   gene	   in	   R2866.	   A	   gene	   speF,	   encoding	   an	   ornithine	  decarboxylase	  enzyme,	  was	  the	  second	  most	  highly	  up-­‐regulated	  gene	  in	  the	  Rd	  strain	  (see	  Table	  4.4).	  This	  enzyme	  is	  involved	  in	  the	  biosynthesis	  of	  putrescine	  from	  L-­‐ornithine	  and	  is	  co-­‐transcribed	  with	  a	  gene	  potE,	  encoding	  a	  putrescine-­‐ornithine	  antiporter,	  which	  was	  also	  up-­‐regulated	  in	  both	  strains	  (Kashiwagi	  et	  al.,	  1992)	  (see	  Appendix	  B).	  In	  contrast,	  genes	  from	  a	  putative	  spermidine	  and	  putrescine	  uptake	  locus,	  potABCD,	  were	  down-­‐regulated	  in	  both	  (Furuchi	  et	  al.,	  1991).	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Table	  4.3:	  The	  ten	  most	  highly	  up-­‐regulated	  and	  down-­‐regulated	  genes	  in	  
the	   R2866	   strain	   during	   growth	   at	   stationary	   phase,	   compared	   to	   mid-­‐
exponential	  phase.	  	  





tnaA	   Tryptophanase	   123.37	   -­‐	  
-­‐	   Alkylhydroperoxidase	  AhpD	  family	  core	  domain	  protein	   56.49	   28.79	  
tnaB	   Tryptophan	  permease	   32.04	   -­‐	  
afuA	   Ferric	  transport	  system	  AfuABC;	  periplasmic-­‐binding	  protein	  component	   28.36	   8.43	  
hxuC	   Haem-­‐hemopexin	  utilization	  protein	  C	   27.20	   -­‐	  
hxuB	   Haem-­‐hemopexin	  utilization	  protein	  B	   23.48	   -­‐	  
hxuA	   Haem-­‐hemopexin	  utilization	  protein	  A	   20.61	   2.14	  
yjiG	   Inner	  membrane	  protein	  YjiG	   20.30	   -­‐	  
-­‐	   Sporulation	  integral	  membrane	  protein	  YlbJ	   17.38	   -­‐	  
-­‐	   Putative	  peptidase	   14.64	   -­‐	  
Down-­‐regulated	  genes	  
rpL29	   50S	  ribosomal	  protein	  L29	   23.53	   12.64	  
artP	   Arginine	  ABC	  transporter;	  ATP-­‐binding	  protein	  ArtP	   23.51	   82.19	  
rpL16	   50S	  ribosomal	  protein	  L16	   22.41	   12.12	  
rpS17	   30S	  ribosomal	  protein	  S17	   20.09	   10.40	  
rpS3	   30S	  ribosomal	  protein	  S3	   18.93	   10.91	  
rpL7	   50S	  ribosomal	  protein	  L7/L12	   18.41	   17.69	  
rpL22	   50S	  ribosomal	  protein	  L22	   17.49	   11.06	  
artM	   Arginine	  ABC	  transporter;	  permease	  protein	  ArtM	   16.75	   22.57	  
rpS19	   30S	  ribosomal	  protein	  S19	   16.64	   10.44	  
potD	   Spermidine/putrescine	  ABC	  transporter;	  periplasmic-­‐binding	  protein	   16.20	   26.39	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Table	  4.4:	  The	  ten	  most	  highly	  up-­‐regulated	  and	  down-­‐regulated	  genes	  in	  
the	   Rd	   strain	   during	   growth	   at	   stationary	   phase,	   compared	   to	   mid-­‐
exponential	  phase.	  	  





-­‐	   Alkylhydroperoxidase	  AhpD	  family	  core	  domain	  protein	   28.79	   56.49	  
speF	   Ornithine	  decarboxylase	   22.04	   7.69	  
-­‐	   RarD	  protein	   19.86	   4.00	  
fucI	   L-­‐fucose	  isomerase	   18.19	   9.14	  
dps	   DNA	  protection	  during	  starvation	  protein	   13.55	   12.87	  
potE	   Putrescine	  transporter	   11.39	   4.16	  
glpK	   Glycerol	  kinase	   10.59	   11.21	  
fucR	   L-­‐fucose	  operon	  activator	   10.27	   5.17	  
-­‐	   DNA	  polymerase	  V	  subunit	  UmuD	   9.75	   -­‐	  
glpF_1	   Glycerol	  uptake	  facilitator	  protein	   9.54	   11.60	  
Down-­‐regulated	  genes	  
artP	   Arginine	  transporter	  ATP-­‐binding	  protein	   82.19	   23.51	  
artI	   Arginine	  ABC	  transporter	  substrate-­‐binding	  protein	   40.84	   13.75	  
potD_2	   Spermidine/putrescine	  ABC	  transporter	  substrate-­‐binding	  protein	   26.39	   16.20	  
deaD	   ATP-­‐dependent	  RNA	  helicase	   23.54	   8.57	  
artM	   Arginine	  transporter	  permease	  subunit	  ArtM	   22.57	   16.75	  
cca	   Multifunctional	  tRNA	  nucleotidyl	  transferase	   18.02	   14.88	  
rplL	   50S	  ribosomal	  protein	  L7/L12	   17.69	   18.41	  
trpE	   Anthranilate	  synthase	  component	  I	   16.50	   -­‐	  
artQ	   Arginine	  transporter	  permease	  subunit	  ArtQ	   16.36	   11.50	  
nrfA	   Cytochrome	  c552	   13.93	   2.30	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Among	   other	   metabolism-­‐associated	   gene	   loci,	   down-­‐regulated	   during	  stationary	   phase,	   was	   the	   artIMPQ	   operon,	  which	   is	   known	   to	   be	   involved	   in	  arginine	  uptake	  in	  E.	  coli	   (see	  Appendix	  B)	  (Wissenbach	  et	  al.,	  1995).	  Genes	   in	  this	  operon	  were	  all	  down-­‐regulated	  at	  stationary	  phase	  in	  both	  Rd	  and	  R2866.	  Gene	  artP,	  encoding	  an	  arginine	  transporter	  ATP-­‐binding	  protein,	  was	  the	  most	  highly	  down-­‐regulated	  gene	  in	  the	  Rd	  strain	  (over	  82-­‐fold)	  (see	  Table	  4.4).	  	  	  
4.2.2.4.1.2	  Induction	  of	  competence	  	  There	   was	   induction	   of	   competence-­‐related	   genes	   during	   stationary	   phase	   in	  both	   strains.	   This	  was	   evident	   from	   up-­‐regulation	   of	   the	   operon	   comABCDEF,	  which	  has	  a	  characterised	  role	   in	  competence	  and	  transformation	  induction	  in	  
H.	  influenzae	  (see	  Appendix	  B)	  (Tomb	  et	  al.,	  1991).	  The	  expression	  of	  two	  genes,	  
rec-­‐2	   and	   tfoX,	   with	   characterised	   roles	   in	   DNA	   transformation,	   was	   also	  induced	   (Barouki	   and	   Smith,	   1985,	   Zulty	   and	   Barcak,	   1995).	   There	   was	   also	  induction	   of	   genes	   radA	  and	   recN,	  homologues	   of	   which	   are	   involved	   in	   DNA	  repair	   and	   general	   stress	   response	   in	   E.	   coli	   (Finch	   et	   al.,	   1985,	   Beam	   et	   al.,	  2002).	  	  
4.2.2.4.1.3	  Oxidative	  stress	  response	  Multiple	  genes	  involved	  in	  oxidative	  stress	  response	  were	  up-­‐regulated	  in	  both	  strains	   during	   stationary	   phase.	   The	  most	   highly	   up-­‐regulated	   gene	   (over	   28-­‐fold)	  in	  the	  Rd	  strain	  during	  stationary	  phase	  encoded	  an	  alkylhydroperoxidase	  family	  core	  domain	  protein,	  AhpD	  (see	  Table	  4.4).	   It	  was	  also	  the	  second	  most	  highly	  up-­‐regulated	  gene	  in	  R2866	  (over	  56-­‐fold)	  (see	  Table	  4.3).	  This	  gene	  was	  annotated	   as	   a	   hypothetical	   protein	   in	   the	   original	   Rd	   and	   R2866	   published	  genome	   sequences.	   The	   amino	   acid	   sequence	   search	   in	   the	   InterPro	   database	  revealed	   this	   protein	   to	   contain	   a	   50	   amino	   acid	   long	   alkylhydroperoxidase	  AhpD	  core	  domain.	  	  	  Other	  up-­‐regulated	  genes	  in	  Rd	  and	  R2866	  with	  known	  roles	  in	  oxidative	  stress	  response	  were	   a	   catalase	   gene,	  hktE,	   a	   peroxiredoxin	   gene,	  pgdX,	   and	   the	  dps	  gene	  (see	  Table	  4.4)	  (see	  Appendix	  B)	  (see	  sections	  1.1.8.1).	  The	  expression	  of	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several	  other	  genes	  with	  putative	  roles	  in	  oxidative	  stress	  was	  induced	  either	  in	  Rd	   or	   R2866.	   Interestingly,	   a	   two-­‐component	   system	   gene,	   arcA,	   with	   a	  characterised	  role	  in	  oxidative	  stress,	  was	  down-­‐regulated	  in	  Rd	  only	  (Wong	  et	  al.,	   2007).	   In	   addition,	   a	  putative	  peroxiredoxin	   gene,	  ahpC,	   absent	   in	  Rd,	  was	  highly	  down-­‐regulated	  (7.6-­‐fold)	  in	  the	  R2866	  strain.	  	  	  
4.2.2.4.1.4	  Induction	  of	  iron	  acquisition	  There	   were	   multiple	   up-­‐regulated	   genes	   with	   putative	   and	   known	   roles	   in	  bacterial	  iron	  acquisition	  during	  stationary	  phase.	  This	  was	  especially	  evident	  in	  the	   R2866	   strain,	   where	   four	   iron-­‐related	   genes	   were	   among	   the	   ten	   most	  highly	   up-­‐regulated	   genes	   (see	   Table	   4.3).	   This	   included	   the	   hxuABC	   operon,	  which	  encodes	  haem	  utilisation	  proteins.	  The	  whole	  operon	  was	  up-­‐regulated	  over	  20-­‐fold	  in	  R2866,	  though	  only	  the	  hxuA	  gene	  was	  up-­‐regulated	  in	  Rd	  (see	  Appendix	  B).	  	  	  The	   expression	   of	   tbp1	   and	   tbp2	   genes,	   encoding	   characterised	   transferrin-­‐binding	  proteins,	  was	  highly	  induced	  (over	  10-­‐fold)	  in	  R2866,	  whereas	  only	  the	  
tbp1	   gene	   was	   up-­‐regulated	   in	   Rd	   (Gray-­‐Owen	   and	   Schryvers,	   1995).	   In	  contrast,	   there	   were	   two	   genes,	   ftnA1	   and	   ftnA2,	   coding	   for	   putative	   ferritin	  proteins,	   which	   were	   down-­‐regulated	   in	   R2866.	   Putative	   metal	   transport-­‐associated	  genes,	  yfeA	  and	  yfeB,	  were	  both	   induced	   in	  R2866,	   though	  only	   the	  latter	   was	   up-­‐regulated	   in	   Rd	   (see	   Appendix	   B).	   There	   also	   appeared	   to	   be	  induction	  of	   iron-­‐sulphur	  cluster	   formation	  during	  stationary	  phase	   in	  Rd	  and	  R2866.	   This	   was	   inferred	   from	   the	   up-­‐regulation	   of	   genes	   hscAB,	   fdx-­‐1,	   and	  
iscARSU,	  which	  have	  putative	  roles	  in	  the	  formation	  of	  iron-­‐sulphur	  clusters.	  	  	  
4.2.2.4.1.5	  Reduction	  in	  protein	  biosynthesis	  and	  export	  There	   was	   an	   apparent	   reduction	   in	   protein	   biosynthesis	   during	   stationary	  phase	   in	   Rd	   and	   R2866,	   as	   inferred	   from	   enriched	   functional	   groups	   (see	  Figures	  4.17;	  4.18).	  This	  was	  also	  evident	   from	  the	  down-­‐regulation	  of	  a	   large	  number	  of	  ribosomal	  protein	  genes	  as	  well	  as	  genes	  coding	  for	  elongation	  and	  translation	   initiation	   factors	   and	   multiple	   tRNAs	   (see	   Figure	   4.19)	   (see	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Appendix	   B).	   The	   most	   highly	   down-­‐regulated	   gene	   in	   R2866	   was	   rpL29,	  encoding	  a	  50S	  ribosomal	  protein	  L29	  (see	  Table	  4.3).	  Coupled	  with	  an	  increase	  in	   amino	   acid	   synthesis,	   this	   suggests	   that	   a	   classic	   stringent	   response	   was	  induced	  in	  H.	  influenzae	  during	  stationary	  phase.	   In	  addition,	   there	  was	  down-­‐regulation	   of	   genes	   involved	   in	   protein	   export,	   including	   the	   Sec	   pathway	   in	  both	  strains	  and	  twin-­‐arginine	  protein	  export	  genes	  in	  Rd	  only.	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Figure	   4.17:	   Functional	   group	   enrichment	   analysis	   of	   down-­‐regulated	  
genes	   in	   the	   Rd	   strain	   during	   growth	   at	   stationary	   phase,	   compared	   to	  
growth	  at	  mid-­‐exponential	  phase.	  Groups	  were	  ordered	  from	  top	  to	  bottom	  based	  on	  the	  decreasing	  adjusted	  p-­‐value.	  The	  x-­‐axis	  displays	  the	  percentage	  of	  down-­‐regulated	  genes	  that	  belonged	  to	  each	  functional	  group.	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Figure	   4.18:	   Functional	   group	   enrichment	   analysis	   of	   down-­‐regulated	  
genes	  in	  the	  R2866	  strain	  during	  growth	  at	  stationary	  phase,	  compared	  to	  
growth	  at	  mid-­‐exponential	  phase.	  Groups	  were	  ordered	  from	  top	  to	  bottom	  based	  on	  the	  decreasing	  adjusted	  p-­‐value.	  The	  x-­‐axis	  displays	  the	  percentage	  of	  down-­‐regulated	  genes	  that	  belonged	  to	  each	  functional	  group.	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Figure	  4.19:	  Down-­‐regulation	  of	  ribosomal	  protein	  genes	   in	  H.	  influenzae	  
during	   stationary	   phase.	   The	   KEGG	   diagram	   depicts	   down-­‐regulated	  ribosomal	  protein	  genes	  in	  the	  R2866	  strain.	  Light	  green	  boxes	  represent	  genes	  present	  in	  H.	  influenzae,	  while	  red	  boxes	  show	  down-­‐regulated	  genes.	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4.2.2.4.1.6	  Reduction	  in	  bacterial	  respiration	  Several	   gene	   loci	   with	   putative	   roles	   in	   bacterial	   respiration	   were	   down-­‐regulated	   in	  Rd	  and	  R2866	  during	  stationary	  phase.	  These	   included	  a	  putative	  ATP	  synthase	  operon,	  atpABCDEFGHI,	  a	  putative	  electron	  transport	  complex,	  as	  well	  as	  genes	  cydA	  and	  cydB,	  encoding	  predicted	  cytochrome	  oxidase	  subunits	  (see	   Appendix	   B).	   The	   nqrABCDEF	   operon,	   encoding	   subunits	   of	   a	   sodium-­‐transport	  NADH-­‐quinone	  reductase,	  was	  also	  down-­‐regulated	  in	  Rd	  and	  R2866	  (Hayashi	  et	  al.,	  1996).	  	  	  
4.2.2.4.1.7	   Differential	   expression	   of	   mobile	   genetic	   elements	   and	   other	  
notable	  genes	  Multiple	   genes	   from	   mobile	   genetic	   elements	   were	   differentially	   expressed	  during	   stationary	   phase.	   Among	   these	   were	   up-­‐regulated	   genes	   from	   the	   ICE	  and	   a	   putative	   prophage	   in	   R2866	   as	  well	   as	   down-­‐regulated	   genes	   from	   the	  FluMu	   prophage	   in	   Rd	   (see	   Appendix	   B).	   Among	   other	   notable	   differentially	  expressed	   genes	   was	   a	   putative	   heat-­‐shock	   RNA	   polymerase	   sigma	   factor-­‐32	  gene,	  rpoH,	  up-­‐regulated	  in	  Rd	  only,	  as	  well	  as	  putative	  chaperone	  genes,	  groEL	  and	  groES,	  up-­‐regulated	  in	  both	  strains.	  Members	  of	  a	  type	  IV	  pilus	  gene	  cluster,	  
pilA,	   pilB	   and	   pilD,	   along	   with	   genes	   from	   another	   major	   pilus	   gene	   locus,	  
hifABCDE,	  were	  up-­‐regulated	  in	  R2866	  only	  (Mhlanga-­‐Mutangadura	  et	  al.,	  1998,	  Bakaletz	  et	  al.,	  2005).	  Furthermore,	  the	  expression	  of	  two	  genes,	  siaA	  and	  lsgB,	  involved	  in	  the	  processing	  of	  LOS	  in	  H.	  influenzae,	  was	   induced	  in	  R2866	  (Abu	  Kwaik	   et	   al.,	   1991,	   Jones	   et	   al.,	   2002).	   Finally,	   a	   characterised	   toxin-­‐antitoxin	  locus,	  vapBC1,	  was	  down-­‐regulated	  in	  R2866	  only	  (Daines	  et	  al.,	  2007).	  	  	  
4.2.2.4.2	   Transcriptional	   response	   of	   Rd	   and	   R2866	   strains	   to	  
oxidative	  stress	  A	   total	   of	   150	   genes	   were	   differentially	   expressed	   in	   the	   Rd	   strain	   during	  oxidative	   stress	   compared	   to	   normal	   growth	   at	   mid-­‐exponential	   phase	   (see	  Appendix	  B).	  Of	  these,	  53	  were	  up-­‐regulated	  and	  97	  were	  down-­‐regulated.	  For	  the	  R2866	  strain,	  there	  were	  96	  genes	  that	  were	  differentially	  expressed	  during	  oxidative	   stress,	  when	   compared	   to	   normal	   growth	   at	  mid-­‐exponential	   phase,	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69	   of	  which	  were	   up-­‐regulated	   and	   27	  were	   down-­‐regulated.	   As	   described	   in	  more	  detail	  below,	  there	  was	  induction	  of	  oxidative	  stress	  and	  SOS	  responses	  as	  well	  as	  differential	  regulation	  of	  metabolic	  and	  iron-­‐uptake	  pathways.	  	  
4.2.2.4.2.1	  Induction	  of	  oxidative	  stress	  response	  There	  was	   a	   clear	   induction	   of	   oxidative	   stress	   response	   in	   both	   strains.	   The	  catalase	   gene,	   hktE,	   was	   the	   most	   highly	   up-­‐regulated	   gene	   in	   both	   Rd	   and	  R2866	  (see	  Tables	  4.5;	  4.6).	  Other	  up-­‐regulated	  genes	  with	  well-­‐characterised	  roles	  in	  oxidative	  stress	  were	  a	  glutathione-­‐dependent	  peroxidase	  gene,	  pgdX,	  a	  6-­‐phosphogluconate	  dehydrogenase	  gene,	  gnd,	  as	  well	  as	  genes	  pntA	  and	  pntB,	  encoding	  proteins	  with	  homology	  to	  subunits	  of	  NAD(P)	  transhydrogenase	  in	  E.	  
coli	  (see	  Appendix	  B)	  (Clarke	  and	  Bragg,	  1985,	  Yoon	  et	  al.,	  1989,	  Pauwels	  et	  al.,	  2003).	  The	   last	   two	  genes	  were	  not	  up-­‐regulated	   in	   the	  R2866	  strain.	  The	  dps	  gene,	   encoding	   a	   ferritin-­‐like	   protein	   with	   a	   characterised	   role	   in	   oxidative	  stress	   in	   H.	   influenzae,	   was	   up-­‐regulated	   in	   both	   strains	   over	   10-­‐fold	   (see	  section	   1.1.8.1).	   The	   oxidative	   stress	   response	   of	   Rd	   and	   R2866	   was	   further	  supported	   by	   the	   enrichment	   of	   functional	   groups	   related	   to	   the	   response	   to	  stress	  (see	  Figures	  4.20;	  4.21).	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Table	  4.5:	  The	  ten	  most	  highly	  up-­‐regulated	  and	  down-­‐regulated	  genes	  in	  
the	  Rd	  strain	  during	  oxidative	  stress,	  compared	  to	  normal	  growth.	  





hktE	   Catalase	   76.94	   111.22	  
acpD	   Acyl	  carrier	  protein	  phosphodiesterase	   26.07	   11.36	  
-­‐	   DoxX	   14.58	   3.68	  
ilvC	   Ketol-­‐acid	  reductoisomerase	   11.48	   -­‐	  
dps	   DNA	  protection	  during	  starvation	  protein	   10.31	   13.68	  
-­‐	   DNA	  polymerase	  V	  subunit	  UmuD	   10.31	   13.26	  
-­‐	   Peroxiredoxin	  hybrid	  Prx5	   7.56	   8.30	  
ilvI	   Acetolactate	  synthase	  3	  catalytic	  subunit	   4.88	   -­‐	  
recN	   DNA	  repair	  protein	   4.68	   8.78	  
ilvH	   Acetolactate	  synthase	  3	  regulatory	  subunit	   4.52	   -­‐	  
Down-­‐regulated	  genes	  
artP	   Arginine	  transporter	  ATP-­‐binding	  protein	   21.55	   -­‐	  
dmsA_3	   Anaerobic	  dimethyl	  sulfoxide	  reductase	  subunit	  A	   11.89	   -­‐	  
artI	   Arginine	  ABC	  transporter	  substrate-­‐binding	  protein	   11.01	   -­‐	  
artQ	   Arginine	  transporter	  permease	  subunit	  ArtQ	   9.12	   -­‐	  
dmsB	   Anaerobic	  dimethyl	  sulfoxide	  reductase	  subunit	  B	   7.98	   -­‐	  
nrfC	   Nitrite	  reductase	  Fe-­‐S	  protein	   7.75	   -­‐	  
artM	   Arginine	  transporter	  permease	  subunit	  ArtM	   7.63	   -­‐	  
nrfB	   Cytochrome	  c	  nitrite	  reductase	  pentaheme	  subunit	   7.50	   -­‐	  
-­‐	   Twin-­‐argninine	  leader-­‐binding	  protein	  DmsD	   7.24	   -­‐	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Table	  4.6:	  The	  ten	  most	  highly	  up-­‐regulated	  and	  down-­‐regulated	  genes	  in	  
the	  R2866	  strain	  during	  oxidative	  stress,	  compared	  to	  normal	  growth.	  





hktE	   Catalase	   111.22	   76.94	  
-­‐	   Hypothetical	  protein	   26.61	   2.57	  
-­‐	   Hypothetical	  protein	   19.57	   -­‐	  
-­‐	   Putative	  NAD-­‐dependent	  protein	  deacetylase	   17.02	   -­‐	  
-­‐	   Hypothetical	  protein	   15.63	   -­‐	  
dpsA	   DPS	  ferritin-­‐like	  protein	   13.68	   10.31	  
-­‐	   DNA	  polymerase	  V	  subunit	  UmuD	   13.26	   10.31	  
-­‐	   Putative	  5'(3')-­‐deoxyribonucleotidase	   12.87	   -­‐	  
azoR	   FMN-­‐dependent	  NADH-­‐azoreductase	   11.36	   26.07	  
-­‐	   Hypothetical	  protein	   10.23	   -­‐	  
Down-­‐regulated	  genes	  
Hgd	   2-­‐(hydroxymethyl)glutarate	  dehydrogenase	   7.82	   3.12	  
-­‐	   Hypothetical	  protein	   6.52	   -­‐	  
ygbM	   Putative	  hydroxypyruvate	  isomerase	  YgbM	   6.11	   2.92	  
ygbL	   Putative	  sugar	  aldolase/epimerase	   5.98	   2.91	  
-­‐	   Putative	  sugar	  epimerase	   4.00	   2.54	  
-­‐	   Putative	  permease	   3.18	   2.37	  
ftnA2	   Ferritin	  protein	  A2	   2.67	   -­‐	  
-­‐	   Hypothetical	  protein	   2.57	   -­‐	  
galR	   Galactose	  operon	  regulator	   2.53	   3.30	  
rpS18	   30S	  ribosomal	  subunit	  protein	  S18	   2.41	   -­‐	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Figure	  4.20:	  Functional	  group	  enrichment	  analysis	  of	  up-­‐regulated	  genes	  
in	   the	   Rd	   strain	   during	   oxidative	   stress,	   compared	   to	   normal	   growth.	  Groups	  were	  ordered	   from	  top	  to	  bottom	  based	  on	  the	  decreasing	  adjusted	  p-­‐value.	  The	  x-­‐axis	  displays	  the	  percentage	  of	  up-­‐regulated	  genes	  that	  belonged	  to	  each	  functional	  group.	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Figure	  4.21:	  Functional	  group	  enrichment	  analysis	  of	  up-­‐regulated	  genes	  
in	  the	  R2866	  strain	  during	  oxidative	  stress,	  compared	  to	  normal	  growth.	  Groups	  were	  ordered	   from	  top	  to	  bottom	  based	  on	  the	  decreasing	  adjusted	  p-­‐value.	  The	  x-­‐axis	  displays	  the	  percentage	  of	  up-­‐regulated	  genes	  that	  belonged	  to	  each	  functional	  group.	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Among	  other	  highly	  up-­‐regulated	  genes	  with	  putative	  roles	   in	  oxidative	  stress	  response	  was	  a	  gene	  annotated	  as	  azoR	  in	  R2866	  and	  acpD	  in	  Rd	  (see	  Appendix	  B).	  It	  encodes	  a	  protein	  homologous	  to	  an	  azoreductase	  enzyme	  in	  E.	  coli,	  with	  a	  characterised	   role	   in	   thiol-­‐specific	   stress	   (Liu	   et	   al.,	   2009).	   In	   addition,	   there	  were	  other	  multiple	  up-­‐regulated	  genes	  with	  putative	  roles	   in	  oxidative	  stress	  response.	   In	   contrast,	   a	   two-­‐component	   system	   gene,	   arcA,	   with	   a	   role	   in	  oxidative	   stress	   in	   H.	   influenzae,	   was	   down-­‐regulated	   in	   Rd,	   while	   a	  peroxiredoxin	  gene,	  ahpC,	  was	  down-­‐regulated	  in	  R2866	  (Wong	  et	  al.,	  2007).	  	  
4.2.2.4.2.2	  SOS	  response	  There	  were	  multiple	  up-­‐regulated	  genes	  involved	  in	  DNA	  protection	  and	  repair,	  reflected	  by	  several	  enriched	  functional	  groups	  associated	  with	  DNA	  repair	  and	  response	   to	   DNA	   damage	   (see	   Figures	   4.20;	   4.21).	   Among	   these	   were	   genes	  
recA,	   recN,	   recX,	   and	   radA,	   encoding	  proteins	  with	   characterised	   roles	   in	  DNA	  repair	  in	  H.	  influenzae	  and	  E.	  coli	  (see	  Appendix	  B)	  (Finch	  et	  al.,	  1985,	  Setlow	  et	  al.,	  1988,	  Beam	  et	  al.,	  2002,	  Pages	  et	  al.,	  2003).	  There	  was	  also	  up-­‐regulation	  of	  a	  small	  putative	  gene	  locus,	  ruvAB,	  in	  both	  strains.	  It	  codes	  for	  proteins	  involved	  in	  Holliday	  junction	  processing	  in	  E.	  coli,	  with	  roles	  in	  DNA	  repair	  (Iwasaki	  et	  al.,	  1989).	   The	   lexA	   gene	  was	   up-­‐regulated	   over	   3-­‐fold	   in	   both	   Rd	   and	   R2866.	   It	  encodes	  a	  homologue	  of	  the	  E.	  coli	  LexA	  protein,	  which	  is	  a	  major	  repressor	  of	  the	  SOS	  regulon	  (Little	  et	  al.,	  1981).	  	  
4.2.2.4.2.3	  Induction	  of	  iron	  uptake	  The	   expression	   of	   several	   iron-­‐associated	   genes	   was	   induced	   in	   both	   Rd	   and	  R2866	   during	   oxidative	   stress.	   These	   included	   several	   genes	   with	   predicted	  roles	   in	   iron-­‐sulphur	   cluster	   formation	  and	   iron	  acquisition	   (see	  Appendix	  B).	  The	  expression	  of	  the	  haem	  utilisation	  locus,	  hxuABC,	  as	  well	  as	  tbp1	  and	  tbp2	  genes,	   coding	   for	   transferrin-­‐binding	   proteins,	   was	   induced	   in	   R2866	   only.	  Other	   iron-­‐associated	   genes	   that	  were	   up-­‐regulated	   in	   R2866	   only	  were	  hitA,	  part	   of	   the	   iron	   acquisition	   operon,	   hitABC,	   and	   hemR,	   encoding	   a	   haemin	  receptor.	   In	   contrast,	   there	   was	   down-­‐regulation	   of	   two	   putative	   ferritin-­‐like	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genes,	   ftnA1	   and	   ftnA2,	   in	   R2866	   only.	   Several	   other	   putative	   iron-­‐associated	  genes	  were	  down-­‐regulated	  in	  Rd	  only.	  	  
4.2.2.4.2.4	  Metabolic	  response	  during	  oxidative	  stress	  There	   seemed	   to	   be	   an	   overall	   difference	   in	   gene	   down-­‐regulation	   during	  oxidative	  stress	  between	  Rd	  and	  R2866	  strains.	  The	  whole	  arginine-­‐uptake	  gene	  locus,	   artIMPQ,	   was	   among	   the	   ten	   most	   highly	   down-­‐regulated	   genes	   in	   Rd,	  while	  it	  was	  not	  down-­‐regulated	  in	  R2866	  at	  all	  (see	  Table	  4.5).	  The	  most	  highly	  down-­‐regulated	   gene	   in	   R2866	   during	   oxidative	   stress	   was	   Hgd,	   encoding	   a	  putative	   2-­‐(hydroxymethyl)glutarate	   dehydrogenase	   enzyme	   (see	   Table	   4.6).	  This	  gene	  was	  part	  of	  a	  six-­‐gene	  locus,	  which	  was	  down-­‐regulated	  over	  3-­‐fold	  in	  R2866	  and	  to	  a	  lesser	  extent	  in	  Rd	  (see	  Appendix	  B).	  The	  locus	  encoded	  putative	  enzymes	  involved	  in	  the	  processing	  of	  carbohydrates.	  	  	  Several	   other	   metabolism-­‐associated	   gene	   clusters	   were	   differentially	  expressed	  during	  oxidative	  stress.	  Genes	  ilvC,	  ilvI	  and	  ilvH,	  with	  putative	  roles	  in	  the	  biosynthesis	  of	   leucine,	   isoleucine	  and	  valine	  amino	  acids,	  were	  highly	  up-­‐regulated	  in	  the	  Rd	  strain	  only	  (Ricca	  et	  al.,	  1988).	  Among	  other	  notable	  genes	  highly	  down-­‐regulated	  in	  Rd	  only	  were	  a	  putative	  DMSO	  reductase	  gene	  locus,	  
dmsABC,	   and	   a	   nitrite	   reductase	   gene	   locus,	   nrfABCD	   (see	   Appendix	   B).	   In	  addition,	  there	  was	  down-­‐regulation	  of	  several	  ribosomal	  protein	  genes	  in	  both	  strains.	  	  
4.2.2.4.3	  Transcriptional	  response	  of	  Rd	  and	  R2866	  strains	  to	   iron-­‐
starvation	  stress	  A	  total	  of	  175	  genes	  were	  differentially	  expressed	  in	  the	  Rd	  strain	  during	  iron-­‐starvation	   stress	  when	   compared	   to	   normal	   growth	   at	  mid-­‐exponential	   phase	  (see	   Appendix	   B).	   Of	   these,	   90	   genes	   were	   up-­‐regulated	   and	   85	   were	   down-­‐regulated.	   188	   genes	   were	   differentially	   expressed	   in	   R2866	   during	   iron-­‐starvation	  stress	  when	  compared	   to	  normal	  growth	  at	  mid-­‐exponential	  phase,	  of	   which	   55	   were	   up-­‐regulated	   and	   133	   were	   down-­‐regulated.	   As	   described	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below,	   there	  was	   induction	   of	   iron	   acquisition,	   heat-­‐shock	   response	   and	   LOS-­‐associated	  pathways,	  while	  metabolic	  and	  transport	  pathways	  were	  reduced.	  
	  
4.2.2.4.3.1	  Induction	  of	  iron	  acquisition	  There	   was	   a	   large	   number	   of	   iron	   transport-­‐associated	   genes	   that	   were	   up-­‐regulated	   in	   both	   strains,	   reflected	   by	   enriched	   functional	   groups	   related	   to	  metal	   and	   ion	   transport	   (see	   Figures	   4.22;	   4.23).	   However,	   this	   was	   more	  evident	  in	  the	  R2866	  strain,	  where	  a	  larger	  number	  of	  such	  genes	  were	  induced.	  A	   gene	   encoding	   a	   putative	   TonB-­‐dependent	   transport	   protein	   was	   the	   most	  highly	  up-­‐regulated	  (35-­‐fold)	  in	  R2866,	  but	  was	  only	  induced	  3.5-­‐fold	  in	  Rd	  (see	  Table	  4.7)	   (see	  Appendix	  B).	  While	   the	   iron	  acquisition	   locus,	  hitABC,	  was	  up-­‐regulated	   in	   both	   strains,	   the	   expression	   of	   the	   hitA	   gene	   in	   particular	   was	  induced	  30.6-­‐fold	  in	  the	  R2866	  strain.	  A	  putative	  metal	  transporter	  gene	  locus,	  
yfeABCD,	  and	  a	  haemin	  receptor	  gene,	  hemR,	  were	  up-­‐regulated	  in	  both	  strains,	  though	  again	  to	  a	  higher	  extent	  in	  R2866.	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Figure	  4.22:	  Functional	  group	  enrichment	  analysis	  of	  up-­‐regulated	  genes	  
in	  the	  Rd	  strain	  during	  iron-­‐starvation	  stress,	  compared	  to	  normal	  growth.	  Groups	  were	  ordered	   from	  top	  to	  bottom	  based	  on	  the	  decreasing	  adjusted	  p-­‐value.	  The	  x-­‐axis	  displays	  the	  percentage	  of	  up-­‐regulated	  genes	  that	  belonged	  to	  each	  functional	  group.	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Figure	  4.23:	  Functional	  group	  enrichment	  analysis	  of	  up-­‐regulated	  genes	  
in	   the	   R2866	   strain	   during	   iron-­‐starvation	   stress,	   compared	   to	   normal	  
growth.	   Groups	   were	   ordered	   from	   top	   to	   bottom	   based	   on	   the	   decreasing	  adjusted	  p-­‐value.	  The	  x-­‐axis	  displays	  the	  percentage	  of	  up-­‐regulated	  genes	  that	  belonged	  to	  each	  functional	  group.	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Table	  4.7:	  The	  ten	  most	  highly	  up-­‐regulated	  and	  down-­‐regulated	  genes	  in	  
the	   R2866	   strain	   during	   iron-­‐starvation	   stress,	   compared	   to	   normal	  
growth.	  





-­‐	   Putative	  TonB-­‐dependent	  transport	  protein	   35.06	   3.52	  
hxuC	   Haem-­‐hemopexin	  utilization	  protein	  C	   30.77	   -­‐	  
hitA	   Iron(III)	  ABC	  transporter	  periplasmic-­‐binding	  protein	   30.60	   2.12	  
ompU1	   Putative	  outer	  membrane	  protein	  OmpU1	   23.72	   2.87	  
hxuB	   Haem-­‐hemopexin	  utilization	  protein	  B	   23.46	   -­‐	  
tbp2	   Transferrin-­‐binding	  protein	  2	   17.21	   -­‐	  
tbp1	   Transferrin-­‐binding	  protein	  1	   15.68	   -­‐	  
hxuA	   Haem-­‐hemopexin	  utilization	  protein	  A	   15.01	   -­‐	  
copZ3_1	   Copper	  chaperone	  protein	   10.93	   2.25	  
hitB	   Iron(III)	  ABC	  transporter	  permease	  protein	   10.83	   2.13	  
Down-­‐regulated	  genes	  
ydjN	   Putative	  transporter	   10.68	   17.82	  
metQ	   DL-­‐methionine	  transporter;	  periplasmic	  binding	  protein	  MetQ	   9.13	   9.96	  
metI	   DL-­‐methionine	  transporter;	  permease	  protein	  MetI	   7.52	   8.60	  
potD	   Spermidine/putrescine	  ABC	  transporter;	  periplasmic-­‐binding	  protein	   7.09	   3.01	  
metN	   DL-­‐methionine	  transporter;	  ATP	  binding	  protein	  MetN	   7.01	   7.72	  
artP	   Arginine	  ABC	  transporter;	  ATP-­‐binding	  protein	  ArtP	   6.18	   -­‐	  
tcyA	   L-­‐cystine	  ABC	  transporter;	  periplasmic-­‐binding	  protein	  TcyA	   5.53	   7.80	  
argH	   Argininosuccinate	  lyase	   5.24	   -­‐	  
fdnG_1	   Formate	  dehydrogenase-­‐N;	  major	  subunit	   5.13	   3.13	  
fdnI	   Formate	  dehydrogenase-­‐N;	  cytochrome	  B556(Fdn)	  gamma	  subunit;	  nitrate-­‐inducible	   4.66	   2.75	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Among	   other	   notable	   up-­‐regulated	   iron-­‐associated	   genes	   were	   the	   haem	  utilisation	  locus,	  hxuABC,	  and	  the	  tonB	  gene,	  known	  to	  play	  an	  important	  role	  in	  iron	  acquisition	  in	  H.	  influenzae	  (see	  Appendix	  B)	  (Jarosik	  et	  al.,	  1994,	  Jarosik	  et	  al.,	  1995).	  Other	  iron-­‐related	  genes,	  induced	  in	  the	  R2866	  strain	  only,	  were	  tbp1	  and	   tbp2,	   encoding	   transferrin-­‐binding	   proteins,	   as	   well	   as	   exbB	   and	   exbD,	  coding	  for	  putative	  biopolymer	  transporter	  proteins	  (Morton	  et	  al.,	  1999).	  The	  latter	   two	   genes	   are	   homologous	   to	   and	   complement	   genes	   in	   E.	   coli,	   which	  encode	   TonB	   accessory	   proteins	   (Jarosik	   and	   Hansen,	   1995).	   Several	   other	  putative	  metal	  transport	  and	  efflux	  pump	  genes	  were	  up-­‐regulated	  during	  iron-­‐starvation	  in	  both	  strains.	  Interestingly,	  some	  predicted	  metal-­‐associated	  genes	  were	   down-­‐regulated	   in	   both	   Rd	   and	   R2866,	   including	   a	   haem-­‐binding	  lipoprotein	  gene,	  hbpA	  (annotated	  as	  dppA	  in	  Rd).	  	  
4.2.2.4.3.2	  Induction	  of	  LOS-­‐related	  genes	  As	  with	   iron	   acquisition-­‐associated	   gene	   clusters,	   the	   rest	   of	   the	   up-­‐regulated	  genes	   also	   mostly	   differed	   between	   Rd	   and	   R2866.	   The	   most	   highly	   up-­‐regulated	  gene	  in	  the	  Rd	  strain	  was	  lptF,	  encoding	  a	  putative	  lipopolysaccharide	  export	   system	  permease	   protein,	  which	  was	   not	   induced	   in	   R2866	   at	   all	   (see	  Table	  4.8).	  The	  second	  and	  third	  most	  highly	  up-­‐regulated	  genes	  in	  Rd	  encoded	  putative	   proteins	   associated	   with	   LOS	   biosynthesis.	   Other	   LOS-­‐related	   up-­‐regulated	   genes	   in	   Rd	   included	   lptA	   and	   lptC,	   encoding	   putative	  lipopolysaccharide	   (LPS)	   export	   system	   proteins	   (see	   Appendix	   B).	   The	   latter	  was	  the	  only	  putative	  LOS-­‐associated	  gene	  to	  be	  induced	  in	  the	  R2866	  strain.	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Table	  4.8:	  The	  ten	  most	  highly	  up-­‐regulated	  and	  down-­‐regulated	  genes	  in	  
the	  Rd	  strain	  during	  iron-­‐starvation	  stress,	  compared	  to	  normal	  growth.	  





lptF	   Lipopolysaccharide	  export	  system	  permease	  protein	  LptF	   22.71	   -­‐	  
-­‐	   Lipopolysaccharide	  biosynthesis	  protein	   6.30	   -­‐	  
-­‐	   Lipopolysaccharide	  biosynthesis	  protein	   5.50	   -­‐	  
-­‐	   Na(+)-­‐translocating	  NADH-­‐quinone	  reductase	  subunit	  E	   4.95	   -­‐	  
ppc	   Phosphoenolpyruvate	  carboxylase	   4.92	   -­‐	  
merR2	   Mercuric	  resistance	  operon	  regulatory	  protein	   4.77	   -­‐	  
-­‐	   Branched	  chain	  amino	  acid	  ABC	  transporter	  substrate-­‐binding	  protein	   4.59	   -­‐	  
-­‐	   Hypothetical	  protein	   4.59	   -­‐	  
-­‐	   Cobalt	  transport	  protein	  CbiM	   4.55	   -­‐	  
-­‐	   Cobalt	  ABC	  transporter;	  permease	  protein	  CbiQ	   4.37	   -­‐	  
Down-­‐regulated	  genes	  
-­‐	   Proton	  glutamate	  symport	  protein	   17.82	   10.68	  
hlpA	   D-­‐methionine-­‐binding	  lipoprotein	  MetQ	   9.96	   9.13	  
pstA_1	   Phosphate	  ABC	  transporter	  permease	   8.60	   7.52	  
-­‐	   Amino-­‐acid	  ABC	  transporter	  ATP-­‐binding	  protein	   8.56	   2.21	  
-­‐	   Amino	  acid	  ABC	  transporter	  substrate-­‐binding	  protein	   7.80	   5.53	  
metN	   DL-­‐methionine	  transporter	  ATP-­‐binding	  protein	   7.72	   7.01	  
-­‐	   Amino	  acid	  ABC	  transporter	  permease	   7.04	   2.41	  
dppA	   Haem-­‐binding	  lipoprotein	   5.41	   4.49	  
-­‐	   Long	  chain	  fatty	  acid	  CoA	  ligase	   5.19	   -­‐	  
merT	   Mercuric	  ion	  transport	  protein	   4.69	   3.67	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4.2.2.4.3.3	  Heat-­‐shock	  response	  Both	   Rd	   and	   R2866	   switched	   on	   their	   heat-­‐shock	   response	   during	   iron-­‐starvation.	  This	  was	  apparent	  from	  the	  up-­‐regulation	  of	  dnaK,	  groES	  and	  groEL	  genes,	  encoding	  chaperone	  proteins	  with	  roles	  in	  heat-­‐shock	  response	  in	  E.	  coli	  (see	  Appendix	  B)	  (Fayet	  et	  al.,	  1989,	  Liberek	  et	  al.,	  1992).	  Another	  up-­‐regulated	  gene	  locus	  with	  a	  putative	  role	  in	  heat-­‐shock	  response	  was	  the	  ATP-­‐dependent	  protease	  locus,	  hslUV	  (Kanemori	  et	  al.,	  1997).	  	  	  
4.2.2.4.3.4	  Regulation	  of	  metabolism	  and	  transport	  Many	  metabolic	  and	  transport-­‐associated	  gene	  clusters	  were	  down-­‐regulated	  in	  both	   strains	   during	   iron-­‐starvation.	   The	   most	   highly	   down-­‐regulated	   gene	  (17.8-­‐fold)	   in	   the	   Rd	   strain	   encoded	   a	   putative	   proton	   glutamate	   symport	  protein	  (see	  Table	  4.8).	  It	  was	  annotated	  as	  a	  putative	  transporter	  gene	  ydjN	  in	  the	  R2866	  strain	  and	  was	   the	  most	  highly	  down-­‐regulated	  gene	   (10.7-­‐fold)	   in	  that	   strain	  as	  well	   (see	  Table	  4.7).	  The	  ydjN	   gene	  was	  previously	  shown	   to	  be	  responsible	   for	   uptake	   of	   cystine	   in	   E.	   coli	   (Chonoles	   Imlay	   et	   al.,	   2015).	   In	  agreement	   with	   this,	   a	   putative	   L-­‐cystine	   uptake	   locus,	   tcyABC,	   was	   down-­‐regulated	  in	  both	  strains	  (see	  Appendix	  B).	  	  Among	  other	  highly	  down-­‐regulated	  gene	  loci,	  associated	  with	  metabolism	  and	  transport,	   was	   a	   putative	   DL-­‐methionine	   ABC	   transporter	   locus,	  metINQ	   (see	  Appendix	   B)	   (Merlin	   et	   al.,	   2002).	   Genes	  metI	   and	  metQ	   were	   annotated	   as	  
ptsa_1	  and	  hlpA	  respectively	  in	  the	  Rd	  strain.	  There	  was	  also	  down-­‐regulation	  of	  putative	  formate	  dehydrogenase	  and	  nitrite	  reductase	  loci,	  as	  well	  as	  genes	  ilvA,	  
ilvC	  and	   ilvD,	  with	  predicted	   roles	   in	   the	  biosynthesis	   of	   isoleucine	   and	   valine	  amino	  acids.	  	  	  Among	   metabolic	   genes	   down-­‐regulated	   in	   Rd	   only	   were	   members	   of	   the	  histidine	   operon,	   hisABCDFGHIE,	   putative	   tryptophan	   synthase	   subunit	   genes,	  
trpA	  and	  trpB,	  as	  well	  as	  the	  ilvHI	  locus,	  encoding	  putative	  acetolactate	  synthase	  subunits	   (see	   Appendix	   B).	   Other	   metabolic	   and	   respiratory	   genes	   down-­‐regulated	  in	  R2866	  only	  were	  the	  putative	  arginine	  uptake	  operon,	  artIMPQ,	  the	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tryptophanase	   locus,	   tnaAB,	   the	   putative	   fumarate	   reductase	   operon,	   frdABCD	  and	  genes	  from	  a	  putative	  ATP	  synthase	  locus,	  atpABCDEFGHI.	  There	  were	  also	  multiple	  down-­‐regulated	  ribosomal	  protein	  genes	  in	  the	  R2866	  strain,	  reflected	  by	   a	   large	   number	   of	   enriched	   functional	   groups	   being	   associated	   with	  ribosomal	  subunits	  and	  the	  translation	  process	  (see	  Figure	  4.24).	  Among	  other	  notable	   genes	   down-­‐regulated	   only	   in	   R2866	   was	   a	   putative	   peroxiredoxin	  gene,	  ahpC.	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Figure	   4.24:	   Functional	   group	   enrichment	   analysis	   of	   down-­‐regulated	  
genes	   in	   the	   R2866	   strain	   during	   iron-­‐starvation	   stress,	   compared	   to	  
normal	   growth.	   Groups	   were	   ordered	   from	   top	   to	   bottom	   based	   on	   the	  decreasing	   adjusted	   p-­‐value.	   The	   x-­‐axis	   displays	   the	   percentage	   of	   down-­‐regulated	  genes	  that	  belonged	  to	  each	  functional	  group.	  	  	  	  	  













	  	   153	  
4.2.2.4.4	   Transcriptional	   response	   of	   the	   Rd	   strain	   to	   nutritional	  
stress	  A	   total	   of	   231	   genes	   were	   differentially	   expressed	   in	   the	   Rd	   strain	   during	  growth	  in	  the	  chemically-­‐defined	  MIV	  medium,	  compared	  to	  growth	  in	  the	  rich	  sBHI	  medium	  (see	  Appendix	  B).	  Of	  these,	  135	  genes	  were	  up-­‐regulated	  and	  96	  were	   down-­‐regulated.	   As	   described	   in	   detail	   below,	   multiple	   metabolic	   and	  iron-­‐associated	   pathways,	   along	   with	   competence	   and	   oxidative	   stress	  response,	  were	  up-­‐regulated,	  while	  purine	  biosynthesis	  and	  transport	  pathways	  were	  reduced.	  
	  
4.2.2.4.4.1	  Metabolic	  and	  iron-­‐associated	  response	  There	   was	   up-­‐regulation	   of	   multiple	   metabolic	   pathways	   as	   well	   as	   iron	  transport-­‐associated	  gene	  clusters,	  reflected	  by	  the	  enriched	  functional	  groups	  (see	  Figure	  4.25).	  Genes	   sdaA	  and	  sdaC,	   encoding	  putative	  L-­‐serine	  deaminase	  and	  serine	   transporter	  proteins	   respectively,	  were	  among	   the	  most	  highly	  up-­‐regulated	  genes	   (see	  Table	  4.9).	   In	   addition,	   there	  was	  up-­‐regulation	  of	   genes	  with	  putative	  roles	  in	  glycogen	  processing,	  glycerol	  utilisation,	  sugar-­‐phosphate	  transport	   and	   oligopeptide	   transport	   (see	   Appendix	   B).	   Putative	   down-­‐regulated	   metabolic	   gene	   clusters	   included	   formate	   dehydrogenase	   and	  arginine	   uptake	   loci.	   Among	   induced	   iron	   transport-­‐related	   genes	   were	   the	  iron-­‐acquisition	  complex,	  hitABC,	  members	  of	  a	  putative	  cytochrome	  c	  synthesis	  and	  haem	  transport	   locus,	  ccmABCDEFGH,	   as	  well	  as	  a	  gene	  encoding	  an	   iron-­‐associated	  protein,	  TonB.	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Figure	  4.25:	  Functional	  group	  enrichment	  analysis	  of	  up-­‐regulated	  genes	  
in	  the	  Rd	  strain	  during	  nutritional	  stress,	  compared	  to	  growth	  in	  the	  rich	  
medium.	   Groups	   were	   ordered	   from	   top	   to	   bottom	   based	   on	   the	   decreasing	  adjusted	  p-­‐value.	  The	  x-­‐axis	  displays	  the	  percentage	  of	  up-­‐regulated	  genes	  that	  belonged	  to	  each	  functional	  group.	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Table	  4.9:	  The	  ten	  most	  highly	  up-­‐regulated	  and	  down-­‐regulated	  genes	  in	  
the	   Rd	   strain	   during	   nutritional	   stress,	   compared	   to	   growth	   in	   the	   rich	  
medium.	  
Gene	   Product	   Fold	  change	  
Up-­‐regulated	  genes	  
dps	   DNA	  protection	  during	  starvation	  protein	   11.82	  
sdaA	   L-­‐serine	  deaminase	   10.55	  
sdaC	   Serine	  transporter	   10.22	  
gntP_1	   Gluconate	  permease	   7.84	  
garK	   Glycerate	  2-­‐kinase	   7.54	  
-­‐	   Aldolase	   7.21	  
dprA	   DNA	  processing	  chain	  A	   7.16	  
-­‐	   Hypothetical	  protein	   6.85	  
-­‐	   3-­‐hydroxyisobutyrate	  dehydrogenase	   6.57	  
ygbM	   Putative	  hydroxypyruvate	  isomerase	  YgbM	   6.51	  
Down-­‐regulated	  genes	  
yjcD	   Putative	  permease	  YjcD	   66.56	  
purH	  
Bifunctional	  phosphoribosylaminoimidazolecarboxamide	  formyltransferase	   59.93	  
purD	   Phosphoribosylamine-­‐glycine	  ligase	   35.82	  
purM	   Phosphoribosylaminoimidazole	  synthetase	   35.77	  
purE	   Phosphoribosylaminoimidazole	  carboxylase	  catalytic	  subunit	   33.62	  
purN	   Phosphoribosylglycinamide	  formyltransferase	   22.74	  
purK	   Phosphoribosylaminoimidazole	  carboxylase	  ATPase	  subunit	   19.39	  
mtr	   Tryptophan-­‐specific	  transport	  protein	   17.58	  
lctP	   L-­‐lactate	  permease	   11.89	  
-­‐	   Short	  chain	  dehydrogenase/reductase	   10.51	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4.2.2.4.4.2	  Competence-­‐related	  response	  There	   was	   a	   clear	   induction	   of	   competence-­‐related	   genes	   during	   nutritional	  stress	  in	  Rd.	  This	  was	  apparent	  from	  enriched	  functional	  groups	  as	  well	  as	  the	  competence-­‐associated	   operon,	   comABCDEF,	   being	   up-­‐regulated	   in	   Rd	   (see	  Figure	   4.25)	   (see	   Appendix	   B).	   Among	   other	   genes	   with	   predicted	   roles	   in	  competence	   was	   dprA,	   encoding	   a	   DNA	   processing	   chain	   A,	   which	   was	  previously	  characterised	  as	  having	  a	  role	  in	  DNA	  transformation	  in	  H.	  influenzae	  (Karudapuram	  et	  al.,	  1995).	  Interestingly,	  there	  was	  down-­‐regulation	  of	  the	  rec-­‐
2	  gene,	  encoding	  a	  protein	  involved	  in	  DNA	  transformation,	  and	  a	  putative	  SOS	  regulon	  repressor,	  lexA.	  	  
4.2.2.4.4.3	  Reduction	  in	  purine	  biosynthesis	  and	  transport	  There	   was	   down-­‐regulation	   of	   purine	   biosynthetic	   and	   metabolic	   pathways	  during	   nutritional	   stress,	   which	   was	   particularly	   evident	   from	   the	   enriched	  functional	   groups	   (see	   Figures	   4.26).	   The	   most	   highly	   down-­‐regulated	   gene	  (66.6-­‐fold)	   was	   yjcD,	   encoding	   a	   putative	   permease	   (see	   Table	   4.9).	   The	  homologue	  of	  this	  gene	  in	  E.	  coli	  was	  previously	  shown	  to	  be	  involved	  in	  purine	  transport	  (Kozmin	  et	  al.,	  2013,	  Papakostas	  et	  al.,	  2013).	  Consistent	  with	  that,	  the	  whole	  pur	  regulon,	  with	  a	  putative	  role	  in	  purine	  biosynthesis,	  was	  also	  highly	  down-­‐regulated	  in	  Rd	  (Zhang	  et	  al.,	  2008).	  The	  down-­‐regulation	  of	  the	  pathway	  leading	  to	  generation	  of	  the	  purine	  precursor,	  inosinic	  acid	  (IMP),	  is	  depicted	  in	  Figure	  4.27.	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Figure	   4.26:	   Functional	   group	   enrichment	   analysis	   of	   down-­‐regulated	  
genes	  in	  the	  Rd	  strain	  during	  nutritional	  stress,	  compared	  to	  growth	  in	  the	  
rich	   medium.	   Groups	   were	   ordered	   from	   top	   to	   bottom	   based	   on	   the	  decreasing	   adjusted	   p-­‐value.	   The	   x-­‐axis	   displays	   the	   percentage	   of	   down-­‐regulated	  genes	  that	  belonged	  to	  each	  functional	  group.	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4.2.2.4.4.4	  Induction	  of	  oxidative	  stress	  response	  during	  nutritional	  stress	  There	  was	  induction	  of	  several	  genes	  involved	  in	  the	  oxidative	  stress	  response	  during	   nutritional	   stress.	   The	  most	   highly	   up-­‐regulated	   gene	   was	   dps,	   with	   a	  well-­‐characterised	  role	   in	  oxidative	  stress	  response	   in	  H.	  influenzae	   (see	  Table	  4.9)	  (see	  section	  1.1.8.1).	  A	  peroxiredoxin	  gene,	  pgdX,	  with	  a	  protective	  role	  in	  protection	  against	  oxidative	  stress,	  was	  also	  up-­‐regulated	  (see	  Appendix	  B)	  (see	  section	   1.1.8.1).	   Several	   bacterial	   respiration	   genes	   were	   induced	   as	   well,	  including	   DMSO,	   nitrate	   and	   nitrite	   reductase	   operons,	   as	   well	   as	   a	   putative	  electron	   transport	   locus	   (Stewart	   and	   Bledsoe,	   2005).	   Interestingly,	   the	   arcA	  gene,	  involved	  in	  oxidative	  stress	  defence	  in	  H.	  influenzae,	  was	  down-­‐regulated	  during	  nutritional	  stress	  (Wong	  et	  al.,	  2007).	  	  
4.2.2.4.5	   Comparison	   of	   transcriptional	   response	   of	   Rd	   and	   R2866	  
across	  different	  conditions	  There	  were	  several	  genes	  in	  both	  Rd	  and	  R2866	  strains	  that	  were	  up-­‐regulated	  or	  down-­‐regulated	  in	  more	  than	  one	  RNA-­‐Seq	  condition	  (see	  Figure	  4.28)	  (see	  Appendix	   B).	   Over	   half	   of	   up-­‐regulated	   genes	   in	   oxidative	   stress	   were	   also	  induced	   during	   stationary	   phase	   in	   both	   strains.	   A	   glutamate	   dehydrogenase	  gene,	  gdhA,	  was	  the	  only	  up-­‐regulated	  gene	  in	  all	  four	  conditions	  in	  Rd.	  Among	  up-­‐regulated	   genes	   in	   Rd,	   common	   to	   three	   conditions	   and	   associated	   with	  oxidative	  stress,	  were	  pgdX	  and	  dps,	  while	  the	  arcA	  gene	  was	  down-­‐regulated.	  It	  was	   also	   noteworthy	   that	   several	   iron	   acquisition-­‐associated	   genes	   were	   up-­‐regulated	  in	  all	  three	  conditions	  in	  R2866,	  including	  the	  whole	  haem	  utilisation	  locus,	  hxuABC,	  the	  iron	  acquisition	  gene,	  hitA,	  the	  haem	  receptor	  gene,	  hemR,	  as	  well	  as	  genes	  tbp1	  and	  tbp2,	  encoding	  transferrin-­‐binding	  proteins.	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Figure	   4.28:	   Venn	   diagrams	   of	   common	   differentially	   expressed	   genes	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4.2.2.5	  The	  whole	   transcriptome	  across	  different	  conditions	   in	  
Rd	  and	  R2866	  strains	  The	   absolute	   expression	   of	   whole	   genomes	   across	   different	   conditions	   was	  compared	   in	   both	   Rd	   and	   R2866	   strains.	   The	   DESeq2	   normalisation	   method	  relies	   on	   the	   geometric	   mean	   of	   gene	   expression	   across	   all	   samples	   that	   are	  being	   compared	   between	   two	   RNA-­‐Seq	   conditions.	   The	   normalisation	   data	   is	  thus	  specific	  to	  each	  differential	  gene	  expression	  analysis	  and	  is	  not	  comparable	  across	   several	   different	   RNA-­‐Seq	   experiments.	   Therefore,	   the	   expression	   data	  for	   each	   gene	   in	   each	   condition	  was	  normalised	  using	   the	  TPM	  method.	  Gene	  expression	   during	  mid-­‐exponential	   phase	   was	   the	  most	   similar	   to	   nutritional	  stress	  and	  oxidative	  stress	  in	  the	  Rd	  strain,	  and	  to	  oxidative	  stress	  in	  the	  R2866	  strain	  (see	  Figures	  4.29;	  4.30).	  Gene	  expression	  during	  stationary	  phase	  was	  the	  least	  similar	  to	  all	  other	  conditions	   in	  both	  strains.	  The	  most	  highly	  expressed	  gene	  across	  all	  conditions	  in	  both	  strains	  was	  the	  ssrA	  gene,	  encoding	  a	  transfer-­‐messenger	  RNA.	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Figure	   4.29:	   Comparison	   of	   the	   whole	   genome	   expression	   across	   five	  
different	   conditions	  used	   in	  RNA-­‐Seq	  experiments	   in	   the	  Rd	   strain.	  RNA-­‐Seq	  conditions	  were	   clustered	  based	  on	   the	  euclidean	  distance	  between	  TPM-­‐normalised	  expression	  of	  the	  whole	  genome.	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Figure	   4.30:	   Comparison	   of	   the	   whole	   genome	   expression	   across	   four	  
different	   conditions	   used	   in	   RNA-­‐Seq	   experiments	   in	   the	   R2866	   strain.	  RNA-­‐Seq	   conditions	  were	   clustered	   based	   on	   the	   euclidean	   distance	   between	  TPM-­‐normalised	  expression	  of	  the	  whole	  genome.	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4.3	  Discussion	  This	  is	  the	  first	  time	  that	  HTS	  has	  been	  applied	  to	  study	  whole	  transcriptomes	  of	  Rd	   and	   R2866	   strains	   of	   H.	   influenzae	   during	   infection-­‐relevant	   conditions.	  These	   included	   growth	   during	   stationary	   phase,	   growth	   in	   nutrient-­‐limiting	  medium	   as	   well	   as	   oxidative	   and	   iron-­‐starvation	   stresses.	   Differentially	  expressed	   genes	   were	   identified	   in	   each	   of	   the	   conditions	   in	   comparison	   to	  growth	  at	  mid-­‐exponential	  phase.	  In	  addition,	  an	  invasion	  assay	  in	  a	  human	  cell	  culture	   model	   was	   optimised	   for	   Rd	   and	   R2866	   strains.	   The	   number	   of	  recovered	  intracellular	  bacteria	  was	  maximised	  for	  each	  strain	  to	  enable	  robust	  transcriptomic	   analyses	   of	  H.	   influenzae	   infection	   in	   future	   studies.	   The	   data	  presented	  here	  also	  established	  that	  Rd	  and	  R2866	  strains	  of	  H.	  influenzae	  used	  in	   this	   laboratory	  were	  able	   to	  cause	   infection	   in	   the	  human	  A549	  cell	   culture	  model.	  This	  directly	  supports	  the	  study	  of	  the	  transcriptional	  response	  of	  these	  strains	  during	  infection-­‐relevant	  conditions.	  	  
4.3.1	  Development	  of	  the	  eukaryotic	  invasion	  assay	  
As	   expected,	   using	  100	  bacteria	   per	   single	   host	   cell	   in	   the	   optimised	   invasion	  assay	   resulted	   in	   the	   highest	   intracellular	   numbers	   for	   both	   Rd	   and	   R2866.	  100:1	  is	  at	  the	  upper	  limit	  of	  accepted	  MOI	  and	  is	  not	  likely	  to	  be	  representative	  of	   a	   natural	   infection	   (Letourneau	   et	   al.,	   2011).	   An	   even	   higher	   MOI	   could	  potentially	   induce	   cellular	   damage	   and	  would	  make	   the	   infection	  model	   even	  more	  different	  from	  the	  natural	  infection.	  However,	  maximising	  the	  number	  of	  invading	  bacteria	  is	  important	  for	  future	  host-­‐pathogen	  transcriptomic	  studies,	  where	  sufficient	  amounts	  of	  bacterial	  RNA	  will	  need	  to	  be	  extracted.	  In	  addition,	  bacterial	   invasion	   tends	   to	   be	   a	   heterogeneous	   process,	   meaning	   that	   not	   all	  eukaryotic	   cells	   are	   infected	   equally,	   with	   some	   cells	   potentially	   remaining	  completely	  non-­‐invaded	  (Gerceker	  et	  al.,	  2000).	  A	  higher	  MOI	  would	  therefore	  ensure	  a	   lower	   transcriptional	  noise,	   as	   the	  possibility	   for	  a	   eukaryotic	   cell	   to	  remain	  non-­‐infected	  would	  be	  reduced.	  This	  will	  be	  particularly	   important	   for	  future	  dual	  RNA-­‐Seq	  experiments	  of	  both	  H.	  influenzae	  and	  the	  human	  host.	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The	   optimal	   infection	   time	   was	   selected	   as	   3	   hours,	   due	   to	   the	   following	  decrease	   in	   the	   number	   of	   intracellular	   bacteria	   at	   4	   hours.	   The	   subsequent	  increase	   in	   the	   number	   of	   invading	  H.	   influenzae	   at	   5	   hours	   is	   curious.	   These	  fluctuations	   in	   intracellular	   numbers	   could	   possibly	   be	   explained	   by	   the	  complex	   dynamics	   of	   a	   bacterial	   infection,	   where	   killed	   intracellular	   bacteria	  could	  be	  replaced	  by	  new	  invading	  H.	  influenzae.	  	  	  The	  experiment	  with	  H.	  influenzae	  grown	  in	  DMEM	  with	  varying	  concentrations	  of	  FBS	  suggests	  that	  H.	  influenzae	  requires	  FBS	  in	  order	  to	  grow	  in	  DMEM.	  The	  initial	   growth	   and	   subsequent	   death	   in	   the	   presence	   of	   FBS	   in	   the	   medium	  indicates	  FBS	  sustaining	  the	  growth	  of	  H.	  influenzae	  over	  a	  limited	  time	  period.	  At	  3	  hours	  post-­‐inoculation,	  CFU/ml	  values	  for	  both	  Rd	  and	  R2866	  were	  higher	  than	   at	   the	   start	   of	   the	   experiment	  when	   grown	   in	   the	   presence	   of	   10%	   FBS	  (same	  as	   the	   infection	  medium).	  Therefore,	   in	   the	   invasion	   assay,	   the	   starting	  MOI	  actually	  increases	  over	  3	  hours	  and	  is	  higher	  for	  the	  Rd	  strain	  compared	  to	  R2866	  at	  the	  time	  of	  the	  gentamicin	  treatment.	  This	  could	  explain	  why	  a	  higher	  number	  of	   intracellular	  bacteria	  was	  observed	  for	  Rd	  compared	  to	  an	  invasive	  R2866	  strain	  in	  this	  study.	  	  
4.3.1.1	   Enrichment	   of	   bacterial	   RNA	   in	   a	  mixed	   bacterial-­‐host	  
sample	  	  RNA	  isolation	  from	  host	  cells	  infected	  with	  H.	  influenzae	  was	  carried	  out	  in	  this	  study.	  Since	  the	  proportion	  of	  bacterial	  RNA	  in	  a	  mixed	  sample	  is	  expected	  to	  be	  very	  low,	  the	  read	  depth	  for	  sufficient	  detection	  of	  bacterial	  transcription	  would	  only	  be	  achievable	  using	  high-­‐end	  sequencers	  like	  the	  HiSeqTM.	  However,	  due	  to	  financial	   constraints,	   the	   inability	   to	   use	   high-­‐end	   sequencing	   instruments	  meant	   that	   the	  method	  needed	   to	   be	   further	   optimised	  by	   enriching	  bacterial	  RNA	   in	   a	   mixed	   sample.	   While	   the	   enrichment	   resulted	   in	   the	   significant	  depletion	  of	  18S	  and	  28S	  rRNA,	   it	  was	  not	  possible	   to	  observe	  bacterial	   rRNA	  bands	  in	  the	  Bioanalyzer	  electropherogram	  image,	  suggesting	  that	  the	  majority	  of	   RNA	   in	   the	   sample	  was	   still	   eukaryotic	   RNA.	   Nevertheless,	   the	   enrichment	  ensured	  that	  the	  proportion	  of	  bacterial	  RNA	  in	  the	  sample	  was	  now	  higher	  than	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in	   the	   original	   sample.	   This	   could	   now	   potentially	   allow	   sequencing	   of	   the	  bacterial	   RNA	   in	   the	   enriched	   sample	   at	   the	   appropriate	   read	   depth	   using	   a	  benchtop	  instrument	  like	  the	  MiSeqTM.	  The	  optimised	  invasion	  assay	  could	  also	  be	   used	   directly	   for	   a	   dual	   RNA-­‐Seq	   experiment	   to	   study	   gene	   expression	   of	  both	  H.	  influenzae	  and	  the	  human	  host.	  Potential	  heterogeneity	  in	  the	  number	  of	  invaded	   and	   non-­‐invaded	   eukaryotic	   cells	   could	   be	   overcome	   by	   utilising	   a	  recently	   described	   method,	   where	   non-­‐infected	   cells	   are	   differentiated	   via	  fluorescence-­‐activated	  cell	  sorting	  technology	  (Westermann	  et	  al.,	  2016).	  	  
4.3.2	   The	   transcriptional	   response	   of	   Rd	   and	   R2866	  
strains	  during	  infection-­‐relevant	  conditions	  
4.3.2.1	   R2866	   is	   more	   sensitive	   to	   oxidative	   stress	   and	   iron-­‐
starvation	  than	  Rd	  It	  was	  interesting	  to	  observe	  that	  an	  invasive	  R2866	  strain	  was	  more	  sensitive	  to	   both	   iron-­‐starvation	   and	   oxidative	   stresses	   than	   a	   standard	   laboratory	   Rd	  strain,	  based	  on	  the	  growth	  kinetics.	  While	  R2866	  may	  be	  more	  susceptible	  to	  environmental	   stresses	   examined	   in	   this	   study,	   it	   was	   shown	   to	   be	   highly	  resistant	  to	  human	  serum	  through	  complement	  evasion,	  which	  is	  the	  most	  likely	  explanation	  for	  its	  invasive	  phenotype	  (Williams	  et	  al.,	  2001).	  	  The	   optimised	   concentration	   of	   hydrogen	   peroxide	   for	   the	   induction	   of	  oxidative	  stress	  in	  this	  study	  was	  5	  mM.	  The	  R2866	  strain	  had	  a	  greater	  growth	  defect	  in	  reaction	  to	  this	  treatment	  than	  Rd,	  highlighting	  the	  variability	  in	  stress	  response	  between	  different	  strains.	  Concentrations	  of	  up	  to	  20	  mM	  of	  hydrogen	  peroxide	  did	  not	  have	  an	  effect	  on	  the	  viability	  of	  the	  wild	  type	  86-­‐028NP	  strain	  of	   H.	   influenzae,	   when	   grown	   in	   the	   MIV	   medium	   (Juneau	   et	   al.,	   2015).	   In	  contrast,	  the	  same	  strain	  grown	  in	  the	  rich	  sBHI	  medium	  was	  sensitive	  to	  as	  low	  as	  0.5	  mM	  of	  hydrogen	  peroxide,	  revealing	  the	  significant	  effect	  that	  the	  growth	  medium	   seems	   to	   have	   on	   the	   sensitivity	   of	  H.	   influenzae	   strains	   to	   hydrogen	  peroxide	   treatment.	   (Harrison	   et	   al.,	   2007).	   The	   millimolar	   concentrations	   of	  hydrogen	  peroxide	   tested	   in	   this	   study	  were	  similar	   to	   the	  amounts	  produced	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by	  a	  co-­‐pathogen	  S.	  pneumoniae	  as	  well	  as	  active	  neutrophil	  cells	  (Duane	  et	  al.,	  1993,	  Pericone	  et	  al.,	  2003).	  	  	  As	  with	  the	  hydrogen	  peroxide	  treatment,	  5	  mM	  of	  2,2-­‐bipyridine	  was	  selected	  as	   the	   optimal	   concentration	   for	   iron	   chelation	   in	   this	   study.	   A	   much	   lower	  concentration	  of	  0.5	  mM	  was	  previously	  used	  for	  iron	  chelation	  in	  the	  86-­‐028NP	  strain,	  though	  the	  effect	  on	  the	  bacterial	  growth	  was	  not	  described	  in	  that	  study	  (Harrison	  et	  al.,	  2013).	  In	  addition,	  as	  with	  hydrogen	  peroxide,	  it	  is	  likely	  there	  is	  a	   large	   inter-­‐strain	  variation	   in	   sensitivity	   to	   iron	  chelation	   in	  H.	  influenzae.	  This	  was	  indeed	  observed	  in	  this	  study,	  where	  R2866	  was	  more	  sensitive	  to	  the	  treatment	   with	   2,2-­‐bipyridine	   than	   Rd.	   While	   depletion	   of	   iron	   was	   not	  measured	  quantitatively	  in	  this	  study,	  a	  reliable	  indication	  of	  iron	  chelation	  was	  the	   colour	   change	   to	  dark	   red,	   observed	   in	  broth	   cultures	  within	  1	  hour	   after	  treatment.	  This	  was	  due	  to	  2,2-­‐bipyridine	  interacting	  with	  ferrous	  iron	  to	  form	  an	   iron(II)	   bipyridyl	   complex	   responsible	   for	   an	   intense	   dark	   red	   colour	  (O'Sullivan	  et	  al.,	  1990).	  	  	  Another	   difference	   between	   the	   two	   strains	   was	   that	   R2866	   had	   a	   different	  distribution	   of	   rRNA	   bands	   compared	   to	   Rd,	   most	   likely	   resulting	   from	   the	  fragmentation	  of	  23S	  rRNA.	  This	  phenomenon	  has	   indeed	  been	  observed	   in	  H.	  
influenzae	  and	  has	  been	  linked	  to	  the	  presence	  of	  intervening	  sequences	  (IVS)	  in	  the	   23S	   rRNA	   gene	   (Song	   et	   al.,	   1999).	   IVSs	   have	   been	   previously	   associated	  with	  pathogenic	  strains	  in	  other	  bacteria,	  though	  their	  exact	  role	  remains	  to	  be	  characterised	  (Skurnik	  and	  Toivanen,	  1991).	  	  
4.3.2.2	   Oxidative	   stress:	   differences	   in	   strain	   sensitivity	   to	  
hydrogen	   peroxide	   only	   partially	   translates	   to	   transcriptional	  
response	  Induction	   of	   oxidative	   stress	   resulted	   in	   the	   lowest	   number	   of	   differentially	  expressed	   genes	   compared	   to	   other	   RNA-­‐Seq	   experiments.	   This	   is	   likely	   the	  result	   of	   a	   targeted	   bacterial	   response	   to	   this	   environmental	   stress.	   Catalase,	  which	  is	  a	  member	  of	  the	  OxyR	  regulon	  in	  the	  86-­‐028NP	  strain,	  was	  previously	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shown	   to	   be	   responsible	   for	   scavenging	   high	   concentrations	   of	   hydrogen	  peroxide	   in	  H.	   influenzae	   (Pauwels	   et	   al.,	   2004,	   Harrison	   et	   al.,	   2007).	   A	   very	  high	   up-­‐regulation	   of	   the	   catalase	   gene,	   hktE,	   in	   this	   study	   implies	   that	   the	  majority	   of	   hydrogen	   peroxide	   was	   scavenged	   by	   catalase	   in	   both	   Rd	   and	  R2866.	  This	  supports	  the	  idea	  that	  oxidative	  stress	  led	  to	  a	  more	  targeted	  and	  straightforward	  response	  than	  other	  tested	  infection-­‐relevant	  conditions	  in	  this	  study.	  As	  the	  oxyR	  gene	  is	  an	  important	  mediator	  of	  oxidative	  stress	  defence	  in	  
H.	  influenzae,	   it	  was	  surprising	  that	  there	  was	  no	  change	  in	  oxyR	  expression	  in	  this	   study.	   It	   is	   possible	   that	   the	   changes	   of	   the	   oxyR	   mRNA	   transcript	   levels	  were	   rapid	   and	   transient.	   As	   observed	   in	   a	   study	   by	   Whitby	   et	   al.,	   oxyR	  transcript	   levels	   returned	   to	   normal	   levels	  within	   10	  minutes	   after	   treatment	  with	  hydrogen	  peroxide	  (Whitby	  et	  al.,	  2012).	  	  	  A	  total	  of	  11	  members	  of	  the	  oxyR	  regulon	  were	  previously	  identified	  in	  the	  86-­‐028NP	  strain	  of	  H.	  influenzae,	   all	  of	  which	  were	  up-­‐regulated	  during	  oxidative	  stress	  in	  a	  microarray	  study	  (Harrison	  et	  al.,	  2007).	  Of	  these,	  hktE,	  gnd,	  pgdX	  and	  
dps	   were	   up-­‐regulated	   in	   both	   Rd	   and	   R2866	   during	   oxidative	   stress	   in	   this	  study.	  An	  OxyR-­‐regulated	  gene,	  NTHI0684,	   in	  the	  86-­‐028NP	  strain,	  encoding	  a	  hypothetical	   protein,	   was	   also	   up-­‐regulated	   in	   both	   strains	   in	   this	   study.	  Interestingly,	   it	   coded	   for	   a	   putative	  membrane	   protein	   in	   Rd	   and	   a	   putative	  CRISPR-­‐associated	   protein,	   Cas2,	   in	   R2866.	   Sequence	   search	   on	   the	   InterPro	  database	   revealed	   no	   homology	   to	   known	   protein	   families	   or	   domains.	  Remaining	   members	   of	   the	   OxyR	   regulon	   were	   genes	   pntA	   and	   pntB,	   up-­‐regulated	  in	  Rd	  only,	  as	  well	  as	  the	  yfeABCD	  locus,	  the	  expression	  of	  which	  was	  not	  induced	  in	  either	  of	  the	  strains	  in	  this	  study.	  This	  is	  different	  to	  a	  microarray	  study	  by	  Whitby	  et	  al.,	  where	  the	  yfeB	  gene	  was	  up-­‐regulated	  in	  Rd	  in	  response	  to	   hydrogen	   peroxide,	   while	   gnd	   was	   not	   (Whitby	   et	   al.,	   2012).	   The	   yfeABCD	  locus	  was	   also	   highly	   up-­‐regulated	   in	   response	   to	   oxidative	   stress	   in	   another	  microarray	  study	  by	  Harrison	  et	  al.	  (Harrison	  et	  al.,	  2007).	  While	  there	  are	  clear	  inter-­‐strain	  variations	  as	  well	  as	  differences	  between	  study	  designs,	  the	  overall	  OxyR-­‐dependent	   response	   to	   oxidative	   stress	   seems	   to	   be	   similar	   among	   H.	  
influenzae	  strains.	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Several	   iron	   acquisition	   and	   ferritin-­‐like	   protein	   genes	   were	   up-­‐regulated	  during	   oxidative	   stress	   as	   well.	   Ferritin-­‐like	   proteins	   sequester	   ferrous	   iron,	  thus	   preventing	   further	   oxidative	   damage	   through	   Fenton	   reaction.	   The	   up-­‐regulation	   of	   iron	   uptake	   could	   be	   utilised	   for	   the	   repair	   of	   damaged	   iron-­‐sulphur	   cluster	   proteins.	   Iron-­‐sulphur	   clusters	   are	   present	   as	   cofactors	   in	   a	  large	   number	   of	   enzymes,	   mediating	   a	   variety	   of	   different	   roles	   in	   bacteria	  (Yoch	  and	  Carithers,	  1979).	  There	  was	  up-­‐regulation	  of	   genes	  associated	  with	  iron-­‐sulphur	  cluster	  formation	  in	  both	  strains	  as	  well.	  The	  iron	  acquisition	  gene	  locus,	  hxuABC,	  as	  well	  as	  genes	  tbp1,	  tbp2,	  hitA	  and	  hemR,	  up-­‐regulated	  in	  R2866	  only,	   were	   shown	   to	   be	   part	   of	   the	   Fur	   regulon	   in	   the	   86-­‐028NP	   strain,	  suggesting	   that	   this	   transcriptional	   regulator	   plays	   a	   role	   in	   oxidative	   stress	  defence	  in	  R2866	  as	  well.	  Iron	  homeostasis,	  including	  transcriptional	  regulation	  by	  Fur,	  plays	  an	  important	  role	  during	  oxidative	  stress	  in	  H.	  influenzae	  as	  shown	  in	  this	  and	  previous	  studies	  (Harrison	  et	  al.,	  2015).	  	  Genes	   recA,	   lexA,	   recX	   and	   ruvA,	   up-­‐regulated	   in	   both	   strains	   during	   oxidative	  stress,	   were	   previously	   shown	   to	   be	   involved	   in	   the	   SOS	   response	   in	   H.	  
influenzae	  as	  part	  of	  the	  LexA	  regulon	  (Sweetman	  et	  al.,	  2005).	  The	  expression	  of	  genes	  recA	  and	  recN	  was	  also	  shown	  to	  be	  induced	  in	  the	  86-­‐028NP	  strain	  in	  response	   to	  hydrogen	  peroxide	   (Harrison	   et	   al.,	   2007).	  Up-­‐regulation	  of	   these	  genes,	  along	  with	  multiple	  other	  genes	  with	  predicted	  roles	  in	  SOS	  response	  and	  protection	   against	   DNA	   damage,	   highlights	   the	   drastic	   damaging	   effect	   that	  hydrogen	  peroxide	  has	  on	  bacterial	  DNA	  (Rohwer	  and	  Azam,	  2000).	  	  	  Up-­‐regulation	   of	   the	   acetolactate	   synthase	   gene	   locus,	   ilvHI,	   in	   Rd	   during	  oxidative	   stress	   was	   curious.	   This	   enzyme,	   along	   with	   an	   up-­‐regulated	   ketol-­‐acid	   reductoisomerase	   gene,	   ilvC,	   is	   involved	   in	   the	   biosynthesis	   of	   branched-­‐chain	  amino	  acids	  leucine,	   isoleucine	  and	  valine	  (Ricca	  et	  al.,	  1988).	  Branched-­‐chain	  amino	  acid	  supplementation	  has	  been	  shown	  to	  decrease	  oxidative	  stress	  levels	   in	   eukaryotic	   cells,	   though	   it	   is	   not	   clear	   whether	   this	   translates	   to	  prokaryotes	  as	  well	  (Iwasa	  et	  al.,	  2013).	  In	  addition,	  the	  lack	  of	  branched-­‐chain	  amino	  acids	   in	   the	  host	   cells	   induced	  expression	  of	  virulence	  genes	   in	  Listeria	  
monocytogenes	   (Lobel	  et	  al.,	  2012).	  Therefore,	   the	  concurrent	  up-­‐regulation	  of	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branched-­‐chain	  amino	  acid	  biosynthesis	  during	  oxidative	  stress	  could	  represent	  
H.	  influenzae	  responding	  to	  host-­‐like	  conditions.	  	  Although	   the	   induced	   expression	   of	   genes	   during	   oxidative	   stress	   in	   Rd	   and	  R2866	  was	  largely	  similar,	  there	  were	  a	  lot	  more	  differences	  in	  down-­‐regulated	  genes.	   For	   instance,	  R2866	  only	   contained	  27	  down-­‐regulated	  genes,	  whereas	  Rd	   had	   97.	   In	   addition,	   there	   was	   no	   overlap	   in	   the	   ten	   most	   highly	   down-­‐regulated	  genes	  between	  the	  two	  strains.	   It	   is	  not	  clear	  why	  the	  response	  was	  this	  different,	  but	  a	  partial	  explanation	  could	  be	  that	  the	  gene	  expression	  of	  one	  of	   the	   R2866	   replicates	   from	   the	   mid-­‐exponential	   group	   noticeably	   differed	  from	  the	  other	  two,	  as	  inferred	  with	  hierarchical	  clustering.	  Therefore,	  it	  could	  result	  in	  the	  underestimation	  of	  some	  differentially	  expressed	  genes.	  However,	  since	  the	  up-­‐regulated	  genes	  in	  R2866	  had	  a	  much	  greater	  similarity	  to	  Rd,	  this	  cannot	  plausibly	  be	  the	  whole	  reason.	  The	  difference	  in	  down-­‐regulation	  could	  be	  simply	  explained	  by	  different	  strategies	  that	  R2866	  employs	  during	  oxidative	  stress.	  	  As	   there	   were	   a	   large	   number	   of	   up-­‐regulated	   iron-­‐related	   genes	   during	  oxidative	  stress,	  down-­‐regulation	  of	  several	  other	  iron-­‐associated	  genes	  during	  the	   same	   condition	   highlights	   the	   complex	   dynamic	   of	   iron	   homeostasis	   and	  oxidative	  stress	   in	  H.	  influenzae.	  Down-­‐regulation	  of	  several	  ribosomal	  protein	  genes	  was	  most	  likely	  related	  to	  a	  reduction	  in	  protein	  synthesis	  resulting	  from	  a	  general	  response	  to	  a	  stress	  condition.	  	  The	   arginine	   uptake	   locus,	   which	   is	   part	   of	   the	   Fur	   regulon	   in	   the	   86-­‐028NP	  strain,	   was	   down-­‐regulated	   during	   oxidative	   stress	   in	   the	   Rd	   strain.	   In	  agreement	  with	  that,	  there	  was	  also	  down-­‐regulation	  of	  other	  gene	  clusters	  that	  were	   Fur-­‐regulated	   in	   the	   86-­‐028NP	   strain.	   This	   included	   DMSO	   and	   nitrite	  reductase	  loci	  as	  well	  as	  the	  hbpA	  gene	  (Harrison	  et	  al.,	  2013).	  Genes	  ftnA1	  and	  
ftnA2	  were	  the	  only	  down-­‐regulated	  genes	  in	  R2866	  that	  are	  regulated	  by	  Fur.	  The	   disparate	   down-­‐regulation	   of	   Fur-­‐associated	   genes	   in	   Rd	   and	   R2866	  possibly	   represents	   their	   varied	   response	   to	   hydrogen	   peroxide.	   This	   is	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supported	  by	  the	  fact	  that	  most	  of	  up-­‐regulated	  Fur-­‐regulated	  genes	  were	  only	  present	  in	  the	  R2866	  strain,	  as	  described	  earlier.	  	  The	  only	  gene	  locus	  that	  was	  down-­‐regulated	  over	  3-­‐fold	  during	  oxidative	  stress	  in	   R2866	   contained	   genes	   encoding	   proteins	   with	   putative	   roles	   in	  carbohydrate	  processing.	  The	  most	  highly	  down-­‐regulated	  gene,	  Hgd,	  encoded	  a	  putative	   2-­‐(hydroxymethyl)glutarate	   dehydrogenase,	   which	   is	   involved	   in	  nicotinate	  fermentation	  in	  Eubacterium	  barkeri	  (Reitz	  et	  al.,	  2008).	  This	  gene	  is	  part	  of	  the	  same	  family	  of	  β-­‐hydroxyacid	  dehydrogenases	  as	  gnd,	  which	  was	  up-­‐regulated	   in	   both	   strains.	   It	   is	   probable	   that	   the	   predicted	   annotation	   of	   this	  whole	   locus	   is	  wrong.	   Further	   investigation	   is	   required	   to	   determine	   the	   real	  function	  of	  this	  locus	  and	  its	  role	  in	  oxidative	  stress.	  	  
4.3.2.3	  Different	  transcriptional	  behaviour	  of	  Rd	  and	  R2866	  in	  
response	  to	  iron-­‐starvation	  As	  expected,	  many	  characterised	  and	  putative	  iron-­‐	  and	  metal-­‐associated	  genes,	  including	  those	  related	  to	  iron	  uptake,	  were	  up-­‐regulated	  during	  iron-­‐starvation	  stress	  in	  both	  strains.	  However,	  a	  lot	  of	  these	  genes	  were	  induced	  in	  the	  R2866	  strain	  only.	  In	  addition,	  those	  iron-­‐related	  genes	  that	  were	  up-­‐regulated	  in	  both	  strains	  were	  largely	  induced	  to	  a	  higher	  fold	  change	  in	  R2866.	  As	  demonstrated	  by	  growth	  kinetics,	  R2866	  was	  more	  sensitive	  to	  iron-­‐starvation	  stress	  than	  Rd	  in	   this	   study.	   Hence	   this	   can	   explain	   the	   increased	   requirement	   for	   iron	  acquisition	   and	   metabolism	   in	   R2866.	   As	   discussed	   earlier,	   the	   higher	  susceptibility	  of	  the	  R2866	  stress	  to	  environmental	  stresses	  is	  likely	  surpassed	  by	  its	  resistance	  to	  human	  serum	  during	  natural	  infection.	  	  It	   was	   curious	   that	   Rd	   had	   several	   LOS-­‐related	   genes	   that	   were	   highly	   up-­‐regulated	   during	   iron-­‐starvation.	   One	   possibility	   is	   that	   Rd	   sensing	   an	   iron-­‐limiting	   environment,	  which	  H.	   influenzae	   is	   likely	   to	   encounter	   in	   its	   natural	  niche,	   induced	   the	   expression	  of	   genes	   involved	   in	   its	  pathogenesis.	  However,	  apart	  from	  the	   lptC	  gene,	  the	  expression	  of	  LOS-­‐related	  genes	  was	  not	  induced	  in	  R2866.	  This	  is	  likely	  due	  to	  this	  strain	  experiencing	  iron-­‐starvation	  stress	  to	  a	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higher	  degree	  than	  Rd	  and	  therefore	  employing	  different	  survival	  strategies	  by	  primarily	   inducing	   iron	   acquisition	   pathways.	   It	   would	   be	   interesting	   to	  examine	  the	  transcriptional	  response	  of	  R2866	  to	  a	  lower	  concentration	  of	  the	  iron	  chelator	  in	  future	  work.	  	  	  There	  was	  up-­‐regulation	  of	  Fur-­‐regulated	  genes,	  hitABC,	  yfeABCD	  and	  hemR,	   in	  both	   strains,	   while	   hxuABC,	   tonB,	   exbBD,	   tbp1,	   tbp2	   and	   tnaA	   were	   only	   up-­‐regulated	  in	  R2866	  (Harrison	  et	  al.,	  2013).	  In	  addition,	  the	  expression	  of	  these	  genes	   was	   induced	   in	   both	   strains	   during	   iron-­‐starvation	   in	   previous	  microarray	   studies	   (Whitby	   et	   al.,	   2013).	   The	   hitABC	   locus	   was	   shown	   to	   be	  highly	   up-­‐regulated	   in	  H.	   influenzae	   infecting	   human	   cells,	   demonstrating	   the	  requirement	  for	  iron	  acquisition	  in	  a	  limited	  environment	  (Baddal	  et	  al.,	  2015).	  LOS-­‐related	   genes	   were	   not	   up-­‐regulated	   in	   a	   microarray	   study	   where	   iron-­‐starvation	  was	   induced	   in	   the	  Rd	   strain	   (Whitby	  et	   al.,	   2006).	  The	  differences	  between	   these	   studies	   are	   most	   likely	   due	   to	   different	   methodologies	   of	  inducing	  iron-­‐starvation.	  In	  addition	  to	  other	  iron	  uptake	  genes,	  there	  was	  also	  up-­‐regulation	  of	  multiple	  putative	  metal	  transporters,	  which	  are	  likely	  to	  have	  a	  role	  in	  iron	  transport.	  There	  was	  also	  up-­‐regulation	  of	  several	  genes	  involved	  in	  heat	   shock	   response	   in	   both	   strains.	   This	   likely	   represents	   a	   dynamic	   and	  overlapping	  response	  to	  iron-­‐starvation	  and	  general	  bacterial	  stress.	  	  Consistent	  with	  up-­‐regulated	  genes	  during	  iron-­‐starvation,	  several	  of	  the	  genes	  down-­‐regulated	   in	   this	   study	   were	   part	   of	   the	   Fur	   regulon	   in	   the	   86-­‐028NP	  strain	  (Harrison	  et	  al.,	  2013).	  These	  included	  a	  haem-­‐binding	  lipoprotein	  gene,	  
hbpA,	   as	   well	   as	   formate	   dehydrogenase	   and	   nitrite	   reductase	   operons.	  Moreover,	   the	   Fur	   regulation	  was	   again	  more	   evident	   in	   the	   R2866	   strain,	   as	  arginine	  uptake	  and	   fumarate	  reductase	  operons	  were	  down-­‐regulated	   in	   that	  strain	   only.	   The	   higher	   sensitivity	   of	   R2866	   to	   iron-­‐starvation	   was	   also	  highlighted	  by	  down-­‐regulation	  of	  several	  translation-­‐associated	  genes.	  	  L-­‐cystine	  and	  DL-­‐methionine	  uptake	  genes	  were	  highly	  down-­‐regulated	  during	  iron-­‐starvation	   in	   both	   strains.	   Cysteine	   and	   methionine	   are	   both	   sulphur-­‐containing	   amino	   acids,	   therefore	   the	   decrease	   in	   their	   uptake	   could	   be	   the	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means	   of	   maintaining	   cellular	   sulphur	   metabolism.	   L-­‐cysteine	   indeed	   acts	   a	  substrate	   for	   a	   sulphur	   transport	   system	   in	   E.	   coli,	   with	   implicated	   roles	   in	  processes	  like	  oxidative	  stress	  (Dai	  and	  Outten,	  2012).	  This	  could	  possibly	  have	  implications	  for	  the	  maintenance	  of	  iron-­‐sulphur	  clusters	  during	  growth	  at	  iron-­‐limiting	  conditions	  in	  both	  Rd	  and	  R2866.	  	  	  Down-­‐regulation	   of	   ilvC,	   ilvH	   and	   ilvI	   genes,	   encoding	   a	   ketol-­‐acid	  reductoisomerase	  and	  acetolactate	  synthase	  subunits,	  during	  iron-­‐starvation	  in	  both	   strains	   was	   consistent	   with	   the	   reduced	   expression	   of	   these	   genes	   in	   a	  microarray	  study	  where	  iron-­‐starvation	  was	  induced	  in	  the	  Rd	  strain	  (Whitby	  et	  al.,	  2006).	  However,	  their	  exact	  role	  in	  the	  iron-­‐starvation	  response	  is	  not	  clear.	  Other	  notable	  down-­‐regulated	  genes	  with	  unidentified	  roles	   in	   iron-­‐starvation	  were	  histidine	  and	  tryptophan	  biosynthesis	  loci	  as	  well	  as	  genes	  from	  the	  ATP	  synthase	  locus,	  atpABCDEFGHI,	  with	  a	  role	  in	  bacterial	  respiration.	  One	  possible	  reason	  is	  simply	  the	  need	  to	  reduce	  respiratory	  and	  biosynthetic	  processes	  in	  a	  slow-­‐growing	  bacterial	  community	  in	  response	  to	  stress.	  	  
4.3.2.4	  Nutrient	  limitation	  in	  the	  Rd	  strain	  leads	  to	  induction	  of	  
competence	  and	  iron-­‐starvation	  response	  The	  MIV	  medium	  is	  chemically-­‐defined	  and	  is	  nutrient-­‐limiting	  compared	  to	  the	  rich	  sBHI	  medium	  (Herriott	  et	  al.,	  1970).	  Therefore,	   it	  was	  not	  surprising	   that	  several	   nutrient	  metabolism-­‐	   and	   transport-­‐associated	   loci	  were	   up-­‐regulated	  in	   Rd	   during	   nutritional	   stress	   in	   the	   MIV	   medium.	   This	   included	   glycogen	  biosynthesis	  and	  metabolism	  genes,	  glycerol	  utilisation	  locus	  as	  well	  as	  several	  other	   gene	   clusters	   involved	   in	   carbohydrate	   and	   amino	   acid	  metabolism	  and	  uptake.	   The	  most	   highly	   up-­‐regulated	   gene	   during	   nutritional	   stress	  was	  dps,	  which	   was	   consistent	   with	   this	   gene	   being	   present	   intracellularly	   in	   large	  quantities	   during	   starvation	   conditions	   in	   E.	   coli	   (Almiron	   et	   al.,	   1992).	   The	  inability	  of	  the	  R2866	  strain	  to	  grow	  in	  the	  MIV	  medium	  again	  highlighted	  the	  increased	  sensitivity	  of	  this	  strain	  to	  environmental	  stresses.	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The	  up-­‐regulation	  of	  several	  iron-­‐associated	  genes	  during	  nutritional	  stress	  was	  most	  likely	  due	  to	  the	  reduced	  availability	  or	  iron	  in	  the	  MIV	  medium.	  Indeed,	  a	  lower	  amount	  of	  haemin	  was	  present	  in	  the	  MIV	  medium	  (10	  μg/ml)	  compared	  to	  the	  sBHI	  medium	  (15	  μg/ml).	  This	  is	  in	  addition	  to	  any	  other	  iron-­‐containing	  compounds,	   which	   are	   present	   in	   the	   rich	   medium,	   being	   absent	   from	   the	  chemically-­‐defined	   MIV	   medium.	   There	   was	   also	   up-­‐regulation	   of	   multiple	  genes	  with	   a	   role	   in	   energy	   generation	   from	  metabolites,	   including	   a	   putative	  electron	   transport	   locus	  and	  nitrate	   reductase	  genes.	  This	  possibly	   represents	  bacteria	   scavenging	   available	   nutrients	   from	   the	   medium	   and	   inducing	   the	  expression	  of	  energy-­‐producing	  genes	  required	  for	  the	  exponential	  growth.	  	  As	   expected,	   a	   competence-­‐associated	   operon,	   comABCDEF,	   was	   up-­‐regulated	  during	   nutritional	   stress,	   as	   the	   MIV	   medium	   was	   originally	   developed	   to	  facilitate	   the	   competence	   process	   in	  H.	   influenzae	   under	   starvation	   conditions	  (Herriott	  et	  al.,	  1970).	  The	  expression	  of	  this	  operon	  was	  also	  previously	  shown	  to	   be	   induced	   in	   the	   Rd	   strain	   of	   H.	   influenzae	   after	   transfer	   from	   the	   sBHI	  medium	   to	   MIV	   (Redfield	   et	   al.,	   2005).	   Whilst	   the	   comABCDEF	   operon	   is	  involved	   in	   the	   DNA	   uptake,	   genes	   responsible	   for	   DNA	   integration	  were	   up-­‐regulated	  as	  well,	  including	  comM	  and	  dprA	  (Karudapuram	  et	  al.,	  1995,	  Gwinn	  et	  al.,	  1998).	  The	  expression	  of	  these	  two	  genes	  was	  previously	  highly	  induced	  in	  Rd	  when	  grown	  in	  the	  MIV	  medium	  (Redfield	  et	  al.,	  2005).	  This	  highlights	  that	  both	   stages	   of	   the	   competence	   process,	   DNA	   uptake	   and	   integration,	   were	  initiated	  during	  nutritional	  stress	  in	  this	  study.	  	  Depletion	  of	  purine	  pools	  in	  the	  growth	  medium	  has	  been	  previously	  shown	  to	  be	  a	  necessary	  signal	  for	  competence	  induction	  in	  H.	  influenzae	  (MacFadyen	  et	  al.,	   2001).	   This	   is	   directly	   related	   to	   down-­‐regulation	   of	   multiple	   purine	  biosynthesis-­‐associated	   genes	   during	   nutritional	   stress	   in	   Rd.	   Moreover,	   the	  most	   highly	   down-­‐regulated	   gene	   in	   Rd	   encoded	   a	   permease	   protein	   with	   a	  putative	   role	   in	   purine	   import.	   Purine	   uptake	   and	   biosynthetic	   genes	   are	  repressed	   by	   PurR	   in	   response	   to	   available	   purine	   pools	   in	  E.	   coli	   (Cho	   et	   al.,	  2011).	   It	   is	   curious	   as	   to	  why	   the	   expression	   of	   purine-­‐associated	   genes	  was	  reduced,	   as	   the	  MIV	  medium	   is	  nutrient-­‐limiting	   and	   it	   is	   thus	   expected	   to	  be	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starved	  of	  purines	  as	  compared	  to	  the	  sBHI	  medium.	  Down-­‐regulation	  of	  purine	  uptake	   and	   biosynthetic	   pathways	   in	   this	   study	   could	   therefore	   be	   possibly	  linked	   to	   other	   regulatory	   networks	   responsible	   for	   competence	   initiation.	  There	  was	  also	  down-­‐regulation	  of	  a	  DNA	  transformation-­‐associated	  gene,	  rec-­‐
2,	  which	  was	  puzzling	  (Barouki	  and	  Smith,	  1985).	  It	  was	  previously	  discovered	  that	  the	  rec-­‐2	  gene	  contains	  a	  putative	  PurR	  binding	  site,	  though	  it	  was	  shown	  experimentally	  in	  the	  same	  study	  that	  PurR	  does	  not	  repress	  rec-­‐2	  (Sinha	  et	  al.,	  2013).	  	  Consistent	   with	   the	   up-­‐regulation	   of	   Fur-­‐regulated	   iron	   acquisition	   locus,	  
hitABC,	  during	  nutritional	  stress,	  there	  were	  several	  down-­‐regulated	  genes	  that	  also	   belonged	   to	   the	   Fur	   regulon,	   including	   arginine	   uptake	   and	   formate	  dehydrogenase	   gene	   loci.	   This	   possible	   regulation	   by	   Fur	   during	   nutritional	  stress	  is	  likely	  a	  result	  of	  reduced	  iron	  in	  the	  medium,	  thus	  mimicking	  the	  iron-­‐starvation	  stress	  to	  some	  extent.	  	  
4.3.2.5	   The	   metabolic	   response	   of	   H.	   influenzae	   during	  
stationary	  phase	  This	   was	   the	   first	   study	   to	   investigate	   how	   H.	   influenzae	   behaves	   during	  stationary	   phase	   in	   comparison	   to	   mid-­‐exponential	   phase	   on	   a	   whole	  transcriptome	  level.	  Due	  to	  the	  limiting	  nature	  of	  the	  environmental	  niche	  that	  
H.	  influenzae	   inhabits,	   it	   is	   likely	   to	  persist	   at	   stationary	  phase	  during	  most	  of	  human	   colonisation	   and	   infection.	   Of	   all	   four	   studied	   infection-­‐relevant	  conditions,	   the	   highest	   number	   of	   differentially	   expressed	   genes	   was	   at	  stationary	   phase.	   This	   highlights	   the	   complex	   and	   multifactorial	   bacterial	  reprogramming	  required	  during	  transition	  from	  exponential	  to	  stationary	  phase	  growth.	  	  	  As	  expected,	  a	  large	  number	  of	  gene	  loci,	  up-­‐regulated	  during	  stationary	  phase,	  were	  involved	  in	  metabolic	  pathways.	  This	  was	  apparent	  from	  the	  up-­‐regulation	  of	   multiple	   genes	   involved	   in	   pentose	   and	   hexose	   monosaccharide	   metabolic	  processes,	   including	   gene	   clusters	   responsible	   for	   L-­‐fucose,	   D-­‐ribose	   and	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galactose	   metabolism.	   The	   ability	   to	   utilise	   alternative	   sugars	   can	   confer	  advantage	   during	   bacterial	   infection	   by	   improving	   survival	   rates,	   modifying	  surface	   structures	   as	  well	   as	   sugars	   acting	   as	   ligands	  necessary	   for	   successful	  colonisation.	  Indeed,	  the	  L-­‐fucose	  metabolic	  pathway	  was	  previously	  associated	  with	   increased	   virulence	   in	   Campylobacter	   jejuni	   (Stahl	   et	   al.,	   2011).	   The	  galactose	   locus	  was	   shown	   to	   play	   a	   role	   in	   pathogenesis	   of	  H.	   influenzae,	   by	  affecting	  the	  LOS	  composition	  (Maskell	  et	  al.,	  1992).	  	  	  Up-­‐regulation	   of	   the	   whole	   histidine	   biosynthesis	   operon,	   glycerol	   utilisation	  locus	  as	  well	  as	  glycogen	  biosynthesis	  and	  metabolism	  genes	  during	  stationary	  phase	   signifies	   the	   ability	   to	   produce	   essential	   nutrients	   in	   a	   limiting	  environment,	  which	   could	  potentially	   confer	   important	   advantage	   to	   bacterial	  colonisation	  and	  persistence.	  This	  is	  exemplified	  by	  the	  histidine	  operon	  being	  previously	  shown	  to	  be	  more	  prevalent	  in	  H.	  influenzae	  strains	  isolated	  from	  the	  middle	   ear	   (Juliao	   et	   al.,	   2007).	   Glycogen	   acts	   as	   an	   important	   carbon	   source	  reserve	  and	  was	  previously	  shown	  to	  have	  a	  role	  in	  survival	  and	  persistence	  of	  
S.	   enterica	   (McMeechan	   et	   al.,	   2005).	   Similarly,	   the	   up-­‐regulation	   of	   a	   sugar-­‐phosphate	  transport	   locus,	  afuABC,	  oligopeptide	  genes,	  oppA	  and	  oppB,	  as	  well	  as	   short-­‐chain	   fatty	   acid	   utilisation	   locus,	  atoABCD,	  was	   likely	   induced	   by	   the	  bacterial	   need	   to	   scavenge	   any	   available	   nutrients	   in	   the	   exhausted	  medium.	  The	   presence	   of	   the	   afuABC	   locus	   was	   also	   shown	   to	   be	   associated	   with	  virulence	  in	  the	  enteric	  pathogen	  Citrobacter	  rodentium	  (Sit	  et	  al.,	  2015).	  	  	  The	   ornithine	   decarboxylase	   gene,	   speF,	   was	   highly	   up-­‐regulated	   during	  stationary	   phase	   in	   both	   strains.	   It	   is	   responsible	   for	   the	   production	   of	  putrescine,	  which	   is	  a	  polyamine	  compound	  with	  a	  wide	  range	  of	   functions	   in	  bacteria.	  Putrescine	   can	  bind	  directly	   to	  mRNA	  and	   its	   supplementation	  could	  partially	   restore	   virulence	   in	   Shigella	   flexneri	   mutants	   that	   were	   not	   able	   to	  produce	  modified	  nucleosides	  for	  the	  tRNA	  synthesis	  (Durand	  and	  Bjork,	  2003).	  Putrescine	  is	  also	  responsible	  for	  enhancement	  of	  protein	  synthesis	  of	  a	  sigma	  factor	   RpoS,	   which	   is	   an	   important	   regulator	   of	   genes	   expressed	   during	  stationary	  phase	  (Igarashi	  and	  Kashiwagi,	  2006).	  Therefore,	  the	  increased	  levels	  of	  putrescine	  in	  the	  bacterial	  cell	  could	  be	  involved	  in	  the	  maintenance	  of	  levels	  
	  	   177	  
of	   RpoS,	   thus	   promoting	   survival	   at	   stationary	   phase.	   Up-­‐regulation	   of	   a	  putrescine	  export	  gene,	  potE,	   likely	  played	  a	  role	   in	  balancing	  the	   intracellular	  levels	   of	   putrescine.	   Down-­‐regulation	   of	   putrescine	   and	   spermidine	   uptake	  genes	  in	  both	  strains	  was	  in	  agreement	  with	  up-­‐regulation	  of	  putrescine	  export	  in	  this	  study	  and	  likely	  plays	  a	  role	  in	  intracellular	  putrescine	  homeostasis.	  	  The	   tryptophanase	   locus	   is	   absent	   in	   the	   Rd	   strain,	   but	   it	   was	   highly	   up-­‐regulated	  in	  the	  R2866	  strain	  during	  growth	  at	  stationary	  phase.	  As	  mentioned	  earlier,	   it	   is	   responsible	   for	   indole	   production	   and	   was	   previously	   used	   as	   a	  marker	  for	  virulence	  in	  H.	  influenzae	  (Kilian,	  1976).	  High	  levels	  of	   intracellular	  indole	  have	  also	  been	  implicated	  in	  the	  induction	  of	  stationary	  phase	  in	  E.	  coli,	  with	   a	   proposed	   role	   in	   promoting	   the	   long-­‐term	   survival	   of	   bacterial	   cells	  (Gaimster	  et	  al.,	  2014).	  	  	  
4.3.2.6	   H.	   influenzae	   experiences	   oxidative	   stress	   and	   iron-­‐
starvation	  during	  stationary	  phase	  Investigation	   of	   the	   transcriptional	   behaviour	   of	   H.	   influenzae	   during	   four	  different	   infection-­‐relevant	   conditions	   in	   this	   study	   revealed	   that	   it	   possesses	  overlapping	  responses	  to	  different	  stresses.	  In	  particular,	  Rd	  and	  R2866	  strains	  seemed	   to	   experience	   oxidative	   stress	   and	   iron-­‐starvation	   during	   stationary	  phase,	   as	   described	   below.	   Therefore,	   this	   study	   highlights	   the	   advantage	   of	  utilising	  RNA-­‐Seq	   in	   order	   to	   analyse	  different	   bacterial	   responses,	  which	   can	  then	   be	   used	   to	   identify	   common	   trends	   in	   bacterial	   adaptation	   and	   survival	  during	  host	  colonisation	  and	  disease	  progression.	  	  Multiple	   genes	   with	   characterised	   and	   predicted	   roles	   in	   oxidative	   stress	  defence,	  including	  multiple	  members	  of	  the	  OxyR	  regulon,	  were	  up-­‐regulated	  at	  stationary	  phase	  in	  both	  strains.	  The	  most	  highly	  up-­‐regulated	  gene	  in	  Rd	  was	  a	  gene	   encoding	   a	   putative	   alkylhydroperoxidase	   AhpD-­‐like	   protein.	   The	  possession	   of	   the	   AhpD-­‐like	   domain	   suggests	   that	   this	   protein	   may	   have	  alkylhydroperoxidase	   or	   other	   antioxidant	   activity	   in	  H.	   influenzae.	   The	   AhpD	  protein	   has	   been	   shown	   to	   have	   antioxidative	   activity	   in	   Mycobacterium	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tuberculosis,	   with	   a	   role	   in	   protection	   against	   oxidative	   stress	   (Hillas	   et	   al.,	  2000).	   In	   addition,	   the	   up-­‐regulation	   of	   several	   genes	   encoding	   DNA	   repair	  proteins	   suggests	   of	   the	   DNA	   damage,	   which	   was	   possibly	   occurring	   due	   to	  oxidative	  stress,	  as	  observed	  previously	  (Rohwer	  and	  Azam,	  2000).	  	  The	   inability	  of	  E.	  coli	   strains,	   lacking	  oxidative	  stress	  defence	  mechanisms,	   to	  survive	  at	   stationary	  phase	  suggests	   that	  oxidative	   stress	   indeed	  plays	  a	   large	  part	  during	  this	  growth	  phase	  (Dukan	  and	  Nystrom,	  1999).	  This	  phenomenon	  is	  further	  exaggerated	  by	  the	  fact	  that	   in	  both	  Rd	  and	  R2866	  strains	  there	  was	  a	  large	   number	   of	   overlapping	   genes	   that	   were	   up-­‐regulated	   during	   both	  oxidative	   stress	  and	   stationary	  phase.	  Cell	   starvation	   in	   itself	   seems	   to	   induce	  protection	  against	  environmental	  stresses	  as	  was	  previously	  demonstrated	  in	  E.	  
coli,	  which,	  when	   starved,	  was	  more	   resistant	   to	   heat	   and	   hydrogen	   peroxide	  treatment	   (Jenkins	   et	   al.,	   1988).	   In	   addition,	   one	   of	   the	   consequences	   of	  oxidative	  stress	  is	  protein	  carbonylation,	  which	  is	  also	  used	  as	  a	  biomarker	  for	  cell	  senescence	  (Dukan	  and	  Nystrom,	  1999).	  Chaperone	  genes,	  groEL	  and	  groES,	  were	   up-­‐regulated	   in	   both	   strains,	   while	   the	   expression	   of	   a	   heat-­‐shock	   RNA	  polymerase	   sigma	   factor-­‐32	   gene	   was	   induced	   in	   Rd	   only.	   These	   genes	   have	  been	  previously	  associated	  with	  a	  protective	  role	  against	  protein	  carbonylation	  during	  stationary	  phase	  in	  E.	  coli	  (Fredriksson	  et	  al.,	  2005).	  	  	  The	  catalase	  activity	  in	  the	  Rd	  strain	  of	  H.	  influenzae	  was	  previously	  shown	  to	  be	  higher	   at	   mid-­‐exponential	   phase	   rather	   than	   stationary	   phase	   (Bishai	   et	   al.,	  1994).	   Interestingly,	   the	   opposite	   was	   true	   for	   the	   expression	   of	   the	   catalase	  gene	  in	  both	  strains	  in	  this	  study.	  As	  stationary	  phase	  is	  a	  complex	  and	  dynamic	  growth	  phase,	  this	  variability	  could	  have	  arisen	  due	  to	  a	  difference	  in	  sampling	  methods	  as	  well	  as	  differing	  laboratory	  conditions.	  The	  dps	  gene	  was	  highly	  up-­‐regulated	  at	  stationary	  phase	  in	  Rd	  and	  R2866.	  It	  was	  indeed	  shown	  to	  be	  the	  most	  abundant	  protein	  during	  stationary	  phase	  in	  E.	  coli	  (Almiron	  et	  al.,	  1992).	  In	  addition	  to	  its	  ferritin-­‐like	  properties,	  Dps	  is	  able	  to	  bind	  the	  DNA	  and	  protect	  it	   from	   environmental	   assaults,	   particularly	   in	   starved	   cells	   (Almiron	   et	   al.,	  1992).	  Dps	  also	  plays	  a	  role	  in	  virulence	  as	  it	  was	  shown	  to	  promote	  survival	  of	  
H.	  influenzae	  in	  the	  experimental	  chinchilla	  model	  (Pang	  et	  al.,	  2012).	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Several	   genes,	   related	   to	   the	   competence	   process	   (both	   DNA	   uptake	   and	  integration),	  were	  up-­‐regulated	  in	  both	  strains	  at	  stationary	  phase.	  Competence	  is	   indeed	   induced	  by	  nutrient	   limitation	  and	  high	   cell	   density,	  which	  are	  both	  features	   of	   bacterial	   stationary	   phase	   (Solomon	   and	   Grossman,	   1996).	   The	  availability	  of	  purine	  nucleotides	  has	  also	  been	  shown	  to	  repress	  the	  expression	  of	   competence	   genes	   in	   H.	   influenzae	   (MacFadyen	   et	   al.,	   2001).	   Therefore,	  starvation	   conditions	   during	   stationary	   phase	   would	   likely	   result	   in	   nutrient	  and	  purine	  limitation,	  and	  induction	  of	  the	  competence	  phenotype.	  	  	  There	  were	  several	  up-­‐regulated	  genes	  associated	  with	  iron	  and	  other	  metals	  at	  stationary	   phase,	   which	   was	   likely	   due	   to	   exhaustion	   of	   available	   iron	   in	   the	  medium.	   The	   up-­‐regulation	   of	   iron	   uptake	   genes	   was	   greater	   in	   the	   R2866	  strain	  than	  in	  Rd,	  again	  highlighting	  that	  the	  former	  strain	  is	  more	  sensitive	  to	  iron-­‐limitation	  than	  the	  latter.	  Several	  up-­‐regulated	  genes	  were	  part	  of	  the	  Fur	  regulon	   in	   the	   86-­‐028NP	   strain.	   These	   included	   a	   haem	   utilisation	   locus,	  
hxuABC,	  metal	  transport	  genes,	  yfeA	  and	  yfeB,	  the	  tryptophanase	  gene,	  tnaA,	  as	  well	  as	  genes	   tbp1	  and	   tbp2,	   coding	   for	   transferrin-­‐binding	  proteins	  (Harrison	  et	  al.,	  2013).	  	  Up-­‐regulation	   of	   genes	   involved	   in	   iron-­‐sulphur	   cluster	   formation	   is	   possibly	  linked	  to	   the	  restoration	  of	  clusters	  damaged	  during	  oxidative	  stress,	  which	   is	  likely	  to	  occur	  during	  stationary	  phase	  as	  discussed	  above.	  Oxidative	  stress	  can	  result	   in	   the	   release	   of	   ferrous	   iron	   leading	   to	   increased	   stress	   levels	   via	   the	  Fenton	  reaction	  (Keyer	  and	  Imlay,	  1996).	  The	  iscR	  gene,	  which	  encodes	  an	  iron-­‐sulphur	   cluster	   transcriptional	   regulator	   and	   was	   up-­‐regulated	   in	   this	   study,	  was	   previously	   shown	   to	   be	   involved	   in	   the	   oxidative	   stress	   defence	   in	   H.	  
influenzae	  (Wong	  et	  al.,	  2013).	  	  There	  was	  up-­‐regulation	  of	  bacteriophage	  and	  ICE	  genes	  in	  the	  R2866	  strain	  at	  stationary	   phase.	   In	   contrast,	   several	   genes	   from	   a	   prophage	   were	   down-­‐regulated	  in	  the	  Rd	  strain.	  This	  highlights	  the	  diversity	  of	  these	  mobile	  genetic	  elements	   and	   their	   difference	   in	   the	   induction	   of	   gene	   expression.	   There	  was	  also	  up-­‐regulation	  of	  several	  pilus	  and	  LOS	  modification	  genes	  in	  R2866,	  which	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might	  contribute	  to	  its	  invasive	  phenotype	  by	  promoting	  survival	  in	  the	  limiting	  environment.	  	  Multiple	  ribosomal	  protein	  and	  tRNA	  genes	  were	  highly	  down-­‐regulated	  in	  both	  Rd	  and	  R2866	  during	  stationary	  phase.	  This	  highlights	  the	  need	  for	  bacteria	  to	  conserve	   the	   energy	   during	   this	   growth	   phase	   due	   to	   reduced	   nutrient	  availability.	  Down-­‐regulated	  ribosomal	  protein	  genes	  encoded	  members	  of	  30S	  and	   50S	   ribosomal	   subunits.	   There	  was	   no	   down-­‐regulation	   observed	   for	   5S,	  16S	   and	   23S	   rRNA	   genes	   due	   to	   the	   efficient	   depletion	   of	   rRNA	   transcripts	  during	  cDNA	  library	  preparation.	  	  Genes	   involved	   in	   the	   oxidative	   phosphorylation	   pathway	   as	  well	   as	   electron	  transport	   were	   down-­‐regulated	   in	   Rd	   and	   R2866	   at	   stationary	   phase.	   This	  signifies	  reduced	  respiration	  in	  a	  non-­‐growing	  bacterial	  community	  as	  has	  been	  previously	   demonstrated	   (Riedel	   et	   al.,	   2013).	   Down-­‐regulation	   of	   the	   toxin-­‐antitoxin	  locus,	  vapBC-­‐1,	  in	  R2866	  during	  stationary	  phase	  was	  consistent	  with	  a	  previous	  observation	  of	  its	  expression	  levels	  being	  inverse	  to	  H.	  influenzae	  cell	  density	  (Daines	  et	  al.,	  2007).	  On	  the	  other	  hand,	  it	  was	  not	  clear	  why	  members	  of	  both	  Sec	  and	  Sec-­‐independent	  protein	  export	  systems	  were	  down-­‐regulated	  in	  this	  study.	  A	  possible	  explanation	  for	  it	  is	  the	  concurrent	  reduction	  in	  protein	  synthesis	  and	  the	  need	  to	  conserve	  energy.	  	  	  The	   arginine	   uptake	   operon	   was	   highly	   down-­‐regulated	   during	   growth	   at	  stationary	   phase	   in	   both	   Rd	   and	   R2866.	   It	   was	   previously	   shown	   that	   the	  arginine	  uptake	  locus	  was	  regulated	  by	  Fur	  in	  the	  86-­‐028NP	  strain	  (Harrison	  et	  al.,	  2013).	  There	  was	  up-­‐regulation	  of	  several	  genes	  from	  the	  Fur	  regulon	  in	  this	  study;	   hence	   down-­‐regulation	   of	   arginine	   uptake	   could	   be	   Fur-­‐mediated	   at	  stationary	  phase.	  In	  addition,	  ferritin-­‐like	  genes,	  ftnA1	  and	  ftnA2,	  also	  part	  of	  the	  Fur	  regulon,	  were	  down-­‐regulated	  in	  R2866.	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4.3.2.7	  Presence	  of	  genes	  in	  H.	  influenzae	  with	  roles	  in	  multiple	  
stress	  responses	  Among	   noteworthy	   genes	   that	   were	   differentially	   expressed	   in	   multiple	  conditions	   was	   arcA,	   a	   two-­‐component	   regulator	   gene,	   which	   was	   down-­‐regulated	  in	  oxidative	  stress,	  stationary	  phase	  and	  nutritional	  stress	  in	  Rd	  only.	  The	   down-­‐regulation	   of	   arcA	   was	   interesting,	   particularly	   during	   oxidative	  stress,	   as	   it	   was	   implicated	   in	   the	   positive	   regulation	   of	   dps	   as	   well	   as	   other	  genes	  with	  putative	   roles	   in	  oxidative	  stress	  defence	  during	  anaerobic	  growth	  (Wong	   et	   al.,	   2007).	   Its	   consistent	   down-­‐regulation	   in	   this	   study	   suggests	   a	  different	   role	   for	   this	   transcriptional	   regulator	   during	   aerobic	   growth.	   A	  glutamate	  dehydrogenase	  gene,	  gdhA,	  was	  up-­‐regulated	  in	  all	  four	  conditions	  in	  Rd.	   While	   its	   exact	   role	   in	   tested	   conditions	   is	   not	   clear,	   it	   was	   previously	  implicated	  in	  conferring	  advantage	  to	  virulent	  strains	  of	  Clostridium	  botulinum	  (Hammer	   and	   Johnson,	   1988).	   The	   up-­‐regulation	   of	   several	   iron-­‐associated	  genes	   in	   all	   three	   conditions	   in	   the	   R2866	   strain	   again	   demonstrated	   its	  susceptibility	  to	  limited	  iron	  availability.	  	  The	  data	  presented	  in	  this	  chapter	  provide	  an	  important	  foundation	  for	  future	  work,	   where	   genes	   with	   putative	   roles	   during	   infection-­‐relevant	   conditions	  could	   be	   further	   investigated	   and	   characterised.	   This	   could	   then	   lead	   to	   the	  discovery	  of	  novel	  targets	  for	  vaccine	  or	  antibiotic	  development.	  The	  optimised	  invasion	  assay	  also	  serves	  as	  a	  preliminary	  basis	  for	  future	  work,	  where	  whole	  transcriptomes	   of	   intracellular	   H.	   influenzae	   and	   the	   human	   host	   could	   be	  studied	  simultaneously	  in	  a	  dual	  RNA-­‐Seq	  experiment.	  This	  will	  help	  to	  further	  elucidate	  the	  important	  processes	  involved	  in	  the	  pathogenesis	  of	  H.	  influenzae	  as	  well	  as	  host	  response	  and	  adaptation	  to	  the	  progression	  of	  bacterial	  infection.	  In	   addition,	   RNA-­‐Seq	   conditions	   used	   in	   this	   study	   will	   be	   essential	   for	   the	  subsequent	  identification	  and	  analysis	  of	  novel	  RNA	  transcripts	  (see	  Chapter	  5).	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Chapter	  5:	  Robust	  identification	  and	  
analysis	  of	  non-­‐coding	  RNAs	  in	  H.	  influenzae	  
5.1	  Introduction	  Non-­‐coding	  RNAs,	  including	  sRNAs,	  play	  a	  variety	  of	  important	  roles	  in	  bacterial	  cells,	  such	  as	  stress	  response	  and	  virulence	  regulation	  (see	  section	  1.2.2).	  While	  there	  are	  available	  tools	  for	  computational	  prediction	  of	  these	  RNA	  structures	  in	  bacterial	   genomes,	   very	   few	  programs	  exist	   that	  use	  RNA-­‐Seq	  data	   to	   identify	  ncRNAs	  based	  on	   their	   expression	   (Sridhar	   et	   al.,	   2010,	  McClure	   et	   al.,	   2013).	  General	  lack	  of	  robust	  online	  tools	  for	  ncRNA	  identification	  means	  researchers	  have	   to	   rely	  on	  either	   a	   visual	   inspection	  of	   the	  data	  or	   custom	  programming	  language	  scripts.	  Therefore,	  more	  robust	  and	  reproducible	  methods,	  specifically	  designed	   to	   identify	   putative	   ncRNAs	   from	   the	  whole-­‐transcriptome	   data,	   are	  required.	  	  	  The	   first	  major	  goal	  of	   this	  study	  was	  to	  develop	  a	  new	  robust	  and	  systematic	  tool	   for	   reproducible	   identification	   of	   ncRNA	   transcripts	   from	   RNA-­‐Seq	   data.	  For	  that	  purpose,	  the	  transcriptomic	  dataset,	  used	  earlier	  for	  the	  analysis	  of	  the	  transcriptional	   response	   of	  H.	   influenzae	  during	   infection-­‐relevant	   conditions,	  was	   utilised	   (see	   Chapter	   4).	   This	   was	   combined	   with	   the	   bacterial	   whole-­‐genome	  annotation	  to	  identify	  ncRNAs	  present	  in	  intergenic	  regions	  as	  well	  as	  those	  antisense	  to	  coding	  sequences.	  Furthermore,	  UTRs	  were	  detected	  for	  each	  gene,	  along	  with	  intergenic	  regions	  belonging	  to	  putative	  operons.	  	  The	   number	   of	   sRNAs	   in	   bacteria	   has	   been	   suggested	   to	   be	   inversely	  proportional	  to	  the	  size	  of	  the	  genome	  (Guell	  et	  al.,	  2011).	  Thus,	   it	   is	  expected	  that	  H.	   influenzae	   should	   contain	   a	   relatively	   large	   number	   of	   ncRNAs	   due	   its	  small	   genome	   size	   (~1.8	  Mb).	   There	   have	   only	   been	   two	   studies	   to-­‐date	   that	  have	  addressed	  the	  presence	  of	  ncRNAs,	  including	  sRNAs,	  in	  H.	  influenzae.	  The	  only	  ncRNA	  that	  has	  been	  experimentally	  validated	   in	  H.	  influenzae	   is	  HrrF	  -­‐	  a	  Fur-­‐regulated	  sRNA	   in	   the	  86-­‐028NP	  strain	   (Santana	  et	  al.,	  2014).	   In	  addition,	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Baddal	  et	  al.	  discovered	  only	  18	  putative	  ncRNAs	  in	  an	  otitis	  media	  isolate	  of	  H.	  
influenzae,	  by	  manually	   inspecting	   expression	  of	   intergenic	   regions	   (Baddal	   et	  al.,	  2015).	  This	  highlights	  that	  there	  needs	  to	  be	  a	  more	  systematic	  and	  robust	  identification	   and	   characterisation	   of	   these	   possibly	   abundant	   and	   potentially	  important	  RNA	  elements	  in	  H.	  influenzae.	  	  	  The	   second	   major	   aim	   of	   this	   study	   was	   to	   identify	   a	   repertoire	   of	   putative	  ncRNAs	  in	  H.	  influenzae,	  by	  employing	  the	  tool	  developed	  in	  the	  same	  study.	  For	  that	  purpose,	  all	   the	  RNA-­‐Seq	  data	   from	  infection-­‐relevant	  conditions	  used	   for	  differential	   gene	   expression	   studies	   in	   Chapter	   4	   were	   utilised	   in	   order	   to	  enable	  a	  more	  robust	  detection	  of	  novel	  RNA	  elements.	  This	  was	  facilitated	  by	  the	   ncRNA	   expression	   being	   diverse	   and	   dependent	   on	   the	   bacterial	   growth	  phase	   and	   response	   to	   stress,	   as	   observed	   previously	   (Rau	   et	   al.,	   2015).	  Consistent	   with	   that,	   the	   differential	   expression	   of	   ncRNAs	   during	   infection-­‐relevant	   conditions	  was	   also	   investigated	   in	   this	   study.	   In	   addition,	   identified	  ncRNAs	  were	   examined	   for	   the	  possibility	   of	   encoding	   small	   proteins.	   Finally,	  selected	   ncRNAs	   were	   validated	   using	   the	   northern	   blotting	   technique,	   along	  with	   predicting	   their	   secondary	   structure	   and	   mRNA	   targets.	   This	   work	   is	  important	  for	  future	  studies	  where	  ncRNAs	  can	  be	  further	  investigated	  for	  their	  potential	  roles	  in	  the	  pathogenesis	  of	  H.	  influenzae.	  	  
5.2	  Results	  
5.2.1	  Development	  of	  a	  script	  to	  identify	  ncRNAs	  
The	   Python	   programming	   language	   was	   used	   to	   write	   a	   script	   for	   the	  identification	  of	  putative	  ncRNAs	  in	  a	  bacterial	  genome	  from	  the	  RNA-­‐Seq	  data.	  The	   name	   for	   the	   script	   was	   chosen	   as	   "toRNAdo"	   (see	   Appendix	   C).	   As	  described	  in	  section	  2.12.11,	  the	  script	  requires	  the	  RNA-­‐Seq	  read	  coverage	  for	  every	  nucleotide	  in	  a	  genome	  (both	  DNA	  strands	  and	  each	  strand	  separately)	  as	  input.	   This	   is	   in	   addition	   to	   another	   input	   file	   containing	   the	   coordinates	   of	  annotated	   coding	   sequences	   in	   a	   bacterial	   genome.	   The	   script	  was	   developed	  based	   on	   the	   RNA-­‐Seq	   data	   acquired	   in	   Chapter	   4,	   specifically	   the	   nutritional	  
	  	   184	  







	  	   185	  
	  
Figure	   5.1:	   Flow	   chart	   showing	   a	   simplified	   workflow	   of	   the	   toRNAdo	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5.2.1.1	  Normalisation	  of	  nucleotide	  coverage	  The	  nucleotide	  coverage	  data	  had	  to	  be	  normalised,	  so	  that	  the	  script	  could	  be	  applied	   to	   different	   RNA-­‐Seq	   samples.	   First,	   a	   sum	   of	   all	   nucleotide	   coverage	  values	   in	   a	   genome	   was	   calculated.	   Each	   nucleotide	   coverage	   value	   was	  subsequently	  divided	  by	   that	  sum	  and	  multiplied	  by	  1010.	  The	   formula	   for	   the	  normalised	  nucleotide	  coverage	  (NNC)	  was:	  
NNC = 𝐶!𝐶!!∈! ×10!"	  where	   N	   stands	   for	   a	   set	   of	   all	   nucleotides	   in	   a	   genome,	   n	   stands	   for	   each	  individual	  nucleotide	  and	  Cn	  is	  individual	  nucleotide	  coverage.	  	  	  
5.2.1.2	   Initial	   detection	   of	   UTRs	   as	   well	   as	   intergenic	   and	  
antisense	  regions	  Next,	   the	   expression	   threshold	   needed	   to	   be	   set	   up	   in	   order	   to	   reduce	  background	   and	   decrease	   the	   number	   of	   false	   positive	   ncRNAs.	   After	  manual	  inspection	  of	  multiple	  NNC	  values,	  the	  expression	  threshold	  was	  chosen	  as	  100.	  This	   value	   can	   be	   user-­‐modified	   in	   order	   to	   adjust	   the	   ncRNA	   detection	  stringency.	  	  	  Starting	   from	   the	   5'	   or	   3'	   end	   of	   every	   annotated	   coding	   sequence,	   each	  nucleotide	  was	  tested	  to	  see	  if	  its	  NNC	  value	  was	  above	  the	  threshold.	  If	  it	  was,	  then	  it	  was	  assigned	  to	  a	  5'	  or	  3'	  UTR	  and	  the	  next	  nucleotide	  was	  in	  turn	  tested	  the	   same	   way.	   This	   process	   continued	   until	   reaching	   a	   nucleotide	   below	   the	  NNC	  threshold,	  thus	  forming	  a	  complete	  UTR	  (see	  Figure	  5.2A).	  Next,	  if	  the	  NNC	  value	   of	   a	   nucleotide,	   present	   in	   an	   intergenic	   region	   and	   not	   as	   part	   of	   an	  assigned	  UTR,	  was	   above	   the	   threshold,	   it	  was	   then	   assigned	   to	   an	   intergenic	  ncRNA	  (see	  Figure	  5.2B).	  Similarly,	  if	  the	  NNC	  value	  of	  a	  nucleotide,	  present	  on	  the	  opposite	  strand	  to	  an	  annotated	  coding	  sequence,	  was	  above	  the	  threshold,	  it	  was	  assigned	  to	  an	  antisense	  ncRNA	  (see	  Figure	  5.2C).	  	  	  
	  
















Figure	   5.2:	   Examples	   of	   putative	   ncRNA	   elements	   identified	   by	   the	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Figure	   5.3:	   Example	   of	   an	   operon	   element	   identified	   by	   the	   toRNAdo	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5.2.1.4	  Further	  script	  optimisation	  Quality	   control	   of	   assigned	   putative	   ncRNA	   groups	   revealed	   that	   there	   were	  several	   script	   errors,	   which	   resulted	   in	   multiple	   ncRNAs	   being	   misassigned.	  Therefore,	  the	  remaining	  steps	  were	  further	  improvements	  and	  adjustments	  to	  the	  toRNAdo	  script.	  First,	  there	  were	  several	  instances	  where	  coding	  sequences	  on	   opposite	   strands	   overlapped	   each	   other.	   In	   that	   case,	   the	   script	   originally	  assigned	  a	  UTR	  of	  one	  gene	  as	  antisense	  of	  another	  (see	  Figure	  5.4).	  In	  addition,	  several	   UTRs	  were	   found	   to	   be	   very	   long	   and	   extended	   beyond	   an	   intergenic	  region	  into	  an	  antisense	  region	  of	  an	  adjacent	  coding	  sequence	  on	  the	  opposite	  strand	   (see	   Figure	   5.5).	   Hence,	   the	   first	   optimisation	   step	   was	   to	   reassign	  misclassified	  antisense	  regions	  to	  appropriate	  UTR	  groups.	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  	   191	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Figure	  5.4:	  Example	  of	  a	  3'	  UTR	  misassigned	  as	  an	  antisense	  ncRNA	  by	  the	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Figure	  5.5:	  Two	  3'	  UTRs	  misassigned	  as	  antisense	  ncRNAs	  by	  the	  toRNAdo	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Figure	  5.6:	  Example	  of	  a	  putative	  "mixed"	  ncRNA	  with	  both	  intergenic	  and	  






















Figure	   5.7:	   Example	   of	   a	   putative	   "mixed"	   ncRNA,	   which	   spans	   two	  
antisense	  regions,	  as	  assigned	  by	  the	  toRNAdo	  script.	  The	  "mixed"	  ncRNA	  is	  highlighted	   in	   red,	   as	   depicted	   in	   the	   Artemis	   genome	   browser.	   Light	   blue	  rectangles	  are	  coding	  sequences.	  Forward	  and	  reverse	  strands	  are	  represented	  by	  "+"	  and	  "-­‐"	  symbols	  respectively.	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5.2.1.5	   Filtering	   of	   ncRNAs	   based	   on	   the	   presence	   of	   an	  





















Figure	   5.8:	  Example	   of	   expression	   "peaks"	   present	   in	   UTRs	   and	   operon	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The	  presence	  of	  an	  expression	  peak	  meant	  greater	  transcriptional	  activity	  and	  thus	   a	   higher	   likelihood	   that	   a	   putative	   ncRNA	   was	   real	   and	   not	   part	   of	  background	   expression.	  With	   that	   in	  mind,	   the	   same	   peak-­‐size	   threshold	   of	   a	  five-­‐to-­‐one	   ratio	  was	   applied	   to	   all	   identified	   antisense,	   intergenic	   and	  mixed	  putative	   ncRNAs.	   Only	   ncRNAs	   that	   possessed	   the	   expression	   peak	   were	  considered	   for	   further	   analyses,	   though	   putative	   ncRNAs	   below	   the	   threshold	  were	   also	   retained	   for	   any	   other	   user	   needs.	   The	   peak-­‐size	   threshold	   can	   be	  user-­‐modified	  in	  order	  to	  adjust	  the	  stringency	  of	  the	  ncRNA	  detection.	  	  




















Figure	  5.9:	  The	  toRNAdo	  script	  output	  in	  the	  WIG	  format,	  as	  imported	  into	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5.2.2	   Identification	   and	   analysis	   of	   ncRNAs	   in	   Rd	   and	  
R2866	  strains	  of	  H.	  influenzae	  
5.2.2.1	  Discovery	  of	  putative	  ncRNAs	  in	  Rd	  and	  R2866	  from	  the	  
RNA-­‐Seq	  data	  The	  toRNAdo	  script	  was	  used	  to	  identify	  putative	  ncRNAs	  (intergenic,	  antisense	  and	  mixed)	   across	   different	   infection-­‐relevant	  RNA-­‐Seq	   conditions	   in	   both	  Rd	  and	   R2866	   strains.	   These	   conditions	   were	   mid-­‐exponential	   phase,	   stationary	  phase,	   oxidative	   stress,	   iron-­‐starvation	   stress,	   and	  nutritional	   stress	   (Rd	  only)	  (see	   Chapter	   4).	   Putative	   ncRNAs	   were	   only	   considered	   valid	   if	   they	   were	  present	  in	  all	  replicates	  of	  a	  particular	  condition.	  The	  putative	  ncRNA	  data	  were	  then	   merged	   across	   all	   tested	   RNA-­‐Seq	   conditions	   for	   each	   strain.	   When	  combining	   ncRNAs	   present	   in	   multiple	   replicates	   or	   conditions,	   a	   minimum	  start	  position	  and	  a	  maximum	  end	  position	  were	  used	  to	  define	  the	  new	  length,	  in	  order	  to	  cover	  all	  nucleotides	  that	  were	  putatively	  part	  of	  each	  ncRNA.	  	  First,	   168	   and	   169	   putative	   ncRNAs	  were	   identified	   in	   Rd	   and	   R2866	   strains	  respectively	   across	   all	   tested	   RNA-­‐Seq	   conditions.	   These	   were	   subsequently	  inspected	  manually	  to	  find	  any	  false	  positive	  sequences.	  Two	  ncRNAs	  in	  Rd	  and	  four	  in	  R2866	  were	  filtered	  out,	  as	  they	  contained	  repetitive	  sequences,	  which	  were	   likely	   to	   have	   false	   expression	   values	   due	   to	   errors	   in	   RNA-­‐Seq	   read	  alignment.	  This	  was	  in	  addition	  to	  one	  putative	  ncRNA	  in	  Rd	  and	  two	  in	  R2866,	  which	  were	  misclassified	  as	  ncRNAs	  by	  the	  toRNAdo	  script.	  Therefore,	  the	  final	  number	  of	  true	  putative	  ncRNAs	  was	  165	  for	  Rd	  and	  163	  for	  R2866.	  Of	  these,	  36	  were	  intergenic,	  37	  were	  antisense	  and	  92	  were	  mixed	  ncRNAs	  in	  Rd,	  while	  39	  were	   intergenic,	  35	  were	  antisense	  and	  89	  were	  mixed	  ncRNAs	   in	  R2866	  (see	  Table	  5.1).	  The	  majority	  of	  putative	  ncRNAs	  were	  identified	  at	  stationary	  phase.	  The	  uniform	  genomic	  distribution	  of	  all	  putative	  ncRNAs	  as	  well	  as	  in	  each	  RNA-­‐Seq	  condition	  individually	  is	  shown	  in	  Figures	  5.10	  and	  5.11	  for	  Rd	  and	  R2866	  respectively.	  Complete	  tables	  with	  putative	  ncRNA	  coordinates,	  length	  and	  type	  are	  presented	  in	  Appendix	  D.	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Table	  5.1:	  Number	  of	  putative	  ncRNAs	  identified	  in	  Rd	  and	  R2866	  strains.	  






All	  conditions	   165	   36	   37	   92	  Mid-­‐exponential	  phase	   36	   14	   6	   16	  Stationary	  phase	   139	   28	   32	   79	  Iron-­‐starvation	  stress	   83	   25	   15	   43	  Oxidative	  stress	   71	   21	   11	   39	  Nutritional	  stress	   80	   17	   19	   44	  
R2866	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The	  Rfam	  database	  can	  be	  used	  to	  search	  for	  bacterial	  ncRNA	  families,	  including	  characterised	   sRNAs	   (Nawrocki	   et	   al.,	   2015).	   In	   this	   study,	   it	   was	   used	   to	  investigate	  if	  any	  of	  the	  putative	  ncRNAs	  were	  homologous	  to	  any	  known	  RNA	  elements.	  Three	  such	  ncRNAs	  were	  identified	  in	  both	  Rd	  and	  R2866:	  they	  were	  homologous	   to	  6S	  RNA	   (Rd_082;	  R2866_132),	  RNase	  P	  RNA	   subunit	   (Rd_152;	  R2866_062)	   and	   GcvB	   (Rd_114;	   R2866_097)	   ncRNAs.	   6S	   RNA	  was	   previously	  shown	  to	  be	  involved	  in	  the	  control	  of	  gene	  expression	  during	  stationary	  phase	  in	   E.	   coli	   (Wassarman	   and	   Storz,	   2000).	   RNase	   P	   is	   a	   ribonucleic	   enzyme	  involved	  in	  the	  processing	  of	  tRNAs	  (Evans	  et	  al.,	  2006).	  Finally,	  GcvB	  is	  a	  well-­‐characterised	   bacterial	   sRNA	   that	   has	   been	   shown	   to	   regulate	   amino	   acid	  uptake	  and	  metabolism	  (Sharma	  et	  al.,	  2011).	  	  HrrF,	   the	   only	   discovered	   and	   validated	   sRNA	   in	   the	   86-­‐028NP	   strain	   of	   H.	  
influenzae,	   was	   not	   identified	   as	   one	   of	   the	   putative	   ncRNAs	   in	   this	   study	  (Santana	  et	  al.,	  2014).	  Manual	  examination	  of	   its	  homologue	   in	  Rd	  and	  R2866	  revealed	   it	   to	  have	   similar	   expression	   to	   adjacent	   genes	   in	   all	   tested	  RNA-­‐Seq	  conditions	  (see	  Figure	  5.12).	  This	  meant	  that	  the	  toRNAdo	  script	  classified	  it	  as	  part	  of	  an	  operon	  instead	  of	  a	  separate	  intergenic	  ncRNA.	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Figure	  5.12:	  An	  HrrF	  homologue	  in	  an	  Rd	  replicate	  during	  iron-­‐starvation	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Figure	  5.13:	  Heatmaps	  of	   log10-­‐transformed	  TPM	  expression	  values	  of	  all	  

































Figure	   5.14:	   Heatmaps	   of	   log10-­‐transformed	   TPM	   expression	   values	   of	  






















































Figure	   5.15:	   Heatmaps	   of	   log10-­‐transformed	   TPM	   expression	   values	   of	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5.2.2.3	   Differential	   expression	   of	   putative	   ncRNAs	   across	  
infection-­‐relevant	  conditions	  Next,	   differential	   expression	   analysis	   of	   all	   putative	   ncRNAs	   in	   infection-­‐relevant	   conditions	   was	   carried	   out.	   The	   number	   of	   differentially	   expressed	  ncRNAs,	   along	   with	   those	   common	   to	   more	   than	   one	   infection-­‐relevant	  condition,	   is	  depicted	   in	  Figure	  5.16.	  There	  was	  a	  much	  higher	  number	  of	  up-­‐regulated	  ncRNAs	  during	  stationary	  phase,	  when	  compared	  to	  other	  conditions:	  109	  in	  Rd	  and	  97	  in	  R2866.	  23	  ncRNAs	  were	  down-­‐regulated	  during	  nutritional	  stress	   in	   Rd,	   while	   only	   one	   was	   up-­‐regulated.	   Figures	   5.17	   and	   5.18	   show	  genomic	  positions	  of	  all	  ncRNAs	  that	  were	  differentially	  expressed	  in	  each	  of	  the	  infection-­‐relevant	  conditions.	  Full	   tables	  of	  all	  differentially	  expressed	  ncRNAs	  are	  presented	  in	  Appendix	  D.	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Figure	   5.16:	  Venn	   diagrams	   of	   common	   differentially	   expressed	   ncRNAs	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Figure	   5.17:	   Positions	   of	   differentially	   expressed	   ncRNAs	   in	   the	   Rd	  
genome.	   The	   locations	   of	   ncRNAs	   are	   shown	   in	   five	   inner	   concentric	   circles.	  The	   outer	   circle	   shows	   the	   positions	   of	   all	   identified	   ncRNAs.	   The	   remaining	  four	  circles	  show	  the	  positions	  of	  ncRNAs	  that	  were	  up-­‐regulated	  (red	  strokes)	  and	   down-­‐regulated	   (blue	   strokes)	   in	   individual	   conditions	   as	   compared	   to	  control.	  The	  circles	  represent	  (going	  inward):	  1)	  stationary	  phase,	  2)	  oxidative	  stress,	  3)	  iron-­‐starvation	  stress,	  4)	  nutritional	  stress.	  	  	  	  	  
Rd	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Figure	   5.18:	   Positions	   of	   differentially	   expressed	   ncRNAs	   in	   the	   R2866	  
genome.	   The	   locations	   of	   ncRNAs	   are	   shown	   in	   four	   inner	   concentric	   circles.	  The	   outer	   circle	   shows	   the	   positions	   of	   all	   identified	   ncRNAs.	   The	   remaining	  three	  circles	  show	  the	  positions	  of	  ncRNAs	  that	  were	  up-­‐regulated	  (red	  strokes)	  and	   down-­‐regulated	   (blue	   strokes)	   in	   individual	   conditions	   as	   compared	   to	  control.	  The	  circles	  represent	  (going	  inward):	  1)	  stationary	  phase,	  2)	  oxidative	  stress,	  3)	  iron-­‐starvation	  stress.	  	  	  	  
R2866	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Several	   ncRNAs	   were	   differentially	   expressed	   in	   more	   than	   one	   RNA-­‐Seq	  condition	  (see	  Figure	  5.16).	  Among	  these	  was	  a	  GcvB	  homologue,	  which	  was	  up-­‐regulated	  during	  stationary	  phase	  and	  iron-­‐starvation	  (nearly	  5-­‐fold)	  in	  the	  Rd	  strain	   (see	  Appendix	  D).	   In	  R2866,	   it	  was	  only	  up-­‐regulated	  during	   stationary	  phase.	  None	  of	  the	  differentially	  expressed	  ncRNAs	  were	  common	  to	  all	  tested	  RNA-­‐Seq	  conditions.	  	  	  As	   cis-­‐acting	   sRNAs	   are	   normally	   present	   as	   antisense	   transcripts,	   it	   was	  interesting	   to	   examine	   which	   putative	   antisense	   ncRNAs	   were	   differentially	  expressed	   in	   this	   study	   (see	   section	   1.2.1).	   Several	   ncRNAs	   in	   the	   Rd	   strain,	  antisense	   to	   putative	   hemoglobin-­‐binding	   and	   transferrin-­‐binding	   proteins,	  were	   up-­‐regulated	   during	   iron-­‐starvation	   and	   stationary	   phase,	   but	   down-­‐regulated	  during	  nutritional	   stress.	  Among	  other	  notable	  ncRNAs,	  which	  were	  up-­‐regulated	  at	  stationary	  phase,	  was	  ncRNA	  antisense	  to	  the	  catalase	  gene	  hktE	  in	  Rd	  as	  well	  as	  ncRNAs	  antisense	  to	  the	  iron-­‐acquisition	  gene	  hitB	  and	  several	  pilus	   genes	   in	   R2866.	   6S	   RNA	   and	   RNase	   P	   homologues	   were	   up-­‐regulated	  during	  stationary	  phase	  in	  both	  strains.	  	  
5.2.2.4	  Homology	  of	  putative	  ncRNAs	  between	  Rd	  and	  R2866	  BLASTn	  was	  used	  to	   identify	  which	  putative	  ncRNAs	  were	  conserved	  between	  Rd	  and	  R2866	  strains.	  Just	  over	  40%	  of	  putative	  ncRNAs	  were	  found	  in	  both	  Rd	  and	  R2866	  strains	  by	  the	  toRNAdo	  script	  (see	  Table	  5.2).	  However,	  over	  80%	  of	  ncRNAs	  in	  Rd	  had	  homologous	  sequences	  in	  the	  R2866	  genome,	  while	  over	  70%	  of	   ncRNAs	   in	   R2866	   had	   homologous	   sequences	   in	   Rd.	   Figure	   5.19	   shows	  positions	  of	  all	  homologous	  ncRNA	  sequences	  in	  Rd	  and	  R2866	  whole	  genomes.	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Table	   5.2:	  Homology	   of	   putative	   ncRNAs	   between	   Rd	   and	   R2866	   strains	  
based	  on	  the	  BLASTn	  analysis.	  E-­‐value	  cut-­‐off	  for	  homology	  was	  1e-­‐05.	  
Strain	  
Percentage	  (%)	  of	  ncRNAs	  homologous	  to:	  Putative	  ncRNAs	  in	  the	  other	  strain	   Any	  sequence	  in	  the	  other	  strain	  
Rd	   43.6	   81.8	  
R2866	   41.7	   73.0	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5.2.2.5	   Identification	   of	   potential	   protein-­‐coding	   genes	   among	  
putative	  ncRNAs	  The	   Prokka	   software,	   used	   in	   this	   study	   to	   annotate	   whole	   re-­‐sequenced	  genomes	   of	   Rd	   and	  R2866,	   did	   not	   predict	   protein-­‐coding	   genes	   shorter	   than	  250	  bp.	   It	   is	   therefore	  possible	   that	  some	  true	  short	  protein-­‐coding	  sequences	  were	  missed	  in	  the	  genome	  annotation.	  If	  they	  contained	  expression	  "peaks"	  in	  the	   RNA-­‐Seq	   data,	   then	   they	   would	   have	   likely	   been	   identified	   as	   putative	  ncRNAs	  by	  the	  toRNAdo	  script.	  Thus	  it	  was	  important	  to	  investigate	  if	  any	  of	  the	  putative	  ncRNAs	  in	  this	  study	  were	  in	  fact	  potential	  protein-­‐coding	  genes.	  	  	  In	   order	   to	   classify	   a	   putative	   ncRNA	   as	   a	   potential	   protein-­‐coding	   gene,	   an	  ncRNA	   needed	   to	   possess	   a	   start	   codon	   (AUG,	   GUG	   or	   UUG)	   within	   an	   open	  reading	  frame,	  covering	  the	  expression	  of	  the	  ncRNA	  as	  observed	  from	  the	  RNA-­‐Seq	  data.	  After	  manually	   inspecting	   all	   putative	  ncRNAs,	   25	  potential	   protein-­‐coding	   genes	   were	   identified	   in	   Rd,	   while	   23	   were	   identified	   in	   R2866	   (see	  Tables	  5.3;	  5.4).	  Several	  sequences	  did	  not	  produce	  any	  hits,	  while	  the	  majority	  of	  top	  BLASTx	  hits	  for	  the	  remaining	  sequences	  were	  hypothetical	  proteins.	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Table	  5.3:	  Putative	  ncRNAs,	  present	  in	  the	  Rd	  strain,	  which	  contain	  a	  start	  
codon	  and	  an	  open	   reading	   frame,	   suggesting	   the	  presence	  of	   a	  protein-­‐
coding	   gene.	   Top	   BLASTx	   are	   shown	   along	   with	   the	   name	   of	   the	   species	  containing	  a	  putative	  homologue.	  	  
ID	   Start	  position	  
End	  
position	   Strand	   Top	  BLASTx	  hit	  (species	  name)	  Rd_009	   155135	   155395	   +	   -­‐	  Rd_018	   227136	   227665	   -­‐	   Hypothetical	  protein	  (H.	  influenzae)	  Rd_027	   281280	   281477	   +	   Hypothetical	  protein	  (Haemophilus	  aegyptius)	  Rd_034	   320889	   321185	   +	   -­‐	  Rd_054	   557547	   558857	   +	   Integrase	  (H.	  influenzae)	  Rd_059	   662409	   662498	   -­‐	   Ornithine	  carbamoyltransferase	  (H.	  influenzae)	  Rd_065	   708324	   708556	   -­‐	   Hypothetical	  protein	  (Haemophilus	  sp.	  oral	  taxon	  851)	  Rd_066	   721899	   722015	   +	   Glycerophosphodiester	  phosphodiesterase	  (H.	  influenzae)	  Rd_082	   885347	   885661	   +	   -­‐	  Rd_086	   915521	   915888	   -­‐	   Hypothetical	  protein	  (H.	  influenzae)	  Rd_090	   994816	   995745	   +	   -­‐	  Rd_105	   1173203	   1173472	   -­‐	   Membrane	  protein	  (H.	  influenzae)	  Rd_106	   1173213	   1173455	   +	   -­‐	  Rd_109	   1203265	   1203822	   +	   -­‐	  Rd_120	   1318219	   1318845	   -­‐	   Hypothetical	  protein	  (H.	  aegyptius)	  Rd_121	   1323679	   1323971	   +	   Hypothetical	  protein	  (H.	  influenzae)	  Rd_135	   1518769	   1518894	   -­‐	   ATP-­‐dependent	  metalloprotease,	  partial	  (H.	  influenzae)	  Rd_137	   1545292	   1545803	   -­‐	   -­‐	  Rd_145	   1624072	   1624299	   -­‐	   -­‐	  Rd_147	   1666018	   1666223	   -­‐	   -­‐	  Rd_151	   1714817	   1715360	   +	   Hypothetical	  protein	  (Mannheimia	  haemolytica)	  Rd_158	   1785066	   1785298	   +	   Hypothetical	  protein	  (H.	  influenzae)	  Rd_160	   1788561	   1789102	   -­‐	   Mercuric	  ion	  scavenger	  protein	  (H.	  influenzae)	  Rd_163	   1794537	   1795072	   +	   Cytidylate	  kinase,	  partial	  (H.	  influenzae)	  Rd_165	   1796507	   1796828	   +	   Hypothetical	  protein	  (H.	  influenzae)	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Table	  5.4:	  Putative	  ncRNAs,	  present	   in	  the	  R2866	  strain,	  which	  contain	  a	  
start	   codon	   and	   an	   open	   reading	   frame,	   suggesting	   the	   presence	   of	   a	  
protein-­‐coding	   gene.	   Top	   BLASTx	   are	   shown	   along	   with	   the	   name	   of	   the	  species	  containing	  a	  putative	  homologue.	  
	  	  	  	  	  	  
ID	   Start	  position	  
End	  
position	   Strand	   Top	  BLASTx	  hit	  (species	  name)	  R2866_017	   397982	   398500	   -­‐	   Hypothetical	  protein	  (H.	  aegyptius)	  R2866_018	   398271	   398538	   +	   -­‐	  R2866_024	   452241	   452552	   +	   Hypothetical	  protein	  (H.	  aegyptius)	  R2866_025	   452279	   452786	   -­‐	   Hypothetical	  protein,	  partial	  (H.	  influenzae)	  R2866_028	   474416	   474668	   -­‐	   -­‐	  R2866_034	   499358	   500645	   +	   Uncharacterized	  protein	  (H.	  influenzae)	  R2866_040	   548285	   548624	   -­‐	   Transcriptional	  regulator	  (H.	  influenzae)	  R2866_044	   570011	   570339	   -­‐	   -­‐	  R2866_063	   791708	   792149	   -­‐	   hypothetical	  protein	  (M.	  haemolytica)	  R2866_065	   821541	   822128	   -­‐	  	   Conserved	  hypothetical	  protein	  (H.	  influenzae)	  R2866_068	   875603	   876167	   -­‐	   Hypothetical	  protein	  (H.	  aegyptius)	  R2866_079	   995263	   995765	   -­‐	   Hypothetical	  protein	  (H.	  influenzae)	  R2866_080	   1006041	   1006276	   +	   -­‐	  R2866_105	   1277352	   1278405	   -­‐	   -­‐	  R2866_108	   1307763	   1308096	   +	   Hypothetical	  protein	  (H.	  influenzae)	  R2866_109	   1307782	   1308061	   -­‐	   -­‐	  R2866_118	   1473212	   1475161	   -­‐	   -­‐	  R2866_125	   1554103	   1554489	   +	   Hypothetical	  protein	  (H.	  influenzae)	  R2866_128	   1567612	   1567841	   -­‐	   Polysaccharide	  polymerase	  (H.	  influenzae)	  R2866_132	   1592489	   1592795	   -­‐	   -­‐	  R2866_133	   1592505	   1592681	   +	   -­‐	  R2866_147	   1780641	   1780933	   -­‐	   Trk	  system	  potassium	  uptake	  protein	  TrkH	  (H.	  influenzae)	  R2866_162	   1908264	   1908555	   +	   -­‐	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5.2.2.6	  Validation	  of	  two	  ncRNAs	  present	  in	  R2866	  To	   identify	   whether	   any	   of	   the	   putative	   ncRNAs	   were	   actually	   present	   in	  H.	  
influenzae	   as	   distinct	   RNA	   transcripts,	   they	   needed	   to	   be	   experimentally	  validated.	  For	  that	  purpose,	  two	  putative	  ncRNAs	  from	  an	  invasive	  strain	  R2866	  were	  chosen	  for	  validation	  using	  the	  northern	  blot	  technique.	  Selection	  of	  these	  ncRNAs	  was	   based	   on	   high	   TPM	   expression	   values,	   in	   order	   to	  maximise	   the	  probability	   of	   transcript	   detection.	   Chosen	   ncRNAs	   were	   R2866_101	   and	  R2866_118,	   both	   of	   which	   were	   up-­‐regulated	   over	   4-­‐fold	   during	   stationary	  phase	   in	   R2866	   (see	   Figure	   5.20)	   (see	   Appendix	   D).	   The	   latter	   ncRNA	   was	  interesting,	   as	   it	   formed	   two	   large	   adjacent	   peaks,	   one	   of	  which	   contained	   an	  opening	   reading	   frame	   with	   a	   start	   codon	   and	   could	   therefore	   potentially	  encode	  a	  small	  protein	  (see	  Table	  5.4).	  Northern	  blotting	  revealed	  both	  ncRNAs	  to	  be	  present	   as	  RNA	   transcripts	   of	   150-­‐200	  bp	   in	   size,	  which	  was	   consistent	  with	   the	   size	   of	   ncRNA	   sequences	   (see	   Figure	   5.21).	   These	   transcripts	   were	  present	   in	   all	   three	   tested	   biological	   replicates	   at	   mid-­‐exponential	   and	  stationary	  growth	  phases.	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Figure	  5.20:	  Two	  ncRNA	  candidates	  for	  validation	  with	  northern	  blotting,	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Figure	   5.21:	   Northern	   blot	   validation	   of	   R2866_101	   and	   R2866_118	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5.2.2.6.1	   Secondary	   structure	   and	   target	   prediction	   of	   validated	  
ncRNAs	  Secondary	   RNA	   structures	   of	   two	   validated	   ncRNAs	  were	   predicted	   based	   on	  the	   minimum	   free	   energy	   for	   RNA	   folding	   (see	   Figure	   5.22).	   Minimum	   free	  energy	   values	   were	   -­‐82.20	   kcal/mol	   for	   R2866_101	   and	   -­‐64.10	   kcal/mol	   for	  R2866_118.	  Gene	   target	  prediction	  was	  subsequently	  carried	  out	   for	   the	  same	  two	   validated	   ncRNAs	   using	   the	   CopraRNA	   online	   tool	   (Wright	   et	   al.,	   2013,	  Wright	   et	   al.,	   2014).	   Predicted	   targets	   for	   R2866_101	  were	   largely	  metabolic	  genes,	  with	  the	  top	  hit	  being	  a	  gene	  encoding	  a	  tRNA	  modification	  protein.	  Two	  tRNA-­‐related	   genes	   were	   also	   among	   the	   top	   five	   putative	   targets	   for	  R2866_118.	  Interestingly,	  the	  top	  hit	  for	  R2866_118	  was	  a	  bacteriophage	  gene,	  whilst	  another	  putative	  target	  gene,	  encoding	  a	  hypothetical	  protein,	  was	  part	  of	  the	  ICE,	  homologous	  to	  ICEHin1056	  (Juhas	  et	  al.,	  2007).	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Figure	   5.22:	   Predicted	   secondary	   RNA	   structures	   of	   validated	   ncRNAs	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Table	   5.5:	   Top	   five	   predicted	   gene	   targets	   for	   the	   validated	   ncRNAs	  
R2866_101	  and	  R2866_118,	  based	  on	  the	  lowest	  p-­‐values.	  
Target	  gene	   Gene	  annotation	   P-­‐value	  R2866_101	  
gidA	   tRNA	  uridine	  5-­‐carboxymethylaminomethyl	  modification	  enzyme	   0.000278038	  
rnfD	   Electron	  transport	  complex	  protein	  RnfD	   0.001267742	  
hsdR	   Type	  I	  restriction	  enzyme	  HindVIIP,	  R	  protein	   0.002250713	  
secB	   Protein	  export	  chaperone	  SecB	   0.00311078	  
atpG	   Membrane-­‐bound	  ATP	  synthase,	  F1	  sector,	  gamma-­‐subunit	   0.00326923	  R2866_118	  -­‐	   Bacteriophage	  Lambda	  NinG	  protein	   0.000332415	  
serC	   Phosphoserine	  aminotransferase	   0.000337151	  
ygfZ	   tRNA-­‐modifying	  protein	   0.000757476	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5.3	  Discussion	  This	   study	   provides	   the	   most	   comprehensive	   repertoire	   of	   putative	   ncRNAs	  identified	   in	   H.	   influenzae	   to-­‐date.	   In	   particular,	   this	   is	   the	   first	   time	   that	  antisense	  ncRNAs	  have	  been	  systematically	   investigated	   in	   this	  organism	  on	  a	  whole-­‐genome	   scale.	   In	   addition,	   two	  novel	   intergenic	   ncRNAs,	  with	   potential	  roles	   as	   trans-­‐acting	   sRNAs,	   were	   validated	   in	   an	   invasive	   strain	   R2866.	   The	  identification	   of	   ncRNAs	   from	   the	   RNA-­‐Seq	   data	   in	   H.	   influenzae	   was	   made	  possible	   by	   the	   development	   of	   a	   robust	   new	   tool	   "toRNAdo".	   It	   can	   be	   used	  with	   any	   bacterial	   transcriptomic	   data	   to	   identify	   potentially	   important	   RNA	  elements,	   including	   UTRs,	   operon	   regions	   as	  well	   as	   intergenic	   and	   antisense	  ncRNAs.	  	  	  The	   toRNAdo	   script,	   developed	   in	   this	   study,	   proved	   to	   be	   robust	   across	  different	  RNA-­‐Seq	  conditions,	  with	  a	  very	  low	  number	  of	  false	  positive	  ncRNAs.	  Additional	  script	  optimisation	  could	  be	  carried	  out	  in	  the	  future	  to	  improve	  the	  accuracy	  even	  further.	  One	  of	  the	  biggest	  strengths	  of	  the	  toRNAdo	  script	  is	  that	  it	   is	   not	   limited	   to	   putative	   intergenic	   ncRNAs,	   but	   rather	   explores	   the	  whole	  complexity	   of	   a	   bacterial	   transcriptome,	   which	   also	   includes	   antisense	   and	  mixed	  transcripts.	  This	  is	  in	  contrast	  to	  a	  previous	  study	  on	  the	  putative	  ncRNAs	  in	  H.	  influenzae,	  which	  only	  focused	  on	  intergenic	  regions	  (Baddal	  et	  al.,	  2015).	  In	   addition,	   the	   script	   allows	   exploration	   of	   UTRs	   and	   operon	   regions.	  While	  identifying	  these	  RNA	  elements	  in	  H.	  influenzae	  was	  not	  the	  aim	  of	  this	  study,	  it	  will	  be	   important	   for	   future	  work.	  Finally,	   the	   script	  has	  been	   tested	  by	  other	  members	   of	   the	   laboratory	   on	   different	   bacterial	   species	   with	   similarly	  successful	   and	   reproducible	   outcomes.	   This	   further	   reaffirms	   the	   toRNAdo	  script	   as	   an	   appropriate	   new	   tool	   for	   exploring	   bacterial	   transcriptional	  landscape.	  	  This	   study	   clearly	   demonstrated	   the	   importance	   of	   using	   different	   growth	  conditions	   when	   attempting	   to	   discover	   novel	   putative	   ncRNAs.	   There	   was	   a	  clear	   difference	   in	   the	   number	   of	   identified	   ncRNAs	   between	   different	  conditions.	  This	  supports	  the	  idea	  that	  bacterial	  transcriptional	  response	  is	  of	  a	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very	   sensitive	   nature	   and	   is	   highly	   dependent	   on	   environmental	   factors.	  Therefore,	   a	   higher	   number	   of	   conditions	   used	  would	   likely	   result	   in	   a	   larger	  total	   number	   of	   identified	   ncRNAs	   for	   that	   organism.	   This	   approach	   has	   been	  previously	   utilised	   to	   explore	   the	   repertoire	   of	   putative	   sRNAs	   in	   other	  pathogenic	  bacteria	  like	  S.	  enterica	  (Kroger	  et	  al.,	  2013).	  	  	  The	  majority	  of	  all	  putative	  ncRNAs	  were	  identified	  during	  stationary	  phase	  in	  both	   Rd	   and	   R2866	   strains.	   Differential	   ncRNA	   expression	   analysis	   revealed	  most	  ncRNAs	  to	  be	  up-­‐regulated	  during	  stationary	  phase	  as	  well,	  which	  was	  the	  most	   likely	   reason	   for	   their	   abundant	   discovery	   at	   that	   particular	   condition.	  While	   some	   sRNAs	   have	   a	   positive	   effect	   on	   gene	   expression,	   the	  majority	   of	  them	  act	  to	  inhibit	  translation	  (see	  section	  1.2).	  Therefore,	  a	  subset	  of	  ncRNAs,	  identified	   in	   this	   study,	   could	  be	   acting	   in	  cis	   or	   trans	   to	   inhibit	   translation	  of	  specific	   mRNAs.	   In	   particular,	   as	   observed	   in	   Chapter	   4,	   protein	   biosynthesis	  was	   reduced	   overall	   during	   stationary	   phase	   in	   both	   strains,	   supporting	   the	  increase	  in	  ncRNA	  expression	  and	  their	  potential	  role	  in	  translation	  inhibition.	  This	   is	   concurrent	   with	   a	   high	   number	   of	   intergenic	   and	   antisense	   ncRNA	  sequences	   being	   up-­‐regulated	   during	   stationary	   phase	   in	   E.	   coli	   and	  
Pseudomonas	  aeruginosa	  (Argaman	  et	  al.,	  2001,	  Gomez-­‐Lozano	  et	  al.,	  2014).	  	  	  A	   low	   number	   of	   ncRNAs	   identified	   during	   mid-­‐exponential	   phase	   in	   both	  strains	  was	  most	  likely	  due	  to	  a	  high	  number	  of	  replicates,	  as	  this	  condition	  was	  used	   in	   all	   RNA-­‐Seq	   experiments.	   There	   were	   a	   total	   of	   nine	   replicates	   for	  R2866	   and	   twelve	   for	   Rd	   during	   mid-­‐exponential	   phase,	   while	   all	   other	  conditions	  contained	  three	  replicates	  each.	  As	  one	  of	  the	  criteria	  for	  classifying	  ncRNAs	   was	   their	   appearance	   in	   all	   replicates,	   the	   variations	   in	   expression	  among	  a	  large	  number	  of	  replicates	  could	  therefore	  result	  in	  the	  loss	  of	  ncRNAs	  with	   low	  expression.	  However,	   this	  caveat	  was	  partially	  overcome	  using	  other	  RNA-­‐Seq	   conditions	   in	   this	   study,	   enabling	   the	  detection	  of	  ncRNAs	   that	  were	  enriched	  in	  response	  to	  other	  environmental	  factors	  and	  growth	  conditions.	  	  
	  	   228	  
The	  only	  previously	  characterised	  sRNA	  in	  H.	  influenzae	  was	  the	  Fur-­‐regulated	  HrrF	  (Santana	  et	  al.,	  2014).	  In	  this	  study,	  it	  did	  not	  form	  an	  expression	  peak	  in	  any	  of	  the	  RNA-­‐Seq	  conditions	  and	  was	  therefore	  not	  identified	  by	  the	  toRNAdo	  script.	  In	  fact,	  it	  was	  not	  observed	  to	  form	  an	  expression	  peak	  during	  standard	  and	   iron-­‐starvation	   conditions	   in	   the	   study	   by	   Santana	   et	   al.	   either.	   The	  induction	   of	   its	   expression	   was	   only	   observed	   in	   a	   fur	   deletion	   mutant.	  However,	   in	   the	   study	   by	   Baddal	   et	   al.	   HrrF	   was	   identified	   among	   putative	  intergenic	   ncRNAs	   expressed	   during	   infection	   of	   human	   cells	   (Baddal	   et	   al.,	  2015).	  This	  again	  highlights	  the	  specific	  nature	  of	  these	  RNA	  elements,	  some	  of	  which	   can	   only	   be	   identified	   under	   certain	   experimental	   conditions.	  Nevertheless,	   among	   18	   putative	   ncRNAs	   identified	   by	   Baddal	   et	   al.	   were	  homologues	   of	   RNase	   P	   and	  GcvB,	   both	   of	  which	  were	   present	   in	   the	   current	  dataset	  (Baddal	  et	  al.,	  2015).	  	  The	  GcvB	  homologue	  was	  previously	  computationally	  predicted	  to	  be	  in	  the	  H.	  
influenzae	  genome	  and	  this	  is	  the	  second	  time	  that	  its	  expression	  was	  observed	  in	   this	   organism	   (Pulvermacher	   et	   al.,	   2008,	   Baddal	   et	   al.,	   2015).	   It	   was	   up-­‐regulated	  during	  stationary	  phase	  in	  both	  strains,	  which	  is	  supported	  by	  its	  up-­‐regulation	  during	  this	  growth	  phase	  in	  E.	  coli	  (Argaman	  et	  al.,	  2001).	  However,	  it	  was	  particularly	  interesting	  that	  the	  GcvB	  homologue	  was	  up-­‐regulated	  almost	  5-­‐fold	   during	   iron-­‐starvation	   in	   the	  Rd	   strain.	   The	   lack	   of	   its	   up-­‐regulation	   in	  R2866	   further	   emphasises	   the	  difference	   in	   iron-­‐starvation	   response	  between	  these	   strains,	   as	   explored	   in	   Chapter	   4.	  While	   the	   role	   of	   GcvB	   in	   amino	   acid	  transport	   and	   metabolism	   is	   well	   documented,	   its	   significance	   during	   iron	  homeostasis	   has	   not	   been	   previously	   observed	   (Sharma	   et	   al.,	   2011).	   Further	  investigation	  into	  this	  ncRNA	  could	  lead	  to	  discovering	  potential	  new	  pathways	  that	  H.	  influenzae	  possesses	  for	  colonisation	  of	  iron-­‐restricted	  environments.	  	  Up-­‐regulation	  of	  6S	  RNA	  and	  RNase	  P	  homologues	  during	   stationary	  phase	   in	  both	  strains	  was	  not	  surprising.	  6S	  RNA	  was	  previously	  shown	  to	  be	  abundant	  during	   stationary	   phase	   in	   E.	   coli,	   as	   compared	   to	   mid-­‐exponential	   phase	  (Wassarman	   and	   Storz,	   2000).	   It	   is	   involved	   in	   regulation	   of	   global	   gene	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expression	   through	   specific	   interaction	   with	   a	   sigma-­‐70	   holoenzyme	   of	   RNA	  polymerase.	  RNase	  P	  plays	  a	  role	  in	  tRNA	  maturation,	  which	  is	  likely	  important	  during	  stationary	  growth	  phase	  where	  global	  changes	   in	   translation	  processes	  occur	  (Evans	  et	  al.,	  2006).	  It	  was	  striking	  that	  the	  absolute	  expression	  of	  these	  two	   ncRNAs	  was	   the	   highest	   among	   all	   identified	   ncRNAs	   across	   all	   RNA-­‐Seq	  conditions	   in	   both	   strains,	   signifying	   the	   important	   functions	   that	   these	   RNA	  elements	  possess.	  	  	  While	   some	   intergenic	   ncRNAs	   have	   been	   identified	   and	   explored	   in	   H.	  
influenzae	   previously,	   there	   has	   been	   no	   systematic	   investigation	   of	   antisense	  transcripts	  or	  RNA	  elements	  that	  have	  both	  antisense	  and	  intergenic	  properties	  (Santana	  et	  al.,	  2014,	  Baddal	  et	  al.,	  2015).	  Therefore,	  this	  study	  provides	  the	  first	  robust	  identification	  of	  these	  RNA	  structures	  in	  H.	  influenzae.	  It	  was	  interesting	  that	   several	   of	   ncRNAs,	   up-­‐regulated	   during	   stationary	   phase	   and	   iron-­‐starvation,	   were	   antisense	   to	   iron-­‐related	   genes	   as	  well	   as	   catalase	   and	   pilus	  genes.	   They	   could	   possibly	   act	   in	   cis	   to	   modulate	   the	   expression	   of	   these	  infection-­‐relevant	   genes.	   Their	   further	   validation	   would	   provide	   important	  insight	   into	   transcriptional	   regulation	   of	   H.	   influenzae	   during	   infection.	  Additional	   validation	   and	   characterisation	   is	   also	   required	   for	   potential	   small	  proteins	   that	   were	   identified	   in	   the	   ncRNA	   dataset.	   In	   addition,	   while	   only	  intergenic	  ncRNAs	  were	  investigated	  for	  the	  presence	  of	  an	  open	  reading	  frame	  in	  this	  study,	  there	  is	  a	  possibility	  that	  some	  of	  the	  antisense	  ncRNAs	  encoded	  small	   proteins	   as	   well.	   This	   phenomenon	   has	   been	   previously	   observed	   in	  
Pseudomonas	  fluorescens,	  where	  authors	   identified	  and	  characterised	  one	  such	  "hidden"	   antisense	   protein	   (Silby	   and	   Levy,	   2008).	   Exploration	   of	   potential	  antisense	  proteins	  in	  H.	  influenzae	  will	  be	  part	  of	  future	  work.	  	  The	   R2866_118	   ncRNA	   contained	   two	   clear	   large	   expression	   peaks,	   one	   of	  which	  possessed	  an	  open	  reading	  frame	  with	  a	  start	  codon.	  However,	  northern	  blotting	  revealed	  the	  region	  covering	  both	  expression	  peaks	  to	  be	  transcribed	  as	  a	   single	   RNA	  molecule.	   It	   is	   possible	   that	   the	   region	   contains	   both	   a	   putative	  intergenic	  sRNA	  sequence	  and	  a	  protein-­‐coding	  gene,	  as	  has	  been	  observed	  for	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other	   characterised	   sRNAs,	   such	   as	   RNA	   III	   (Benito	   et	   al.,	   2000).	   Further	  experimental	  validation	   is	  required	  to	  better	  characterise	   this	  region	   in	   future	  work.	  It	  was	  curious	  that	  some	  of	  the	  top	  target	  genes	  for	  R2866_118	  belonged	  to	   mobile	   genetic	   elements,	   such	   as	   prophage	   and	   ICE.	   Regulation	   of	  horizontally	   acquired	   genes	   was	   previously	   reported	   for	   an	   sRNA	   SgrS	   in	   S.	  
enterica	   (Papenfort	   et	   al.,	   2012).	   Other	   putative	   target	   genes	   for	   both	  R2866_101	   and	   R2866_118	   were	   involved	   in	   tRNA	   modification,	   which	   is	  supported	   by	   up-­‐regulation	   of	   these	   ncRNAs	   during	   stationary	   phase,	   where	  protein	  biosynthesis	  is	  reduced.	  	  	  Overall,	   this	   study	  has	   significantly	  enlarged	   the	  known	  repertoire	  of	  putative	  ncRNAs	   in	   H.	   influenzae.	   Future	   work	   will	   involve	   generation	   of	   mutants	   of	  validated	  ncRNAs	  in	  H.	  influenzae,	   followed	  by	  investigation	  of	  their	  behaviour	  in	  different	  infection-­‐relevant	  conditions.	  In	  addition,	  dRNA-­‐Seq,	  a	  new	  method	  for	  identifying	  transcriptional	  start	  sites	  and	  primary	  transcripts,	  will	  be	  used	  to	  improve	  identification	  and	  annotation	  of	  novel	  RNA	  structures	   in	  H.	  influenzae	  (Sharma	   et	   al.,	   2010).	   Finally,	   the	   developed	   toRNAdo	   script	   will	   be	   used	   for	  discovery	  of	  ncRNAs	  in	  other	  bacteria	  and	  will	  help	  to	  drive	  important	  studies	  into	  these	  novel	  RNA	  elements.	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Chapter	  6:	  Conclusions	  and	  future	  work	  
Even	   after	   the	   introduction	   of	   the	   Hib	   vaccine,	   H.	   influenzae	   remains	   an	  important	  human	  pathogen,	  being	  one	  of	   the	  main	  aetiological	  agents	  of	  otitis	  media	  and	  other	  respiratory	  tract	  infections,	  such	  as	  pneumonia	  and	  bronchitis	  (King,	   2012).	   Invasive	  disease	  due	   to	  NTHi,	   for	  which	  no	  effective	   vaccine	  yet	  exists,	  has	  also	  been	  on	  the	  rise	  in	  recent	  years	  (Langereis	  and	  de	  Jonge,	  2015).	  Understanding	   the	  behaviour	  of	  H.	  influenzae	   during	   infection	   is	   an	   important	  step	  towards	  identifying	  novel	  vaccine	  targets,	  necessary	  for	  prevention	  of	  NTHi	  disease.	  Thus	  the	  primary	  objectives	  of	  the	  work	  presented	  in	  this	  thesis	  were	  to	  expand	  on	  the	  current	  knowledge	  of	  the	  response	  of	  H.	  influenzae	  to	  relevant	  stress	   conditions	   as	  well	   as	   to	   identify	   and	   characterise	   a	   repertoire	   of	   novel	  RNA	  elements	  with	  potentially	  important	  roles	  in	  infection.	  	  The	   initial	   part	   of	   this	   study,	   described	   in	   Chapter	   3,	   provided	   an	   important	  basis	  for	  subsequent	  work	  as	  well	  as	  having	  important	  implications	  in	  itself.	  The	  first	   sequenced	   whole	   genome	   of	   a	   free-­‐living	   organism,	   the	   Rd	   strain	   of	   H.	  
influenzae,	  was	  re-­‐sequenced	  and	  re-­‐annotated	   for	   the	   first	   time	  (Fleischmann	  et	   al.,	   1995).	   The	   discovery	   of	   multiple	   nucleotide-­‐level	   variants	   between	  original	  and	  re-­‐sequenced	  Rd	  genome	  sequences	  highlighted	  the	  risks	  in	  relying	  on	   old	   genome	   annotations.	   An	   important	   finding	  was	   that	   a	   large	   number	   of	  indels	  corrected	  frameshifts,	  which	  were	  present	  in	  pseudogenes	  in	  the	  original	  Rd	  genome	  and	  were	  likely	  a	  result	  of	  original	  sequencing	  errors.	  In	  addition,	  an	  up-­‐to-­‐date	  genome	  annotation	  of	  both	  Rd	  and	  an	   invasive	  NTHi	  strain,	  R2866,	  ensured	  that	  the	  subsequent	  study	  of	  differential	  gene	  expression	  included	  the	  latest	  characterised	  bacterial	  genome	  features.	  	  	  Discovery	   of	   multiple	   SNPs	   between	   original	   and	   re-­‐sequenced	   Rd	   genomes	  suggests	   sequencing	   errors,	   true	   genetic	   changes,	   or	   a	   combination	   of	   both.	  Accumulation	  of	  genotypic	  changes	  over	  time	  can	  lead	  to	  phenotypic	  differences	  between	   the	   same	   strains	   in	   different	   locations.	   Further	   studies	   should	  determine	   whether	   any	   of	   the	   SNPs	   in	   Rd	   actually	   caused	   changes	   in	   the	  phenotype,	   particularly	   the	   SNP	   present	   in	   the	   mutS	   gene.	   This	   work	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emphasises	  the	   importance	  of	  re-­‐sequencing	  reference	  genomes,	  which	  can	  be	  used	   to	   correct	   assumptions	   about	   bacterial	   genetic	   composition.	   Both	   the	  evolution	   of	   model	   bacterial	   strains	   as	   well	   as	   the	   use	   of	   old	   genome	  annotations	   need	   to	   be	   addressed	   in	   bacteriological	   research.	   This	   has	  implications	  for	  defining	  a	  model	  organism,	  as	  important	  differences	  may	  exist	  between	   the	   genotype	   of	   a	   model	   bacterial	   strain	   and	   its	   published	   genome	  sequence.	  	  A	   detailed	   analysis	   of	   the	   accessory	   genome	  of	  Rd	   and	  R2866	  highlighted	   the	  heterogeneity	  between	  these	  two	  strains.	  As	  expected,	  R2866	  contained	  a	  larger	  number	  of	  virulence-­‐associated	  genes	  than	  Rd,	  likely	  making	  the	  former	  a	  more	  successful	   pathogen.	   On	   the	   other	   hand,	   Rd	   possessed	   unique	   metabolic	  pathways,	   which	   may	   prove	   advantageous	   during	   growth	   in	   different	  environments.	   The	   genomic	   heterogeneity	   between	   Rd	   and	   R2866	   has	  implications	   for	   the	   study	   of	   pathogenic	   behaviour	   in	   bacteria	   using	   model	  bacterial	   strains,	  which	  could	  potentially	  be	   less	  virulent	   than	  other	  strains	  of	  the	   same	   organism.	   In	   addition,	   this	  work	   contributed	   to	   the	   identification	   of	  differentially	   expressed	   genes	   that	  were	  present	   in	   only	   one	  of	   the	   strains,	   as	  described	  in	  Chapter	  4.	  	  One	   of	   the	   main	   objectives	   of	   this	   study	   was	   to	   explore	   the	   behaviour	   of	  H.	  
influenzae	   during	   infection-­‐relevant	   conditions.	   For	   that	   purpose,	   the	  transcriptional	  response	  of	  H.	  influenzae	  to	  stationary	  phase,	  nutritional	  stress,	  iron	   starvation	   and	   oxidative	   stress	   was	   characterised	   using	   the	   RNA-­‐Seq	  technology.	   An	   intriguing	   finding	   was	   increased	   sensitivity	   of	   the	   invasive	  strain,	  R2866,	  to	  oxidative	  stress	  and	  iron	  starvation	  as	  compared	  to	  Rd,	  which	  is	   a	   standard	   laboratory	   strain.	   This	   was	   supported	   by	   differences	   in	   the	  transcriptional	   response	   of	   Rd	   and	   R2866	   to	   these	   stress	   conditions.	   In	  particular,	  R2866	  had	  a	  more	  profound	  Fur-­‐mediated	  response	  to	  both	  stresses,	  suggesting	  a	  stronger	  requirement	  to	  maintain	  iron	  homeostasis	  in	  this	  strain.	  	  	  	  This	   was	   the	   first	   time	   that	   the	   behaviour	   of	  H.	   influenzae	   during	   stationary	  phase	  and	  nutritional	  stress	  were	  examined	  on	  a	  whole-­‐transcriptome	  level.	  Not	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surprisingly,	   iron-­‐starvation	   response	   and	   competence	   were	   induced	   in	   both	  conditions.	   In	   particular,	   the	   transcriptional	   profile	   of	   H.	   influenzae	   during	  stationary	   phase	   was	   found	   to	   be	   multifactorial,	   resembling	   oxidative,	   iron-­‐starvation	   and	   nutritional	   stress	   responses.	   This	   highlights	   the	   advantage	   of	  utilising	  several	  infection-­‐relevant	  conditions	  to	  enable	  identification	  of	  shared	  metabolic	  and	  stress	  response	  pathways,	  which	  are	  more	  likely	  to	  be	  exploited	  during	  natural	  infection.	  	  	  An	  intriguing	  route	  for	  future	  studies	  would	  be	  a	  combination	  of	  oxidative	  and	  iron-­‐starvation	   stress	   conditions.	   It	  was	   previously	   shown	   that	   iron	   chelation	  during	   oxidative	   stress	   restores	   the	   viability	   of	   H.	   influenzae	   (Juneau	   et	   al.,	  2015).	   This	   is	   most	   likely	   due	   to	   low	   intracellular	   iron	   levels	   leading	   to	  reduction	   in	   generated	   hydroxyl	   radicals	   through	   the	   Fenton	   reaction.	   Other	  relevant	   conditions,	   which	   could	   be	   explored	   using	   the	   RNA-­‐Seq	   method,	  include	   the	  effect	  of	   sub-­‐inhibitory	  concentrations	  of	  antibiotics	  as	  well	   as	   co-­‐culture	  with	  other	  bacterial	  pathogens	  that	  share	  the	  same	  ecological	  niche,	  as	  discussed	  below.	  	  	  
S.	   pneumoniae	   and	   Moraxella	   catarrhalis	   have	   been	   identified	   alongside	   H.	  
influenzae	   as	   the	   most	   important	   aetiological	   agents	   of	   otitis	   media;	   the	  significance	   of	   the	  multispecies	   biofilm,	   formed	   by	   these	   three	   organisms,	   for	  disease	   progression	   was	   previously	   reported	   (Hall-­‐Stoodley	   et	   al.,	   2006).	   S.	  
pneumoniae	   is	   a	   particularly	   important	   co-­‐pathogen,	   as	   it	   produces	   hydrogen	  peroxide,	  which	  causes	  oxidative	  stress	  for	  H.	  influenzae	  and	  inhibits	  its	  growth	  (Pericone	  et	  al.,	  2000).	  While	  the	  transcriptional	  response	  during	  co-­‐culture	  of	  
S.	   pneumoniae	   and	   the	   Rd	   strain	   of	   H.	   influenzae	   has	   already	   been	   explored	  using	  the	  RNA-­‐Seq	  approach,	  it	  would	  be	  interesting	  to	  study	  these	  interactions	  using	  other	  strains	  of	  H.	  influenzae	  (Tikhomirova	  et	  al.,	  2015b).	  In	  addition,	  the	  interactions	   between	   H.	   influenzae	   and	   another	   co-­‐pathogen,	   M.	   catarrhalis,	  should	  also	  be	  investigated	  in	  future	  work.	  	  The	  optimised	  invasion	  assay	  was	  used	  to	  establish	  that	  Rd	  and	  R2866	  strains	  of	  H.	   influenzae,	   used	   in	   this	   laboratory,	   were	   able	   to	   infect	   human	   epithelial	  
	  	   234	  
cells.	   An	   attempt	   was	   also	   made	   to	   isolate	   RNA	   from	   the	   infected	   host	   and	  subsequently	   enrich	  bacterial	  RNA	   in	   the	   sample.	  This	   is	   important	   for	   future	  studies,	  where	  transcriptomic	  analysis	  of	  intracellular	  H.	  influenzae	  would	  help	  to	   elucidate	   potentially	   important	   pathways	   that	   occur	   during	   the	   invasion	  process.	  This	  would	  be	  a	  more	  targeted	  approach	  than	  the	  dual	  RNA-­‐Seq	  study	  by	   Baddal	   et	   al.,	   where	   adhesion	   and	   invasion	   processes	   were	   not	   separated	  (Baddal	  et	  al.,	  2015).	  This	  work	  could	  then	  be	  developed	  further,	  by	  using	  high-­‐end	  sequencing	  instruments	  to	  characterise	  the	  transcriptional	  response	  of	  both	  the	  host	  and	  H.	  influenzae	  during	  invasion.	  Future	  studies	  would	  also	  utilise	  the	  optimised	   invasion	   model	   to	   characterise	   the	   transcriptional	   profile	   of	   H.	  
influenzae	  during	  co-­‐infection	  with	  a	  co-­‐pathogen	  S.	  pneumoniae.	  	  A	  detailed	  repertoire	  of	  putative	  intergenic	  and	  antisense	  ncRNAs	  was	  identified	  in	  H.	  influenzae	   in	   this	  study,	  as	  described	   in	  Chapter	  5.	   In	  particular,	   this	  was	  the	   first	   time	   that	   antisense	   ncRNAs	   were	   systematically	   described	   in	   this	  organism	   on	   a	   whole-­‐genome	   scale.	   This	   work	   significantly	   increased	   the	  current	   number	   of	   known	   ncRNAs	   in	   H.	   influenzae.	   Differentially	   expressed	  ncRNAs	   during	   infection-­‐relevant	   conditions,	   with	   potential	   regulatory	   roles	  during	   natural	   infection,	   were	   also	   identified.	   In	   addition,	   two	   intergenic	  ncRNAs	  from	  the	  R2866	  strain	  were	  validated	  with	  northern	  blotting,	  adding	  to	  a	  very	  low	  number	  of	  previously	  validated	  ncRNAs	  in	  H.	  influenzae	  (Santana	  et	  al.,	   2014).	  This	  work	  provides	   an	   important	  basis	   for	   future	   investigation	  and	  characterisation	   of	   these	   potentially	   important	   intergenic	   and	   antisense	   RNA	  elements.	   Further	   work	   is	   required	   to	   characterise	   if	   any	   of	   the	   identified	  ncRNAs	  are	  in	  fact	  functional	  sRNAs.	  Their	  potential	  role	  in	  the	  pathogenesis	  of	  
H.	   influenzae	   should	   also	   be	   explored,	   which	   could	   be	   coupled	   with	  transcriptomic	   studies	   of	   the	   optimised	   invasion	   assay.	   The	   identification	   of	  virulence-­‐associated	   ncRNAs	   could	   potentially	   facilitate	   the	   utilisation	   of	  ncRNAs	  for	  the	  vaccine	  development	  in	  the	  future.	  
	  The	   toRNAdo	   script,	   developed	   in	   this	   study,	   uses	   RNA-­‐Seq	   data	   to	   identify	  multiple	   RNA	   elements	   in	   a	   bacterial	   genome,	   including	   UTRs,	   intergenic	   and	  antisense	   transcripts	   as	   well	   as	   regions	   belonging	   to	   operons.	   Investigating	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UTRs	   in	   future	  work	   could	  potentially	   reveal	   other	   important	   regulatory	  RNA	  structures,	  such	  as	  riboswitches.	  In	  addition,	  it	  would	  be	  interesting	  to	  explore	  putative	  operons	  on	  a	  whole-­‐genome	  scale	  and	  identify	  possible	  differences	   in	  operon	   structures	   across	   different	   conditions.	   Finally,	   the	   characterisation	   of	  transcriptional	  start	  sites	  on	  a	  whole-­‐genome	  level	  using	  the	  dRNA-­‐Seq	  method	  should	  also	  be	  carried	  out	  in	  further	  studies	  (Sharma	  et	  al.,	  2010).	  The	  toRNAdo	  script	  could	  be	   further	  modified	  to	   improve	  the	  discovery	  of	  ncRNAs	   from	  the	  dRNA-­‐Seq	   data,	   based	   on	   the	   presence	   of	   primary	   transcripts	   containing	  transcriptional	  start	  sites.	  	  Overall,	   this	   study	   highlighted	   the	   complex	   transcriptional	   response	   of	   H.	  
influenzae	  to	  infection-­‐relevant	  conditions	  and	  emphasised	  issues	  regarding	  old	  genome	   annotations	   and	   the	   evolution	   of	   bacterial	   strains.	   Importantly,	   a	  comprehensive	  repertoire	  of	  putative	  ncRNAs,	  with	  potentially	  important	  roles	  during	  natural	  infection,	  was	  identified	  and	  will	  be	  further	  characterised	  in	  the	  future.	  This	  study	  improves	  the	  current	  understanding	  of	  the	  pathogenesis	  of	  H.	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Appendix	  A:	  Recipes	  for	  media	  and	  solutions	  
All	   reagents	   and	   chemicals	   were	   purchased	   from	   Sigma,	   UK,	   unless	   stated	  otherwise.	  	  
MIV	  medium	  MIV	  medium	  was	  prepared	  by	  adding	  0.5	  ml	  of	  solutions	  22,	  23,	  24	  and	  40	  each	  to	  50	  ml	  of	  solution	  21.	  	  Solution	  21:	  4	  g	  of	  L-­‐aspartic	  acid,	  0.2	  g	  of	  L-­‐glutamic	  acid,	  1	  g	  of	  fumaric	  acid,	  4.7	  g	  of	  sodium	  chloride,	  0.87	  g	  of	  dipotassium	  phosphate,	  0.67	  g	  of	  potassium	  phosphate	  and	  0.2	  ml	  of	  Tween®	  80	  was	  added	  to	  850	  ml	  of	  distilled	  water.	  	  Solution	  22:	  0.04	  g	  of	  L-­‐cystine	  and	  0.1	  g	  of	  L-­‐tyrosine	  were	  dissolved	  in	  10	  ml	  of	   1	   M	   hydrochloric	   acid	   at	   37	   °C,	   volume	   adjusted	   to	   100	   ml	   with	   distilled	  water,	  followed	  by	  adding	  0.06	  g	  of	  L-­‐citrulline,	  0.2	  g	  of	  L-­‐phenylalanine,	  0.3	  g	  of	  L-­‐serine	  and	  0.2	  g	  of	  L-­‐alanine.	  The	  solution	  was	  then	  sterilised	  through	  a	  0.45	  μm	  filter.	  	  Solution	  23:	  0.1	  M	  solution	  of	  calcium	  chloride	  in	  distilled	  water.	  	  Solution	  24:	  0.1	  M	  solution	  of	  magnesium	  sulphate	  in	  distilled	  water.	  	  Solution	  40:	  5%	  (w/v)	  vitamin-­‐free	  casamino	  acids	  in	  distilled	  water.	  	  Solutions	  23,	  24	  and	  40	  were	  sterilised	  by	  autoclaving.	  	  	  MIV	  medium	  was	  supplemented	  with	  10	  μg/ml	  haemin,	  4	  μg/ml	  NAD,	  2	  μg/ml	  thiamine,	  2	  μg/ml	  pantothenic	  acid	  and	  20	  μg/ml	  hypoxanthine.	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TE	  buffer	  For	  a	  100	  ml	  buffer,	  1	  ml	  of	  1	  M	  Tris	  and	  0.2	  ml	  of	  0.5	  M	  EDTA	  was	  mixed	  and	  volume	  adjusted	  to	  100	  ml	  with	  distilled	  water.	  The	  solution	  was	  sterilised	  by	  autoclaving.	  	  
MOPS	  buffer	  10x	   buffer	   was	   prepared	   by	   mixing	   200	   mM	   MOPS	   powder,	   50	   mM	   sodium	  acetate,	  10	  mM	  EDTA	  and	  adjusting	  pH	  to	  7.0.	  	  
RNA	  sample	  loading	  buffer	  Buffer	   was	   prepared	   by	   mixing	   6.5	   ml	   of	   formamide,	   1.2	   ml	   of	   34%	  formaldehyde,	  2	  ml	  of	  10x	  MOPS	  buffer,	  0.4	  ml	  of	  50%	  sucrose	  solution,	  30	  mg	  of	  Orange	  G	  dye.	  Buffer	  was	  stored	  at	  -­‐20	  °C.	  	  
Transfer	  buffer	  Buffer	  was	   prepared	   by	  mixing	   0.01	  M	   of	   sodium	  hydroxide	   and	   3	  M	   sodium	  chloride.	  	  
Neutralisation	  solution	  Solution	  was	  prepared	  by	  adjusting	  100	  mM	  of	  Tris	  solution	  to	  pH	  7.4.	  	  
SSC	  solution	  20x	  solution	  was	  prepared	  by	  adding	  88.23	  g	  of	  sodium	  acetate	  dihydrate	  and	  175.32	  g	  of	  sodium	  chloride	  to	  850	  ml	  of	  distilled	  water,	  adjusting	  pH	  to	  7.0	  and	  topping	  up	  to	  1	  l	  with	  distilled	  water.	  Solution	  was	  sterilised	  by	  autoclaving.	  
	  
Buffer	  1	  10x	  buffer	  was	  prepared	  by	  adding	  116.07	  g	  of	  maleic	  acid,	  87.66	  g	  of	  sodium	  chloride	  and	  72.00	  g	  of	  sodium	  hydroxide	  to	  850	  ml	  of	  distilled	  water,	  adjusting	  pH	  to	  7.5	  and	  topping	  up	  to	  1	  l	  with	  distilled	  water.	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Blocking	  solution	  10%	  solution	  was	  prepared	  by	  adding	  blocking	  20	  g	  of	  Blocking	  reagent	  (Roche)	  to	  200	  ml	  of	  1x	  Buffer	  1.	  	  
Pre-­‐hybridisation	  solution	  Solution	  has	  the	  following	  composition:	  0.1%	  sodium	  N-­‐lauroylsarcosinate,	  7%	  sodium	  dodecyl	  sulphate	  (SDS),	  1%	  blocking	  solution,	  50%	  formamide,	  topped	  up	  with	  5x	  SSC.	  Solution	  was	  stored	  at	  -­‐20	  °C.	  	  
Wash	  solution	  I	  Solution	  was	  prepared	  by	  mixing	  100	  ml	  of	  20x	  SSC	  and	  10	  ml	  of	  10%	  SDS,	  and	  topping	  up	  to	  1	  l	  with	  distilled	  water.	  	  
Wash	  solution	  II	  Solution	  was	  prepared	  by	  mixing	  10	  ml	  of	  20x	  SSC	  and	  10	  ml	  of	  10%	  SDS,	  and	  topping	  up	  to	  1	  l	  with	  distilled	  water.	  	  
Wash	  buffer	  Buffer	  was	  prepared	  by	  mixing	  3	  ml	  of	  Tween®	  20	  and	  100	  ml	  of	  10x	  Buffer	  1,	  and	  topping	  up	  to	  1	  l	  with	  distilled	  water.	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Appendix	  B:	  Supplementary	  tables	  for	  
Chapter	  4	  
	  
Table	  S1:	  Differentially	  expressed	  genes	  in	  the	  Rd	  strain	  during	  stationary	  
phase.	  
	  
Gene	   Product	   Fold	  change	  
Adjusted	  





Up-­‐regulated	  genes	   Down-­‐regulated	  genes	  
-­‐	   Alkylhydroperoxidase	  AhpD	  family	  core	  domain	  protein	   28.79	   9.05E-­‐201	   artP	   Arginine	  transporter	  ATP-­‐binding	  protein	   82.19	   2.75E-­‐24	  
speF	   Ornithine	  decarboxylase	   22.04	   9.29E-­‐128	   artI	   Arginine	  ABC	  transporter	  substrate-­‐binding	  protein	   40.84	   1.11E-­‐87	  
-­‐	   RarD	  protein	   19.86	   1.35E-­‐114	   potD_2	   Spermidine/putrescine	  ABC	  transporter	  substrate-­‐binding	  protein	   26.39	   2.70E-­‐102	  
fucI	   L-­‐fucose	  isomerase	   18.19	   4.85E-­‐126	   deaD	   ATP-­‐dependent	  RNA	  helicase	   23.54	   1.38E-­‐208	  
dps	   DNA	  protection	  during	  starvation	  protein	   13.55	   2.13E-­‐83	   artM	   Arginine	  transporter	  permease	  subunit	  ArtM	   22.57	   2.90E-­‐96	  
potE	   Putrescine	  transporter	   11.39	   2.64E-­‐138	   cca	   Multifunctional	  tRNA	  nucleotidyl	  transferase/2'3'-­‐cyclic	  phosphodiesterase/2'nucleotidase/phosphatase	   18.02	   1.00E-­‐95	  
glpK	   Glycerol	  kinase	   10.59	   5.22E-­‐118	   rplL	   50S	  ribosomal	  protein	  L7/L12	   17.69	   2.59E-­‐158	  
fucR	   L-­‐fucose	  operon	  activator	   10.27	   1.74E-­‐98	   trpE	   Anthranilate	  synthase	  component	  I	   16.5	   7.40E-­‐123	  
-­‐	   DNA	  polymerase	  V	  subunit	  UmuD	   9.75	   2.52E-­‐48	   artQ	   Arginine	  transporter	  permease	  subunit	  ArtQ	   16.36	   8.59E-­‐103	  
glpF_
1	  
Glycerol	  uptake	  facilitator	  protein	   9.54	   2.77E-­‐96	   nrfA	   Cytochrome	  c552	   13.93	   4.39E-­‐12	  
gntP_
2	   Gluconate	  permease	   9.4	   2.92E-­‐44	   rplI	   50S	  ribosomal	  protein	  L9	   13.47	   6.17E-­‐250	  
rebM	   Demethylrebeccamycin-­‐D-­‐glucose	  O-­‐methyltransferase	   9.01	   1.18E-­‐131	   -­‐	   SH3	  domain-­‐containing	  protein	   13.17	   1.41E-­‐92	  
-­‐	   Sulfatase-­‐like	  protein	   8.78	   4.46E-­‐43	   rpsR	   30S	  ribosomal	  protein	  S18	   13.05	   2.00E-­‐191	  
fbp	   Fructose-­‐1,6-­‐bisphosphatase	   8.63	   3.94E-­‐40	   rpmC	   50S	  ribosomal	  protein	  L29	   12.64	   6.48E-­‐141	  
yidK	   Putative	  symporter	  YidK	   8.59	   6.78E-­‐25	   rplP	   50S	  ribosomal	  protein	  L16	   12.12	   6.40E-­‐146	  
msrA	  
Bifunctional	  methionine	  sulfoxide	  reductase	  subunits	  A/B	   8.48	   6.29E-­‐34	   -­‐	   Phosphate	  transport	  regulator	   11.89	   7.84E-­‐47	  
afuA	   Ferric	  ABC	  transporter	  protein	   8.43	   2.85E-­‐06	   -­‐	   Thiamine	  biosynthesis	  protein	   11.68	   5.86E-­‐91	  
fucA	   L-­‐fuculose	  phosphate	  aldolase	   8.01	   8.28E-­‐75	   -­‐	   Primosomal	  replication	  protein	  N	   11.48	   9.09E-­‐110	  
fucP	   L-­‐fucose	  permease	   7.84	   3.86E-­‐71	   rplJ	   50S	  ribosomal	  protein	  L10	   11.39	   1.77E-­‐95	  
glpC_
1	  
sn-­‐glycerol-­‐3-­‐phosphate	  dehydrogenase	  subunit	  C	   7.79	   3.77E-­‐125	   -­‐	   ABC	  transporter	  permease	   11.31	   1.27E-­‐29	  
deoC	   deoxyribose-­‐phosphate	  aldolase	   7.74	   1.84E-­‐156	   rplV	   50S	  ribosomal	  protein	  L22	   11.06	   1.91E-­‐128	  
tehB	   tellurite	  resistance	  protein	  TehB	   7.05	   2.68E-­‐139	   rpsC	   30S	  ribosomal	  protein	  S3	   10.91	   4.57E-­‐134	  
gor	   glutathione	  reductase	   6.89	   9.57E-­‐73	   rnb	   Exoribonuclease	  II	   10.49	   1.70E-­‐43	  
iscR	   HTH-­‐type	  transcriptional	  regulator	  IscR	   6.79	   4.11E-­‐94	   rpsS	   30S	  ribosomal	  protein	  S19	   10.44	   1.47E-­‐114	  
-­‐	   Hypothetical	  protein	   6.72	   2.82E-­‐94	   argG	   Argininosuccinate	  synthase	   10.44	   1.66E-­‐85	  
moa
D	  
Molybdopterin	  synthase	  small	  subunit	   6.67	   2.45E-­‐55	   rpsQ	   30S	  ribosomal	  protein	  S17	   10.4	   1.30E-­‐146	  
-­‐	   Manganese	  transport	  protein	  MntH	   6.58	   1.27E-­‐54	   rpsI	   30S	  ribosomal	  protein	  S9	   9.67	   5.77E-­‐190	  
nifS	   Cysteine	  desulfurase	   6.51	   3.19E-­‐69	   fis	   DNA-­‐binding	  protein	  Fis	   9.58	   4.40E-­‐73	  
fucU	   Fucose	  operon	  protein	   6.39	   1.46E-­‐33	   -­‐	   Lipoprotein	  NlpI	   9.26	   4.72E-­‐140	  
kipA	   KipI	  antagonist	   6.37	   9.26E-­‐38	   yecO	   S-­‐adenosyl-­‐L-­‐methionine-­‐dependent	  methyltransferase	   9.22	   8.70E-­‐59	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   Down-­‐regulated	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-­‐	   Zinc-­‐type	  alcohol	  dehydrogenase	   6.36	   6.33E-­‐05	   rpsF	   30S	  ribosomal	  protein	  S6	   9.19	   2.65E-­‐105	  
fabA	   3-­‐hydroxydecanoyl-­‐ACP	  dehydratase	   6.28	   2.90E-­‐43	   rplB	   50S	  ribosomal	  protein	  L2	   9.16	   1.05E-­‐109	  
xylG	   Xylose	  transporter	  ATP-­‐binding	  protein	   6.26	   1.72E-­‐18	   trmD	   tRNA	  (guanine-­‐N(1)-­‐)-­‐methyltransferase	   9.15	   3.28E-­‐148	  
-­‐	   Peroxiredoxin	  hybrid	  Prx5	   6.24	   5.25E-­‐139	   betT	   High	  affinity	  choline	  transport	  protein	   8.91	   1.58E-­‐117	  
hisB	  
Imidazole	  glycerol-­‐phosphate	  dehydratase/histidinol	  phosphatase	   6.12	   2.73E-­‐77	   dmsA_3	   Anaerobic	  dimethyl	  sulfoxide	  reductase	  subunit	  A	   8.8	   1.33E-­‐06	  
-­‐	   Pyridoxamine	  kinase	   6.1	   7.25E-­‐75	   rplS	   50S	  ribosomal	  protein	  L19	   8.79	   1.09E-­‐153	  
iscU	   Scaffold	  protein	   6.02	   5.26E-­‐121	   -­‐	   Cobalt	  transport	  protein	  CbiM	   8.65	   3.35E-­‐49	  
dipZ_
2	  
Thiol:disulfide	  interchange	  protein	   6.02	   3.19E-­‐15	   -­‐	   Phosphate	  permease	   8.6	   3.91E-­‐54	  
merT	   mercuric	  ion	  transport	  protein	   6.02	   2.44E-­‐23	   cydA	   Cytochrome	  D	  ubiquinol	  oxidase	  subunit	  I	   8.33	   1.23E-­‐82	  
-­‐	   LamB/YcsF	  family	  protein	   5.8	   1.05E-­‐38	   bioD_1	   Dithiobiotin	  synthetase	   8.22	   5.35E-­‐09	  
moaC	   Molybdenum	  cofactor	  biosynthesis	  protein	  MoaC	   5.79	   1.57E-­‐65	   rplW	   50S	  ribosomal	  protein	  L23	   8.2	   2.00E-­‐101	  
purL_
2	  
Phosphoribosylformylglycinamidine	  synthase	   5.7	   8.25E-­‐27	   -­‐	   TPR	  repeat-­‐containing	  protein	  precursor	   8.14	   1.12E-­‐71	  
-­‐	   Hypothetical	  protein	   5.61	   5.03E-­‐57	   rplD	   50S	  ribosomal	  protein	  L4	   7.87	   1.70E-­‐106	  
-­‐	   Iron-­‐sulfur	  cluster	  insertion	  protein	  ErpA	   5.52	   8.23E-­‐53	   argR	   Arginine	  repressor	   7.79	   3.68E-­‐17	  
fdx-­‐1	   Ferredoxin	   5.47	   3.92E-­‐58	   rimM	   16S	  rRNA-­‐processing	  protein	  RimM	   7.77	   2.29E-­‐159	  
ssrA	   Transfer-­‐messenger	  RNA,	  SsrA	   5.46	   3.42E-­‐48	   rplM	   50S	  ribosomal	  protein	  L13	   7.46	   2.07E-­‐170	  
-­‐	   Allantoate	  amidohydrolase	   5.44	   2.99E-­‐62	   -­‐	   tRNA-­‐Ala(tgc)	   7.46	   2.99E-­‐35	  
xylA	   Xylose	  isomerase	   5.38	   6.59E-­‐14	   -­‐	   tRNA-­‐Ile(gat)	   7.43	   9.84E-­‐39	  
moaE	   Molybdopterin	  converting	  factor	  subunit	  2	   5.28	   2.61E-­‐40	   tbpA	   Thiamin	  ABC	  transporter	  substrate-­‐binding	  protein	   7.38	   4.57E-­‐129	  
yeaD	   Putative	  glucose-­‐6-­‐phosphate	  1-­‐epimerase	   5.25	   1.42E-­‐38	   rpsB	   30S	  ribosomal	  protein	  S2	   7.34	   3.31E-­‐119	  
-­‐	   Hypothetical	  protein	   5.22	   3.97E-­‐50	   rplC	   50S	  ribosomal	  protein	  L3	   7.27	   1.04E-­‐115	  
yiaO_
1	  
Extracytoplasmic	  solute	  receptor	  protein	  YiaO	   5.19	   6.87E-­‐33	   -­‐	   Hemoglobin-­‐binding	  protein	   7.18	   3.09E-­‐33	  
hisG	   ATP	  phosphoribosyltransferase	   5.18	   3.38E-­‐76	   ilvC	   Ketol-­‐acid	  reductoisomerase	   7.13	   9.04E-­‐54	  
-­‐	   Phosphate-­‐starvation-­‐inducible	  protein	  PsiE	   5.15	   5.37E-­‐30	   -­‐	   Epimerase	  family	  protein	   7.02	   1.19E-­‐32	  
recN	   DNA	  repair	  protein	   5.14	   6.78E-­‐71	   -­‐	   Mg2+/Co2+	  transporter	   6.96	   1.76E-­‐63	  
fucK	   L-­‐fuculokinase	   5.07	   8.07E-­‐35	   tsf	   Elongation	  factor	  Ts	   6.84	   8.81E-­‐114	  
-­‐	   Sigma	  factor	  regulatory	  protein	   4.86	   1.58E-­‐38	   potD_1	   Spermidine/putrescine	  ABC	  transporter	  substrate-­‐binding	  protein	   6.7	   1.80E-­‐49	  
nhaC	   Na+/H+	  antiporter	   4.77	   2.17E-­‐32	   rpsJ	   30S	  ribosomal	  protein	  S10	   6.69	   1.35E-­‐115	  
glgC	   Glucose-­‐1-­‐phosphate	  adenylyltransferase	   4.74	   1.12E-­‐68	   rpsP	   30S	  ribosomal	  protein	  S16	   6.61	   6.90E-­‐138	  
yadA	   Adhesin	  YadA	  precursor	   4.74	   8.23E-­‐10	   cydD_2	   ABC	  transporter	  ATP-­‐binding	  protein	   6.61	   1.26E-­‐31	  
-­‐	   Thioredoxin	   4.72	   1.37E-­‐47	   -­‐	   Hemoglobin-­‐binding	  protein	   6.61	   2.73E-­‐18	  
uspA	   Universal	  stress	  protein	  A	   4.61	   0.004405658	   infB	   Translation	  initiation	  factor	  IF-­‐2	   6.49	   6.38E-­‐74	  
fnr_1	   Anaerobic	  regulatory	  protein	   4.6	   0.000514492	   topB	   DNA	  topoisomerase	  III	   6.08	   5.46E-­‐46	  
glgX	   Glycogen	  operon	  protein	   4.59	   9.40E-­‐55	   -­‐	   Hypothetical	  protein	   6	   1.10E-­‐20	  
gdhA	   Glutamate	  dehydrogenase	   4.57	   3.54E-­‐49	   -­‐	   Transcriptional	  activator	   5.99	   1.78E-­‐41	  
patB	   Cystathionine	  beta-­‐lyase	  PatB	   4.56	   0.00049419	   lrgA	   Antiholin-­‐like	  protein	  LrgA	   5.84	   2.61E-­‐06	  
-­‐	   FeS	  assembly	  protein	  IscX	   4.54	   1.42E-­‐45	   rimP	   Ribosome	  maturation	  factor	  RimP	   5.79	   3.80E-­‐50	  
glgB	   Glycogen	  branching	  protein	   4.52	   1.44E-­‐50	   nusA	   Transcription	  elongation	  factor	  NusA	   5.71	   1.07E-­‐72	  
-­‐	   Integral	  membrane	  protein	  transporter	   4.51	   2.59E-­‐34	   -­‐	   Branched	  chain	  amino	  acid	  ABC	  transporter	  substrate-­‐binding	  protein	   5.62	   2.82E-­‐69	  
merP
_2	  
Mercuric	  ion	  scavenger	  protein	   4.47	   1.05E-­‐15	   argH	   Argininosuccinate	  lyase	   5.61	   7.38E-­‐29	  
hisH_
1	  
Imidazole	  glycerol	  phosphate	  synthase	  subunit	  HisH	   4.43	   5.64E-­‐41	   -­‐	   tRNA-­‐Phe(gaa)	   5.61	   7.12E-­‐18	  
hisC	   Histidinol-­‐phosphate	   4.38	   1.13E-­‐63	   -­‐	   Cobalt	  ABC	  transporter,	   5.61	   5.90E-­‐23	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yiaM_
2	  
2,3-­‐diketo-­‐L-­‐gulonate	  TRAP	  transporter	  small	  permease	  protein	  YiaM	   4.35	   1.50E-­‐14	   lolB	   Outer	  membrane	  lipoprotein	  LolB	   5.57	   2.15E-­‐21	  
yiaO_
2	  
Extracytoplasmic	  solute	  receptor	  protein	  YiaO	   4.34	   5.45E-­‐36	   -­‐	   ABC	  transporter	  ATP-­‐binding	  protein	   5.55	   1.33E-­‐31	  
kipI	   Sporulation	  inhibitor	  KipI	   4.31	   6.13E-­‐19	   rplO	   50S	  ribosomal	  protein	  L15	   5.49	   1.02E-­‐62	  
clpB	   ATP-­‐dependent	  Clp	  protease	  ATPase	  subunit	   4.31	   6.62E-­‐55	   secY	   Preprotein	  translocase	  subunit	  SecY	   5.49	   3.03E-­‐80	  
mobB	  
Molybdopterin-­‐guanine	  dinucleotide	  biosynthesis	  protein	  B	   4.3	   3.75E-­‐36	   rplR	   50S	  ribosomal	  protein	  L18	   5.47	   1.73E-­‐54	  
dapA	   Dihydrodipicolinate	  synthase	   4.26	   1.93E-­‐49	   -­‐	   Lysozyme	   5.44	   2.74E-­‐38	  
atoA	   Acetate	  CoA-­‐transferase	  subunit	  beta	   4.2	   2.01E-­‐11	   cydB	   Cytochrome	  oxidase	  subunit	  II	   5.42	   3.64E-­‐56	  
pepP	   Aminopeptidase	  P	   4.14	   1.71E-­‐40	   rpsE	   30S	  ribosomal	  protein	  S5	   5.41	   1.58E-­‐53	  
rbsB	   D-­‐ribose	  transporter	  subunit	  RbsB	   4.13	   5.93E-­‐42	   -­‐	   tRNA-­‐Asn(gtt)	   5.39	   4.62E-­‐17	  
moaA	   Molybdenum	  cofactor	  biosynthesis	  protein	  A	   4.09	   9.82E-­‐34	   trpG_2	   Anthranilate	  synthase	  component	  II	   5.37	   6.22E-­‐33	  
atoE	   Short	  chain	  fatty	  acids	  transporter	   4.05	   1.58E-­‐20	   yhhQ	   Inner	  membrane	  protein	  YhhQ	   5.33	   4.03E-­‐14	  
trxM	   Thioredoxin	   4.03	   1.20E-­‐26	   -­‐	   Hypothetical	  protein	   5.32	   4.95E-­‐21	  
-­‐	   UDP-­‐2,3-­‐diacylglucosamine	  hydrolase	   4.02	   5.60E-­‐45	   rplK	   50S	  ribosomal	  protein	  L11	   5.31	   5.21E-­‐102	  
ribA	   GTP	  cyclohydrolase	  II	   3.94	   3.30E-­‐10	   recR	   Recombination	  protein	  RecR	   5.15	   1.31E-­‐18	  
atoB	   Acetyl-­‐CoA	  acetyltransferase	   3.94	   2.39E-­‐17	   rplA	   50S	  ribosomal	  protein	  L1	   5.12	   9.56E-­‐95	  
radA	   DNA	  repair	  protein	  RadA	   3.93	   1.18E-­‐33	   rplF	   50S	  ribosomal	  protein	  L6	   5.12	   3.15E-­‐76	  
hisD	   Histidinol	  dehydrogenase	   3.91	   2.86E-­‐50	   -­‐	   Hypothetical	  protein	   5.12	   1.29E-­‐48	  
-­‐	   Malic	  enzyme	   3.83	   0.003848486	   recG	   ATP-­‐dependent	  DNA	  helicase	  RecG	   4.99	   5.10E-­‐33	  
-­‐	   Molybdate-­‐binding	  periplasmic	  protein	   3.83	   5.96E-­‐26	   -­‐	   tRNA-­‐Glu(ttc)	   4.96	   1.02E-­‐19	  
xylH	   D-­‐xylose	  ABC	  transporter	  permease	   3.82	   9.00E-­‐14	   nrfB	   Cytochrome	  c	  nitrite	  reductase	  pentaheme	  subunit	   4.95	   7.89E-­‐11	  
yiaM_
1	  
2,3-­‐diketo-­‐L-­‐gulonate	  TRAP	  transporter	  small	  permease	  protein	  YiaM	   3.79	   3.78E-­‐13	   rpsH	   30S	  ribosomal	  protein	  S8	   4.93	   4.12E-­‐72	  
pstA_
2	  
Phosphate	  ABC	  transporter	  permease	   3.77	   2.43E-­‐23	   rpmD	   50S	  ribosomal	  protein	  L30	   4.91	   1.01E-­‐46	  
hktE	   Catalase	   3.75	   2.69E-­‐46	   -­‐	   Short	  chain	  dehydrogenase/reductase	   4.9	   1.12E-­‐40	  
-­‐	   Putative	  integral	  membrane	  protein	   3.74	   9.53E-­‐38	   folK	   2-­‐amino-­‐4-­‐hydroxy-­‐6-­‐	  hydroxymethyldihydropteridine	  pyrophosphokinase	   4.85	   2.45E-­‐29	  
-­‐	   MerR	  family	  transcriptional	  regulator	   3.73	   5.05E-­‐18	   -­‐	   Aldolase	   4.74	   1.32E-­‐31	  
hisA	  
1-­‐(5-­‐phosphoribosyl)-­‐5-­‐[(5-­‐	  phosphoribosylamino)methylideneamino]	  imidazole-­‐4-­‐carboxamide	  isomerase	   3.73	   3.43E-­‐34	   atpH	   F0F1	  ATP	  synthase	  subunit	  delta	   4.69	   5.04E-­‐95	  
pckA	   Phosphoenolpyruvate	  carboxykinase	   3.73	   0.020677855	   cydD_1	   ABC	  transporter	  ATP-­‐binding	  protein	   4.69	   1.34E-­‐14	  
-­‐	   Outer	  membrane	  protein	   3.71	   4.95E-­‐42	   rpmG	   50S	  ribosomal	  protein	  L33	   4.61	   3.59E-­‐41	  
cysT	   Sulfate	  transport	  system	  permease	  protein	  CysT	   3.66	   2.91E-­‐10	   yidC	   Inner	  membrane	  protein	  translocase	  component	  YidC	   4.6	   5.96E-­‐27	  
yqaA	   Inner	  membrane	  protein	  YqaA	   3.65	   3.09E-­‐46	   frr	   Ribosome	  recycling	  factor	   4.57	   3.13E-­‐47	  
glpB	  
Anaerobic	  glycerol-­‐3-­‐phosphate	  dehydrogenase	  subunit	  B	   3.64	   1.62E-­‐48	   mutT	   Mutator	  protein	   4.56	   1.33E-­‐11	  
-­‐	   Transglutaminase-­‐like	  superfamily	  protein	   3.61	   1.79E-­‐46	   yidD	   Putative	  membrane	  protein	  insertion	  efficiency	  factor	   4.54	   1.73E-­‐17	  
hscB	   Co-­‐chaperone	  HscB	   3.59	   2.99E-­‐30	   rplQ	   50S	  ribosomal	  protein	  L17	   4.52	   1.51E-­‐64	  
-­‐	   HTH-­‐type	  transcriptional	  regulator	   3.58	   2.96E-­‐19	   ccmA	   Cytochrome	  c	  biogenesis	  protein	  CcmA	   4.47	   8.30E-­‐15	  
yhcB	   Putative	  cytochrome	  d	  ubiquinol	  oxidase	  subunit	  3	   3.57	   1.50E-­‐30	   -­‐	   Hypothetical	  protein	   4.37	   1.34E-­‐51	  
-­‐	   Long	  chain	  fatty	  acid	  CoA	  ligase	   3.55	   3.52E-­‐22	   cyaA	   Adenylate	  cyclase	   4.36	   3.00E-­‐22	  
-­‐	   16S	  ribosomal	  RNA	   3.55	   1.75E-­‐09	   rpsN	   30S	  ribosomal	  protein	  S14	   4.36	   3.27E-­‐65	  
hcpC	   Putative	  beta-­‐lactamase	  HcpC	  precursor	   3.54	   3.62E-­‐26	   psd	   Phosphatidylserine	  decarboxylase	   4.32	   1.35E-­‐42	  
-­‐	   Di-­‐	  and	  tricarboxylate	  transporter	   3.54	   0.001862815	   ttgI	   Toluene	  efflux	  pump	  outer	  membrane	  protein	  TtgI	   4.3	   4.24E-­‐32	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Up-­‐regulated	  genes	   Down-­‐regulated	  genes	  
fhuA	   Ferric	  hydroxamate	  uptake	   3.53	   2.24E-­‐18	   ponB	   Penicillin-­‐binding	  protein	  1B	   4.26	   3.55E-­‐33	  
-­‐	   RutC	  family	  protein	   3.53	   2.52E-­‐63	   -­‐	   Hypothetical	  protein	   4.25	   1.01E-­‐17	  
-­‐	   2,3-­‐diketo-­‐L-­‐gulonate	  reductase	   3.51	   6.55E-­‐09	   rplX	   50S	  ribosomal	  protein	  L24	   4.24	   2.79E-­‐76	  
-­‐	   Transcriptional	  regulator	   3.45	   8.56E-­‐28	   comEA	   ComE	  operon	  protein	  1	   4.22	   1.37E-­‐13	  
lon	   ATP-­‐dependent	  proteinase	   3.4	   2.34E-­‐46	   ygbM	   Putative	  hydroxypyruvate	  isomerase	  YgbM	   4.22	   1.92E-­‐45	  
talB	   Transaldolase	  B	   3.36	   5.15E-­‐29	   -­‐	   Putative	  protein-­‐S-­‐isoprenylcysteine	  methyltransferase	   4.21	   3.33E-­‐35	  
psiE	   Mig-­‐7	   3.35	   4.27E-­‐22	   -­‐	   ABC	  transporter	  ATP-­‐binding	  protein	   4.13	   1.16E-­‐14	  
-­‐	   tRNA-­‐seC(tca)	   3.34	   7.27E-­‐09	   thiP	   Thiamine	  transporter	  membrane	  protein	   4.1	   1.38E-­‐32	  
hisIE	  
Bifunctional	  phosphoribosyl-­‐AMP	  cyclohydrolase/phosphoribosyl-­‐ATP	  pyrophosphatase	   3.33	   5.86E-­‐28	   rplE	   50S	  ribosomal	  protein	  L5	   4.06	   7.24E-­‐70	  
raiA	   Ribosome-­‐associated	  inhibitor	  A	   3.32	   3.64E-­‐15	   -­‐	   Lipoprotein	   4.02	   6.19E-­‐29	  
-­‐	   TonB-­‐dependent	  Receptor	  Plug	  Domain	  protein	   3.32	   1.69E-­‐16	   atpG	   F0F1	  ATP	  synthase	  subunit	  gamma	   3.99	   2.76E-­‐55	  
-­‐	   Integral	  membrane	  protein	  transporter	   3.31	   1.20E-­‐34	   rpmB	   50S	  ribosomal	  protein	  L28	   3.99	   1.63E-­‐31	  
-­‐	   Acetyl-­‐CoA:acetoacetyl-­‐CoA	  transferase	  subunit	  alpha	   3.27	   2.21E-­‐06	   ipk	   4-­‐diphosphocytidyl-­‐2-­‐C-­‐methyl-­‐D-­‐erythritol	  kinase	   3.97	   5.45E-­‐36	  
-­‐	   Hypothetical	  protein	   3.27	   4.31E-­‐07	   murI	   Glutamate	  racemase	   3.97	   1.48E-­‐24	  
-­‐	   Sulfite	  exporter	  TauE/SafE	   3.25	   4.29E-­‐18	   -­‐	   Hypothetical	  protein	   3.91	   8.28E-­‐49	  
-­‐	   Glycerol-­‐3-­‐phosphate	  acyltransferase	  PlsY	   3.24	   2.84E-­‐27	   -­‐	   tRNA-­‐Asn(gtt)	   3.88	   6.03E-­‐14	  
hisF	   Imidazole	  glycerol	  phosphate	  synthase	  subunit	  HisF	   3.24	   2.93E-­‐25	   rpsT	   30S	  ribosomal	  protein	  S20	   3.87	   2.99E-­‐28	  
rfaD	   ADP-­‐L-­‐glycero-­‐D-­‐mannoheptose-­‐6-­‐epimerase	   3.23	   4.10E-­‐18	   -­‐	   ABC	  transporter	  ATP-­‐binding	  protein	   3.84	   6.74E-­‐20	  
-­‐	   N-­‐acetylmannosamine-­‐6-­‐phosphate	  2-­‐epimerase	   3.2	   0.000825603	   atpF	   F0F1	  ATP	  synthase	  subunit	  B	   3.82	   2.60E-­‐63	  
rbsA	   D-­‐ribose	  transporter	  ATP	  binding	  protein	   3.2	   2.41E-­‐06	   tuf_2	   Elongation	  factor	  Tu	   3.82	   1.35E-­‐45	  
mod
D	  
Molybdenum	  transport	  protein	  ModD	   3.2	   3.81E-­‐11	   cusC	   Cation	  efflux	  system	  protein	  CusC	  precursor	   3.8	   4.31E-­‐22	  
cdsA	   CDP-­‐diglyceride	  synthetase	   3.19	   1.08E-­‐21	   rho	   Hypothetical	  protein	   3.79	   3.39E-­‐18	  
-­‐	   RNA	  polymerase	  sigma	  factor	   3.17	   1.41E-­‐23	   pcnB	   PolyA	  polymerase	   3.78	   5.48E-­‐20	  
-­‐	   TPR	  repeat-­‐containing	  protein	  precursor	   3.15	   1.33E-­‐07	   phnA	   Alkylphosphonate	  uptake	  protein	   3.77	   5.58E-­‐22	  
glpA	   sn-­‐glycerol-­‐3-­‐phosphate	  dehydrogenase	  subunit	  A	   3.15	   0.001635678	   tuf_4	   Elongation	  factor	  Tu	   3.77	   5.04E-­‐41	  
sucD	   Succinyl-­‐CoA	  synthetase	  subunit	  alpha	   3.15	   5.31E-­‐21	   atpC	   F0F1	  ATP	  synthase	  subunit	  epsilon	   3.74	   1.16E-­‐38	  
-­‐	   Hypothetical	  protein	   3.14	   6.51E-­‐27	   -­‐	   5S	  ribosomal	  RNA	   3.7	   0.000799	  
-­‐	   Helix-­‐turn-­‐helix	   3.13	   4.95E-­‐21	   -­‐	   ABC	  transporter	  ATP-­‐binding	  protein	   3.66	   3.04E-­‐22	  
upp	   Uracil	  phosphoribosyltransferase	   3.12	   1.17E-­‐18	   tuf_3	   Elongation	  factor	  Tu	   3.65	   3.73E-­‐45	  
queE	   7-­‐carboxy-­‐7-­‐deazaguanine	  synthase	   3.1	   2.85E-­‐22	   -­‐	   DksA-­‐like	  zinc	  finger	  domain	  containing	  protein	   3.63	   2.32E-­‐11	  
-­‐	   Glycine	  radical	  enzyme,	  YjjI	  family	   3.1	   3.35E-­‐10	   fabH	   3-­‐oxoacyl-­‐ACP	  synthase	   3.61	   7.80E-­‐15	  
-­‐	   Hypothetical	  protein	   3.08	   7.26E-­‐28	   atpA	   F0F1	  ATP	  synthase	  subunit	  alpha	   3.6	   1.27E-­‐60	  
rbsR	   RBS	  repressor	   3.07	   9.18E-­‐23	   dcuB_2	   Anaerobic	  C4-­‐dicarboxylate	  transporter	   3.58	   2.38E-­‐15	  
-­‐	   Aminotransferase	  AlaT	   3.05	   2.60E-­‐15	   secD	   Preprotein	  translocase	  subunit	  SecD	   3.57	   1.87E-­‐51	  
-­‐	   23S	  ribosomal	  RNA	   3.02	   2.96E-­‐18	   -­‐	   tRNA-­‐dihydrouridine	  synthase	  A	   3.56	   3.84E-­‐39	  
-­‐	   SNARE	  associated	  Golgi	  protein	   3.01	   6.75E-­‐35	   -­‐	   Lipooligosaccharide	  biosynthesis	  protein	   3.55	   2.48E-­‐10	  
emrB
_1	  
Multidrug	  resistance	  protein	  B	   3	   9.37E-­‐17	   glnE	   Bifunctional	  glutamine-­‐synthetase	  adenylyltransferase/deadenyltransferase	   3.54	   3.58E-­‐41	  
-­‐	   Hypothetical	  protein	   2.98	   0.00048165	   atpD	   F0F1	  ATP	  synthase	  subunit	  beta	   3.54	   1.34E-­‐48	  
eda	   Keto-­‐hydroxyglutarate-­‐ 2.94	   5.16E-­‐30	   -­‐	   ABC	  transporter	  ATP-­‐binding	   3.54	   3.75E-­‐59	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Up-­‐regulated	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   Down-­‐regulated	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rec2	   Recombination	  protein	   2.94	   8.70E-­‐09	   tsaA	   Putative	  tRNA	  (adenine(37)-­‐N6)-­‐methyltransferase	   3.53	   1.32E-­‐11	  
pstC	   Phosphate	  ABC	  transporter	  permease	   2.93	   2.49E-­‐14	   -­‐	   Nucleoid-­‐associated	  protein	   3.51	   4.79E-­‐16	  
pflA_
2	  
Pyruvate	  formate	  lyase-­‐activating	  enzyme	  1	   2.92	   7.45E-­‐14	   -­‐	   GTP-­‐binding	  protein	   3.51	   2.14E-­‐18	  
hscA	   Chaperone	  protein	  HscA	   2.92	   7.48E-­‐39	   miaA	   tRNA	  delta(2)-­‐isopentenylpyrophosphate	  transferase	   3.43	   3.69E-­‐26	  
-­‐	   DNA	  uptake	  protein	   2.92	   2.52E-­‐14	   yecK	   Cytochrome	  C-­‐like	  protein	   3.39	   0.007932	  
galK	   Galactokinase	   2.92	   8.91E-­‐15	   tuf_1	   Elongation	  factor	  Tu	   3.36	   3.09E-­‐35	  
gcvA	   DNA-­‐binding	  transcriptional	  activator	  GcvA	   2.92	   1.37E-­‐17	   -­‐	   Sodium-­‐dependent	  transporter	   3.32	   5.60E-­‐26	  
-­‐	   tRNA-­‐Lys(ctt)	   2.92	   5.86E-­‐25	   infA	   Translation	  initiation	  factor	  IF-­‐1	   3.29	   3.44E-­‐10	  
-­‐	   tRNA-­‐Arg(acg)	   2.89	   4.39E-­‐22	   rplN	   50S	  ribosomal	  protein	  L14	   3.28	   1.31E-­‐48	  
lyx	   L-­‐xylulose	  kinase	   2.87	   8.18E-­‐21	   trpB	   Tryptophan	  synthase	  subunit	  beta	   3.28	   1.25E-­‐32	  
-­‐	   Hypothetical	  protein	   2.87	   8.83E-­‐23	   -­‐	   Hypothetical	  protein	   3.26	   1.34E-­‐06	  
-­‐	   Autonomous	  glycyl	  radical	  cofactor	  GrcA	   2.85	   1.28E-­‐19	   cydC	   Cysteine/glutathione	  ABC	  transporter	  membrane	  protein/ATP-­‐binding	  protein	   3.22	   6.53E-­‐32	  
-­‐	   D-­‐mannonate	  oxidoreductase	   2.85	   1.54E-­‐30	   hslO	   Hsp33-­‐like	  chaperonin	   3.21	   2.79E-­‐30	  
uvrA	   Excinuclease	  ABC	  subunit	  A	   2.85	   1.16E-­‐24	   rpmF	   50S	  ribosomal	  protein	  L32	   3.19	   6.36E-­‐34	  
galM	   Aldose	  1-­‐epimerase	   2.83	   6.77E-­‐16	   atpE	   F0F1	  ATP	  synthase	  subunit	  C	   3.19	   5.75E-­‐40	  
-­‐	   Hypothetical	  protein	   2.83	   4.16E-­‐12	   -­‐	   tRNA-­‐Thr(ggt)	   3.16	   2.65E-­‐37	  
oppA	   Oligopeptide	  ABC	  transporter	  substrate-­‐binding	  protein	   2.82	   6.15E-­‐11	   -­‐	   Hypothetical	  protein	   3.12	   7.25E-­‐14	  
-­‐	   6-­‐pyruvoyl	  tetrahydrobiopterin	  synthase	   2.81	   1.54E-­‐11	   ycaO	   Ribosomal	  protein	  S12	  methylthiotransferase	  accessory	  factor	  YcaO	   3.11	   6.55E-­‐24	  
lexA	   LexA	  repressor	   2.8	   1.95E-­‐41	   fusA	   Elongation	  factor	  G	   3.09	   1.06E-­‐43	  
sgbE	   L-­‐ribulose-­‐5-­‐phosphate	  4-­‐epimerase	   2.8	   4.52E-­‐17	   secA	   Preprotein	  translocase	  subunit	  SecA	   3.09	   1.45E-­‐29	  
murQ	   N-­‐acetylmuramic	  acid-­‐6-­‐phosphate	  etherase	   2.79	   1.57E-­‐21	   pepT	   Peptidase	  T	   3.09	   0.013601253	  
atzC	   N-­‐isopropylammelide	  isopropyl	  amidohydrolase	   2.79	   2.08E-­‐12	   znuA	   High-­‐affinity	  zinc	  transporter	  substrate-­‐binding	  protein	   3.07	   5.80E-­‐19	  
-­‐	   Phage-­‐associated	  protein,	  family	   2.79	   0.000105183	   rpoA	   DNA-­‐directed	  RNA	  polymerase	  subunit	  alpha	   3.04	   4.45E-­‐40	  
comD	   Competence	  protein	  D	   2.78	   0.001498987	   -­‐	   ABC	  transporter	  ATP-­‐binding	  protein	   3.04	   1.41E-­‐18	  
rbsK	   Ribokinase	   2.77	   2.85E-­‐30	   tig	   Trigger	  factor	   3.03	   2.18E-­‐32	  
fnr_2	   Fumarate/nitrate	  reduction	  transcriptional	  regulator	   2.77	   7.68E-­‐12	   sapF	   Anti	  peptide	  resistance	  ABC	  transporter	  ATPase	   3.03	   9.52E-­‐24	  
uraA	   Uracil	  permease	   2.76	   4.11E-­‐10	   -­‐	   Dissimilatory	  sulfite	  reductase,	  desulfoviridin	  subunit	  gamma	   3.01	   7.37E-­‐20	  
-­‐	   tRNA-­‐Ser(gct)	   2.74	   1.41E-­‐23	   coaA	   Pantothenate	  kinase	   2.99	   1.30E-­‐20	  
-­‐	  
Type	  I	  restriction-­‐modification	  system,	  M	  subunit	   2.74	   1.56E-­‐06	   -­‐	   Hypothetical	  protein	   2.99	   1.95E-­‐10	  
pgi	   Glucose-­‐6-­‐phosphate	  isomerase	   2.73	   2.58E-­‐27	   rpsD	   30S	  ribosomal	  protein	  S4	   2.94	   1.56E-­‐43	  
pepA
_1	   Leucyl	  aminopeptidase	   2.73	   3.96E-­‐16	   rpsA	   30S	  ribosomal	  protein	  S1	   2.94	   3.38E-­‐45	  
-­‐	   tRNA-­‐Lys(ttt)	   2.73	   3.84E-­‐21	   dksA	   dnaK	  suppressor	  protein	   2.93	   3.56E-­‐14	  
-­‐	   SprT-­‐like	  family	  protein	   2.72	   2.54E-­‐09	   por	   Oxidoreductase	   2.92	   2.19E-­‐25	  
spxA	   Regulatory	  protein	  spx	   2.71	   1.45E-­‐30	   potC	   Spermidine/putrescine	  ABC	  transporter	  membrane	  protein	   2.92	   2.99E-­‐35	  
-­‐	   Hypothetical	  protein	   2.71	   2.14E-­‐17	   epmC	   Elongation	  factor	  P	  hydroxylase	   2.91	   2.14E-­‐14	  
-­‐	   HTH-­‐type	  transcriptional	  regulator	   2.7	   7.01E-­‐14	   -­‐	   Ribonuclease	  R	  winged-­‐helix	  domain	  protein	   2.91	   5.50E-­‐11	  
ndk	   Nucleoside	  diphosphate	  kinase	   2.7	   2.71E-­‐18	   tyrA	   Bifunctional	  chorismate	  mutase/prephenate	  dehydrogenase	   2.89	   1.83E-­‐26	  
glgA	   Glycogen	  synthase	   2.7	   1.47E-­‐21	   prsA	   Ribose-­‐phosphate	  pyrophosphokinase	   2.89	   5.16E-­‐20	  
lrp	   Leucine-­‐responsive	  transcriptional	  regulator	   2.7	   1.05E-­‐13	   -­‐	   Branched-­‐chain	  amino	  acid	  ABC	  transporter	  permease	   2.85	   2.89E-­‐06	  
cyaY	   Frataxin-­‐like	  protein	   2.68	   2.71E-­‐13	   -­‐	   tRNA-­‐Gly(tcc)	   2.84	   7.88E-­‐32	  
-­‐	   Hypothetical	  protein	   2.68	   5.22E-­‐24	   -­‐	   Integrase/recombinase	   2.82	   3.30E-­‐10	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tpx	   Thiol	  peroxidase	   2.67	   1.41E-­‐16	   rpL25	   50S	  ribosomal	  protein	  L25	   2.81	   5.87E-­‐29	  
sucC	   Succinyl-­‐CoA	  synthetase	  subunit	  beta	   2.67	   1.24E-­‐15	   rnhB	   Ribonuclease	  HII	   2.79	   2.36E-­‐14	  
-­‐	   Hypothetical	  protein	   2.67	   0.01119026	   dcuB_1	   Anaerobic	  C4-­‐dicarboxylate	  transporter	   2.78	   8.67E-­‐07	  
rbsD	   D-­‐ribose	  pyranase	   2.66	   0.044433338	   -­‐	   Iron	  chelatin	  ABC	  transporter	  ATP-­‐binding	  protein	   2.78	   9.91E-­‐06	  
-­‐	   Hypothetical	  protein	   2.66	   2.20E-­‐16	   -­‐	   tRNA-­‐Cys(gca)	   2.78	   1.09E-­‐18	  
kdgK	   2-­‐dehydro-­‐3-­‐deoxygluconokinase	   2.65	   3.69E-­‐19	   -­‐	   Hypothetical	  protein	   2.78	   4.35E-­‐10	  
frdD	   Fumarate	  reductase	  subunit	  D	   2.65	   4.55E-­‐20	   eno	   Phosphopyruvate	  hydratase	   2.77	   7.63E-­‐09	  
-­‐	   Transcriptional	  regulator	   2.65	   2.01E-­‐35	   tgt	   Queuine	  tRNA-­‐ribosyltransferase	   2.75	   2.67E-­‐17	  
-­‐	   tRNA-­‐Arg(acg)	   2.62	   1.91E-­‐22	   -­‐	   Hydroxyethylthiazole	  kinase	   2.75	   2.48E-­‐28	  
-­‐	   Transposase	   2.62	   2.45E-­‐06	   -­‐	   Nickel	  uptake	  substrate-­‐specific	  transmembrane	  region	   2.73	   4.84E-­‐15	  
rbsC	   Ribose	  ABC	  transporter	  permease	   2.6	   1.76E-­‐13	   -­‐	   Hypothetical	  protein	   2.72	   1.71E-­‐23	  
-­‐	   Plasmid	  RP4	  TraN-­‐like	  protein	   2.6	   5.86E-­‐15	   pheS	   Phenylalanyl-­‐tRNA	  synthetase	  subunit	  alpha	   2.71	   2.45E-­‐21	  
-­‐	   Hypothetical	  protein	   2.6	   5.77E-­‐16	   -­‐	   Transporter	   2.7	   3.81E-­‐13	  
menG	   Ribonuclease	  activity	  regulator	  protein	  RraA	   2.58	   1.13E-­‐13	   tbp2_1	   Transferrin-­‐binding	  protein	  2	   2.7	   1.30E-­‐21	  
-­‐	   Xylulose	  kinase	   2.58	   1.43E-­‐16	   pnp	   Polynucleotide	  phosphorylase/polyadenylase	   2.69	   8.76E-­‐23	  
-­‐	   tRNA-­‐Ser(gga)	   2.58	   9.72E-­‐05	   rnfG	   Electron	  transport	  complex	  protein	  RnfG	   2.69	   1.84E-­‐12	  
yabJ	   Enamine/imine	  deaminase	   2.57	   2.53E-­‐18	   mutL	   DNA	  mismatch	  repair	  protein	   2.68	   6.38E-­‐21	  
serC	   Phosphoserine	  aminotransferase	   2.56	   1.45E-­‐14	   rpmE	   50S	  ribosomal	  protein	  L31	   2.68	   4.65E-­‐21	  
hsdR_
3	   Type	  I	  restriction	  enzyme	   2.56	   2.98E-­‐14	   arcA	   Two-­‐component	  response	  regulator	   2.68	   0.006266088	  
-­‐	   Hypothetical	  protein	   2.56	   7.11E-­‐05	   secF	   Preprotein	  translocase	  subunit	  SecF	   2.66	   2.64E-­‐22	  
dod	   Ribulose-­‐phosphate	  3-­‐epimerase	   2.54	   1.41E-­‐22	   pfs	   5'-­‐methylthioadenosine/S-­‐adenosylhomocysteine	  nucleosidase	   2.66	   7.84E-­‐15	  
yhxB_
2	  
Tail	  fiber	  protein/phosphomannomutase	   2.53	   0.0182819	   -­‐	   Mu-­‐like	  prophage	  protein	  gp29	   2.66	   1.58E-­‐13	  
purR	   DNA-­‐binding	  transcriptional	  repressor	  PurR	   2.53	   1.11E-­‐14	   truB	   tRNA	  pseudouridine	  synthase	  B	   2.65	   5.08E-­‐25	  
mazG	   Nucleoside	  triphosphate	  pyrophosphohydrolase	   2.52	   4.95E-­‐17	   thiE	   Thiamine-­‐phosphate	  pyrophosphorylase	   2.63	   3.93E-­‐18	  
-­‐	   Hypothetical	  protein	   2.52	   2.03E-­‐11	   tyrS	   Tyrosyl-­‐tRNA	  synthetase	   2.63	   4.25E-­‐34	  
yccA	   Modulator	  of	  FtsH	  protease	  YccA	   2.51	   1.47E-­‐21	   brnQ	   Branched-­‐chain	  amino	  acid	  ABC	  transporter	   2.62	   2.69E-­‐08	  
trkH	   Trk	  system	  potassium	  uptake	  protein	  TrkH	   2.51	   2.33E-­‐16	   -­‐	   Mu-­‐like	  prophage	  FluMu	  G	  protein	   2.62	   2.19E-­‐06	  
-­‐	   Hypothetical	  protein	   2.51	   1.07E-­‐06	   -­‐	   Hypothetical	  protein	   2.62	   0.010955	  
-­‐	   Sulfur	  transfer	  protein	  SirA	   2.5	   2.40E-­‐17	   queF_2	   7-­‐cyano-­‐7-­‐deazaguanine	  reductase	   2.6	   9.06E-­‐07	  
-­‐	   Putative	  phage-­‐encoded	  protein	   2.5	   3.95E-­‐06	   -­‐	   tRNA-­‐Thr(tgt)	   2.6	   2.33E-­‐24	  
oppB	   Oligopeptide	  transporter	  permease	   2.49	   1.12E-­‐18	   -­‐	   Transglycosylase	   2.59	   8.41E-­‐13	  
galT	   Galactose-­‐1-­‐phosphate	  uridylyltransferase	   2.48	   2.58E-­‐05	   -­‐	   C32	  tRNA	  thiolase	   2.59	   5.92E-­‐10	  
emrB
_2	  
Multidrug	  resistance	  protein	  B	   2.48	   7.70E-­‐21	   thiI	   tRNA	  sulfurtransferase	   2.58	   5.99E-­‐13	  
-­‐	   Translation	  initiation	  factor	  Sui1	   2.47	   1.64E-­‐15	   tatB	   Sec-­‐independent	  translocase	   2.58	   3.38E-­‐12	  
anm
K	  
Anhydro-­‐N-­‐acetylmuramic	  acid	  kinase	   2.46	   1.21E-­‐29	   -­‐	   tRNA-­‐Leu(taa)	   2.58	   4.39E-­‐12	  
-­‐	   Error-­‐prone	  DNA	  polymerase	   2.46	   3.07E-­‐12	   -­‐	   Oligopeptide	  transporter,	  OPT	  family	   2.57	   1.08E-­‐22	  
-­‐	   Hypothetical	  protein	   2.45	   0.010955231	   trpC	   Bifunctional	  indole-­‐3-­‐glycerol	  phosphate	  synthase/phosphoribosylanthranilate	  isomerase	   2.55	   5.75E-­‐15	  
msbB	   Lipid	  A	  biosynthesis	  (KDO)2-­‐ 2.44	   1.62E-­‐10	   -­‐	   Membrane-­‐fusion	  protein	   2.54	   1.13E-­‐22	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nrdD	   Anaerobic	  ribonucleoside	  triphosphate	  reductase	   2.43	   3.30E-­‐16	   rpS7	   30S	  ribosomal	  protein	  S7	   2.53	   7.86E-­‐33	  
nudF	   ADP-­‐ribose	  pyrophosphatase	   2.43	   0.010232	   rnpA	   Ribonuclease	  P	   2.53	   4.36E-­‐09	  
comF	   Competence	  protein	  F	   2.43	   1.74E-­‐12	   -­‐	   Hypothetical	  protein	   2.53	   6.90E-­‐07	  
yigZ	   IMPACT	  family	  member	  YigZ	   2.41	   4.59E-­‐14	   hitC	   Iron(III)	  ABC	  transporter	  ATP-­‐binding	  protein	   2.52	   2.76E-­‐11	  
gph	   Phosphoglycolate	  phosphatase	   2.41	   9.94E-­‐20	   -­‐	   Diaminobutyrate-­‐-­‐2-­‐oxoglutarate	  aminotransferase	   2.52	   3.30E-­‐07	  
-­‐	   Holo-­‐(acyl	  carrier	  protein)	  synthase	  2	   2.41	   3.43E-­‐16	   hrpa	   ATP-­‐dependent	  RNA	  helicase	  HrpA	   2.51	   3.28E-­‐25	  
ygiX	   Transcriptional	  regulatory	  protein	   2.4	   2.54E-­‐23	   -­‐	   tRNA-­‐Tyr(gta)	   2.51	   5.12E-­‐22	  
dnaJ	   Chaperone	  protein	  DnaJ	   2.38	   5.36E-­‐09	   narP	   Nitrate/nitrite	  response	  regulator	  protein	   2.49	   3.75E-­‐21	  
-­‐	   Hypothetical	  protein	   2.38	   0.000861431	   tatA	   Sec-­‐independent	  protein	  secretion	  pathway	  component	  TatA	   2.47	   8.26E-­‐09	  
-­‐	   SEC-­‐C	  motif	   2.38	   1.69E-­‐19	   kicB	   Condesin	  subunit	  F	   2.47	   7.90E-­‐13	  
-­‐	   Hypothetical	  protein	   2.38	   0.018713902	   yohK	   Inner	  membrane	  protein	  YohK	   2.46	   0.020121282	  
recX	   Recombination	  regulator	  RecX	   2.37	   7.45E-­‐14	   thiD	   Phosphomethylpyrimidine	  kinase	   2.46	   1.68E-­‐19	  
gcp_1	  
DNA-­‐binding/iron	  metalloprotein/AP	  endonuclease	   2.36	   1.59E-­‐20	   -­‐	   Protein	  of	  unknown	  function,	  DUF	   2.46	   1.15E-­‐13	  
groE
L	   Chaperonin	  GroEL	   2.36	   1.16E-­‐11	   -­‐	   Thiamin	  ABC	  transporter	  ATP-­‐binding	  protein	   2.44	   3.36E-­‐20	  
-­‐	   AraC	  family	  transcriptional	  regulator	   2.36	   2.14E-­‐16	   potB	   Spermidine/putrescine	  ABC	  transporter	  membrane	  protein	   2.44	   4.15E-­‐30	  
-­‐	   ABC	  transporter	  ATP-­‐binding	  protein	   2.36	   0.004527839	   -­‐	   EamA-­‐like	  transporter	  family	  protein	   2.44	   8.09E-­‐19	  
-­‐	   Hypothetical	  protein	   2.36	   3.11E-­‐07	   rnt	   Ribonuclease	  T	   2.43	   5.28E-­‐11	  
comE	   Competence	  protein	  E	   2.35	   1.33E-­‐11	   -­‐	   tRNA-­‐Val(gac)	   2.43	   0.000187	  
zwf	   Glucose-­‐6-­‐phosphate	  1-­‐dehydrogenase	   2.34	   1.52E-­‐18	   higB-­‐1	   Toxin	  HigB-­‐1	   2.42	   1.10E-­‐10	  
hsdR_
2	   Type	  I	  restriction	  enzyme	   2.34	   9.52E-­‐11	   mltA	   Murein	  transglycosylase	  A	   2.42	   1.17E-­‐14	  
cdaR	   Sugar	  diacid	  regulator	   2.33	   8.46E-­‐09	   rep	   ATP-­‐dependent	  DNA	  helicase	   2.42	   1.37E-­‐16	  
pepD	   Aminoacyl-­‐histidine	  dipeptidase	   2.33	   7.13E-­‐18	   -­‐	   tRNA-­‐Gly(gcc)	   2.42	   5.49E-­‐12	  
-­‐	   Phage-­‐related	  protein	   2.33	   8.04E-­‐11	   rumA	   23S	  rRNA	  5-­‐methyluridine	  methyltransferase	   2.41	   7.94E-­‐17	  
-­‐	   YecA	  family	  protein	   2.33	   2.81E-­‐25	   ksgA	   Dimethyladenosine	  transferase	   2.41	   1.68E-­‐09	  
-­‐	   N-­‐acetylneuraminic	  acid	  mutarotase	   2.32	   1.89E-­‐22	   -­‐	   Hsf-­‐like	  protein	   2.41	   1.28E-­‐15	  
phoB	  
Phosphate	  regulon	  transcriptional	  regulatory	  protein	  PhoB	   2.32	   8.88E-­‐18	   rpS11	   30S	  ribosomal	  protein	  S11	   2.39	   1.15E-­‐26	  
-­‐	   Hypothetical	  protein	   2.32	   0.001297	   -­‐	   Putative	  assembly	  protein	   2.39	   1.85E-­‐10	  
rpoH	   RNA	  polymerase	  factor	  sigma-­‐32	   2.31	   1.04E-­‐10	   fadL	   Long-­‐chain	  fatty	  acid	  transport	  protein	   2.38	   3.57E-­‐14	  
tbp1	   Transferrin-­‐binding	  protein	  1	   2.31	   5.47E-­‐16	   dnaX	   DNA	  polymerase	  III	  subunits	  gamma	  and	  tau	   2.37	   2.76E-­‐17	  
glpC_
2	  
sn-­‐glycerol-­‐3-­‐phosphate	  dehydrogenase	  subunit	  C	   2.3	   4.06E-­‐25	   -­‐	   Hypothetical	  protein	   2.37	   2.20E-­‐12	  
hsdM
_1	   Type	  I	  modification	  enzyme	   2.3	   3.28E-­‐14	   mukB	   Cell	  division	  protein	  MukB	   2.36	   1.96E-­‐17	  
malP	   Maltodextrin	  phosphorylase	   2.29	   3.06E-­‐24	   yjcD	   Putative	  permease	  YjcD	   2.34	   3.50E-­‐09	  
vapD	   Virulence-­‐associated	  protein	  D	   2.26	   1.21E-­‐12	   thrB	   Homoserine	  kinase	   2.34	   8.21E-­‐17	  
-­‐	  
Undecaprenyl-­‐phosphate	  alpha-­‐N-­‐acetylglucosaminyltransferase	   2.26	   1.85E-­‐15	   lpxB	   Lipid-­‐A-­‐disaccharide	  synthase	   2.34	   2.24E-­‐12	  
groE
S	   Co-­‐chaperonin	  GroES	   2.25	   1.37E-­‐14	   -­‐	   Branched-­‐chain	  amino	  acid	  ABC	  transporter	  permease	   2.34	   7.47E-­‐09	  
recD	   Exodeoxyribonuclease	  V	  subunit	  alpha	   2.25	   1.58E-­‐13	   -­‐	   Putative	  epimerase/dehydratase	   2.33	   1.08E-­‐16	  
dld	   D-­‐lactate	  dehydrogenase	   2.25	   5.48E-­‐14	   -­‐	   Na(+)-­‐translocating	  NADH-­‐quinone	  reductase	  subunit	  C	   2.32	   1.30E-­‐11	  
-­‐	   TPR	  repeat-­‐containing	   2.24	   0.001480 mtr	   Tryptophan-­‐specific	   2.32	   8.00E-­‐13	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afuB	   Ferric	  transport	  system	  permease-­‐like	  protein	   2.24	   3.39E-­‐14	   glyS	   Glycyl-­‐tRNA	  synthetase	  subunit	  beta	   2.32	   2.98E-­‐22	  
asd	   Aspartate-­‐semialdehyde	  dehydrogenase	   2.24	   2.04E-­‐11	   ftsL	   Cell	  division	  protein	   2.32	   1.24E-­‐10	  
truA	   tRNA	  pseudouridine	  synthase	  A	   2.23	   1.44E-­‐13	   pykA	   Pyruvate	  kinase	   2.31	   4.84E-­‐14	  
fbpC	   Ferric	  transporter	  ATP-­‐binding	  protein	   2.22	   1.64E-­‐08	   pgpB	   Phosphatidylglycerophosphatase	  B	   2.3	   1.74E-­‐12	  
-­‐	   Two	  component	  signal	  transduction	  system	  protein	   2.22	   0.016579113	   hindIIR	   Type	  II	  restriction	  endonuclease	   2.3	   2.55E-­‐11	  
glpX	   Fructose	  1,6-­‐bisphosphatase	  II	   2.22	   6.55E-­‐09	   rbfA	   Ribosome-­‐binding	  factor	  A	   2.3	   1.57E-­‐12	  
-­‐	   RNA	  2'-­‐O-­‐ribose	  methyltransferase	   2.22	   9.66E-­‐16	   nhaA	   pH-­‐dependent	  sodium/proton	  antiporter	   2.29	   2.73E-­‐15	  
ygiY	   Sensor	  protein	  QseC	   2.21	   1.49E-­‐14	   polA	   DNA	  polymerase	  I	   2.29	   1.56E-­‐26	  
-­‐	   Amino	  acid	  carrier	  protein	   2.2	   2.88E-­‐13	   -­‐	   16S	  ribosomal	  RNA	  methyltransferase	  RsmE	   2.28	   1.80E-­‐13	  
-­‐	   Lipoprotein	   2.2	   1.29E-­‐16	   -­‐	   Transporter	   2.27	   9.92E-­‐15	  
comB	   Competence	  protein	  B	   2.19	   0.007688	   ureH	   Urease	  accessory	  protein	   2.26	   2.62E-­‐15	  
arcC	   Carbamate	  kinase	   2.18	   1.23E-­‐19	   pta	   Phosphate	  acetyltransferase	   2.26	   1.41E-­‐24	  
ybaK	   Cys-­‐tRNA(Pro)/Cys-­‐tRNA(Cys)	  deacylase	  YbaK	   2.18	   1.06E-­‐07	   -­‐	   Opacity	  protein	   2.26	   1.57E-­‐06	  
-­‐	   Hypothetical	  protein	   2.18	   3.45E-­‐05	   -­‐	   Uracil	  DNA	  glycosylase	  superfamily	  protein	   2.26	   1.64E-­‐07	  
mesJ	   Cell	  cycle	  protein	   2.17	   3.13E-­‐15	   -­‐	   Lipoprotein	   2.25	   1.51E-­‐15	  
purN	   Phosphoribosylglycinamide	  formyltransferase	   2.17	   3.38E-­‐06	   -­‐	   Protease	   2.24	   0.000129221	  
uxuA	   Mannonate	  dehydratase	   2.16	   1.19E-­‐12	   gpmA	   Phosphoglyceromutase	   2.24	   1.35E-­‐06	  
-­‐	   Hemoglobin-­‐binding	  protein	   2.16	   2.39E-­‐13	   -­‐	   tRNA-­‐Met(cat)	   2.24	   6.98E-­‐12	  
xylR	   Xylose	  operon	  regulatory	  protein	   2.15	   2.48E-­‐11	   pyrG	   CTP	  synthetase	   2.22	   2.39E-­‐06	  
hsdR_
1	  
Type	  I	  restriction	  enzyme	  EcoR124II	  R	  protein	   2.15	   3.29E-­‐08	   -­‐	   tRNA-­‐Leu(tag)	   2.22	   6.48E-­‐10	  
pflA_
1	  
Pyruvate	  formate	  lyase-­‐activating	  enzyme	  1	   2.14	   9.82E-­‐16	   dsbE_1	   Thiol-­‐disulfide	  interchange	  protein	   2.21	   1.46E-­‐06	  
hxuA	   Haem-­‐hemopexin	  utilization	  protein	  A	   2.14	   7.32E-­‐11	   spoT	   Guanosine-­‐3'5'-­‐bis(diphosphate)	  3'-­‐	  pyrophosphohydrolase	   2.21	   1.68E-­‐18	  
glpE	   Thiosulfate	  sulfurtransferase	  GlpE	   2.14	   6.77E-­‐08	   -­‐	   Hypothetical	  protein	   2.21	   2.51E-­‐13	  
-­‐	   RarD	  protein	   2.13	   2.71E-­‐16	   dam	   DNA	  adenine	  methylase	   2.2	   4.12E-­‐06	  
ilvE	   Branched-­‐chain	  amino	  acid	  aminotransferase	   2.13	   4.73E-­‐10	   accC	   Acetyl-­‐CoA	  carboxylase	  biotin	  carboxylase	  subunit	   2.2	   1.19E-­‐11	  
-­‐	   Hydroxyacylglutathione	  hydrolase	   2.13	   1.03E-­‐12	   -­‐	   Electron	  transport	  complex	  RsxE	  subunit	   2.2	   1.49E-­‐10	  
-­‐	   Glycerate	  dehydrogenase	   2.13	   5.99E-­‐14	   fdnG	   Formate	  dehydrogenase,	  nitrate-­‐inducible,	  major	  subunit	  precursor	   2.19	   3.05E-­‐08	  
yfeB	   Iron	  (chelated)	  transporter	  ATP-­‐binding	  protein	   2.12	   7.17E-­‐17	   kicA	   Condesin	  subunit	  E	   2.19	   1.92E-­‐17	  
trxB	   Thioredoxin	  reductase	   2.12	   2.30E-­‐17	   -­‐	   Mu-­‐like	  prophage	  FluMu	  protein	  gp28	   2.19	   1.91E-­‐08	  
-­‐	   N-­‐acetylmannosamine	  kinase	   2.11	   4.20E-­‐06	   fumC	   Fumarate	  hydratase	   2.17	   0.025787	  
fadD	   Long-­‐chain-­‐fatty-­‐acid-­‐-­‐CoA	  ligase	   2.11	   3.73E-­‐19	   -­‐	   UDP-­‐GlcNAc-­‐-­‐lipooligosaccharide	  N-­‐acetylglucosaminyl	  glycosyltransferase	   2.17	   1.14E-­‐13	  
arcB	   Ornithine	  carbamoyltransferase	   2.11	   7.92E-­‐17	   nqrB	   Na(+)-­‐translocating	  NADH-­‐quinone	  reductase	  subunit	  B	   2.16	   1.89E-­‐09	  
aroE_
2	   Shikimate	  5-­‐dehydrogenase	   2.11	   5.12E-­‐14	   -­‐	   Na(+)-­‐translocating	  NADH-­‐quinone	  reductase	  subunit	  D	   2.15	   6.64E-­‐13	  
cysZ	   Sulfate	  transport	  protein	  CysZ	   2.11	   1.54E-­‐08	   yajC	   Preprotein	  translocase	  subunit	  YajC	   2.15	   1.47E-­‐12	  
-­‐	   Putative	  esterase	   2.11	   1.87E-­‐10	   aceE	   Pyruvate	  dehydrogenase	  subunit	  E1	   2.15	   3.07E-­‐12	  
ygfZ	   tRNA-­‐modifying	  protein	  YgfZ	   2.1	   1.46E-­‐12	   -­‐	   tRNA-­‐Asp(gtc)	   2.15	   8.96E-­‐08	  
yjjV_
2	  
Putative	  deoxyribonuclease	  YjjV	   2.1	   1.42E-­‐14	   thrA	   Bifunctional	  aspartokinase	  I/homoserine	  dehydrogenase	  I	   2.14	   3.62E-­‐17	  
aroC	   Chorismate	  synthase	   2.09	   2.98E-­‐11	   -­‐	   Putative	  transcriptional	  regulatory	  protein	   2.14	   2.55E-­‐11	  
purL_
1	  
Phosphoribosylformylglycinamidine	  synthase	   2.09	   1.03E-­‐14	   -­‐	   PemK-­‐like	  protein	   2.14	   2.35E-­‐13	  
ulaD	   3-­‐keto-­‐L-­‐gulonate-­‐6-­‐phosphate	  decarboxylase	   2.09	   2.04E-­‐11	   moeB_1	   Molybdopterin	  biosynthesis	  protein	  MoeB	   2.13	   6.64E-­‐08	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Gene	   Product	   Fold	  change	  
Adjusted	  





Up-­‐regulated	  genes	   Down-­‐regulated	  genes	  
-­‐	   Type	  II	  secretory	  pathway,	  component	  PulJ	   2.09	   0.00068264	   sapD	   Peptide	  ABC	  transporter	  ATP-­‐binding	  protein	   2.12	   3.44E-­‐14	  
rnd	   Ribonuclease	  D	   2.08	   6.78E-­‐07	   -­‐	   Isoleucyl-­‐tRNA	  synthetase	   2.11	   7.57E-­‐13	  
birA	   Biotin-­‐protein	  ligase	   2.07	   5.13E-­‐14	   rnfD	   Electron	  transport	  complex	  protein	  RnfD	   2.1	   7.31E-­‐06	  
tfoX	   DNA	  transformation	  protein	   2.07	   0.001263138	   -­‐	   tRNA-­‐Leu(taa)	   2.09	   5.99E-­‐06	  
emrA	   Multidrug	  resistance	  protein	  A	   2.06	   6.86E-­‐13	   vacB	   Virulence-­‐associated	  protein	   2.08	   1.41E-­‐16	  
dsbC	   Thiol-­‐disulfide	  interchange	  protein	   2.06	   9.09E-­‐13	   folC	   Folylpolyglutamate	  synthase/dihydrofolate	  synthase	   2.08	   2.65E-­‐09	  
-­‐	  
UDP-­‐N-­‐acetylmuramoylalanine-­‐D-­‐glutamate	  ligase-­‐like	  protein	   2.05	   2.22E-­‐21	   queF_1	   7-­‐cyano-­‐7-­‐deazaguanine	  reductase	   2.08	   3.36E-­‐10	  
icc	  
Cyclic	  3',5'-­‐adenosine	  monophosphate	  phosphodiesterase	   2.05	   7.04E-­‐06	   licC	   Lic-­‐1	  operon	  protein	   2.08	   2.90E-­‐12	  
-­‐	   Phosphatase/phosphohexomutase	   2.05	   3.74E-­‐09	   ppc	   Phosphoenolpyruvate	  carboxylase	   2.08	   0.000525693	  
iga1_
1	   Immunoglobin	  A1	  protease	   2.05	   4.41E-­‐10	   -­‐	   Hypothetical	  protein	   2.07	   7.28E-­‐13	  
acpD	   Acyl	  carrier	  protein	  phosphodiesterase	   2.04	   2.08E-­‐07	   era	   GTP-­‐binding	  protein	  Era	   2.06	   7.59E-­‐10	  
-­‐	   Hypothetical	  protein	   2.04	   3.26E-­‐10	   acpP	   Acyl	  carrier	  protein	   2.06	   1.01E-­‐16	  
comC	   Competence	  protein	  C	   2.03	   0.023544834	   -­‐	   Sulfur	  transfer	  complex	  subunit	  TusD	   2.06	   1.76E-­‐05	  
dppB	   Dipeptide	  ABC	  transporter	  permease	   2.03	   1.12E-­‐11	   thrC	   Threonine	  synthase	   2.05	   9.23E-­‐14	  
-­‐	   Hypothetical	  protein	   2.03	   2.18E-­‐13	   -­‐	   Formate	  transporter	   2.05	   2.29E-­‐05	  
proC	   Pyrroline-­‐5-­‐carboxylate	  reductase	   2.02	   2.91E-­‐10	   napD	   Nitrate	  reductase	  assembly	  protein	  NapD	   2.05	   3.58E-­‐09	  
napF
_2	   Ferredoxin-­‐type	  protein	   2.02	   0.000174167	   hindIIM	   Modification	  methylase	   2.05	   9.80E-­‐14	  
	   	   	   	   aceF	   Dihydrolipoamide	  acetyltransferase	   2.05	   1.53E-­‐10	  
	   	   	   	   gyrA	   DNA	  gyrase	  subunit	  A	   2.05	   4.02E-­‐18	  
	   	   	   	   -­‐	   Phage	  head	  morphogenesis	  protein,	  SPP1	  gp7	  family	   2.05	   8.63E-­‐07	  
	   	   	   	   -­‐	   Hypothetical	  protein	   2.05	   1.82E-­‐07	  
	   	   	   	   dacA	   Penicillin-­‐binding	  protein	  5	   2.04	   3.14E-­‐12	  
	   	   	   	   acrB	   Acriflavine	  resistance	  protein	   2.04	   2.52E-­‐12	  
	   	   	   	   nrfF	   Cytochrome	  C-­‐type	  biogenesis	  protein	   2.04	   2.92E-­‐11	  
	   	   	   	   -­‐	   Sulfur	  transfer	  complex	  subunit	  TusB	   2.04	   0.001686842	  
	   	   	   	   mtgA	   Monofunctional	  biosynthetic	  peptidoglycan	  transglycosylase	   2.03	   1.47E-­‐05	  
	   	   	   	   modC	   Molybdate	  transporter	  ATP-­‐binding	  protein	   2.02	   2.63E-­‐11	  
	   	   	   	   cstA	   Carbon	  starvation	  protein	  A	   2.01	   1.57E-­‐06	  
	   	   	   	   -­‐	   tRNA-­‐Trp(cca)	   2.01	   0.04627	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Table	   S2:	   Differentially	   expressed	   genes	   in	   the	   R2866	   strain	   during	  
stationary	  phase.	  
	  
Gene	   Product	   Fold	  change	  
Adjusted	  





Up-­‐regulated	  genes	   Down-­‐regulated	  genes	  
tnaA	   Tryptophanase	   123.37	   0	   rpL29	   50S	  ribosomal	  protein	  L29	   23.53	   0	  
-­‐	   Alkylhydroperoxidase	  AhpD	  family	  core	  domain	  protein	   56.49	   0	   artP	   Arginine	  ABC	  transporter,	  ATP-­‐binding	  protein	  ArtP	   23.51	   0	  
tnaB	   Tryptophan	  permease	   32.04	   0	   rpL16	   50S	  ribosomal	  protein	  L16	   22.41	   0	  
afuA	  
Ferric	  transport	  system	  AfuABC;	  periplasmic-­‐binding	  protein	  component	   28.36	   0	   rpS17	   30S	  ribosomal	  protein	  S17	   20.09	   0	  
hxuC	   Haem-­‐hemopexin	  utilization	  protein	  C	   27.2	   0	   rpS3	   30S	  ribosomal	  protein	  S3	   18.93	   0	  
hxuB	   Haem-­‐hemopexin	  utilization	  protein	  B	   23.48	   0	   rpL7	   50S	  ribosomal	  protein	  L7/L12	   18.41	   0	  
hxuA	   Haem-­‐hemopexin	  utilization	  protein	  A	   20.61	   0	   rpL22	   50S	  ribosomal	  protein	  L22	   17.49	   0	  
yjiG	   Inner	  membrane	  protein	  YjiG	   20.3	   0	   artM	   Arginine	  ABC	  transporter,	  permease	  protein	  ArtM	   16.75	   0	  
-­‐	   Sporulation	  integral	  membrane	  protein	  YlbJ	   17.38	   0	   rpS19	   30S	  ribosomal	  protein	  S19	   16.64	   0	  
-­‐	   Putative	  peptidase	   14.64	   0	   potD	   Spermidine/putrescine	  ABC	  transporter,	  periplasmic-­‐binding	  protein	   16.2	   0	  
omp
U1	  
Putative	  outer	  membrane	  protein	  OmpU1	   14.28	   0	   rpL2	   50S	  ribosomal	  protein	  L2	   15.46	   0	  
-­‐	   Hypothetical	  protein	   13.01	   0	   rpL9	   50S	  ribosomal	  subunit	  protein	  L9	   15.33	   0	  
tbp2	   Transferrin-­‐binding	  protein	  2	   12.9	   0	   cca	   tRNA	  nucleotidyltransferase/2'3'-­‐cyclic	  phosphodiesterase/2'nucleotidase	  and	  phosphatase	   14.88	   0	  
-­‐	   Hypothetical	  protein	   12.9	   0	   artI	   Arginine	  ABC	  transporter,	  periplasmic-­‐binding	  protein	  ArtI	   13.75	   0	  
dpsA	   DPS	  ferritin-­‐like	  protein	   12.87	   0	   phoU	   Putative	  phosphate	  regulator	   13.56	   0	  
-­‐	   Hypothetical	  protein	   12.64	   0	   rpS18	   30S	  ribosomal	  subunit	  protein	  S18	   13.16	   0	  
galT	   Galactose-­‐1-­‐phosphate	  uridylyltransferase	   12.63	   0	   pitA	   Putative	  phosphate	  permease	   12.43	   0	  
tehB	   Putative	  tellurite	  resistance	  protein	  B	   12.2	   0	   rpL23	   50S	  ribosomal	  protein	  L23	   12.39	   0	  
-­‐	   Putative	  zinc-­‐type	  alcohol	  dehydrogenase	   11.74	   6.50E-­‐153	   rpL10	   50S	  ribosomal	  protein	  L10	   11.62	   0	  
glpF	   Aquaglyceroporin	  GlpF	   11.6	   0	   artQ	   Arginine	  ABC	  transporter,	  permease	  protein	  ArtQ	   11.5	   0	  
glpK	   Glycerol	  kinase	   11.21	   0	   rpL4	   50S	  ribosomal	  protein	  L4	   11.18	   0	  
-­‐	   Hypothetical	  protein	  p54	   11.13	   2.84E-­‐279	   -­‐	   SH3	  domain-­‐containing	  protein	   10.66	   0	  
tbp1	   Transferrin-­‐binding	  protein	  1	   10.54	   0	   priB	   Primosomal	  replication	  protein	  N	   10.58	   0	  
pckA	   Phosphoenolpyruvate	  carboxykinase	   9.58	   6.27E-­‐89	   rpL3	   50S	  ribosomal	  protein	  L3	   10.22	   0	  
-­‐	   Putative	  TonB-­‐dependent	  transport	  protein	   9.15	   5.74E-­‐167	   rps6	   30S	  ribosomal	  subunit	  protein	  S6	   9.27	   0	  
fucI	   L-­‐fucose	  isomerase	   9.14	   1.29E-­‐178	   rpS10	   30S	  ribosomal	  protein	  S10	   9.23	   0	  
-­‐	   Hypothetical	  protein	  p55	   8.92	   4.89E-­‐148	   rpL19	   50S	  ribosomal	  subunit	  protein	  L19	   9.15	   0	  
galK	   Galactokinase	   8.75	   0	   rpL1	   50S	  ribosomal	  subunit	  protein	  L1	   9.15	   0	  
afuB	  
Ferric	  transport	  system	  AfuABC;	  permease	  component	   8.41	   0	   deaD	   ATP-­‐dependent	  RNA	  helicase	  DeaD	   8.57	   0	  
pilA	   Type	  II	  secretory	  pathway,	  major	  prepilin	  PilA	   7.75	   3.27E-­‐86	   dat	   L-­‐2,4-­‐diaminobutyrate:2-­‐ketoglutarate	  4-­‐aminotransferase	  aminotransferase	   8.44	   0	  
speF	   Ornithine	  decarboxylase	   7.69	   0	   -­‐	   Hypothetical	  protein	   8.36	   1.83E-­‐21	  
yfiA	   Ribosome	  binding	  protein	  Y	   7.67	   7.33E-­‐87	   tsf	   Elongation	  factor	  Ts	   7.97	   0	  
pgdX	   Peroxiredoxin/glutaredoxin	   7.67	   0	   topB_ DNA	  topoisomerase	  III	   7.95	   9.67E-­‐282	  
	  	   249	  
glutathione-­‐dependent	  peroxidase	   1	  
Gene	   Product	   Fold	  change	  
Adjusted	  





Up-­‐regulated	  genes	   Down-­‐regulated	  genes	  
hitA	   Iron(III)	  ABC	  transporter	  periplasmic-­‐binding	  protein	   7.42	   0	   rpL11	   50S	  ribosomal	  subunit	  protein	  L11	   7.76	   0	  
glgB	   1,4-­‐alpha-­‐glucan	  branching	  enzyme	   6.95	   0	   rpS2	   30S	  ribosomal	  protein	  S2	   7.62	   0	  
-­‐	   Putative	  permease	   6.92	   0	   ahpC	   Peroxiredoxin	   7.57	   0	  
gpFII	   Putative	  bacteriophage	  tail	  tube	  protein	   6.79	   3.43E-­‐194	   ytfL_2	   Putative	  hemolysin	   7.57	   1.49E-­‐228	  
uspA	   Universal	  stress	  protein	  A	   6.68	   1.38E-­‐65	   fis	   DNA	  architectural	  protein	  Fis	   7.29	   0	  
galM	   Galactose-­‐1-­‐epimerase	  (mutarotase)	   6.62	   0	   thiE	   Thiamin-­‐phosphate	  pyrophosphorylase	   7.27	   4.13E-­‐159	  
afuC	  
Ferric	  transport	  system	  AfuABC;	  ATP-­‐binding	  component	   6.55	   0	   yidD	   Putative	  membrane	  protein	  insertion	  efficiency	  factor	   6.85	   1.61E-­‐237	  
-­‐	   Hypothetical	  protein	   6.55	   6.64E-­‐238	   rpS9	   30S	  ribosomal	  protein	  S9	   6.61	   0	  
-­‐	   Hypothetical	  protein	   6.37	   5.28E-­‐227	   argG	   Argininosuccinate	  synthetase	   6.46	   0	  
-­‐	   tRNA-­‐Leu(caa)	   6.3	   1.98E-­‐33	   thiM	   Hydroxyethylthiazole	  kinase	   6.42	   2.08E-­‐198	  
-­‐	   Hypothetical	  protein	   6.18	   0	   trmD	   tRNA	  (guanine-­‐N1)-­‐methyltransferase	   6.35	   0	  
-­‐	   Hypothetical	  protein	   6.15	   0	   rho	   Hypothetical	  protein	   6.28	   0	  
gpFI	   Putative	  bacteriophage	  tail	  sheath	  protein	   6.06	   4.42E-­‐238	   yhjE	   Putative	  permease	   6.28	   4.60E-­‐242	  
-­‐	   Hypothetical	  protein	   5.98	   2.42E-­‐99	   potD2	   Spermidine/putrescine	  ABC	  transporter,	  periplasmic-­‐binding	  protein	   6.25	   0	  
pulG	   Type	  II	  secretory	  pathway,	  pseudopilin	   5.93	   3.97E-­‐20	   thiD	   Phosphomethylpyrimidine	  kinase	   6.15	   4.74E-­‐228	  
-­‐	   Putative	  antirestriction	  protein	   5.86	   7.20E-­‐31	   tufA	   Elongation	  factor	  Tu	  (EF-­‐Tu)	   5.96	   0	  
-­‐	   Putative	  bacteriophage	  lysozyme	   5.8	   2.87E-­‐25	   -­‐	   Putative	  ABC	  transporter,	  fused	  permease	  and	  ATP-­‐binding	  components	   5.86	   1.04E-­‐268	  
comA	   Competence	  operon	  protein	  A	   5.77	   2.96E-­‐35	   -­‐	   Hypothetical	  protein	   5.81	   4.21E-­‐168	  
ssrA	   Transfer-­‐messenger	  RNA,	  SsrA	   5.76	   0	   Hgd	   2-­‐(hydroxymethyl)glutarate	  dehydrogenase	   5.71	   1.98E-­‐136	  
ompE	   Adhesin	  protein	  E	  (PE)	   5.75	   9.27E-­‐273	   fdx-­‐2	   Putative	  4Fe-­‐4S	  ferredoxin-­‐type	  protein	   5.69	   3.11E-­‐52	  
-­‐	   Hypothetical	  protein	   5.74	   3.82E-­‐16	   rpL13	   50S	  ribosomal	  protein	  L13	   5.67	   0	  
glgC	   Glucose-­‐1-­‐phosphate	  adenylyltransferase	   5.7	   5.78E-­‐290	   rpS5	   30S	  ribosomal	  protein	  S5	   5.62	   0	  
-­‐	   16S	  ribosomal	  RNA	   5.7	   2.51E-­‐05	   rnb	   Ribonuclease	  II	   5.62	   0	  
-­‐	   Hypothetical	  protein	  p56_2	   5.68	   8.81E-­‐108	   -­‐	   tRNA-­‐Ile(gat)	   5.6	   2.36E-­‐298	  
gpE	   Putative	  bacteriophage	  tail	  protein	  E	   5.68	   1.33E-­‐74	   rimM	   16S	  rRNA	  processing	  protein	  RimM	   5.56	   0	  
gpE+
E'	  
Putative	  bacteriophage	  tail	  protein	  E+E'	   5.68	   5.25E-­‐42	   ygbL	   Putative	  sugar	  aldolase/epimerase	   5.45	   2.75E-­‐91	  
gpO	   Putative	  bacteriophage	  capsid	  scaffolding	  protein	   5.66	   2.32E-­‐146	   argH	   Argininosuccinate	  lyase	   5.44	   2.41E-­‐285	  
-­‐	  
Putative	  TRAP-­‐type	  transport	  system,	  small	  permease	  component	   5.45	   8.18E-­‐57	   fabH	   Beta-­‐ketoacyl-­‐ACP	  synthase	  III	   5.38	   0	  
glgX	   Glycogen	  debranching	  enzyme	   5.41	   9.41E-­‐294	   tufB	   Elongation	  factor	  Tu	  (EF-­‐Tu)	   5.38	   0	  
rbsD	   D-­‐ribose	  pyranase	   5.35	   4.15E-­‐51	   psd	   Phosphatidylserine	  decarboxylase	   5.37	   9.63E-­‐277	  
moa
D	  
Molybdopterin	  synthase,	  small	  subunit	   5.34	   4.76E-­‐247	   ispF	   2-­‐C-­‐methyl-­‐D-­‐erythritol	  2,4-­‐cyclodiphosphate	  synthase	   5.36	   1.83E-­‐207	  
-­‐	  
Putative	  TRAP-­‐type	  transport	  system,	  periplasmic	  component	   5.31	   6.87E-­‐95	   secY	   Protein	  translocase	  subunit	  SecY	   5.35	   0	  
com
M_1	   Competence	  protein	  ComM	   5.28	   4.80E-­‐19	   recJ	   Single-­‐stranded-­‐DNA-­‐specific	  exonuclease	  RecJ	   5.33	   6.98E-­‐229	  
dprA	   DNA	  processing	  chain	  A	   5.26	   6.26E-­‐30	   rpL31	   50S	  ribosomal	  subunit	  protein	  L31	   5.3	   0	  
aspT	   Aspartate/alanine	  antiporter	   5.25	   1.33E-­‐38	   cmoA	   tRNA	  cmo(5)U34	  methyltransferase,	  SAM-­‐dependent	   5.29	   0	  
groE
S	   GroES,	  chaperone	  Hsp10	   5.23	   3.66E-­‐179	   bipA	   Ribosome	  binding	  GTPase	  BipA	   5.26	   0	  
malQ	   4-­‐alpha-­‐glucanotransferase	  (amylomaltase)	   5.23	   4.48E-­‐41	   rpL6	   50S	  ribosomal	  protein	  L6	   5.23	   0	  
fucR	   L-­‐fucose	  operon	  regulator	   5.17	   1.42E-­‐194	   rpL18	   50S	  ribosomal	  protein	  L18	   5.23	   0	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fucA	   L-­‐fuculose	  phosphate	  aldolase	   5.12	   3.39E-­‐54	   mdaB	   NADPH	  quinone	  reductase	   5.03	   4.11E-­‐33	  
fbp	   Fructose-­‐1,6-­‐bisphosphatase	   5.11	   4.98E-­‐276	   rplQ	   50S	  ribosomal	  protein	  L17	   5.01	   0	  
moaE	   Molybdopterin	  synthase,	  large	  subunit	   5.11	   1.38E-­‐271	   -­‐	   Putative	  membrane	  protein	   4.93	   2.46E-­‐82	  
cspD	   Cold	  shock	  protein	  CspD	   5.08	   5.17E-­‐200	   rpS8	   30S	  ribosomal	  protein	  S8	   4.9	   0	  
msrA
B	  
Peptide	  methionine	  sulfoxide	  reductase	   5.06	   1.82E-­‐59	   acrA	   Multidrug	  efflux	  system	  protein	  AcrA	   4.88	   0	  
clpB	   ATP-­‐dependent	  Clp	  protease	  ATPase	  subunit	   5.02	   2.12E-­‐57	   yidC	   Inner	  membrane	  translocation	  protein	  YidC	   4.87	   0	  
trxM	   Thioredoxin	   5.01	   0	   rpL15	   50S	  ribosomal	  protein	  L15	   4.78	   0	  
aspA	   Aspartate	  ammonia-­‐lyase	  (aspartase)	   4.98	   3.22E-­‐37	   recR	   Recombination	  protein	  RecR	   4.74	   7.14E-­‐213	  
gpN	   Putative	  bacteriophage	  major	  capsid	  protein	   4.98	   2.19E-­‐176	   infB	   Translation	  initiation	  factor	  2	   4.7	   0	  
cbiK	  
Nickel	  and	  cobalt	  ABC	  transporter,	  periplasmic	  binding	  protein	   4.96	   2.09E-­‐91	   rimP	   30S	  ribosomal	  maturation	  protein	  RimP	   4.69	   3.46E-­‐164	  
-­‐	   Hypothetical	  protein	  HP2p14	   4.93	   1.89E-­‐291	   ispD	   2-­‐C-­‐methyl-­‐D-­‐erythritol	  4-­‐phosphate	  cytidylyltransferase	   4.65	   2.05E-­‐199	  
rbsB	   D-­‐ribose	  ABC	  transporter,	  periplasmic-­‐binding	  protein	   4.9	   6.93E-­‐171	   acrB	   Multidrug	  efflux	  system	  protein	  AcrB	   4.62	   0	  
-­‐	   Putative	  TPR	  repeat	  protein	   4.89	   7.09E-­‐34	   -­‐	   tRNA-­‐Trp(cca)	   4.61	   8.86E-­‐10	  
-­‐	   DksA-­‐like	  zinc	  finger	  domain	  containing	  protein	   4.88	   1.01E-­‐12	   -­‐	   tRNA-­‐Asn(gtt)	   4.57	   1.27E-­‐63	  
-­‐	   Hypothetical	  protein	   4.87	   1.97E-­‐28	   folK	   7,8-­‐dihydro-­‐6-­‐hydroxymethylpterin-­‐	  pyrophosphokinase	   4.56	   9.32E-­‐86	  
-­‐	   5S	  ribosomal	  RNA	   4.83	   0.032303	   pcnB	   Poly(A)	  polymerase	  I	   4.48	   4.63E-­‐220	  
gpR	   Putative	  bacteriophage	  tail	  completion	  protein	   4.8	   1.18E-­‐12	   -­‐	   tRNA-­‐Ala(tgc)	   4.47	   1.16E-­‐223	  
gpU	   Putative	  bacteriophage	  protein	  U	   4.78	   1.78E-­‐24	   rpS16	   30S	  ribosomal	  subunit	  protein	  S16	   4.45	   0	  
-­‐	   5S	  ribosomal	  RNA	   4.69	   0.035681099	   infA	   Translation	  initiation	  factor	  1	  (IF-­‐1)	   4.44	   4.10E-­‐187	  
-­‐	   Putative	  methyltransferase	   4.67	   7.75E-­‐190	   nlpI	   Lipoprotein	  NlpI	   4.34	   8.43E-­‐219	  
gpP	   Putative	  bacteriophage	  terminase,	  ATPase	  subunit	   4.66	   5.67E-­‐42	   dxr	   1-­‐deoxy-­‐D-­‐xylulose	  5-­‐phosphate	  reductoisomerase	   4.34	   9.75E-­‐248	  
yeaD	   Putative	  glucose-­‐6-­‐phosphate	  1-­‐epimerase	   4.62	   4.83E-­‐199	   rpL30	   50S	  ribosomal	  protein	  L30	   4.33	   0	  
nanM	   Putative	  N-­‐acetylneuraminate	  epimerase	   4.6	   1.52E-­‐239	   rsmE	   16S	  rRNA	  methyltransferase	   4.31	   1.11E-­‐134	  
oppA	  
Oligopeptide	  ABC	  transporter,	  periplasmic-­‐binding	  protein	  OppA	   4.6	   0	   -­‐	   Putative	  membrane	  transporter	   4.29	   3.60E-­‐132	  
galR	   Galactose	  operon	  regulator	   4.5	   1.07E-­‐85	   nusA	   Transcription	  elongation	  factor	  NusA	   4.28	   0	  
pulJ	   Type	  II	  secretory	  pathway,	  pseudopilin	   4.49	   1.41E-­‐20	   mutT	   NTP	  pyrophosphohydrolase	  (MutT)	  (7,8-­‐dihydro-­‐8-­‐oxoguanine-­‐triphosphatase)	   4.23	   1.10E-­‐34	  
gpW	   Putative	  phage	  baseplate	  assembly	  protein	  W	   4.48	   1.26E-­‐24	   rpS14	   30S	  ribosomal	  protein	  S14	   4.2	   0	  
-­‐	   Hypothetical	  protein	   4.44	   5.88E-­‐06	   yegQ	   Putative	  protease	   4.16	   3.17E-­‐256	  
ytfE	   Iron-­‐sulfur	  repair	  protein	  YtfE	   4.42	   1.47E-­‐118	   hslO	   Hsp33-­‐like	  chaperonin	   4.13	   3.63E-­‐120	  
com
M_2	   Competence	  protein	  ComM	   4.41	   2.02E-­‐54	   -­‐	   Putative	  ABC	  transporter	  permease	  protein	   4.1	   9.09E-­‐41	  
hemR	   Putative	  TonB-­‐dependent	  haem	  receptor	   4.4	   4.35E-­‐251	   atpC	   Membrane-­‐bound	  ATP	  synthase,	  F1	  sector,	  epsilon-­‐subunit	   4.08	   1.26E-­‐211	  
-­‐	   LamB/YcsF	  family	  protein	   4.36	   2.51E-­‐90	   betT	   Osmoprotection-­‐related	  protein	  BetT	   4.07	   9.62E-­‐160	  
groE
L	   GroEL,	  chaperone	  Hsp60	   4.34	   1.39E-­‐53	   hrpA	   Putative	  ATP-­‐dependent	  RNA	  helicase	   4.03	   0	  
xylB_
2	   Xylulose	  kinase	   4.31	   4.59E-­‐32	   atpG	   Membrane-­‐bound	  ATP	  synthase,	  F1	  sector,	  gamma-­‐subunit	   4.02	   0	  
-­‐	   Putative	  bacteriophage	  holin	  protein	   4.31	   5.42E-­‐11	   ilvA	   Threonine	  deaminase	   4.02	   2.49E-­‐180	  
-­‐	   Hypothetical	  protein	   4.29	   1.23E-­‐94	   rrf	   Ribosome	  releasing	  factor	   4.02	   3.93E-­‐273	  
-­‐	   Hypothetical	  protein	   4.22	   6.29E-­‐282	   -­‐	   tRNA-­‐Phe(gaa)	   4.01	   1.39E-­‐156	  
comB	   Competence	  operon	  protein	  B	   4.19	   2.50E-­‐12	   fusA	   Elongation	  factor	  G	  (EF-­‐G)	   3.99	   0	  
potE	   Putrescine-­‐ornithine	   4.16	   0	   -­‐	   Putative	  ABC	  transporter	   3.97	   6.77E-­‐54	  
	  	   251	  
antiporter	   periplasmic	  binding	  protein	  
Gene	   Product	   Fold	  change	  
Adjusted	  





Up-­‐regulated	  genes	   Down-­‐regulated	  genes	  
gpM	   Putative	  bacteriophage	  terminase	  subunit	   4.07	   1.04E-­‐101	   -­‐	   tRNA-­‐Asn(gtt)	   3.97	   3.64E-­‐144	  
ccmG
_1	  
Haem	  lyase/disulfide	  oxidoreductase	  (DsbE)	   4.04	   4.10E-­‐20	   -­‐	   tRNA-­‐Glu(ttc)	   3.94	   2.04E-­‐156	  
gpI	   Putative	  bacteriophage	  tail	  protein	  gpI	   4.03	   2.64E-­‐18	   atpH	   Membrane-­‐bound	  ATP	  synthase,	  F1	  sector,	  delta-­‐subunit	   3.93	   2.47E-­‐294	  
-­‐	   Hypothetical	  protein	   4.02	   4.69E-­‐07	   nrdA	   Ribonucleoside-­‐diphosphate	  reductase	  1,	  alpha	  subunit	   3.91	   2.26E-­‐231	  
sdaC	   Putative	  serine	  transporter	   4.02	   2.78E-­‐160	   tusB	   Putative	  tRNA	  2-­‐thiouridine	  synthesizing	  protein	  B	   3.9	   7.30E-­‐32	  
nhaC	   Putative	  Na+/H+	  antiporter	   4.01	   1.08E-­‐117	   glnE	   Glutamate-­‐ammonia-­‐ligase	  adenylyltransferase	  (ATase)	   3.89	   2.93E-­‐180	  
-­‐	   Hypothetical	  protein	   4	   4.24E-­‐81	   -­‐	   tRNA-­‐Thr(ggt)	   3.89	   2.08E-­‐300	  
dsbD
_1	  
Thiol-­‐disulfide	  interchange	  protein	  DsbD	   3.98	   5.61E-­‐21	   rnt	   Ribonuclease	  T	   3.88	   2.83E-­‐161	  
gpD	   Putative	  bacteriophage	  protein	  D	   3.97	   1.63E-­‐36	   fmt	   Methionyl-­‐tRNA	  formyltransferase	   3.86	   5.56E-­‐261	  
pflA_
1	  
Pyruvate	  formate-­‐lyase	  activating	  enzyme	   3.94	   4.28E-­‐189	   -­‐	   Putative	  chromosome	  partitioning	  related	  protein	   3.85	   4.75E-­‐42	  
deoC	   Deoxyribose-­‐phosphate	  aldolase	   3.94	   1.73E-­‐282	   rpS20	   30S	  ribosomal	  protein	  S20	   3.82	   0	  
fucP	   L-­‐fucose	  permease	   3.88	   8.35E-­‐69	   tenA	   Thiaminase-­‐2	   3.8	   6.54E-­‐52	  
bphH	   Putative	  glutathione-­‐S-­‐transferase	   3.84	   3.43E-­‐264	   rnpA	   Ribonuclease	  P,	  protein	  component	   3.79	   1.57E-­‐199	  
rbsC	   D-­‐ribose	  ABC	  transporter,	  permease	  protein	   3.83	   4.83E-­‐64	   ponB	   Penicillin-­‐binding	  protein	  1B	   3.74	   2.89E-­‐110	  
moaC	   Molybdenum	  cofactor	  biosynthesis	  protein	  C	   3.83	   1.15E-­‐213	   cya	   Adenylate	  cyclase	   3.73	   7.78E-­‐273	  
mobB	  
Molybdopterin-­‐guanine	  dinucleotide	  biosynthesis	  protein	  B	   3.82	   5.51E-­‐287	   -­‐	   Hypothetical	  protein	   3.73	   8.91E-­‐116	  
-­‐	   DNA	  binding	  domain,	  excisionase	  family	   3.79	   3.19E-­‐08	   dam_1	   DNA	  adenine	  methylase	   3.72	   3.86E-­‐76	  
-­‐	   Hypothetical	  protein	   3.77	   1.17E-­‐05	   trpX	   tRNA	  delta(2)-­‐isopentenylpyrophosphate	  transferase	  (IPTase)	   3.71	   2.05E-­‐138	  
gpS	   Putative	  bacteriophage	  tail	  completion	  protein	   3.76	   3.29E-­‐07	   rplE	   50S	  ribosomal	  protein	  L5	   3.68	   0	  
rbsA	   D-­‐ribose	  ABC	  transporter,	  ATP-­‐binding	  protein	   3.72	   2.07E-­‐59	   atpD	   Membrane-­‐bound	  ATP	  synthase,	  F1	  sector,	  beta-­‐subunit	   3.66	   0	  
-­‐	   Hypothetical	  protein	  p13	   3.69	   3.60E-­‐155	   yjjP	   Inner	  membrane	  protein	  YjjP	   3.65	   7.82E-­‐18	  
gpL	   Putative	  bacteriophage	  capsid	  completion	  protein	   3.69	   1.01E-­‐21	   vcaM	   Putative	  ABC	  transporter,	  multidrug	  efflux	  pump	   3.64	   7.08E-­‐234	  
-­‐	   Putative	  5'(3')-­‐deoxyribonucleotidase	   3.67	   3.23E-­‐35	   nhaA	   Na+/H+	  antiporter	  1	   3.63	   8.19E-­‐186	  
-­‐	   Putative	  bacteriophage	  tail	  collar	  protein	   3.66	   1.33E-­‐13	   tgt	   tRNA-­‐guanine	  transglycosylase	   3.62	   3.77E-­‐166	  
gpJ	   Phage	  baseplate-­‐assembly	  protein	  J	   3.65	   2.59E-­‐30	   atpF	   Membrane-­‐bound	  ATP	  synthase,	  F0	  sector,	  subunit	  B	   3.6	   3.33E-­‐198	  
hktE	   Catalase	   3.63	   7.16E-­‐87	   -­‐	   Hypothetical	  protein	  HP2p11	   3.58	   2.38E-­‐13	  
kipA	   KipI	  antagonist	   3.63	   5.14E-­‐81	   ygbM	   Putative	  hydroxypyruvate	  isomerase	  YgbM	   3.57	   6.02E-­‐67	  
-­‐	   Putative	  phage	  tail-­‐fiber	  protein	   3.61	   2.30E-­‐06	   lpxB	   Lipid-­‐A-­‐disaccharide	  synthetase	   3.55	   8.00E-­‐211	  
-­‐	   23S	  ribosomal	  RNA	   3.6	   1.17E-­‐06	   ftsB	   Putative	  cell	  division	  protein	  ftsB	   3.54	   2.14E-­‐79	  
-­‐	   Hypothetical	  protein	   3.59	   1.92E-­‐13	   mopI	   Molybdate-­‐binding	  protein	   3.54	   6.78E-­‐49	  
-­‐	   Bacteriophage	  Lambda	  NinG	  protein	   3.58	   6.59E-­‐07	   lolB	   Outer	  membrane	  lipoprotein	  LolB	   3.51	   3.80E-­‐149	  
pilB	   Type	  II	  secretory	  pathway,	  ATPase	  component	  PilB	   3.56	   3.26E-­‐41	   -­‐	   Putative	  ABC	  transport	  system,	  ATP-­‐binding	  protein	   3.5	   1.82E-­‐283	  
comD	   Competence	  operon	  protein	  D	   3.54	   5.15E-­‐11	   rpL33	   50S	  ribosomal	  protein	  L33	   3.48	   3.14E-­‐293	  
merT	   Putative	  heavy	  metal	  transport	  protein	   3.48	   6.35E-­‐42	   rpL24	   50S	  ribosomal	  protein	  L24	   3.47	   0	  
patB	   putative	  PLP-­‐dependent	  aminotransferase	   3.46	   1.58E-­‐21	   rpS1	   30S	  ribosomal	  protein	  S1	   3.46	   0	  
-­‐	   Putative	  short-­‐chain	  alcohol	  dehydrogenase	   3.42	   1.09E-­‐146	   atpA	   Membrane-­‐bound	  ATP	  synthase,	  F1	  sector,	  alpha-­‐subunit	   3.45	   9.39E-­‐283	  
kdgA	   2-­‐keto-­‐3-­‐deoxygluconate	  6-­‐phosphate	  aldolase	  and	  2-­‐ 3.41	   2.44E-­‐125	   pgpB	   Putative	  phosphatidylglycerophospha 3.44	   3.47E-­‐77	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comE	   Outer	  membrane	  secretin	  ComE	   3.41	   1.51E-­‐46	   accC	   Acetyl-­‐CoA	  carboxylase,	  biotin	  carboxylase	  subunit	   3.44	   0	  
-­‐	   Putative	  NAD-­‐dependent	  protein	  deacetylase	   3.41	   5.41E-­‐49	   -­‐	   tRNA-­‐Gly(tcc)	   3.43	   0	  
pflB_
2	   Formate	  acetyltransferase	  1	   3.4	   7.22E-­‐205	   tusE	   tRNA	  2-­‐thiouridine	  synthesizing	  protein	  E	   3.42	   4.64E-­‐64	  
htpG	   Chaperone	  Hsp90	   3.37	   5.51E-­‐108	   -­‐	   Hypothetical	  protein	   3.41	   9.02E-­‐13	  
pdxH	   Putative	  pyridoxamine	  5'-­‐phosphate	  oxidase	   3.37	   1.38E-­‐162	   -­‐	   Nucleoid-­‐associated	  protein	   3.35	   8.93E-­‐141	  
ycsG	   Putative	  transporter	   3.37	   1.11E-­‐89	   oatA_1	   O-­‐acetyltransferase	  OatA	   3.32	   1.09E-­‐31	  
moaA	   Molybdenum	  cofactor	  biosynthesis	  protein	  A	   3.33	   2.88E-­‐283	   tusC	   tRNA	  2-­‐thiouridine	  synthesizing	  protein	  C	   3.32	   3.92E-­‐47	  
ligA	   ATP-­‐dependent	  DNA	  ligase	   3.32	   2.92E-­‐10	   rrmB	   16S	  rRNA	  m5C967	  methyltransferase	   3.32	   9.24E-­‐189	  
-­‐	   Putative	  NAD-­‐dependent	  protein	  deacetylase	   3.3	   7.48E-­‐27	   rimO	   Ribosomal	  protein	  S12	  methylthiotransferase	   3.31	   1.45E-­‐245	  
gpV	   Phage	  baseplate	  assembly	  protein	  V	   3.27	   1.41E-­‐40	   tig	   Trigger	  factor	   3.28	   0	  
fucU	   L-­‐fucose	  mutarotase	   3.26	   4.17E-­‐11	   ttcA	   tRNA	  2-­‐thiocytidine	  biosynthesis	  protein	  TtcA	   3.28	   1.64E-­‐138	  
-­‐	   Glycine	  radical	  enzyme,	  YjjI	  family	   3.25	   5.64E-­‐139	   rnhB	   Ribonuclease	  HII	   3.27	   1.45E-­‐94	  
-­‐	   hypothetical	  protein	   3.25	   1.33E-­‐17	   rpoA	   DNA-­‐directed	  RNA	  polymerase	  subunit	  alpha	   3.26	   0	  
-­‐	   Putative	  TPR	  repeat	  protein	   3.23	   1.46E-­‐09	   -­‐	   YheO-­‐like	  PAS	  domain	  protein	   3.26	   3.06E-­‐154	  
-­‐	   Putative	  type	  II	  secretory	  pathway,	  pseudopilin	   3.23	   1.39E-­‐08	   ruvC	   Holliday	  junction	  resolvasome,	  endodeoxyribonuclease	  subunit	   3.23	   1.52E-­‐84	  
gpX	   Putative	  bacteriophage	  tail	  protein	  X	   3.23	   1.38E-­‐10	   rpL28	   50S	  ribosomal	  protein	  L28	   3.21	   0	  
-­‐	   Hypothetical	  protein	   3.23	   2.10E-­‐41	   -­‐	   Hypothetical	  protein	   3.19	   2.64E-­‐93	  
tnpA	   Transposon	  Tn3	  transposase	   3.22	   9.29E-­‐167	   nlpD	   Putative	  metallopeptidase	   3.18	   1.94E-­‐126	  
-­‐	   Hypothetical	  protein	   3.22	   9.17E-­‐59	   sapF	   Peptide	  ABC	  transporter	  system,	  ATPase	  protein	  SapF	   3.18	   2.12E-­‐87	  
gpQ	   Putative	  bacteriophage	  capsid	  portal	  protein	   3.22	   4.38E-­‐16	   tusD	   tRNA	  2-­‐thiouridine	  synthesizing	  protein	  D	   3.17	   2.85E-­‐83	  
atoA	   Acetyl-­‐CoA:acetoacetyl-­‐CoA	  transferase,	  beta	  subunit	   3.21	   1.93E-­‐16	   rep_2	   ATP-­‐dependent	  DNA	  helicase	  Rep	   3.14	   8.00E-­‐167	  
cbiL	   Nickel	  and	  cobalt	  ABC	  transporter	  component	   3.21	   7.64E-­‐30	   pqiB	   Paraquat-­‐inducible	  protein	  B	   3.13	   2.00E-­‐150	  
-­‐	   Transglutaminase-­‐like	  superfamily	  protein	   3.2	   1.08E-­‐205	   rps7	   30S	  ribosomal	  subunit	  protein	  S7	   3.12	   1.18E-­‐264	  
-­‐	   Hypothetical	  protein	   3.2	   6.93E-­‐38	   cydD2	   Putative	  glutathione	  ABC	  transporter,	  fused	  ATPase	  and	  permease	   3.12	   1.52E-­‐62	  
comC	   Competence	  operon	  protein	  C	   3.19	   3.57E-­‐12	   -­‐	   Hypothetical	  protein	   3.12	   5.50E-­‐29	  
merR
2	  
Putative	  metal-­‐binding	  transcriptional	  regulator	   3.19	   7.11E-­‐62	   thrC	   Threonine	  synthase	   3.1	   9.01E-­‐140	  
mglB	   Galactoside	  ABC	  transporter,	  periplasmic	  binding	  protein	   3.16	   6.19E-­‐241	   ispE	   4-­‐diphosphocytidyl-­‐2-­‐C-­‐methyl-­‐D-­‐erythritol	  kinase	   3.1	   2.05E-­‐207	  
-­‐	   Hypothetical	  protein	  p47	   3.16	   8.30E-­‐25	   ppiB	   Peptidyl-­‐prolyl	  cis-­‐trans	  isomerase	  B	  (rotamase	  B)	   3.06	   2.42E-­‐142	  
talB	   Transaldolase	  B	   3.14	   0	   cydA	   Cytochrome	  D	  ubiquinol	  oxidase	  subunit	  I	   2.99	   3.03E-­‐294	  
iscR	   Transcriptional	  regulator	  IscR	   3.12	   9.64E-­‐197	   -­‐	   Epimerase	  family	  protein	   2.96	   6.66E-­‐68	  
maeB	   NADP-­‐dependent	  malic	  enzyme	  (NADP-­‐ME)	   3.12	   1.32E-­‐139	   brnQ	   Putative	  branched-­‐chain	  amino	  acid	  transport	  system	  II	  carrier	  protein	   2.95	   4.61E-­‐125	  
phoB	  
Phosphate	  regulon	  transcriptional	  regulatory	  protein	   3.11	   3.43E-­‐199	   glmS	   Glucosamine-­‐fructose-­‐6-­‐phosphate	  aminotransferase	   2.95	   2.61E-­‐110	  
fdx-­‐1	   [2FE-­‐2S]	  Ferredoxin,	  electron	  carrer	  protein	   3.1	   3.14E-­‐151	   ksgA	   S-­‐adenosylmethionine-­‐6-­‐N,N-­‐adenosyl	  (rRNA)	  dimethyltransferase	   2.95	   1.96E-­‐85	  
-­‐	   Hypothetical	  protein	  p56_1	   3.1	   1.66E-­‐32	   rlmB	   23S	  rRNA	  methyltransferase	   2.94	   1.10E-­‐66	  
-­‐	   Hypothetical	  protein	  p49	   3.1	   5.77E-­‐146	   -­‐	   Hypothetical	  outer	  membrane	  protein	   2.94	   2.43E-­‐10	  
yciH	   Translation	  initiation	  factor	  Sui1	   3.09	   1.97E-­‐78	   -­‐	   tRNA-­‐Leu(taa)	   2.94	   2.07E-­‐101	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-­‐	   5S	  ribosomal	  RNA	   3.08	   0.04978	   -­‐	   Hypothetical	  protein	   2.93	   2.22E-­‐77	  
yccA	   Modulator	  of	  FtsH	  protease	  YccA	   3.06	   4.25E-­‐235	   ilvD	   Dihydroxyacid	  dehydratase	   2.92	   1.16E-­‐157	  
glgA	   Glycogen	  synthase	   3.06	   3.76E-­‐162	   azlC	   Putative	  branched-­‐chain	  amino	  acid	  permease	  AzlC	   2.92	   4.38E-­‐37	  
serC	   Phosphoserine	  aminotransferase	   3.05	   2.34E-­‐144	   rumA	   23S	  rRNA	  methyltransferase	   2.91	   3.10E-­‐74	  
pstA	   Phosphate	  ABC	  transport	  system,	  permease	  component	   3.05	   8.41E-­‐55	   -­‐	   Putative	  permease	   2.9	   9.74E-­‐97	  
ydeM	   Hypothetical	  protein	   3.05	   7.70E-­‐66	   pilF	   Transformation	  and	  Tfp-­‐related	  protein	  PilF	   2.9	   1.17E-­‐27	  
-­‐	   Hypothetical	  protein	   3.02	   5.53E-­‐50	   fruA	   PTS	  system,	  fructose-­‐specific	  IIBC	  component	   2.89	   5.03E-­‐165	  
lon	   ATP-­‐dependent	  protease	  La	   2.99	   7.94E-­‐197	   -­‐	   Putative	  transport	  protein	   2.87	   2.52E-­‐64	  
-­‐	   Hypothetical	  protein	   2.99	   1.82E-­‐73	   dusB	   tRNA-­‐dihydrouridine	  synthase	  B	   2.87	   6.48E-­‐235	  
-­‐	   Putative	  bacteriophage	  integrase	   2.98	   2.38E-­‐43	   rpS4	   30S	  ribosomal	  protein	  S4	   2.87	   0	  
yabJ	   Enamine/imine	  deaminase	   2.96	   2.52E-­‐64	   res	   Type	  III	  restriction-­‐modification	  system	  restriction	  enzyme	  (HindVIP)	   2.87	   2.83E-­‐202	  
-­‐	   Hypothetical	  protein	   2.96	   1.33E-­‐68	   -­‐	   Putative	  prophage	  antirepressor	  protein	   2.86	   5.64E-­‐18	  
iscS	   Cysteine	  desulfurase	  IscS	   2.95	   2.22E-­‐229	   trpCF	   Indole-­‐3-­‐glycerol	  phosphate	  synthase/phosphoribosylanthranilate	  isomerase	   2.85	   2.03E-­‐71	  
atoD	   Acetyl-­‐CoA:acetoacetyl-­‐CoA	  transferase,	  alpha	  subunit	   2.94	   3.48E-­‐13	   yebS	   Inner	  membrane	  protein	  YebS	   2.84	   9.60E-­‐67	  
gdhA	   Glutamate	  dehydrogenase,	  NADP-­‐specific	   2.92	   4.55E-­‐78	   lpxD	   UDP-­‐3-­‐O-­‐(3-­‐hydroxymyristoyl)-­‐glucosamine	  N-­‐acyltransferase	   2.84	   1.05E-­‐142	  
-­‐	   Hypothetical	  protein	   2.92	   1.02E-­‐37	   polA	   DNA	  polymerase	  I	   2.83	   8.62E-­‐183	  
sixA	   Phosphohistidine	  phosphatase	  SixA	   2.91	   1.93E-­‐35	   prsA	   Ribose-­‐phosphate	  pyrophosphokinase	   2.83	   1.75E-­‐195	  
merP	   Putative	  heavy	  metal	  chaperone	  protein	   2.89	   5.62E-­‐45	   rpL14	   50S	  ribosomal	  protein	  L14	   2.81	   2.52E-­‐283	  
-­‐	   Hypothetical	  protein	   2.88	   1.11E-­‐09	   cydB	   Cytochrome	  d	  ubiquinol	  oxidase	  subunit	  II	   2.8	   4.70E-­‐222	  
-­‐	   Putative	  type	  II	  secretory	  pathway,	  pseudopilin	   2.88	   2.57E-­‐18	   -­‐	   Hypothetical	  protein	   2.8	   9.09E-­‐69	  
rbsK	   Ribokinase	   2.87	   9.69E-­‐83	   rpL25	   50S	  ribosomal	  protein	  L25	   2.79	   6.53E-­‐217	  
metC	   Cystathionine	  beta-­‐lyase	   2.86	   4.88E-­‐163	   menA	   1,4-­‐dihydroxy-­‐2-­‐naphthoate	  octaprenyltransferase	   2.78	   4.98E-­‐70	  
-­‐	   Hypothetical	  protein	   2.86	   0.000291	   -­‐	   tRNA-­‐Tyr(gta)	   2.78	   1.25E-­‐168	  
glmM	   Phosphoglucosamine	  mutase	   2.85	   8.99E-­‐172	   nth	   DNA	  glycosylase	  and	  apyrimidinic	  (AP)	  lyase	  (endonuclease	  III)	   2.77	   3.92E-­‐44	  
-­‐	   Hypothetical	  protein	   2.85	   1.25E-­‐23	   -­‐	   Putative	  transcriptional	  regulatory	  protein	   2.76	   5.78E-­‐151	  
dapA	   Dihydrodipicolinate	  synthetase	   2.84	   2.57E-­‐243	   tdeA	   Outer	  membrane	  efflux	  porin	  TdeA	   2.75	   2.54E-­‐170	  
fucK	   L-­‐fuculokinase	   2.84	   3.34E-­‐13	   acrR	   Putative	  transcriptional	  regulator	  AcrR	   2.73	   1.46E-­‐88	  
-­‐	   Hypothetical	  protein	   2.84	   4.87E-­‐65	   pfs	   5'-­‐methylthioadenosine/S-­‐adenosylhomocysteine	  nucleosidase	   2.73	   9.94E-­‐54	  
-­‐	   Hypothetical	  protein	   2.83	   5.31E-­‐150	   -­‐	   Putative	  protein-­‐S-­‐isoprenylcysteine	  methyltransferase	   2.73	   4.77E-­‐108	  
-­‐	   Hypothetical	  protein	   2.81	   6.49E-­‐38	   -­‐	   Hypothetical	  protein	   2.72	   1.58E-­‐19	  
-­‐	   Hypothetical	  protein	   2.8	   5.38E-­‐17	   rpL32	   50S	  ribosomal	  protein	  L32	   2.71	   1.19E-­‐118	  
-­‐	   Putative	  N-­‐carbamyl-­‐L-­‐amino	  acid	  amidohydrolase	   2.79	   1.67E-­‐131	   azlD	   Putative	  branched-­‐chain	  amino	  acid	  permease	  AzlD	   2.7	   1.07E-­‐11	  
-­‐	   Hypothetical	  protein	   2.79	   0.002605948	   rlmN	   23S	  rRNA	  m(2)	  methyltransferase,	  SAM-­‐dependent	   2.69	   6.77E-­‐113	  
rec2	   Recombination	  protein	  Rec2	   2.75	   4.10E-­‐18	   thiI	   Thiamine	  biosynthesis	  protein	  ThiI	   2.68	   2.33E-­‐120	  
-­‐	   Hypothetical	  protein	   2.75	   8.04E-­‐157	   rpoC	   DNA-­‐directed	  RNA	  polymerase	  beta'	  chain	   2.68	   2.30E-­‐272	  
-­‐	   Hypothetical	  protein	   2.75	   2.10E-­‐25	   can	   Carbonic	  anhydrase	  2	   2.68	   9.46E-­‐78	  
comF	   Competence	  protein	  F	   2.74	   1.36E-­‐19	   argR	   Arginine	  repressor	   2.67	   1.19E-­‐35	  
queE	   Putative	  7-­‐cyano-­‐7-­‐ 2.73	   1.78E-­‐35	   -­‐	   tRNA-­‐Thr(tgt)	   2.67	   2.00E-­‐89	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Up-­‐regulated	  genes	   Down-­‐regulated	  genes	  
-­‐	   Hypothetical	  protein	   2.73	   0.000320446	   greA	   Transcription	  elongation	  factor	  GreA	   2.66	   4.90E-­‐67	  
glpQ	   Glycerophosphoryl	  diester	  phosphodiesterase	   2.72	   4.93E-­‐104	   lic3A	   Lipopolysaccharide	  alpha-­‐2,3-­‐sialyltransferase	  Lic3A	   2.65	   9.98E-­‐24	  
-­‐	   Hypothetical	  protein	  p14_1	   2.72	   6.13E-­‐59	   -­‐	   tRNA-­‐Val(tac)	   2.65	   4.98E-­‐50	  
atoE	   Short	  chain	  fatty	  acids	  transporter	   2.71	   1.60E-­‐21	   -­‐	   tRNA-­‐Cys(gca)	   2.64	   8.63E-­‐114	  
atoB	   Acetyl-­‐CoA	  acetyltransferase	   2.7	   1.65E-­‐33	   cydC	   Cysteine/glutathione	  ABC	  transporter,	  fused	  ATPase	  and	  permease	  components	   2.63	   5.98E-­‐84	  
folP	   7,8-­‐dihydropteroate	  synthase	   2.7	   6.33E-­‐124	   mukE	   Condesin	  subunit	  E	   2.63	   6.83E-­‐69	  
uxuA	   Mannonate	  dehydratase	   2.69	   4.50E-­‐131	   atpE	   Membrane-­‐bound	  ATP	  synthase,	  F0	  sector,	  subunit	  C	   2.62	   2.07E-­‐110	  
purM	   Phosphoribosylaminoimidazole	  synthetase	   2.69	   2.31E-­‐33	   intA	   Putative	  integrase	   2.61	   1.23E-­‐36	  
iscA	   Iron-­‐sulfur	  cluster	  assembly	  protein	  IscA	   2.69	   8.30E-­‐120	   -­‐	   Hypothetical	  protein	   2.61	   1.01E-­‐61	  
-­‐	  
Putative	  TRAP-­‐type	  transport	  system,	  large	  permease	  component	   2.67	   2.69E-­‐81	   dksA	   Regulator	  of	  rRNA	  transcription	  (DksA)	   2.59	   3.23E-­‐73	  
-­‐	   Hypothetical	  protein	   2.67	   0.000281886	   cydC2	   Putative	  glutathione	  ABC	  transporter,	  fused	  ATPase	  and	  permease	   2.59	   9.07E-­‐53	  
nanE	   N-­‐acetylmannosamine-­‐6-­‐phosphate	  2-­‐epimerase	   2.66	   1.46E-­‐55	   rnfG	   Electron	  transport	  complex	  protein	  RnfG	   2.58	   9.69E-­‐45	  
siaA	   Lipooligosaccharide	  sialyltransferase	  SiaA	   2.66	   1.17E-­‐18	   mltA	   Membrane-­‐bound	  lytic	  murein	  transglycosylase	  A	   2.57	   2.33E-­‐88	  
yhcB	   Putative	  cytochrome	  d	  ubiquinol	  oxidase	  subunit	  3	   2.66	   2.72E-­‐67	   vapC1	   Toxin-­‐antitoxin	  locus	  protein	  VapC1	   2.57	   7.06E-­‐56	  
-­‐	   Hypothetical	  protein	   2.64	   4.09E-­‐64	   nrdB	   Ribonucleoside	  diphosphate	  reductase	  1,	  beta	  subunit	   2.56	   5.48E-­‐127	  
comE
1	  
Putative	  DNA	  uptake	  protein	  ComE1	   2.63	   1.98E-­‐25	   rnfD	   Electron	  transport	  complex	  protein	  RnfD	   2.56	   8.51E-­‐78	  
pepP	   Aminopeptidase	  P	   2.63	   4.89E-­‐179	   epmC	   Elongation	  factor	  P	  hydroxylase	   2.56	   2.25E-­‐40	  
-­‐	   Putative	  phage	  tail-­‐fiber	  protein	   2.63	   8.21E-­‐11	   accA	   Acetyl-­‐CoA	  carboxylase,	  subunit	  alpha	   2.55	   8.03E-­‐150	  
sdaA	   L-­‐serine	  deaminase	   2.62	   2.41E-­‐126	   deoD	   Purine-­‐nucleoside	  phosphorylase	  (PNPase)	   2.55	   4.60E-­‐183	  
-­‐	   Hypothetical	  protein	   2.62	   2.75E-­‐58	   rpS21	   30S	  ribosomal	  subunit	  protein	  S21	   2.55	   2.40E-­‐197	  
leuD	   3-­‐isopropylmalate	  dehydratase,	  small	  subunit	   2.61	   1.03E-­‐22	   -­‐	   Putative	  ABC	  transporter	  ATP-­‐binding	  protein	   2.54	   3.33E-­‐32	  
napF
2	  
Putative	  ferredoxin-­‐type	  protein	   2.61	   6.42E-­‐11	   gptA	   Xanthine-­‐guanine	  phosphoribosyltransferase	   2.54	   2.23E-­‐84	  
-­‐	   Hypothetical	  protein	   2.6	   3.07E-­‐26	   -­‐	   tRNA-­‐Val(gac)	   2.54	   2.92E-­‐12	  
hisG	   ATP	  phosphoribosyltransferase	   2.59	   8.42E-­‐29	   -­‐	   tRNA-­‐Val(tac)	   2.53	   1.74E-­‐48	  
iscX	   Fe-­‐S	  cluster	  related	  protein	  IscX	   2.59	   3.04E-­‐73	   secD	   General	  secretory	  pathway	  component	  SecD	   2.52	   3.21E-­‐112	  
kdgK	  
2-­‐dehydro-­‐3-­‐deoxygluconokinase	  (KDG	  kinase)	   2.58	   7.81E-­‐68	   ftsL	   Cell	  division	  protein	  FtsL	   2.52	   9.79E-­‐45	  
xylG	   D-­‐xylose	  ABC	  transporter,	  ATP-­‐binding	  component	   2.57	   1.77E-­‐16	   mukB	   Condesin	  subunit	  B	   2.52	   3.34E-­‐174	  
-­‐	   Hypothetical	  protein	   2.57	   1.15E-­‐10	   potC	   Spermidine/putrescine	  ABC	  transporter,	  permease	  protein	   2.51	   4.56E-­‐134	  
aphA	  
Acid	  phosphatase/phosphotransferase	   2.56	   8.13E-­‐10	   -­‐	   tRNA-­‐Leu(taa)	   2.49	   1.32E-­‐59	  
rseC_
1	  
Sigma-­‐E	  factor	  regulatory	  protein	  RseC	   2.55	   6.65E-­‐38	   rnr	   Exoribonuclease	  R	  (RNase	  R)	   2.47	   5.79E-­‐117	  
hicB	   Hif-­‐contiguous	  protein	  B	   2.55	   1.59E-­‐37	   apbE	   Lipoprotein	  ApbE	   2.46	   8.27E-­‐154	  
-­‐	   tRNA-­‐seC(tca)	   2.55	   3.37E-­‐23	   hisS	   Histidyl-­‐tRNA	  synthetase	   2.46	   6.03E-­‐141	  
rfbP	  
Undecaprenyl-­‐phosphate	  galactose	  phosphotransferase	   2.53	   2.86E-­‐59	   -­‐	   Hypothetical	  protein	   2.45	   9.63E-­‐43	  
xylR	   Xylose	  operon	  regulatory	  protein	   2.52	   3.50E-­‐70	   -­‐	   Oligopeptide	  transporter,	  OPT	  family	   2.45	   1.62E-­‐139	  
lctP	   L-­‐lactate	  permease	   2.51	   4.93E-­‐113	   -­‐	   tRNA-­‐Asp(gtc)	   2.45	   2.61E-­‐30	  
sucA	  
2-­‐oxoglutarate	  dehydrogenase	  E1	  component	   2.51	   6.33E-­‐64	   pyrG	   CTP	  synthetase	   2.43	   9.53E-­‐122	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   Down-­‐regulated	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iscU	   Fe-­‐S	  scaffold	  protein	  IscU	   2.5	   3.19E-­‐187	   lpdA	   Dihydrolipoamide	  dehydrogenase	   2.43	   1.42E-­‐202	  
kipI	   Sporulation	  inhibitor	  KipI	   2.49	   2.15E-­‐27	   efp	   Elongation	  factor	  P	  (EF-­‐P)	   2.42	   1.04E-­‐107	  
hisB	  
Imidazoleglycerolphosphate	  dehydratase	  and	  histidinol-­‐phosphate	  phosphatase	   2.49	   4.48E-­‐57	   yhhQ	   Inner	  membrane	  protein	  YhhQ	   2.4	   3.11E-­‐52	  
grxA	   Glutaredoxin	  1	   2.49	   8.07E-­‐122	   -­‐	   tRNA-­‐Gly(gcc)	   2.39	   1.66E-­‐74	  
yfeA	   Fe/Mn/Zn	  ABC	  transporter	  periplasmic-­‐binding	  protein	   2.48	   6.47E-­‐122	   thrB	   Homoserine	  kinase	   2.38	   1.91E-­‐60	  
-­‐	   Putative	  thioredoxin	   2.48	   4.09E-­‐75	   thiB	   Thiamin	  ABC	  transporter,	  periplasmic-­‐binding	  protein	   2.38	   3.02E-­‐112	  
hslV	   Protease	  HslVU,	  peptidase	  subunit	   2.47	   9.70E-­‐78	   rnfE	   Electron	  transport	  complex	  protein	  RnfE	   2.38	   5.93E-­‐40	  
-­‐	   hypothetical	  protein	   2.47	   2.32E-­‐68	   psiE	   Mig-­‐7	   2.38	   5.21E-­‐27	  
pilD	   Type	  II	  secretory	  pathway,	  prepilin	  signal	  peptidase	  PilD	   2.46	   7.21E-­‐09	   -­‐	   tRNA-­‐Gly(gcc)	   2.38	   1.31E-­‐50	  
dld	   D-­‐lactate	  dehydrogenase	   2.46	   4.57E-­‐89	   -­‐	   Hypothetical	  protein	  HP2p08	   2.38	   1.21E-­‐18	  
-­‐	   Hypothetical	  protein	   2.45	   8.85E-­‐64	   rmuC	   DNA	  recombination	  protein	  rmuC-­‐like	  protein	   2.37	   1.90E-­‐40	  
-­‐	   Hypothetical	  protein	   2.45	   0.02664437	   thrA	   Aspartokinase	  I/homoserine	  dehydrogenase	  I	   2.37	   5.33E-­‐70	  
rbsR	   Ribose	  operon	  repressor	   2.44	   5.44E-­‐38	   znuB	   Zinc	  transporter	  permease	  subunit	  ZnuB	   2.37	   4.86E-­‐66	  
xylA	   D-­‐xylose	  isomerase	   2.43	   7.63E-­‐22	   -­‐	   EamA-­‐like	  transporter	  family	  protein	   2.37	   4.87E-­‐54	  
upp	   Uracil	  phosphoribosyltransferase	   2.43	   1.34E-­‐145	   -­‐	   Hypothetical	  protein	   2.37	   4.82E-­‐48	  
slp	   Outer	  membrane	  protein	  slp	  precursor	   2.42	   2.48E-­‐77	   -­‐	   Hypothetical	  protein	   2.36	   6.33E-­‐212	  
-­‐	   Putative	  DNA	  repair	  protein	   2.41	   2.59E-­‐08	   -­‐	   tRNA-­‐Val(tac)	   2.34	   9.05E-­‐88	  
dnaK	   Molecular	  chaperone	  DnaK	  (Hsp70)	   2.41	   1.93E-­‐15	   -­‐	   tRNA-­‐Gln(ttg)	   2.34	   8.88E-­‐47	  
-­‐	   Putative	  pseudouridylate	  synthase	   2.4	   2.71E-­‐33	   hflC	   Protease	  modulator	  complex	  HflKC,	  subunit	  HflC	   2.33	   4.20E-­‐127	  
glpX	   Fructose	  1,6-­‐bisphosphatase	  II	   2.4	   4.79E-­‐44	   vapB1	   Toxin-­‐antitoxin	  locus	  protein	  VapB1	   2.32	   1.79E-­‐40	  
pyrF	   Orotidine	  5'-­‐phosphate	  decarboxylase	   2.39	   5.97E-­‐105	   rumB	   23S	  rRNA	  m(5)U747-­‐methyltransferase	   2.32	   9.86E-­‐48	  
lldD	   L-­‐lactate	  dehydrogenase,	  FMN-­‐linked	   2.39	   1.07E-­‐144	   mukF	   Condesin	  subunit	  F	   2.32	   4.38E-­‐69	  
-­‐	   Hypothetical	  protein	   2.39	   9.73E-­‐08	   fruB	   PTS	  system,	  fructose-­‐specific	  IIA/fpr	  component	   2.31	   2.98E-­‐111	  
nanA	   N-­‐acetylneuraminate	  lyase	  (aldolase)	   2.38	   2.05E-­‐85	   ispH	   4-­‐hydroxy-­‐3-­‐methylbut-­‐2-­‐enyl	  diphosphate	  reductase	   2.31	   3.86E-­‐76	  
uup_
4	   DNA-­‐binding	  ATPase	  Uup	   2.38	   7.48E-­‐13	   mod	   Type	  III	  restriction-­‐modification	  system	  methylase	  (M.HindVIP)	   2.3	   1.78E-­‐124	  
-­‐	   Hypothetical	  protein	   2.38	   1.15E-­‐78	   nrfA	   Nitrite	  reductase	  complex,	  periplasmic	  cytochrome	  C552	  subunit	   2.3	   1.22E-­‐32	  
yfbQ	   Putative	  aminotransferase	   2.35	   8.13E-­‐114	   rsmH	   16S	  rRNA	  m(4)	  methyltranserfase	   2.3	   5.67E-­‐86	  
pstC	   Phosphate	  ABC	  transport	  system,	  permease	  component	   2.35	   4.56E-­‐22	   hda	   DNA	  replication	  initiation	  factor	  Had	   2.29	   1.26E-­‐52	  
pgi	   Glucose-­‐6-­‐phosphate	  isomerase	   2.35	   1.15E-­‐188	   truC	   tRNA	  U65	  pseudouridine	  synthase	   2.28	   6.83E-­‐40	  
-­‐	   Hypothetical	  protein	   2.35	   4.59E-­‐05	   fruK	   Fructose-­‐1-­‐phosphate	  kinase	   2.28	   1.08E-­‐90	  
-­‐	   Hypothetical	  protein	   2.35	   1.32E-­‐09	   rpoB	   DNA-­‐directed	  RNA	  polymerase	  beta	  chain	   2.28	   5.25E-­‐169	  
hifB	   Pilin	  assembly	  chaperone	  HifB	   2.34	   2.67E-­‐59	   rps12	   30S	  ribosomal	  subunit	  protein	  S12	   2.28	   4.88E-­‐147	  
-­‐	  
Putative	  alkylphosphonate	  utilization	  operon	  protein	  PhnA	   2.34	   1.42E-­‐58	   -­‐	   Hypothetical	  protein	   2.28	   9.21E-­‐50	  
queD	  
Putative	  7-­‐cyano-­‐7-­‐deazaguanine	  (preQ0)	  synthesis	  protein	  QueD	   2.34	   1.32E-­‐21	   rpS11	   30S	  ribosomal	  protein	  S11	   2.28	   1.01E-­‐171	  
vapX	   Toxin/antitoxin	  locus	  vapDX,	  antitoxin	  protein	  VapX	   2.34	   2.41E-­‐62	   accB	   Acetyl-­‐CoA	  carboxylase,	  biotin	  carboxyl	  carrier	  protein	   2.28	   2.71E-­‐130	  
pdxY	   Pyridoxine	  kinase	   2.33	   1.77E-­‐104	   topA_1	   DNA	  topoisomerase	  I	   2.27	   8.50E-­‐130	  
-­‐	   Hypothetical	  protein	   2.31	   0.001486	   -­‐	   tRNA-­‐Lys(ttt)	   2.27	   3.97E-­‐22	  
-­‐	   Exopolysaccharide	  biosynthesis	  protein	   2.31	   5.85E-­‐18	   acpP	   Acyl	  carrier	  protein	   2.26	   3.24E-­‐158	  
oppB	   Oligopeptide	  ABC	   2.3	   1.36E-­‐75	   -­‐	   Putative	  nucleoside	   2.24	   5.49E-­‐167	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transporter,	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Gene	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Up-­‐regulated	  genes	   Down-­‐regulated	  genes	  
glpC_
2	  
Anaerobic	  glycerol-­‐3-­‐phosphate	  dehydrogenase	  subunit	  C	   2.29	   1.27E-­‐92	   -­‐	   Hypothetical	  protein	   2.24	   3.73E-­‐78	  
fabA	   3-­‐hydroxydecanoyl-­‐ACP	  dehydratase	   2.29	   6.05E-­‐85	   yohI	   Truncated	  tRNA-­‐dihydrouridine	  synthase	  YohI	   2.24	   5.24E-­‐16	  
-­‐	   Putative	  integral	  membrane	  protein	   2.29	   2.75E-­‐50	   srmB	   ATP-­‐dependent	  RNA	  helicase	   2.23	   3.99E-­‐82	  
-­‐	   Hypothetical	  protein	   2.28	   7.59E-­‐16	   folC	   Bifunctional	  folylpolyglutamate	  synthase/dihydrofolate	  synthase	   2.23	   9.94E-­‐84	  
-­‐	   Hypothetical	  protein	   2.27	   5.98E-­‐25	   potB	   Spermidine/putrescine	  ABC	  transporter,	  permease	  protein	   2.23	   1.09E-­‐114	  
-­‐	   Putative	  terminase,	  ATPase	  subunit	   2.26	   6.41E-­‐57	   nqrB	   Na+-­‐transporting	  NADH:ubiquinone	  oxidoreductase,	  subunit	  NqrB	   2.22	   7.33E-­‐168	  
-­‐	   Hypothetical	  protein	  p64	   2.26	   2.17E-­‐60	   ompP2	   Outer	  membrane	  protein	  P2	   2.21	   6.77E-­‐172	  
-­‐	   Hypothetical	  protein	  p59_3	   2.26	   4.92E-­‐113	   ntpA	   dATP	  pyrophosphohydrolase	   2.21	   3.45E-­‐45	  
-­‐	   Hypothetical	  protein	   2.25	   2.97E-­‐17	   rseB	   Periplasmic	  negative	  regulator	  of	  sigmaE	   2.21	   6.68E-­‐52	  
-­‐	   Hypothetical	  protein	   2.25	   2.55E-­‐20	   -­‐	   tRNA-­‐Asp(gtc)	   2.21	   2.00E-­‐24	  
-­‐	   Hypothetical	  protein	   2.25	   1.64E-­‐20	   ompP1	   Outer	  membrane	  protein	  P1	  precursor	   2.2	   2.05E-­‐138	  
-­‐	   Hypothetical	  protein	   2.24	   3.48E-­‐48	   thiP	   Thiamin	  ABC	  transporter,	  permease	  protein	   2.2	   1.70E-­‐50	  
-­‐	   Hypothetical	  protein	   2.22	   3.17E-­‐52	   rep_1	   Putative	  rep	  protein	   2.2	   1.14E-­‐29	  
mdh	   Malate	  dehydrogenase	   2.21	   7.23E-­‐60	   -­‐	   Hypothetical	  protein	   2.2	   0.000162	  
-­‐	   Hypothetical	  protein	   2.21	   1.49E-­‐15	   -­‐	   Hypothetical	  protein	   2.19	   4.44E-­‐20	  
queC	  
Putative	  7-­‐cyano-­‐7-­‐deazaguanine	  (preQ0)	  synthesis	  protein	  QueC	   2.2	   2.38E-­‐26	   ftnA2	   Ferritin	  protein	  A2	   2.18	   6.38E-­‐35	  
-­‐	   Hypothetical	  protein	   2.2	   3.75E-­‐06	   -­‐	   tRNA-­‐Val(tac)	   2.18	   4.25E-­‐58	  
pepB	   Aminopeptidase	  B	   2.19	   5.14E-­‐111	   ribB	   3,4-­‐dihydroxy-­‐2-­‐butanone	  4-­‐phosphate	  synthase	   2.16	   5.25E-­‐50	  
nfuA	   Fe/S	  biogenesis	  protein	  NfuA	   2.18	   2.53E-­‐117	   moeB_1	   Molybdopterin	  biosynthesis	  protein	  MoeB	   2.16	   8.66E-­‐42	  
xylB_
1	   Xylulose	  kinase	   2.18	   1.70E-­‐36	   pnp	   Polynucleotide	  phosphorylase	   2.15	   4.60E-­‐152	  
sucD	   Succinyl-­‐CoA	  synthetase,	  alpha	  subunit	   2.18	   1.36E-­‐53	   narP	   Nitrate/nitrite	  response	  regulator	  protein	   2.15	   4.00E-­‐62	  
ssb2	   Single-­‐stranded	  DNA-­‐binding	  protein	   2.17	   5.30E-­‐15	   hugZ	   Haem	  oxygenase	   2.15	   4.51E-­‐99	  
hslU	   Protease	  HslVU,	  ATPase	  subunit	   2.17	   2.02E-­‐13	   trmB	   tRNA	  m(7)G46	  methyltransferase,	  SAM-­‐dependent	   2.14	   1.22E-­‐58	  
-­‐	   Hypothetical	  protein	  p10	   2.17	   2.69E-­‐17	   napD	   Periplasmic	  nitrate	  reductase	  assembly	  protein	  NapD	   2.14	   5.93E-­‐11	  
yfeB	   Fe/Mn/Zn	  ABC	  transporter	  ATP-­‐binding	  protein	   2.16	   1.01E-­‐111	   ftnA1	   Ferritin	  protein	  A1	   2.14	   9.29E-­‐29	  
mgsA	   Methylglyoxal	  synthase	   2.16	   4.11E-­‐76	   -­‐	   Hypothetical	  protein	   2.14	   3.05E-­‐12	  
-­‐	   Hypothetical	  protein	  HP2p34	   2.16	   3.09E-­‐21	   menH	   2-­‐succinyl-­‐6-­‐hydroxy-­‐2,	  4-­‐cyclohexadiene-­‐1-­‐carboxylate	  synthase	   2.13	   7.42E-­‐24	  
-­‐	   Hypothetical	  protein	   2.16	   7.70E-­‐13	   ispA2	   Intracellular	  septation	  protein	  A	   2.13	   3.19E-­‐45	  
hscB	   Fe-­‐S	  cluster	  co-­‐chaperone	  protein	  HscB	   2.15	   1.41E-­‐115	   queF	   NADPH-­‐dependent	  7-­‐cyano-­‐7-­‐deazaguanine	  reductase	  QueF	   2.13	   4.81E-­‐46	  
purK	  
Phosphoribosylaminoimidazole	  carboxylase,	  ATPase	  subunit	   2.15	   1.47E-­‐13	   bcr	   Putative	  efflux	  permease	  Bcr	   2.12	   9.22E-­‐36	  
modE	   Transcriptional	  regulator	  ModE	   2.15	   2.12E-­‐35	   tyrZ	   Tyrosyl-­‐tRNA	  synthetase	   2.12	   9.21E-­‐98	  
-­‐	   Hypothetical	  protein	   2.15	   3.38E-­‐13	   trkA	   TRK	  system	  potassium	  uptake	  protein	   2.11	   2.98E-­‐76	  
-­‐	   Putative	  sulfate	  transport	  protein	  CysZ	   2.14	   1.48E-­‐62	   -­‐	   Putative	  ABC	  transport	  system,	  permease	  protein	   2.11	   7.06E-­‐29	  
-­‐	   tRNA-­‐Lys(ctt)	   2.14	   8.62E-­‐24	   aceF	   Dihydrolipoamide	  acetyltransferase	   2.1	   7.49E-­‐132	  
pqqL	   Putative	  Zn-­‐dependent	   2.13	   1.12E-­‐19	   valS	   Valyl-­‐tRNA	  synthetase	   2.09	   3.26E-­‐134	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Up-­‐regulated	  genes	   Down-­‐regulated	  genes	  
prtR_
2	   Pyocin	  repressor	  protein	   2.13	   1.85E-­‐83	   dacA	   D-­‐alanyl-­‐D-­‐alanine	  carboxypeptidase,	  penicillin-­‐binding	  protein	  5	   2.08	   1.14E-­‐66	  
-­‐	   Hypothetical	  protein	  p50	   2.13	   7.48E-­‐51	   mreC	   Rod	  shape-­‐determining	  protein	  MreC	   2.08	   1.16E-­‐42	  
-­‐	   Hypothetical	  protein	   2.13	   2.72E-­‐67	   secF	   General	  secretory	  pathway	  component	  SecF	   2.08	   1.33E-­‐67	  
-­‐	   Hypothetical	  protein	  p60	   2.12	   7.86E-­‐23	   mraY	   Phospho-­‐N-­‐acetylmuramoyl-­‐pentapeptide-­‐	  transferase	  E	   2.08	   2.24E-­‐58	  
topB_
2	   DNA	  topoisomerase	  III	   2.1	   1.20E-­‐07	   pta	   Phosphate	  acetyltransferase	   2.08	   1.66E-­‐81	  
pyrD	   Dihydroorotate	  dehydrogenase	   2.1	   2.73E-­‐59	   -­‐	   tRNA-­‐Gln(ttg)	   2.08	   2.46E-­‐35	  
sucB	  
2-­‐oxoglutarate	  dehydrogenase	  E2	  component	  dihydrolipoamide	  succinyltransferase	   2.1	   3.02E-­‐58	   fdnI	  
Formate	  dehydrogenase-­‐N,	  cytochrome	  B556(Fdn)	  gamma	  subunit,	  nitrate-­‐inducible	   2.07	   2.21E-­‐51	  
tnpR	   Transposon	  Tn3	  resolvase	   2.1	   6.16E-­‐28	   aroK	   Shikimate	  kinase	  I	   2.07	   1.55E-­‐73	  
-­‐	   Hypothetical	  protein	   2.1	   1.11E-­‐22	   -­‐	   Type	  I	  restriction	  enzyme	  EcoKI	  subunit	  R	   2.07	   6.44E-­‐52	  
-­‐	  
Putative	  long-­‐chain-­‐fatty-­‐acid-­‐-­‐CoA	  ligase	  (Long-­‐chain	  acyl-­‐CoA	  synthetase)	  (LACS)	   2.09	   5.81E-­‐94	   hia	   Adhesin	  Hia	   2.06	   2.02E-­‐131	  
uxuR	   Uxu	  operon	  transcriptional	  regulator	   2.09	   1.39E-­‐35	   rfaL	   Putative	  lipooligosaccharide	  biosynthesis	  protein	   2.06	   1.32E-­‐29	  
hifD	   Pilus	  tip	  protein	  HifD	   2.09	   1.28E-­‐36	   -­‐	   Hypothetical	  protein	   2.05	   3.19E-­‐24	  
lpxH	   UDP-­‐2,3-­‐diacylglucosamine	  hydrolase	   2.08	   1.30E-­‐41	   nqrC	   Na+-­‐transporting	  NADH:ubiquinone	  oxidoreductase,	  subunit	  NqrC	   2.04	   6.78E-­‐122	  
dmsB	   Anaerobic	  dimethyl	  sulfoxide	  reductase,	  subunit	  B	   2.08	   5.04E-­‐27	   murJ	   Peptidoglycan	  lipid	  II	  flippase	   2.04	   3.95E-­‐41	  
-­‐	   Hypothetical	  protein	   2.08	   1.21E-­‐16	   era	   GTP-­‐binding	  protein	   2.03	   3.95E-­‐57	  
-­‐	   Hypothetical	  protein	   2.08	   4.13E-­‐06	   nqrE	   Na+-­‐transporting	  NADH:ubiquinone	  oxidoreductase,	  subunit	  NqrE	   2.03	   8.37E-­‐54	  
nanK	   N-­‐acetylmannosamine	  kinase	   2.07	   9.13E-­‐45	   fdnG_1	   Formate	  dehydrogenase-­‐N,	  major	  subunit	   2.03	   1.16E-­‐100	  
hscA	   Fe-­‐S	  cluster	  chaperone	  protein	  HscA	   2.07	   9.85E-­‐122	   ackA	   Acetate	  kinase	   2.03	   6.60E-­‐113	  
higA	   Putative	  toxin-­‐antitoxin	  locus	  protein	  (HigA-­‐family)	   2.07	   9.65E-­‐58	   nusG	   Transcription	  antitermination	  protein	  NusG	   2.01	   2.61E-­‐88	  
-­‐	   Putative	  capsid	  portal	  protein	   2.07	   2.85E-­‐18	   mtgA	   Biosynthetic	  peptidoglycan	  transglycosylase	   2.01	   1.57E-­‐10	  
-­‐	   Hypothetical	  protein	   2.06	   4.36E-­‐11	   pheS	   Phenylalanyl-­‐tRNA	  synthetase,	  alpha	  subunit	   2.01	   1.27E-­‐76	  
-­‐	   tRNA-­‐Lys(ttt)	   2.05	   8.24E-­‐21	   sapD	   Peptide	  ABC	  transporter	  system,	  ATPase	  protein	  SapD	   2.01	   3.22E-­‐39	  
lsgA_
3	  
Lipopolysaccharide	  biosynthesis	  protein	  LsgA	   2.02	   1.69E-­‐28	   	   	   	   	  
pstS	  
Phosphate	  ABC	  transport	  system,	  periplasmic	  binding	  protein	   2.02	   7.76E-­‐20	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Up-­‐regulated	  genes	   Down-­‐regulated	  genes	  
hktE	   Catalase	   76.94	   0	   artP	   Arginine	  transporter	  ATP-­‐binding	  protein	   21.55	   6.15E-­‐125	  
acpD	   Acyl	  carrier	  protein	  phosphodiesterase	   26.07	   3.32E-­‐153	   dmsA_3	   Anaerobic	  dimethyl	  sulfoxide	  reductase	  subunit	  A	   11.89	   2.25E-­‐31	  
-­‐	   DoxX	   14.58	   3.42E-­‐141	   artI	   Arginine	  ABC	  transporter	  substrate-­‐binding	  protein	   11.01	   1.06E-­‐24	  
ilvC	   Ketol-­‐acid	  reductoisomerase	   11.48	   9.71E-­‐47	   artQ	   Arginine	  transporter	  permease	  subunit	  ArtQ	   9.12	   5.79E-­‐11	  
dps	   DNA	  protection	  during	  starvation	  protein	   10.31	   1.21E-­‐45	   dmsB	   Anaerobic	  dimethyl	  sulfoxide	  reductase	  subunit	  B	   7.98	   9.13E-­‐36	  
-­‐	   DNA	  polymerase	  V	  subunit	  UmuD	   10.31	   6.89E-­‐160	   nrfC	   Nitrite	  reductase	  Fe-­‐S	  protein	   7.75	   1.63E-­‐27	  
-­‐	   Peroxiredoxin	  hybrid	  Prx5	   7.56	   1.06E-­‐137	   artM	   Arginine	  transporter	  permease	  subunit	  ArtM	   7.63	   1.34E-­‐08	  
ilvI	   Acetolactate	  synthase	  3	  catalytic	  subunit	   4.88	   1.39E-­‐33	   nrfB	   Cytochrome	  c	  nitrite	  reductase	  pentaheme	  subunit	   7.5	   2.08E-­‐22	  
recN	   DNA	  repair	  protein	   4.68	   1.28E-­‐98	   -­‐	   Twin-­‐argninine	  leader-­‐binding	  protein	  DmsD	   7.24	   5.31E-­‐41	  
ilvH	   Acetolactate	  synthase	  3	  regulatory	  subunit	   4.52	   1.21E-­‐29	   nrfA	   Cytochrome	  c552	   6.89	   1.32E-­‐09	  
-­‐	   FeS	  assembly	  protein	  IscX	   4.51	   4.91E-­‐48	   hlpA	   D-­‐methionine-­‐binding	  lipoprotein	  MetQ	   6.24	   6.76E-­‐46	  
ribA	   GTP	  cyclohydrolase	  II	   4.43	   2.67E-­‐45	   yecK	   Cytochrome	  C-­‐like	  protein	   6	   3.63E-­‐14	  
fdx-­‐1	   Ferredoxin	   4.42	   7.02E-­‐52	   pstA_1	   Phosphate	  ABC	  transporter	  permease	   5.93	   1.02E-­‐21	  
trxM	   Thioredoxin	   3.98	   2.05E-­‐51	   cydD_2	   ABC	  transporter	  ATP-­‐binding	  protein	   5.59	   4.51E-­‐62	  
gdhA	   Glutamate	  dehydrogenase	   3.98	   3.07E-­‐14	   napF_2	   Ferredoxin-­‐type	  protein	   5.56	   7.16E-­‐21	  
iscU	   Scaffold	  protein	   3.91	   3.58E-­‐58	   pepT	   Peptidase	  T	   5.34	   3.06E-­‐13	  
nifS	   Cysteine	  desulfurase	   3.77	   9.76E-­‐50	   dmsC	   Anaerobic	  dimethyl	  sulfoxide	  reductase	  subunit	  C	   5.27	   9.60E-­‐37	  
lexA	   LexA	  repressor	   3.69	   5.85E-­‐40	   argR	   Arginine	  repressor	   5.26	   9.67E-­‐30	  
hscA	   Chaperone	  protein	  HscA	   3.48	   3.79E-­‐88	   cydD_1	   ABC	  transporter	  ATP-­‐binding	  protein	   5.2	   5.94E-­‐18	  
-­‐	   Transporter	   3.44	   3.11E-­‐20	   -­‐	   ABC	  transporter	  ATP-­‐binding	  protein	   4.87	   1.93E-­‐74	  
-­‐	   Iron-­‐sulfur	  cluster	  insertion	  protein	  ErpA	   3.39	   1.07E-­‐62	   -­‐	   Hypothetical	  protein	   4.86	   3.04E-­‐11	  
hscB	   Co-­‐chaperone	  HscB	   3.3	   1.72E-­‐74	   -­‐	   Hemoglobin-­‐binding	  protein	   4.77	   1.20E-­‐20	  
-­‐	   Hypothetical	  protein	   3.19	   4.41E-­‐47	   argH	   Argininosuccinate	  lyase	   4.72	   3.88E-­‐22	  
recX	   Recombination	  regulator	  RecX	   3.18	   3.26E-­‐46	   nrfD	   Nitrite	  reductase	  transmembrane	  protein	   4.65	   5.16E-­‐27	  
-­‐	   Manganese	  transport	  protein	  MntH	   3.08	   4.51E-­‐32	   argG	   Argininosuccinate	  synthase	   4.56	   8.00E-­‐27	  
gor	   Glutathione	  reductase	   2.96	   3.33E-­‐43	   oapA_3	   Hemoglobin-­‐binding	  protein	   4.45	   3.14E-­‐24	  
uvrA	   Excinuclease	  ABC	  subunit	  A	   2.89	   6.15E-­‐45	   -­‐	   Epimerase	  family	  protein	   4.1	   5.15E-­‐15	  
iscR	   HTH-­‐type	  transcriptional	  regulator	  IscR	   2.86	   3.96E-­‐25	   ccmA	   Cytochrome	  c	  biogenesis	  protein	  CcmA	   3.81	   2.27E-­‐11	  
gnd	   6-­‐phosphogluconate	  dehydrogenase	   2.83	   4.05E-­‐46	   trpE	   Anthranilate	  synthase	  component	  I	   3.78	   0.000118629	  
dapF	   Diaminopimelate	  epimerase	   2.78	   5.45E-­‐74	   metN	   DL-­‐methionine	  transporter	  ATP-­‐binding	  protein	   3.77	   0.000137417	  
ruvB	   Holliday	  junction	  DNA	  helicase	  RuvB	   2.66	   1.06E-­‐43	   -­‐	   Hemoglobin-­‐binding	  protein	   3.68	   2.91E-­‐21	  
pntB	   Pyridine	  nucleotide	  transhydrogenase	   2.66	   8.61E-­‐106	   bisC	   Biotin	  sulfoxide	  reductase	   3.6	   1.20E-­‐14	  
pntA	   NAD(P)	  transhydrogenase	  subunit	  alpha	   2.64	   4.38E-­‐82	   ccmB	   Haem	  exporter	  protein	  B	   3.49	   5.15E-­‐09	  
kipI	   Sporulation	  inhibitor	  KipI	   2.62	   4.37E-­‐13	   ribB	   3,4-­‐dihydroxy-­‐2-­‐butanone	  4-­‐phosphate	  synthase	   3.47	   1.48E-­‐35	  
radA	   DNA	  repair	  protein	  RadA	   2.61	   2.61E-­‐41	   -­‐	   Proton	  glutamate	  symport	  protein	   3.44	   0.003297323	  
recA	   Recombinase	  A	   2.57	   4.77E-­‐58	   bioD_1	   Dithiobiotin	  synthetase	   3.41	   6.66E-­‐08	  
ftsH	   Cell	  division	  protein	   2.57	   1.18E-­‐32	   dppA	   Haem-­‐binding	  lipoprotein	   3.32	   0.003442	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Up-­‐regulated	  genes	   Down-­‐regulated	  genes	  
adhC	   Alcohol	  dehydrogenase	  class	  III	   2.5	   1.51E-­‐62	   galR	   LacI	  family	  transcriptional	  repressor	   3.3	   1.32E-­‐05	  
-­‐	   LamB/YcsF	  family	  protein	   2.47	   1.31E-­‐10	   malQ	   4-­‐alpha-­‐glucanotransferase	   3.29	   1.66E-­‐06	  
ruvA	   Holliday	  junction	  DNA	  helicase	  RuvA	   2.45	   6.73E-­‐29	   cdd	   Cytidine	  deaminase	   3.24	   7.83E-­‐09	  
-­‐	   Cell	  division	  FtsH-­‐like	  protein	   2.45	   1.70E-­‐42	   aspT	   Aspartate/alanine	  antiporter	   3.14	   7.18E-­‐06	  
-­‐	   Alkylhydroperoxidase	  AhpD	  family	  core	  domain	  protein	   2.43	   4.80E-­‐11	   -­‐	   Formate	  transporter	   3.12	   5.08E-­‐11	  
-­‐	   Hypothetical	  protein	   2.42	   6.04E-­‐30	   -­‐	   3-­‐hydroxyisobutyrate	  dehydrogenase	   3.12	   2.35E-­‐06	  
-­‐	   Putative	  membrane	  protein	   2.41	   5.94E-­‐34	   pckA	   Phosphoenolpyruvate	  carboxykinase	   3.07	   1.23E-­‐05	  
-­‐	   Transposase	   2.38	   5.95E-­‐16	   ansB	   L-­‐asparaginase	  II	   3.04	   9.02E-­‐07	  
-­‐	   Esterase	   2.3	   6.08E-­‐41	   rbsD	   D-­‐ribose	  pyranase	   2.95	   1.25E-­‐09	  
nagB
_2	  
Glucosamine-­‐6-­‐phosphate	  deaminase	   2.26	   3.13E-­‐28	   -­‐	   Hypothetical	  protein	   2.93	   9.26E-­‐07	  
kipA	   KipI	  antagonist	   2.25	   4.66E-­‐13	   ygbM	   Putative	  hydroxypyruvate	  isomerase	  YgbM	   2.92	   1.95E-­‐09	  
rsgA_
1	   Ferritin	  like	  protein	  1	   2.23	   4.66E-­‐13	   -­‐	   Aldolase	   2.91	   4.22E-­‐08	  
-­‐	   Hypothetical	  protein	   2.23	   0.00227	   -­‐	   Hypothetical	  protein	   2.83	   0.000184	  
-­‐	   Protease	   2.18	   7.88E-­‐14	   hslO	   Hsp33-­‐like	  chaperonin	   2.73	   7.14E-­‐06	  
-­‐	   Thioredoxin	   2.15	   2.14E-­‐14	   lrgA	   Antiholin-­‐like	  protein	  LrgA	   2.73	   1.43E-­‐07	  
uvrD	   DNA-­‐dependent	  helicase	  II	   2.04	   7.73E-­‐34	   ccrB	   Camphor	  resistance	  protein	  CrcB	   2.72	   9.16E-­‐10	  
	   	   	   	   pepE	   Peptidase	  E	   2.67	   5.96E-­‐08	  
	   	   	   	   -­‐	   Short	  chain	  dehydrogenase/reductase	   2.67	   6.91E-­‐07	  
	   	   	   	   tyrA	  
Bifunctional	  chorismate	  mutase/prephenate	  dehydrogenase	   2.66	   4.56E-­‐13	  
	   	   	   	   ccmC	   Haem	  exporter	  protein	  C	   2.61	   1.09E-­‐07	  
	   	   	   	   mtr	   Tryptophan-­‐specific	  transport	  protein	   2.55	   1.52E-­‐05	  
	   	   	   	   -­‐	   Putative	  epimerase/dehydratase	   2.54	   3.63E-­‐09	  
	   	   	   	   -­‐	   Hemoglobin-­‐binding	  protein	   2.52	   2.54E-­‐11	  
	   	   	   	   -­‐	   Amino	  acid	  ABC	  transporter	  substrate-­‐binding	  protein	   2.51	   0.045661216	  
	   	   	   	   -­‐	   N-­‐acetylmannosamine-­‐6-­‐phosphate	  2-­‐epimerase	   2.5	   1.23E-­‐05	  
	   	   	   	   -­‐	   Haloacid	  dehalogenase-­‐like	  protein	   2.47	   5.52E-­‐10	  
	   	   	   	   uspA	   Universal	  stress	  protein	  A	   2.45	   2.97E-­‐05	  
	   	   	   	   rpmC	   50S	  ribosomal	  protein	  L29	   2.43	   1.30E-­‐70	  
	   	   	   	   sdaC	   Serine	  transporter	   2.38	   0.001485	  
	   	   	   	   gntP_3	   Gluconate	  permease	   2.37	   1.12E-­‐14	  
	   	   	   	   -­‐	   Formate	  acetyltransferase	   2.36	   4.10E-­‐12	  
	   	   	   	   trpG_2	  
Anthranilate	  synthase	  component	  II	   2.36	   0.031678415	  
	   	   	   	   -­‐	  
Nickel	  uptake	  substrate-­‐specific	  transmembrane	  region	   2.36	   1.08E-­‐19	  
	   	   	   	   dcuD	  
Putative	  cryptic	  C4-­‐dicarboxylate	  transporter	  DcuD	   2.35	   2.48E-­‐07	  
	   	   	   	   yohK	   Inner	  membrane	  protein	  YohK	   2.33	   1.84E-­‐06	  
	   	   	   	   nudF	   ADP-­‐ribose	  pyrophosphatase	   2.33	   0.001353	  
	   	   	   	   rplP	   50S	  ribosomal	  protein	  L16	   2.33	   2.57E-­‐60	  
	   	   	   	   galT	   Galactose-­‐1-­‐phosphate	  uridylyltransferase	   2.31	   0.000116	  
	   	   	   	   rpsQ	   30S	  ribosomal	  protein	  S17	   2.27	   2.41E-­‐52	  
	   	   	   	   -­‐	   Autonomous	  glycyl	  radical	  cofactor	  GrcA	   2.26	   6.73E-­‐09	  
	   	   	   	   arcA	   Two-­‐component	  response	  regulator	   2.25	   3.03E-­‐07	  
	   	   	   	   -­‐	   Hypothetical	  protein	   2.25	   1.45E-­‐22	  
	   	   	   	   rpsC	   30S	  ribosomal	  protein	  S3	   2.21	   4.21E-­‐61	  
	   	   	   	   -­‐	   Hypothetical	  protein	   2.21	   0.016991	  
	   	   	   	   vapA	   Virulence-­‐associated	  protein	  A	   2.2	   2.74E-­‐30	  
	   	   	   	   fumC	   Fumarate	  hydratase	   2.2	   1.99E-­‐07	  
	   	   	   	   aspA	   Aspartate	  ammonia-­‐lyase	   2.19	   0.033786	  
	  	   260	  
	   	   	   	   Gene	   Product	   Fold	  change	  
Adjusted	  
p-­‐value	  
	   Down-­‐regulated	  genes	  
	   	   	   	   ccmD	   Haem	  exporter	  protein	  D	   2.19	   6.95E-­‐06	  
	   	   	   	   trpB	   Tryptophan	  synthase	  subunit	  beta	   2.19	   0.000454738	  
	   	   	   	   yjjP	   Inner	  membrane	  protein	  YjjP	   2.13	   6.70E-­‐06	  
	   	   	   	   -­‐	   N-­‐acetylmannosamine	  kinase	   2.13	   3.99E-­‐05	  
	   	   	   	   rplV	   50S	  ribosomal	  protein	  L22	   2.13	   5.83E-­‐40	  
	   	   	   	   -­‐	   Hypothetical	  protein	   2.11	   0.000167	  
	   	   	   	   tyrP_1	  
Tyrosine-­‐specific	  transport	  protein	   2.07	   1.07E-­‐14	  
	   	   	   	   -­‐	   TRAP	  transporter,	  DctM	  subunit	   2.07	   2.06E-­‐06	  
	   	   	   	   -­‐	   tRNA-­‐Trp(cca)	   2.07	   0.004022	  
	   	   	   	   yhxB_1	   Phosphomannomutase	   2.05	   0.000143546	  
	   	   	   	   rpsS	   30S	  ribosomal	  protein	  S19	   2.05	   1.42E-­‐30	  
	   	   	   	   ccmE	   Cytochrome	  c-­‐type	  biogenesis	  protein	  CcmE	   2.04	   3.97E-­‐07	  
	   	   	   	   -­‐	  


















	  	   261	  
Table	   S4:	   Differentially	   expressed	   genes	   in	   the	   R2866	   strain	   during	  
oxidative	  stress.	  
	  
Gene	   Product	   Fold	  change	  
Adjusted	  





Up-­‐regulated	  genes	   Down-­‐regulated	  genes	  
hktE	   Catalase	   111.22	   6.53E-­‐231	   Hgd	   2-­‐(hydroxymethyl)glutarate	  dehydrogenase	   7.82	   8.12E-­‐34	  
-­‐	   Hypothetical	  protein	   26.61	   4.74E-­‐65	   -­‐	   Hypothetical	  protein	   6.52	   1.45E-­‐40	  
-­‐	   Hypothetical	  protein	   19.57	   5.72E-­‐63	   ygbM	   Putative	  hydroxypyruvate	  isomerase	  YgbM	   6.11	   8.91E-­‐32	  
-­‐	   Putative	  NAD-­‐dependent	  protein	  deacetylase	   17.02	   1.99E-­‐69	   ygbL	   Putative	  sugar	  aldolase/epimerase	   5.98	   3.38E-­‐40	  
-­‐	   Hypothetical	  protein	   15.63	   1.71E-­‐20	   -­‐	   Putative	  sugar	  epimerase	   4	   6.23E-­‐09	  
dpsA	   DPS	  ferritin-­‐like	  protein	   13.68	   3.16E-­‐51	   -­‐	   Putative	  permease	   3.18	   1.46E-­‐09	  
-­‐	   DNA	  polymerase	  V	  subunit	  UmuD	   13.26	   9.21E-­‐104	   ftnA2	   Ferritin	  protein	  A2	   2.67	   1.68E-­‐07	  
-­‐	   Putative	  5'(3')-­‐deoxyribonucleotidase	   12.87	   1.22E-­‐40	   -­‐	   Hypothetical	  protein	   2.57	   0.0102554	  
azoR	   FMN-­‐dependent	  NADH-­‐azoreductase	   11.36	   6.37E-­‐29	   galR	   Galactose	  operon	  regulator	   2.53	   1.04E-­‐07	  
-­‐	   Hypothetical	  protein	   10.23	   2.91E-­‐59	   rpS18	   30S	  ribosomal	  subunit	  protein	  S18	   2.41	   2.23E-­‐06	  
-­‐	   Putative	  NAD-­‐dependent	  protein	  deacetylase	   9.75	   5.49E-­‐18	   yjjP	   Inner	  membrane	  protein	  YjjP	   2.35	   0.038421349	  
recN	   DNA	  repair	  protein	  RecN	   8.78	   5.27E-­‐161	   psd	   Phosphatidylserine	  decarboxylase	   2.35	   3.54E-­‐08	  
pgdX	  
Peroxiredoxin/glutaredoxin	  glutathione-­‐dependent	  peroxidase	   8.3	   3.83E-­‐52	   -­‐	   Transglutaminase-­‐like	  superfamily	  protein	   2.35	   1.91E-­‐14	  
doc	   Death	  on	  curing	  protein	   5.46	   1.19E-­‐147	   -­‐	   Selenium	  metabolism	  protein	  YedF	   2.3	   0.005077797	  
lexA	   SOS-­‐response	  transcriptional	  repressor	  LexA	   5.3	   2.78E-­‐15	   siaT	   Sialic	  acid	  TRAP	  transporter,	  fused	  permease	  protein	  SiaT	   2.28	   0.014223162	  
recX	   RecA	  regulator	  RecX	   5.25	   1.14E-­‐102	   ftnA1	   Ferritin	  protein	  A1	   2.27	   2.78E-­‐10	  
gnd	  
6-­‐phosphogluconate	  dehydrogenase,	  decarboxylating	  (6PGD)	   4.96	   9.81E-­‐24	   -­‐	   Hypothetical	  protein	   2.27	   3.92E-­‐08	  
recA	   DNA	  recombination	  protein	  RecA	   4.96	   1.10E-­‐20	   potD	   Spermidine/putrescine	  ABC	  transporter,	  periplasmic-­‐binding	  protein	   2.19	   6.87E-­‐21	  
msrA
B	  
Peptide	  methionine	  sulfoxide	  reductase	   4.64	   6.08E-­‐14	   -­‐	   Hypothetical	  protein	   2.11	   0.0011555	  
-­‐	   Hypothetical	  protein	   4.29	   1.31E-­‐14	   brnQ	   Putative	  branched-­‐chain	  amino	  acid	  transport	  system	  II	  carrier	  protein	   2.1	   0.025729252	  
-­‐	   Hypothetical	  protein	   4.27	   4.40E-­‐27	   merP	   Putative	  heavy	  metal	  chaperone	  protein	   2.1	   0.03213608	  
hxuC	   Haem-­‐hemopexin	  utilization	  protein	  C	   3.97	   7.54E-­‐17	   ahpC	   Peroxiredoxin	   2.08	   7.21E-­‐05	  
hemR	   Putative	  TonB-­‐dependent	  haem	  receptor	   3.9	   2.05E-­‐31	   trpE_1	   Anthranilate	  synthase	  component	  I	   2.07	   0.025063016	  
-­‐	   Hypothetical	  protein	   3.75	   1.31E-­‐32	   cstA	   Carbon	  starvation	  protein	  A	   2.06	   0.000540	  
ruvB	   Holliday	  junction	  resolvasome,	  ATPase	  subunit	   3.72	   2.49E-­‐43	   cdd	   Cytidine	  deaminase	   2.06	   0.045591017	  
-­‐	   DoxX	   3.68	   6.19E-­‐10	   tgt	   tRNA-­‐guanine	  transglycosylase	   2.02	   3.53E-­‐10	  
hitA	   Iron(III)	  ABC	  transporter	  periplasmic-­‐binding	  protein	   3.65	   4.04E-­‐12	   -­‐	   Hypothetical	  protein	   2.01	   0.000521177	  
hxuB	   Haem-­‐hemopexin	  utilization	  protein	  B	   3.63	   1.52E-­‐24	   	   	   	   	  
ruvA	  
Holliday	  junction	  resolvasome,	  DNA-­‐binding	  subunit	   3.5	   6.30E-­‐49	   	   	   	   	  
uvrA	   Excinuclease	  ABC	  subunit	  A	   3.47	   1.49E-­‐34	   	   	   	   	  
radA	   DNA	  repair	  protein	  RadA	   3.43	   4.21E-­‐06	   	   	   	   	  
-­‐	   CRISPR	  associated	  protein	  Cas2	   3.42	   1.38E-­‐32	   	   	   	   	  
fdx-­‐1	   [2FE-­‐2S]	  Ferredoxin,	  electron	  carrer	  protein	   3.37	   1.38E-­‐05	   	   	   	   	  
dapF	   Diaminopimelate	  epimerase	   3.17	   1.62E-­‐42	   	   	   	   	  
trxM	   Thioredoxin	   3.01	   3.92E-­‐08	   	   	   	   	  
ribA	   GTP	  cyclohydrolase	  II	   2.96	   1.12E-­‐06	   	   	   	   	  
uvrD	   DNA	  helicase	  II	   2.84	   1.11E-­‐59	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Gene	   Product	   Fold	  change	  
Adjusted	  
p-­‐value	   	   	   	   	  
Up-­‐regulated	  genes	   	  
mfd	   Transcription-­‐repair	  coupling	  factor	   2.83	   4.19E-­‐29	   	   	   	   	  
hscA	   Fe-­‐S	  cluster	  chaperone	  protein	  HscA	   2.81	   3.50E-­‐11	   	   	   	   	  
zwf	   Glucose-­‐6-­‐phosphate	  dehydrogenase	  (G6PD)	   2.79	   2.30E-­‐14	   	   	   	   	  
iscX	   Fe-­‐S	  cluster	  related	  protein	  IscX	   2.79	   2.78E-­‐15	   	   	   	   	  
-­‐	   Hypothetical	  protein	   2.78	   0.000436	   	   	   	   	  
yeaD	   Putative	  glucose-­‐6-­‐phosphate	  1-­‐epimerase	   2.73	   1.23E-­‐11	   	   	   	   	  
iscU	   Fe-­‐S	  scaffold	  protein	  IscU	   2.72	   0.000432	   	   	   	   	  
bphH	   Putative	  glutathione-­‐S-­‐transferase	   2.68	   1.27E-­‐06	   	   	   	   	  
hxuA	   Haem-­‐hemopexin	  utilization	  protein	  A	   2.61	   1.64E-­‐05	   	   	   	   	  
glpK	   Glycerol	  kinase	   2.57	   3.92E-­‐11	   	   	   	   	  
pgl	  
putative	  6-­‐phosphogluconolactonase	  (6PGL)	   2.54	   5.93E-­‐05	   	   	   	   	  
tbp1	   Transferrin-­‐binding	  protein	  1	   2.52	   1.91E-­‐13	   	   	   	   	  
iscA	   iron-­‐sulfur	  cluster	  assembly	  protein	  IscA	   2.48	   8.14E-­‐20	   	   	   	   	  
gor	   Glutathione	  oxidoreductase	   2.47	   3.19E-­‐10	   	   	   	   	  
iscS	   Cysteine	  desulfurase	  IscS	   2.43	   1.28E-­‐14	   	   	   	   	  
-­‐	   Putative	  thioredoxin	   2.42	   1.02E-­‐05	   	   	   	   	  
fbp	   Fructose-­‐1,6-­‐bisphosphatase	   2.41	   9.32E-­‐12	   	   	   	   	  
artI	  
Arginine	  ABC	  transporter,	  periplasmic-­‐binding	  protein	  ArtI	   2.32	   1.91E-­‐08	   	   	   	   	  
ftsH	   ATP-­‐dependent	  protease	  FtsH	   2.32	   0.000843036	   	   	   	   	  
ccmG
_1	  
Haem	  lyase/disulfide	  oxidoreductase	  (DsbE)	   2.31	   0.000713536	   	   	   	   	  
-­‐	   Alkylhydroperoxidase	  AhpD	  family	  core	  domain	  protein	   2.29	   5.86E-­‐06	   	   	   	   	  
groE
S	   GroES,	  chaperone	  Hsp10	   2.27	   0.01283014	   	   	   	   	  
iscR	   Transcriptional	  regulator	  IscR	   2.24	   4.83E-­‐09	   	   	   	   	  
omp
U1	  
Putative	  outer	  membrane	  protein	  OmpU1	   2.22	   2.11E-­‐05	   	   	   	   	  
-­‐	   Hypothetical	  protein	   2.19	   3.23E-­‐08	   	   	   	   	  
talB	   Transaldolase	  B	   2.16	   1.35E-­‐08	   	   	   	   	  
pgi	   Glucose-­‐6-­‐phosphate	  isomerase	   2.13	   2.13E-­‐06	   	   	   	   	  
groE
L	   GroEL,	  chaperone	  Hsp60	   2.1	   0.038421349	   	   	   	   	  
-­‐	   Transposase	   2.1	   4.05E-­‐05	   	   	   	   	  
dnaK	   Molecular	  chaperone	  DnaK	  (Hsp70)	   2.09	   0.002122231	   	   	   	   	  
tbp2	   Transferrin-­‐binding	  protein	  2	   2.08	   0.000230	   	   	   	   	  
mda
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Table	   S5:	   Differentially	   expressed	   genes	   in	   the	   Rd	   strain	   during	   iron-­‐
starvation	  stress.	  
	  
Gene	   Product	   Fold	  change	  
Adjusted	  





Up-­‐regulated	  genes	   Down-­‐regulated	  genes	  
lptF	  
Lipopolysaccharide	  export	  system	  permease	  protein	  LptF	   22.71	   8.87E-­‐196	   -­‐	   Proton	  glutamate	  symport	  protein	   17.82	   1.58E-­‐59	  
-­‐	   Lipopolysaccharide	  biosynthesis	  protein	   6.3	   2.41E-­‐20	   hlpA	   D-­‐methionine-­‐binding	  lipoprotein	  MetQ	   9.96	   2.51E-­‐97	  
-­‐	   Lipopolysaccharide	  biosynthesis	  protein	   5.5	   1.20E-­‐73	   pstA_1	   Phosphate	  ABC	  transporter	  permease	   8.6	   2.92E-­‐78	  
-­‐	   Na(+)-­‐translocating	  NADH-­‐quinone	  reductase	  subunit	  E	   4.95	   1.55E-­‐18	   -­‐	   Amino-­‐acid	  ABC	  transporter	  ATP-­‐binding	  protein	   8.56	   3.48E-­‐38	  
ppc	   Phosphoenolpyruvate	  carboxylase	   4.92	   3.99E-­‐75	   -­‐	   Amino	  acid	  ABC	  transporter	  substrate-­‐binding	  protein	   7.8	   1.63E-­‐09	  
merR
2	  
Mercuric	  resistance	  operon	  regulatory	  protein	   4.77	   8.18E-­‐26	   metN	   DL-­‐methionine	  transporter	  ATP-­‐binding	  protein	   7.72	   5.30E-­‐54	  
-­‐	  
Branched	  chain	  amino	  acid	  ABC	  transporter	  substrate-­‐binding	  protein	   4.59	   1.43E-­‐63	   -­‐	   Amino	  acid	  ABC	  transporter	  permease	   7.04	   1.77E-­‐12	  
-­‐	   Hypothetical	  protein	   4.59	   3.10E-­‐60	   dppA	   Haem-­‐binding	  lipoprotein	   5.41	   6.17E-­‐10	  
-­‐	   Cobalt	  transport	  protein	  CbiM	   4.55	   1.12E-­‐65	   -­‐	   Long	  chain	  fatty	  acid	  CoA	  ligase	   5.19	   4.47E-­‐69	  
-­‐	   Cobalt	  ABC	  transporter,	  permease	  protein	  CbiQ	   4.37	   7.15E-­‐53	   merT	   Mercuric	  ion	  transport	  protein	   4.69	   2.45E-­‐33	  
-­‐	   ABC	  transporter	  ATP-­‐binding	  protein	   4.36	   9.55E-­‐26	   merP_2	   Mercuric	  ion	  scavenger	  protein	   4.49	   7.82E-­‐24	  
fiu	   TonB-­‐dependent	  receptor	  Fiu	   4.25	   3.26E-­‐71	   fdhE	   Formate	  dehydrogenase	  accessory	  protein	  FdhE	   4	   2.00E-­‐52	  
cspD	   Cold	  shock-­‐like	  protein	   3.73	   6.71E-­‐13	   ilvC	   Ketol-­‐acid	  reductoisomerase	   3.96	   4.12E-­‐36	  
-­‐	  
Nickel	  uptake	  substrate-­‐specific	  transmembrane	  region	   3.7	   3.06E-­‐09	   -­‐	   Transglutaminase-­‐like	  superfamily	  protein	   3.72	   1.53E-­‐34	  
-­‐	   Hypothetical	  protein	   3.69	   2.27E-­‐51	   ilvI	   Acetolactate	  synthase	  3	  catalytic	  subunit	   3.58	   2.17E-­‐26	  
-­‐	   Hypothetical	  protein	   3.54	   2.23E-­‐11	   ilvH	   Acetolactate	  synthase	  3	  regulatory	  subunit	   3.33	   3.83E-­‐28	  
-­‐	   TonB-­‐dependent	  Receptor	  Plug	  Domain	  protein	   3.52	   2.06E-­‐11	   -­‐	   Pyridoxamine	  kinase	   3.31	   1.82E-­‐45	  
-­‐	   Zinc	  protease	   3.46	   4.03E-­‐32	   cydD_2	   ABC	  transporter	  ATP-­‐binding	  protein	   3.29	   2.57E-­‐17	  
rrmJ	   23S	  rRNA	  methyltransferase	  J	   3.45	   1.25E-­‐28	   tgt	   Queuine	  tRNA-­‐ribosyltransferase	   3.23	   1.78E-­‐36	  
-­‐	   Serine	  protease	   3.35	   2.73E-­‐33	   dmsA_3	   Anaerobic	  dimethyl	  sulfoxide	  reductase	  subunit	  A	   3.13	   0.001795612	  
-­‐	  
ABC-­‐type	  uncharacterized	  transport	  system,	  periplasmic	  component	   3.34	   1.56E-­‐14	   yecK	   Cytochrome	  C-­‐like	  protein	   3.12	   0.000319396	  
ltaS1	   Lipoteichoic	  acid	  synthase	  1	   3.21	   3.23E-­‐13	   potD_2	   Spermidine/putrescine	  ABC	  transporter	  substrate-­‐binding	  protein	   3.01	   1.89E-­‐08	  
dnaK	   Molecular	  chaperone	  DnaK	   3.19	   3.80E-­‐05	   oppF	   Oligopeptide	  ABC	  transporter	  ATP-­‐binding	  protein	   3	   2.15E-­‐30	  
lctP	   L-­‐lactate	  permease	   3.18	   4.62E-­‐18	   dcuD	   Putative	  cryptic	  C4-­‐dicarboxylate	  transporter	  DcuD	   2.96	   1.07E-­‐15	  
-­‐	   Hypothetical	  protein	   3.12	   3.35E-­‐09	   nrfB	   Cytochrome	  c	  nitrite	  reductase	  pentaheme	  subunit	   2.92	   2.39E-­‐10	  
ligA_
2	   DNA	  ligase	   3.1	   4.51E-­‐15	   oppD	   Oligopeptide	  transporter	  ATP-­‐binding	  protein	   2.77	   4.22E-­‐34	  
artI	   Arginine	  ABC	  transporter	  substrate-­‐binding	  protein	   3.08	   0.000751252	   fdxI	   Formate	  dehydrogenase	  subunit	  gamma	   2.75	   1.58E-­‐23	  
yjgA	   x96	  protein	   3.02	   1.12E-­‐09	   -­‐	   Diaminobutyrate-­‐-­‐2-­‐oxoglutarate	  aminotransferase	   2.75	   6.00E-­‐08	  
lptC	   Lipopolysaccharide	  export	  system	  protein	  LptC	   2.98	   1.17E-­‐31	   fdxH	   Formate	  dehydrogenase	  subunit	  beta	   2.72	   2.76E-­‐22	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Gene	   Product	   Fold	  change	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Up-­‐regulated	  genes	   Down-­‐regulated	  genes	  
lptA	  
Lipopolysaccharide	  export	  system	  protein	  LptA	  precursor	   2.96	   2.67E-­‐15	   pepE	   Peptidase	  E	   2.7	   3.77E-­‐08	  
com
M	   Competence	  protein	   2.93	   6.47E-­‐29	   nrfA	   Cytochrome	  c552	   2.64	   0.004472781	  
xylF	   D-­‐xylose	  transporter	  subunit	  XylF	   2.92	   5.84E-­‐08	   ilvD	   Dihydroxy-­‐acid	  dehydratase	   2.59	   7.63E-­‐13	  
-­‐	   Aminotransferase	  AlaT	   2.89	   2.30E-­‐22	   aroA	   3-­‐phosphoshikimate	  1-­‐carboxyvinyltransferase	   2.58	   8.83E-­‐16	  
-­‐	   Putative	  epimerase/dehydratase	   2.88	   2.46E-­‐12	   deaD	   ATP-­‐dependent	  RNA	  helicase	   2.55	   4.57E-­‐12	  
-­‐	   TPR	  repeat-­‐containing	  protein	  precursor	   2.87	   5.78E-­‐14	   -­‐	   Hydrolase	   2.53	   5.07E-­‐16	  
dprA	   DNA	  processing	  chain	  A	   2.85	   1.64E-­‐17	   -­‐	   Aminotransferase	  AlaT	   2.51	   1.02E-­‐15	  
radC	   DNA	  repair	  protein	  RadC	   2.8	   2.61E-­‐12	   -­‐	   ABC	  transporter	  ATP-­‐binding	  protein	   2.51	   1.87E-­‐15	  
mutT	   Mutator	  protein	   2.75	   3.93E-­‐13	   mesJ	   Cell	  cycle	  protein	   2.48	   7.42E-­‐20	  
-­‐	   Hypothetical	  protein	   2.75	   2.19E-­‐15	   hisC	   Histidinol-­‐phosphate	  aminotransferase	   2.48	   1.30E-­‐12	  
acrB	   Acriflavine	  resistance	  protein	   2.72	   1.45E-­‐08	   hisB	   Imidazole	  glycerol-­‐phosphate	  dehydratase/histidinol	  phosphatase	   2.46	   2.30E-­‐17	  
-­‐	   Membrane-­‐fusion	  protein	   2.68	   6.30E-­‐30	   tsf	   Elongation	  factor	  Ts	   2.43	   9.81E-­‐16	  
-­‐	   Transcriptional	  repressor	   2.67	   1.53E-­‐09	   hisG	   ATP	  phosphoribosyltransferase	   2.42	   1.76E-­‐22	  
fnr_1	   Anaerobic	  regulatory	  protein	   2.64	   3.00E-­‐14	   ilvA	   Threonine	  dehydratase	   2.42	   1.70E-­‐13	  
clpB	   ATP-­‐dependent	  Clp	  protease	  ATPase	  subunit	   2.64	   3.53E-­‐26	   hisD	   Histidinol	  dehydrogenase	   2.41	   4.46E-­‐14	  
-­‐	   Hypothetical	  protein	   2.63	   2.26E-­‐07	   oppC	   Oligopeptide	  ABC	  transporter	  permease	   2.41	   1.77E-­‐28	  
-­‐	   Putative	  small	  periplasmic	  lipoprotein	   2.58	   0.003511826	   menD	   2-­‐succinyl-­‐5-­‐enolpyruvyl-­‐6-­‐hydroxy-­‐3-­‐	  cyclohexene-­‐1-­‐carboxylate	  synthase	   2.36	   1.71E-­‐27	  
-­‐	   Putative	  permease,	  DMT	  superfamily	   2.56	   9.86E-­‐05	   asd	   Aspartate-­‐semialdehyde	  dehydrogenase	   2.36	   4.36E-­‐10	  
-­‐	   Phi	  X174	  lysis	  protein	   2.51	   2.39E-­‐10	   rpsB	   30S	  ribosomal	  protein	  S2	   2.36	   4.18E-­‐15	  
asnA	   Asparagine	  synthetase	  AsnA	   2.47	   1.55E-­‐07	   nrfC	   Nitrite	  reductase	  Fe-­‐S	  protein	   2.36	   2.41E-­‐12	  
groE
L	   Chaperonin	  GroEL	   2.46	   2.37E-­‐12	   trpA	   Tryptophan	  synthase	  subunit	  alpha	   2.31	   1.41E-­‐12	  
groE
S	   Co-­‐chaperonin	  GroES	   2.44	   6.04E-­‐12	   trpB	   Tryptophan	  synthase	  subunit	  beta	   2.3	   2.24E-­‐16	  
hslU	   ATP-­‐dependent	  protease	  ATP-­‐binding	  subunit	  HslU	   2.42	   2.96E-­‐11	   greA	   Transcription	  elongation	  factor	  GreA	   2.29	   3.69E-­‐06	  
hslV	   ATP-­‐dependent	  protease	  peptidase	  subunit	   2.41	   8.26E-­‐15	   pyrG	   CTP	  synthetase	   2.28	   9.41E-­‐09	  
comA	   Competence	  protein	  A	   2.4	   0.000661	   -­‐	   Hypothetical	  protein	   2.27	   5.80E-­‐22	  
lon	   ATP-­‐dependent	  proteinase	   2.4	   9.82E-­‐19	   -­‐	   Lipoprotein	   2.26	   1.96E-­‐19	  
comD	   Competence	  protein	  D	   2.39	   2.47E-­‐14	   speF	   Ornithine	  decarboxylase	   2.24	   7.13E-­‐13	  
comB	   Competence	  protein	  B	   2.39	   1.30E-­‐26	   nrfD	   Nitrite	  reductase	  transmembrane	  protein	   2.24	   9.81E-­‐09	  
yfeB	   Iron	  (chelated)	  transporter	  ATP-­‐binding	  protein	   2.38	   5.85E-­‐07	   dmsA_1	   Anaerobic	  dimethyl	  sulfoxide	  reductase	  subunit	  A	   2.23	   3.35E-­‐15	  
yfeA	  
Iron-­‐chelated	  ABC	  transporter	  substrate-­‐binding	  protein	   2.38	   2.58E-­‐09	   adhC	   Alcohol	  dehydrogenase	  class	  III	   2.21	   8.43E-­‐09	  
yfeC	   iron	  (chelated)	  ABC	  transporter	  permease	   2.37	   2.65E-­‐10	   dmsB	   Anaerobic	  dimethyl	  sulfoxide	  reductase	  subunit	  B	   2.21	   2.97E-­‐05	  
yfeD_
1	  
Iron	  (chelated)	  ABC	  transporter	  permease	   2.36	   5.10E-­‐06	   purU	   Formyltetrahydrofolate	  deformylase	   2.2	   3.18E-­‐07	  
-­‐	   ABC	  transporter	  permease	   2.34	   1.81E-­‐06	   -­‐	   Hypothetical	  protein	   2.18	   1.01E-­‐09	  
-­‐	   Thiamine	  biosynthesis	  protein	   2.34	   2.32E-­‐09	   -­‐	   SprT-­‐like	  family	  protein	   2.17	   5.31E-­‐07	  
-­‐	   ABC	  transporter	  ATP-­‐binding	  protein	   2.33	   1.28E-­‐23	   -­‐	   TPR	  repeat-­‐containing	  protein	  precursor	   2.16	   7.62E-­‐11	  
-­‐	   Lipooligosaccharide	  biosynthesis	  protein	   2.32	   6.63E-­‐14	   hslO	   Hsp33-­‐like	  chaperonin	   2.16	   4.82E-­‐10	  
-­‐	   Prepilin	  peptidase-­‐dependent	  protein	  D	   2.31	   1.73E-­‐17	   oppB	   Oligopeptide	  transporter	  permease	   2.16	   3.03E-­‐20	  
-­‐	   Protein	  transport	  protein	   2.27	   0.000189	   rplT	   50S	  ribosomal	  protein	  L20	   2.16	   7.53E-­‐16	  
hopD	   Type	  4	  prepilin-­‐like	  protein	  specific	  leader	  peptidase	   2.26	   1.46E-­‐10	   pldB	   Lysophospholipase	  L2	   2.15	   2.60E-­‐06	  
-­‐	   Type	  IV	  pilin	  secretion	   2.26	   1.43E-­‐09	   purK	   Phosphoribosylaminoimid 2.15	   1.62E-­‐06	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protein	   azole	  carboxylase	  ATPase	  subunit	  
Gene	   Product	   Fold	  change	  
Adjusted	  





Up-­‐regulated	  genes	   Down-­‐regulated	  genes	  
merP
_1	  
Mercuric	  ion	  scavenger	  protein	   2.25	   4.03E-­‐21	   mtr	   Tryptophan-­‐specific	  transport	  protein	   2.13	   3.77E-­‐05	  
-­‐	   Mercury	  transport-­‐like	  protein	   2.23	   4.72E-­‐06	   -­‐	   2,3-­‐diketo-­‐L-­‐gulonate	  reductase	   2.13	   2.71E-­‐05	  
-­‐	   Mercury	  transport-­‐like	  protein	   2.22	   3.37E-­‐14	   luxS	   S-­‐ribosylhomocysteinase	   2.12	   2.83E-­‐15	  
queA	   S-­‐adenosylmethionine:tRNA	  ribosyltransferase-­‐isomerase	   2.19	   1.16E-­‐05	   -­‐	   N-­‐acetyl-­‐D-­‐glucosamine	  kinase	   2.1	   8.26E-­‐15	  
brnQ	   Branched-­‐chain	  amino	  acid	  ABC	  transporter	   2.18	   2.96E-­‐14	   nusA	   Transcription	  elongation	  factor	  NusA	   2.1	   1.69E-­‐19	  
-­‐	   Hypothetical	  protein	   2.18	   1.06E-­‐05	   -­‐	   Hypothetical	  protein	   2.1	   4.81E-­‐16	  
-­‐	   Amino	  acid	  carrier	  protein	   2.17	   5.48E-­‐18	   gsp	   Bifunctional	  glutathionylspermidine	  synthetase/amidase	   2.09	   2.21E-­‐19	  
gdhA	   Glutamate	  dehydrogenase	   2.17	   1.24E-­‐25	   napC	   Cytochrome	  C-­‐type	  protein	   2.09	   1.25E-­‐14	  
nagB
_1	  
Glucosamine-­‐6-­‐phosphate	  deaminase	   2.16	   2.99E-­‐09	   infB	   Translation	  initiation	  factor	  IF-­‐2	   2.08	   1.35E-­‐14	  
nanA	   N-­‐acetylneuraminate	  lyase	   2.16	   2.59E-­‐10	   betT	   High	  affinity	  choline	  transport	  protein	   2.08	   2.11E-­‐07	  
siaP	   Neu5Ac-­‐binding	  protein	   2.16	   8.03E-­‐08	   -­‐	   Acyl-­‐CoA	  thioester	  hydrolase	  YfbB	   2.06	   1.76E-­‐05	  
hitC	   Iron(III)	  ABC	  transporter	  ATP-­‐binding	  protein	   2.14	   1.76E-­‐05	   ndk	   Nucleoside	  diphosphate	  kinase	   2.05	   4.54E-­‐11	  
htpG	   Heat	  shock	  protein	  90	   2.14	   5.04E-­‐06	   cydD_1	   ABC	  transporter	  ATP-­‐binding	  protein	   2.03	   0.007520324	  
hemR	   Haemin	  receptor	   2.14	   1.24E-­‐14	   guaA	   GMP	  synthase	   2.02	   2.96E-­‐15	  
hitB	   Iron(III)	  ABC	  transporter	  permease	   2.13	   0.006737257	   fabA	   3-­‐hydroxydecanoyl-­‐ACP	  dehydratase	   2.01	   4.74E-­‐23	  
hitA	   Iron-­‐utilization	  periplasmic	  protein	  hFbpA	   2.12	   3.66E-­‐07	   trmE	   tRNA	  modification	  GTPase	  TrmE	   2	   4.81E-­‐16	  
-­‐	   Nucleotidyltransferase	   2.09	   0.000263	   	   	   	   	  
grpE	   Heat	  shock	  protein	  GrpE	   2.08	   5.28E-­‐07	   	   	   	   	  
yiaM_
1	  
2,3-­‐diketo-­‐L-­‐gulonate	  TRAP	  transporter	  small	  permease	  protein	  YiaM	   2.06	   0.00093868	   	   	   	   	  
yiaO_
1	  
Extracytoplasmic	  solute	  receptor	  protein	  YiaO	   2.06	   2.77E-­‐09	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Table	  S6:	  Differentially	  expressed	  genes	  in	  the	  R2866	  strain	  during	  iron-­‐
starvation	  stress.	  
	  
Gene	   Product	   Fold	  change	  
Adjusted	  





Up-­‐regulated	  genes	   Down-­‐regulated	  genes	  
-­‐	   Putative	  TonB-­‐dependent	  transport	  protein	   35.06	   3.19E-­‐167	   ydjN	   Putative	  transporter	   10.68	   4.35E-­‐124	  
hxuC	   Haem-­‐hemopexin	  utilization	  protein	  C	   30.77	   0	   metQ	   DL-­‐methionine	  transporter,	  periplasmic	  binding	  protein	  MetQ	   9.13	   6.30E-­‐133	  
hitA	   Iron(III)	  ABC	  transporter	  periplasmic-­‐binding	  protein	   30.6	   2.22E-­‐216	   metI	   DL-­‐methionine	  transporter,	  permease	  protein	  MetI	   7.52	   7.10E-­‐133	  
omp
U1	  
Putative	  outer	  membrane	  protein	  OmpU1	   23.72	   3.75E-­‐171	   potD	   Spermidine/putrescine	  ABC	  transporter,	  periplasmic-­‐binding	  protein	   7.09	   1.01E-­‐43	  
hxuB	   Haem-­‐hemopexin	  utilization	  protein	  B	   23.46	   5.21E-­‐193	   metN	   DL-­‐methionine	  transporter,	  ATP	  binding	  protein	  MetN	   7.01	   4.59E-­‐77	  
tbp2	   Transferrin-­‐binding	  protein	  2	   17.21	   1.00E-­‐106	   artP	   Arginine	  ABC	  transporter,	  ATP-­‐binding	  protein	  ArtP	   6.18	   3.40E-­‐07	  
tbp1	   Transferrin-­‐binding	  protein	  1	   15.68	   3.64E-­‐136	   tcyA	   L-­‐cystine	  ABC	  transporter,	  periplasmic-­‐binding	  protein	  TcyA	   5.53	   8.93E-­‐92	  
hxuA	   Haem-­‐hemopexin	  utilization	  protein	  A	   15.01	   9.48E-­‐168	   argH	   Argininosuccinate	  lyase	   5.24	   2.00E-­‐08	  
copZ
3_1	   Copper	  chaperone	  protein	   10.93	   2.38E-­‐120	   fdnG_1	   Formate	  dehydrogenase-­‐N,	  major	  subunit	   5.13	   1.52E-­‐46	  
hitB	   Iron(III)	  ABC	  transporter	  permease	  protein	   10.83	   6.39E-­‐99	   fdnI	   Formate	  dehydrogenase-­‐N,	  cytochrome	  B556(Fdn)	  gamma	  subunit,	  nitrate-­‐inducible	   4.66	   4.66E-­‐34	  
copZ
3_2	   Copper	  chaperone	  protein	   10.68	   1.02E-­‐113	   fdnH	   Formate	  dehydrogenase-­‐N,	  Fe-­‐S	  beta	  subunit,	  nitrate-­‐inducible	   4.58	   8.05E-­‐53	  
-­‐	   Putative	  ABC	  transporter,	  periplasmic-­‐binding	  protein	   7.92	   2.46E-­‐60	   nrfB	   Nitrite	  reductase	  complex,	  periplasmic	  pentaheme	  cytochrome	  subunit	   4.52	   3.60E-­‐15	  
yfeA	   Fe/Mn/Zn	  ABC	  transporter	  periplasmic-­‐binding	  protein	   6.32	   4.89E-­‐79	   ilvC	   Ketol-­‐acid	  reductoisomerase	   4.49	   4.55E-­‐16	  
yfeB	   Fe/Mn/Zn	  ABC	  transporter	  ATP-­‐binding	  protein	   5.62	   1.35E-­‐92	   hbpA	   Dipeptide/Haem	  ABC	  transport	  system,	  periplasmic	  binding	  protein	   4.49	   1.04E-­‐38	  
yfeC	   Fe/Mn/Zn	  ABC	  transporter	  permease	  protein	   5.47	   8.53E-­‐48	   fdnG_2	   Formate	  dehydrogenase-­‐N,	  major	  subunit	   4.37	   1.51E-­‐43	  
hemR	   Putative	  TonB-­‐dependent	  haem	  receptor	   4.77	   2.87E-­‐46	   nrfA	   Nitrite	  reductase	  complex,	  periplasmic	  cytochrome	  C552	  subunit	   4.09	   3.36E-­‐05	  
-­‐	   Putative	  methyltransferase	   4.59	   1.28E-­‐28	   fdhE	   Formate	  dehydrogenase	  formation	  protein	  FdhE	   4.02	   5.62E-­‐17	  
tnaA	   Tryptophanase	   4.57	   1.42E-­‐54	   tgt	   tRNA-­‐guanine	  transglycosylase	   3.96	   3.11E-­‐24	  
hitC	   Iron(III)	  ABC	  transporter	  ATP-­‐binding	  protein	   4.3	   6.16E-­‐25	   dat	   L-­‐2,4-­‐diaminobutyrate:2-­‐ketoglutarate	  4-­‐aminotransferase	  aminotransferase	   3.94	   2.09E-­‐14	  
yfeD	   Fe/Mn/Zn	  ABC	  transporter	  permease	  protein	   4.24	   6.47E-­‐40	   artI	   Arginine	  ABC	  transporter,	  periplasmic-­‐binding	  protein	  ArtI	   3.73	   4.84E-­‐13	  
copA	   Copper-­‐transporting	  ATPase	   4.04	   1.86E-­‐29	   nrfC	   Nitrite	  reductase	  complex,	  Fe-­‐S	  subunit	  NrfC	   3.7	   9.76E-­‐14	  
tehB	   Putative	  tellurite	  resistance	  protein	  B	   3.95	   3.05E-­‐63	   merT	   Putative	  heavy	  metal	  transport	  protein	   3.67	   9.12E-­‐18	  
htrA	   Periplasmic	  serine	  protease	  HtrA	   3.74	   1.26E-­‐58	   hslO	   Hsp33-­‐like	  chaperonin	   3.66	   4.59E-­‐16	  
-­‐	   Hypothetical	  protein	   3.21	   1.46E-­‐07	   ilvD	   Dihydroxyacid	  dehydratase	   3.64	   3.62E-­‐39	  
pqqL	   Putative	  Zn-­‐dependent	  protease	   2.87	   5.67E-­‐14	   deaD	   ATP-­‐dependent	  RNA	  helicase	  DeaD	   3.49	   4.45E-­‐19	  
-­‐	   Hypothetical	  protein	   2.87	   1.31E-­‐31	   ilvA	   Threonine	  deaminase	   3.48	   1.38E-­‐27	  
clpB	   ATP-­‐dependent	  Clp	  protease	  ATPase	  subunit	   2.77	   3.48E-­‐15	   artQ	   Arginine	  ABC	  transporter,	  permease	  protein	  ArtQ	   3.48	   5.74E-­‐15	  
msrA
B	  
Peptide	  methionine	  sulfoxide	  reductase	   2.75	   9.05E-­‐07	   artM	   Arginine	  ABC	  transporter,	  permease	  protein	  ArtM	   3.45	   7.07E-­‐18	  
-­‐	   tRNA-­‐Leu(caa)	   2.65	   0.000109	   pyrG	   CTP	  synthetase	   3.41	   1.20E-­‐10	  
acrR	   Putative	  transcriptional	  regulator	  AcrR	   2.59	   5.39E-­‐08	   torY	   Trimethylamine	  N-­‐oxide	  reductase	  system	  III,	   3.36	   2.64E-­‐08	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cytochrome	  c-­‐type	  subunit	  
Gene	   Product	   Fold	  change	  
Adjusted	  





Up-­‐regulated	  genes	   Down-­‐regulated	  genes	  
queA	  
S-­‐adenosylmethionine:tRNA	  ribosyltransferase-­‐isomerase	  (queuosine	  biosynthesis	  protein)	   2.57	   6.08E-­‐14	   rpL1	   50S	  ribosomal	  subunit	  protein	  L1	   3.28	   1.71E-­‐24	  
mda
B	   NADPH	  quinone	  reductase	   2.53	   8.42E-­‐07	   rpL11	   50S	  ribosomal	  subunit	  protein	  L11	   3.28	   3.85E-­‐21	  
tnaB	   Tryptophan	  permease	   2.5	   1.73E-­‐07	   nrfD	   Nitrite	  reductase	  complex,	  transmembrane	  subunit	  NrfD	   3.24	   4.14E-­‐11	  
dsbD
_1	  
Thiol-­‐disulfide	  interchange	  protein	  DsbD	   2.48	   0.000361234	   glmS	   Glucosamine-­‐fructose-­‐6-­‐phosphate	  aminotransferase	   3.16	   7.14E-­‐17	  
dnaK	   Molecular	  chaperone	  DnaK	  (Hsp70)	   2.46	   3.33E-­‐08	   merP	   Putative	  heavy	  metal	  chaperone	  protein	   3.13	   3.94E-­‐16	  
exbB	   Biopolymer	  transport	  protein	  ExbB	   2.41	   4.75E-­‐21	   -­‐	   Hypothetical	  protein	   3.12	   9.76E-­‐19	  
hgpC	  
Hemoglobin	  and	  hemoglobin-­‐haptoglobin	  binding	  protein	  C	   2.41	   5.17E-­‐12	   -­‐	   Transglutaminase-­‐like	  superfamily	  protein	   3.11	   1.38E-­‐42	  
hslU	   Protease	  HslVU,	  ATPase	  subunit	   2.39	   4.60E-­‐07	   -­‐	   Hypothetical	  protein	   3.06	   5.00E-­‐05	  
-­‐	   16S	  ribosomal	  RNA	   2.38	   0.002201796	   oppF	   Oligopeptide	  ABC	  transporter,	  ATP-­‐binding	  protein	  OppF	   2.96	   1.28E-­‐15	  
lon	   ATP-­‐dependent	  protease	  La	   2.32	   7.21E-­‐16	   -­‐	   tRNA-­‐Ile(gat)	   2.84	   3.33E-­‐15	  
lptC	  
Lipooligosaccharide	  transporter,	  accessory	  protein	  LptC	   2.31	   4.45E-­‐17	   ahpC	   Peroxiredoxin	   2.77	   5.62E-­‐14	  
exbD	   Biopolymer	  transport	  protein	  ExbD	   2.27	   3.41E-­‐13	   aroA	   3-­‐phosphoshikimate-­‐1-­‐carboxyvinyltransferase	   2.75	   7.28E-­‐11	  
hslV	   Protease	  HslVU,	  peptidase	  subunit	   2.24	   2.82E-­‐05	   rpL7	   50S	  ribosomal	  protein	  L7/L12	   2.71	   4.24E-­‐12	  
yfiA	   Ribosome	  binding	  protein	  Y	   2.21	   5.70E-­‐09	   oppD	   Oligopeptide	  ABC	  transporter,	  ATP-­‐binding	  protein	  OppD	   2.71	   1.01E-­‐13	  
groE
L	   GroEL,	  chaperone	  Hsp60	   2.17	   3.09E-­‐13	   -­‐	   Selenium	  metabolism	  protein	  YedF	   2.69	   4.30E-­‐09	  
yjgA	   x96	  protein	   2.13	   1.83E-­‐11	   ompP2	   Outer	  membrane	  protein	  P2	   2.68	   5.57E-­‐30	  
dam_
2	   Putative	  dam	  methylase	   2.13	   0.006054781	   rpL29	   50S	  ribosomal	  protein	  L29	   2.67	   3.08E-­‐23	  
acrA	   Multidrug	  efflux	  system	  protein	  AcrA	   2.08	   3.44E-­‐08	   -­‐	   SH3	  domain-­‐containing	  protein	   2.67	   3.50E-­‐07	  
dprA	   DNA	  processing	  chain	  A	   2.08	   0.000469528	   frdC	   Fumarate	  reductase,	  subunit	  C	   2.66	   6.84E-­‐26	  
pckA	   Phosphoenolpyruvate	  carboxykinase	   2.07	   6.03E-­‐05	   tsf	   Elongation	  factor	  Ts	   2.63	   6.58E-­‐20	  
-­‐	  
Putative	  TRAP-­‐type	  transport	  system,	  periplasmic	  component	   2.07	   3.89E-­‐05	   rimP	   30S	  ribosomal	  maturation	  protein	  RimP	   2.61	   4.57E-­‐06	  
afuA	  
Ferric	  transport	  system	  AfuABC;	  periplasmic-­‐binding	  protein	  component	   2.06	   5.54E-­‐12	   rpL16	   50S	  ribosomal	  protein	  L16	   2.61	   2.10E-­‐23	  
groE
S	   GroES,	  chaperone	  Hsp10	   2.05	   1.97E-­‐06	   rpS17	   30S	  ribosomal	  protein	  S17	   2.6	   2.33E-­‐22	  
tonB	   TonB	  protein	   2.01	   7.60E-­‐10	   rpL9	   50S	  ribosomal	  subunit	  protein	  L9	   2.59	   1.77E-­‐20	  
ribC	   Riboflavin	  synthase,	  subunit	  alpha	   2.01	   6.73E-­‐10	   greA	   Transcription	  elongation	  factor	  GreA	   2.59	   1.30E-­‐05	  
	   	   	   	   tusB	   Putative	  tRNA	  2-­‐thiouridine	  synthesizing	  protein	  B	   2.57	   0.001640568	  
	   	   	   	   atpC	  
Membrane-­‐bound	  ATP	  synthase,	  F1	  sector,	  epsilon-­‐subunit	   2.55	   2.18E-­‐25	  
	   	   	   	   ispF	   2-­‐C-­‐methyl-­‐D-­‐erythritol	  2,4-­‐cyclodiphosphate	  synthase	   2.55	   1.01E-­‐07	  
	   	   	   	   rpS3	   30S	  ribosomal	  protein	  S3	   2.54	   9.25E-­‐25	  
	   	   	   	   -­‐	   tRNA-­‐Ala(tgc)	   2.54	   2.69E-­‐09	  
	   	   	   	   dmsA	   Anaerobic	  dimethyl	  sulfoxide	  reductase,	  subunit	  A	   2.52	   0.020883402	  
	   	   	   	   rpS18	   30S	  ribosomal	  subunit	  protein	  S18	   2.49	   7.88E-­‐16	  
	   	   	   	   nusA	   Transcription	  elongation	  factor	  NusA	   2.48	   6.11E-­‐17	  
	   	   	   	   cca	  
tRNA	  nucleotidyltransferase/2'3'-­‐cyclic	   2.48	   1.04E-­‐09	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phosphodiesterase/2'nucleotidase	  and	  phosphatase	  
	   	   	   	   Gene	   Product	   Fold	  change	  
Adjusted	  
p-­‐value	  
	   Down-­‐regulated	  genes	  
	   	   	   	   rpS19	   30S	  ribosomal	  protein	  S19	   2.45	   5.03E-­‐22	  
	   	   	   	   frdD	   Fumarate	  reductase,	  subunit	  D	   2.45	   2.51E-­‐12	  
	   	   	   	   rpL19	  
50S	  ribosomal	  subunit	  protein	  L19	   2.44	   6.91E-­‐14	  
	   	   	   	   rpS2	   30S	  ribosomal	  protein	  S2	   2.44	   1.52E-­‐17	  
	   	   	   	   deoD	   Purine-­‐nucleoside	  phosphorylase	  (PNPase)	   2.43	   4.97E-­‐15	  
	   	   	   	   frdB	   Fumarate	  reductase,	  subunit	  B	   2.43	   4.94E-­‐19	  
	   	   	   	   frdA	   Fumarate	  reductase,	  subunit	  A	   2.42	   4.76E-­‐12	  
	   	   	   	   -­‐	   Hypothetical	  protein	   2.42	   0.000109	  
	   	   	   	   rpL22	   50S	  ribosomal	  protein	  L22	   2.41	   3.05E-­‐20	  
	   	   	   	   tcyB	   L-­‐cystine	  ABC	  transporter,	  permease	  component	  TcyB	   2.41	   6.27E-­‐24	  
	   	   	   	   atpD	  
Membrane-­‐bound	  ATP	  synthase,	  F1	  sector,	  beta-­‐subunit	   2.39	   2.22E-­‐28	  
	   	   	   	   rpL2	   50S	  ribosomal	  protein	  L2	   2.39	   1.51E-­‐15	  
	   	   	   	   trmU	  
tRNA	  (5-­‐methylaminomethyl-­‐2-­‐thiouridylate)-­‐	  methyltransferase	   2.38	   1.13E-­‐08	  
	   	   	   	   rpL10	   50S	  ribosomal	  protein	  L10	   2.35	   5.14E-­‐11	  
	   	   	   	   -­‐	   Hypothetical	  protein	   2.35	   1.30E-­‐11	  
	   	   	   	   yjcD	   Putative	  membrane	  permease	   2.34	   2.50E-­‐05	  
	   	   	   	   nlpI	   Lipoprotein	  NlpI	   2.34	   1.47E-­‐14	  
	   	   	   	   -­‐	   Putative	  membrane	  protein	   2.31	   0.008362234	  
	   	   	   	   rpL23	   50S	  ribosomal	  protein	  L23	   2.3	   5.94E-­‐16	  
	   	   	   	   fis	   DNA	  architectural	  protein	  Fis	   2.29	   0.017436	  
	   	   	   	   ispD	  
2-­‐C-­‐methyl-­‐D-­‐erythritol	  4-­‐phosphate	  cytidylyltransferase	   2.28	   1.56E-­‐06	  
	   	   	   	   rpL4	   50S	  ribosomal	  protein	  L4	   2.26	   1.33E-­‐12	  
	   	   	   	   rplQ	   50S	  ribosomal	  protein	  L17	   2.26	   2.36E-­‐18	  
	   	   	   	   tilS	   tRNA(Ile)-­‐lysidine	  synthetase	   2.25	   2.57E-­‐16	  
	   	   	   	   tusC	   tRNA	  2-­‐thiouridine	  synthesizing	  protein	  C	   2.25	   0.000962104	  
	   	   	   	   cstA	   Carbon	  starvation	  protein	  A	   2.24	   4.17E-­‐09	  
	   	   	   	   hel	   Outer	  membrane	  protein	  P4	   2.24	   5.25E-­‐22	  
	   	   	   	   argR	   Arginine	  repressor	   2.24	   2.43E-­‐07	  
	   	   	   	   atpH	  
Membrane-­‐bound	  ATP	  synthase,	  F1	  sector,	  delta-­‐subunit	   2.21	   3.63E-­‐14	  
	   	   	   	   tcyC	   L-­‐cystine	  ABC	  transporter,	  ATP-­‐binding	  protein	  TcyC	   2.21	   8.12E-­‐17	  
	   	   	   	   rnb	   Ribonuclease	  II	   2.21	   4.14E-­‐06	  
	   	   	   	   menH	  
2-­‐succinyl-­‐6-­‐hydroxy-­‐2,	  4-­‐cyclohexadiene-­‐1-­‐carboxylate	  synthase	   2.2	   2.28E-­‐05	  
	   	   	   	   atpF	  
Membrane-­‐bound	  ATP	  synthase,	  F0	  sector,	  subunit	  B	   2.2	   8.47E-­‐13	  
	   	   	   	   -­‐	   Hypothetical	  protein	   2.2	   1.83E-­‐11	  
	   	   	   	   rpL3	   50S	  ribosomal	  protein	  L3	   2.2	   5.43E-­‐12	  
	   	   	   	   prtR_2	   Pyocin	  repressor	  protein	   2.19	   9.06E-­‐11	  
	   	   	   	   menD	  
2-­‐succinyl-­‐6-­‐hydroxy-­‐24-­‐cyclohexadiene-­‐1-­‐	  carboxylate	  synthase/2-­‐oxoglutarate	  decarboxylase	   2.18	   9.12E-­‐18	  
	   	   	   	   tusD	   tRNA	  2-­‐thiouridine	  synthesizing	  protein	  D	   2.18	   1.65E-­‐08	  
	   	   	   	   argG	   Argininosuccinate	  synthetase	   2.18	   2.21E-­‐13	  
	   	   	   	   pepE	   Peptidase	  E	   2.16	   5.82E-­‐07	  
	   	   	   	   atpA	   Membrane-­‐bound	  ATP	  synthase,	  F1	  sector,	  alpha-­‐ 2.15	   3.66E-­‐18	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subunit	  
	   	   	   	   Gene	   Product	   Fold	  change	  
Adjusted	  
p-­‐value	  
	   Down-­‐regulated	  genes	  
	   	   	   	   rpS10	   30S	  ribosomal	  protein	  S10	   2.15	   6.03E-­‐10	  
	   	   	   	   atpG	  
Membrane-­‐bound	  ATP	  synthase,	  F1	  sector,	  gamma-­‐subunit	   2.14	   6.99E-­‐16	  
	   	   	   	   priB	   Primosomal	  replication	  protein	  N	   2.14	   9.57E-­‐12	  
	   	   	   	   -­‐	   Putative	  peptidase/hydrolase	   2.12	   4.36E-­‐12	  
	   	   	   	   apbE	   Lipoprotein	  ApbE	   2.11	   2.77E-­‐14	  
	   	   	   	   prmB	   50S	  subunit	  L3	  protein	  glutamine	  methyltransferase	   2.11	   2.45E-­‐10	  
	   	   	   	   -­‐	   YheO-­‐like	  PAS	  domain	  protein	   2.11	   4.90E-­‐11	  
	   	   	   	   yccS	   Inner	  membrane	  protein	  YccS	   2.1	   1.40E-­‐08	  
	   	   	   	   pfs	  
5'-­‐methylthioadenosine/S-­‐adenosylhomocysteine	  nucleosidase	   2.1	   3.15E-­‐09	  
	   	   	   	   oppC	  
Oligopeptide	  ABC	  transporter,	  permease	  protein	  OppC	   2.09	   6.04E-­‐09	  
	   	   	   	   arfA	   Alternative	  ribosome-­‐rescue	  factor	  A	   2.09	   0.009565168	  
	   	   	   	   dcuC	   Putative	  C4-­‐dicarboxylate	  transporter	   2.08	   2.89E-­‐07	  
	   	   	   	   rps6	   30S	  ribosomal	  subunit	  protein	  S6	   2.07	   1.86E-­‐09	  
	   	   	   	   rpL20	   50S	  ribosomal	  protein	  L20	   2.07	   5.81E-­‐12	  
	   	   	   	   infB	   Translation	  initiation	  factor	  2	   2.06	   4.06E-­‐19	  
	   	   	   	   trmD	   tRNA	  (guanine-­‐N1)-­‐methyltransferase	   2.05	   1.18E-­‐12	  
	   	   	   	   secD	   General	  secretory	  pathway	  component	  SecD	   2.05	   0.000117544	  
	   	   	   	   mnmE	  
tRNA	  modification	  GTPase	  mnmE	   2.04	   4.43E-­‐08	  
	   	   	   	   purU	   Formyltetrahydrofolate	  deformylase	   2.03	   1.08E-­‐05	  
	   	   	   	   -­‐	   Epimerase	  family	  protein	   2.02	   1.56E-­‐06	  
	   	   	   	   pdxY	   Pyridoxine	  kinase	   2.02	   5.38E-­‐09	  
	   	   	   	   glpC_2	  
Anaerobic	  glycerol-­‐3-­‐phosphate	  dehydrogenase	  subunit	  C	   2.02	   7.24E-­‐12	  
	   	   	   	   rpoA	   DNA-­‐directed	  RNA	  polymerase	  subunit	  alpha	   2.02	   3.94E-­‐13	  
	   	   	   	   lig	   NAD-­‐dependent	  DNA	  ligase	   2.02	   8.70E-­‐06	  
	   	   	   	   pitA	   Putative	  phosphate	  permease	   2.01	   3.83E-­‐05	  
	   	   	   	   -­‐	   Hypothetical	  protein	  p38_1	   2.01	   0.008883	  
	   	   	   	   -­‐	  
Putative	  ABC	  transporter,	  fused	  permease	  and	  ATP-­‐binding	  components	   2	   0.002748801	  
	   	   	   	   nqrC	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Table	   S7:	   Differentially	   expressed	   genes	   in	   the	   Rd	   strain	   during	  
nutritional	  stress.	  
	  
Gene	   Product	   Fold	  change	  
Adjusted	  





Up-­‐regulated	  genes	   Down-­‐regulated	  genes	  
dps	   DNA	  protection	  during	  starvation	  protein	   11.82	   8.83E-­‐30	   yjcD	   Putative	  permease	  YjcD	   66.56	   2.82E-­‐212	  
sdaA	   L-­‐serine	  deaminase	   10.55	   3.14E-­‐78	   purH	   Bifunctional	  phosphoribosylaminoimidazolecarboxamide	  formyltransferase/IMP	  cyclohydrolase	   59.93	   2.78E-­‐230	  
sdaC	   Serine	  transporter	   10.22	   5.42E-­‐47	   purD	   Phosphoribosylamine-­‐-­‐glycine	  ligase	   35.82	   2.86E-­‐240	  
gntP_
1	   Gluconate	  permease	   7.84	   7.33E-­‐39	   purM	   Phosphoribosylaminoimidazole	  synthetase	   35.77	   7.29E-­‐161	  
garK	   Glycerate	  2-­‐kinase	   7.54	   2.42E-­‐29	   purE	   Phosphoribosylaminoimidazole	  carboxylase	  catalytic	  subunit	   33.62	   1.10E-­‐124	  
-­‐	   Aldolase	   7.21	   4.79E-­‐10	   purN	   Phosphoribosylglycinamide	  formyltransferase	   22.74	   1.24E-­‐233	  
dprA	   DNA	  processing	  chain	  A	   7.16	   3.28E-­‐16	   purK	   Phosphoribosylaminoimidazole	  carboxylase	  ATPase	  subunit	   19.39	   2.90E-­‐41	  
-­‐	   Hypothetical	  protein	   6.85	   6.57E-­‐10	   mtr	   Tryptophan-­‐specific	  transport	  protein	   17.58	   5.16E-­‐66	  
-­‐	   3-­‐hydroxyisobutyrate	  dehydrogenase	   6.57	   2.87E-­‐09	   lctP	   L-­‐lactate	  permease	   11.89	   3.28E-­‐34	  
ygbM	   Putative	  hydroxypyruvate	  isomerase	  YgbM	   6.51	   7.33E-­‐09	   -­‐	   Short	  chain	  dehydrogenase/reductase	   10.51	   2.21E-­‐23	  
arcB	   Ornithine	  carbamoyltransferase	   6.38	   3.91E-­‐09	   -­‐	   Transporter	  protein	   10.21	   2.01E-­‐24	  
arcC	   Carbamate	  kinase	   6.16	   4.96E-­‐08	   hemH_2	   Phosphoribosylaminoimidazole-­‐succinocarboxamide	  synthase	   9.69	   1.41E-­‐57	  
-­‐	   Putative	  epimerase/dehydratase	   6	   1.18E-­‐09	   cvpA	   Colicin	  V	  production	  protein	   8.82	   8.54E-­‐87	  
gntP_
3	   Gluconate	  permease	   5.1	   2.25E-­‐09	   trpE	   Anthranilate	  synthase	  component	  I	   8.51	   7.96E-­‐24	  
hitC	   Iron(III)	  ABC	  transporter	  ATP-­‐binding	  protein	   4.84	   2.50E-­‐12	   ydeM	   Hypothetical	  protein	   8.35	   2.27E-­‐10	  
rnb	   Exoribonuclease	  II	   4.43	   7.42E-­‐11	   purF	   Amidophosphoribosyltransferase	   7.78	   1.68E-­‐58	  
-­‐	   Putative	  cyclase	   4.42	   4.01E-­‐07	   purL_1	   Phosphoribosylformylglycinamidine	  synthase	   6.86	   1.35E-­‐67	  
hitA	   Iron-­‐utilization	  periplasmic	  protein	  hFbpA	   4.19	   9.22E-­‐11	   leuB	   3-­‐isopropylmalate	  dehydrogenase	   6.82	   7.56E-­‐17	  
-­‐	   Formate	  acetyltransferase	   4.13	   9.16E-­‐11	   -­‐	   Haloacid	  dehalogenase-­‐like	  protein	   6.51	   1.04E-­‐18	  
-­‐	   Autonomous	  glycyl	  radical	  cofactor	  GrcA	   4.05	   3.09E-­‐08	   leuC	   Isopropylmalate	  isomerase	  large	  subunit	   6.19	   1.84E-­‐13	  
-­‐	  
Nickel	  uptake	  substrate-­‐specific	  transmembrane	  region	   3.89	   4.21E-­‐18	   leuD	   Isopropylmalate	  isomerase	  small	  subunit	   6.19	   1.41E-­‐10	  
cydD
_2	  
ABC	  transporter	  ATP-­‐binding	  protein	   3.87	   1.91E-­‐06	   ilvC	   Ketol-­‐acid	  reductoisomerase	   5.78	   0.000356275	  
-­‐	   ABC	  transporter	  ATP-­‐binding	  protein	   3.84	   3.03E-­‐06	   glpX	   Fructose	  1,6-­‐bisphosphatase	  II	   5.24	   5.43E-­‐66	  
hitB	   Iron(III)	  ABC	  transporter	  permease	   3.66	   2.21E-­‐05	   ccrB	   Camphor	  resistance	  protein	  CrcB	   5.22	   2.15E-­‐26	  
-­‐	   Twin-­‐argninine	  leader-­‐binding	  protein	  DmsD	   3.61	   0.001860645	   -­‐	   Hypothetical	  protein	   5.19	   3.78E-­‐30	  
-­‐	   Type	  IV	  pilin	  secretion	  protein	   3.53	   1.77E-­‐07	   leuA	   2-­‐isopropylmalate	  synthase	   5.09	   7.57E-­‐14	  
comD	   Competence	  protein	  D	   3.39	   6.30E-­‐05	   chuR	   Anaerobic	  sulfatase-­‐maturating	  enzyme	   5.09	   7.06E-­‐06	  
fabA	   3-­‐hydroxydecanoyl-­‐ACP	  dehydratase	   3.39	   1.11E-­‐15	   -­‐	   Hypothetical	  protein	   5.05	   1.61E-­‐12	  
-­‐	   Lipooligosaccharide	  biosynthesis	  protein	   3.34	   6.62E-­‐06	   fdnG	   Formate	  dehydrogenase,	  nitrate-­‐inducible,	  major	  subunit	  precursor	   4.95	   1.65E-­‐10	  
afuB	   Ferric	  transport	  system	  permease-­‐like	  protein	   3.31	   5.13E-­‐14	   galR	   LacI	  family	  transcriptional	  repressor	   4.95	   3.70E-­‐11	  
fbpC	   Ferric	  transporter	  ATP-­‐ 3.29	   2.22E-­‐12	   uraA	   Uracil	  permease	   4.65	   1.65E-­‐08	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binding	  protein	  
Gene	   Product	   Fold	  change	  
Adjusted	  





Up-­‐regulated	  genes	   Down-­‐regulated	  genes	  
-­‐	   Protein	  transport	  protein	   3.29	   3.29E-­‐07	   fdhE	   Formate	  dehydrogenase	  accessory	  protein	  FdhE	   4.52	   6.26E-­‐08	  
gdhA	   Glutamate	  dehydrogenase	   3.28	   0.000226623	   dmsA_1	   Anaerobic	  dimethyl	  sulfoxide	  reductase	  subunit	  A	   4.48	   3.56E-­‐09	  
glgB	   Glycogen	  branching	  protein	   3.12	   9.55E-­‐09	   atzC	   N-­‐isopropylammelide	  isopropyl	  amidohydrolase	   4.14	   7.69E-­‐20	  
comC	   Competence	  protein	  C	   3.11	   0.000223426	   fdxH	   Formate	  dehydrogenase	  subunit	  beta	   4.05	   4.70E-­‐11	  
asnA	   Asparagine	  synthetase	  AsnA	   3.02	   0.0002759	   artQ	   Arginine	  transporter	  permease	  subunit	  ArtQ	   4.03	   2.73E-­‐07	  
-­‐	   Hydrolase	   2.99	   7.58E-­‐05	   -­‐	   2,3-­‐diketo-­‐L-­‐gulonate	  reductase	   4.01	   1.23E-­‐08	  
hopD	   Type	  4	  prepilin-­‐like	  protein	  specific	  leader	  peptidase	   2.95	   6.26E-­‐08	   artM	   Arginine	  transporter	  permease	  subunit	  ArtM	   3.66	   1.18E-­‐07	  
-­‐	   Hydroxyethylthiazole	  kinase	   2.92	   5.71E-­‐19	   ndh	   NADH	  dehydrogenase	   3.63	   2.91E-­‐16	  
ccmD	   Haem	  exporter	  protein	  D	   2.89	   0.000298756	   rsgA_1	   Ferritin	  like	  protein	  1	   3.63	   0.000119608	  
icc	  
Cyclic	  3',5'-­‐adenosine	  monophosphate	  phosphodiesterase	   2.86	   1.52E-­‐06	   fdxI	   Formate	  dehydrogenase	  subunit	  gamma	   3.62	   2.14E-­‐12	  
cpdB	  
Bifunctional	  2',3'-­‐cyclic	  nucleotide	  2'-­‐phosphodiesterase/3'-­‐nucleotidase	   2.85	   0.000173128	   rsgA_2	   Ferritin	   3.59	   0.000151272	  
-­‐	   Sulfur	  relay	  protein	  TusC	   2.81	   6.77E-­‐06	   arcA	   Two-­‐component	  response	  regulator	   3.53	   2.69E-­‐24	  
-­‐	   TRAP	  transporter,	  DctM	  subunit	   2.8	   0.000424651	   arfA	   Alternative	  ribosome-­‐rescue	  factor	  A	   3.37	   7.08E-­‐10	  
-­‐	   Sulfur	  transfer	  complex	  subunit	  TusB	   2.79	   1.12E-­‐05	   kipI	   Sporulation	  inhibitor	  KipI	   3.35	   7.67E-­‐16	  
comB	   Competence	  protein	  B	   2.77	   0.000578764	   artI	   Arginine	  ABC	  transporter	  substrate-­‐binding	  protein	   3.31	   5.87E-­‐09	  
com
M	   Competence	  protein	   2.73	   1.17E-­‐05	   -­‐	   DNA	  polymerase	  V	  subunit	  UmuD	   3.15	   2.89E-­‐12	  
frr	   Ribosome	  recycling	  factor	   2.71	   3.33E-­‐07	   trpG_2	   Anthranilate	  synthase	  component	  II	   2.95	   2.43E-­‐37	  
thiD	   Phosphomethylpyrimidine	  kinase	   2.7	   2.05E-­‐12	   argG	   Argininosuccinate	  synthase	   2.91	   2.76E-­‐13	  
cydD
_1	  
ABC	  transporter	  ATP-­‐binding	  protein	   2.69	   2.20E-­‐05	   artP	   Arginine	  transporter	  ATP-­‐binding	  protein	   2.85	   9.12E-­‐07	  
-­‐	   Electron	  transport	  complex	  protein	  RnfC	   2.69	   5.24E-­‐09	   trpB	   Tryptophan	  synthase	  subunit	  beta	   2.82	   2.76E-­‐13	  
ccmE	   Cytochrome	  c-­‐type	  biogenesis	  protein	  CcmE	   2.66	   0.00473122	   cmk_1	   Cytidylate	  kinase	   2.78	   4.51E-­‐13	  
-­‐	   Prepilin	  peptidase-­‐dependent	  protein	  D	   2.65	   0.000563633	   dnaJ	   Chaperone	  protein	  DnaJ	   2.76	   0.00368254	  
-­‐	   Glycine	  radical	  enzyme,	  YjjI	  family	   2.65	   5.55E-­‐13	   glyA	   Serine	  hydroxymethyltransferase	   2.75	   2.56E-­‐11	  
-­‐	   1-­‐deoxy-­‐D-­‐xylulose	  5-­‐phosphate	  reductoisomerase	   2.6	   0.000108811	   -­‐	   Zinc-­‐type	  alcohol	  dehydrogenase	   2.74	   0.00037308	  
glgC	   Glucose-­‐1-­‐phosphate	  adenylyltransferase	   2.59	   5.22E-­‐06	   -­‐	   DNA	  replication	  initiation	  factor	   2.66	   0.000489336	  
glpK	   Flycerol	  kinase	   2.58	   2.77E-­‐25	   cmk_2	   Cytidylate	  kinase	   2.61	   2.19E-­‐05	  
znuA	   High-­‐affinity	  zinc	  transporter	  substrate-­‐binding	  protein	   2.55	   2.24E-­‐09	   ygiX	   Transcriptional	  regulatory	  protein	   2.61	   7.77E-­‐11	  
-­‐	   Sulfur	  transfer	  complex	  subunit	  TusD	   2.55	   1.91E-­‐06	   -­‐	   Hypothetical	  protein	   2.61	   7.49E-­‐07	  
napG	   Quinol	  dehydrogenase	  periplasmic	  subunit	   2.53	   3.91E-­‐12	   -­‐	   Esterase	   2.56	   0.006881365	  
nudF	   ADP-­‐ribose	  pyrophosphatase	   2.51	   5.74E-­‐06	   -­‐	   Transcriptional	  regulator	   2.56	   4.78E-­‐19	  
dmsA
_2	  
Anaerobic	  dimethyl	  sulfoxide	  reductase	  subunit	  A	   2.51	   1.13E-­‐10	   -­‐	   Transcriptional	  regulator	   2.56	   2.89E-­‐15	  
napH	   Quinol	  dehydrogenase	  membrane	  subunit	   2.5	   4.19E-­‐14	   infB	   Translation	  initiation	  factor	  IF-­‐2	   2.53	   0.000109576	  
glpF_
1	  
Glycerol	  uptake	  facilitator	  protein	   2.5	   1.13E-­‐18	   adhC	   Alcohol	  dehydrogenase	  class	  III	   2.5	   0.00756002	  
hisH_
2	  
Histidinol-­‐phosphate	  aminotransferase	   2.5	   2.93E-­‐05	   -­‐	   YGGT	  family	  protein	   2.47	   1.57E-­‐08	  
yhhQ	   Inner	  membrane	  protein	  YhhQ	   2.48	   7.84E-­‐24	   pepT	   Peptidase	  T	   2.46	   6.68E-­‐05	  
thiE	   Thiamine-­‐phosphate	  pyrophosphorylase	   2.47	   1.51E-­‐09	   -­‐	   Putative	  membrane	  protein	   2.44	   1.51E-­‐09	  
comE	   Competence	  protein	  E	   2.46	   5.67E-­‐07	   yiaO_1	   Extracytoplasmic	  solute	  receptor	  protein	  YiaO	   2.43	   0.003357859	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Up-­‐regulated	  genes	   Down-­‐regulated	  genes	  
radC	   DNA	  repair	  protein	  RadC	   2.45	   2.13E-­‐05	   ilvH	   Acetolactate	  synthase	  3	  regulatory	  subunit	   2.4	   7.01E-­‐05	  
pflA_
2	  
Pyruvate	  formate	  lyase-­‐activating	  enzyme	  1	   2.44	   1.41E-­‐09	   kipA	   KipI	  antagonist	   2.39	   0.006455781	  
glgX	   Glycogen	  operon	  protein	   2.44	   7.41E-­‐05	   trpR	   Trp	  operon	  repressor	   2.38	   2.52E-­‐07	  
dmsB	   Anaerobic	  dimethyl	  sulfoxide	  reductase	  subunit	  B	   2.43	   0.014864629	   dksA	   dnaK	  suppressor	  protein	   2.36	   7.19E-­‐29	  
-­‐	   Electron	  transport	  complex	  RsxE	  subunit	   2.42	   9.79E-­‐05	   yiaM_2	   2,3-­‐diketo-­‐L-­‐gulonate	  TRAP	  transporter	  small	  permease	  protein	  YiaM	   2.36	   0.007970529	  
nrfD	   Nitrite	  reductase	  transmembrane	  protein	   2.41	   0.013469307	   -­‐	   Transporter	   2.35	   0.002653115	  
ccmF	   Cytochrome	  C-­‐type	  biogenesis	  protein	   2.41	   0.001555007	   yccA	   Modulator	  of	  FtsH	  protease	  YccA	   2.34	   2.21E-­‐27	  
oppB	   Oligopeptide	  transporter	  permease	   2.41	   1.26E-­‐06	   potD_2	   Spermidine/putrescine	  ABC	  transporter	  substrate-­‐binding	  protein	   2.34	   7.28E-­‐08	  
rebM	   Demethylrebeccamycin-­‐D-­‐glucose	  O-­‐methyltransferase	   2.41	   0.000418649	   rpsA	   30S	  ribosomal	  protein	  S1	   2.32	   8.50E-­‐14	  
napB	   Nitrate	  reductase	   2.4	   2.63E-­‐16	   cdd	   Cytidine	  deaminase	   2.31	   6.44E-­‐11	  
yohK	   Inner	  membrane	  protein	  YohK	   2.39	   1.27E-­‐08	   lysC	   Lysine-­‐sensitive	  aspartokinase	  3	   2.26	   4.22E-­‐18	  
-­‐	   Epimerase	  family	  protein	   2.38	   9.25E-­‐19	   lldD	   L-­‐lactate	  dehydrogenase	   2.25	   1.96E-­‐13	  
-­‐	   Peroxiredoxin	  hybrid	  Prx5	   2.37	   0.000773221	   galT	   Galactose-­‐1-­‐phosphate	  uridylyltransferase	   2.24	   4.36E-­‐05	  
tgt	   Queuine	  tRNA-­‐ribosyltransferase	   2.36	   1.21E-­‐09	   uxuR	   Uxu	  operon	  regulator	   2.18	   3.83E-­‐11	  
-­‐	   Selenocysteine	  lyase	   2.36	   5.02E-­‐10	   ilvI	   Acetolactate	  synthase	  3	  catalytic	  subunit	   2.18	   0.000653146	  
yecO	   S-­‐adenosyl-­‐L-­‐methionine-­‐dependent	  methyltransferase	   2.34	   1.94E-­‐18	   rec2	   Recombination	  protein	   2.13	   0.000166948	  
comA	   Competence	  protein	  A	   2.34	   0.001503	   hslO	   Hsp33-­‐like	  chaperonin	   2.1	   0.015907	  
glgA	   Glycogen	  synthase	   2.32	   0.000830233	   nhaA	   pH-­‐dependent	  sodium/proton	  antiporter	   2.09	   7.30E-­‐10	  
-­‐	   Hypothetical	  protein	   2.32	   0.000860	   yecK	   Cytochrome	  C-­‐like	  protein	   2.09	   0.010197	  
menC	   O-­‐succinylbenzoate	  synthase	   2.31	   6.00E-­‐09	   lexA	   LexA	  repressor	   2.09	   3.55E-­‐06	  
-­‐	   YheO-­‐like	  PAS	  domain	  protein	   2.31	   0.001038293	   ygiY	   Sensor	  protein	  QseC	   2.09	   0.000103423	  
afuA	   Ferric	  ABC	  transporter	  protein	   2.29	   1.69E-­‐17	   yiaM_1	   2,3-­‐diketo-­‐L-­‐gulonate	  TRAP	  transporter	  small	  permease	  protein	  YiaM	   2.08	   0.048416645	  
-­‐	   hypothetical	  protein	   2.29	   1.17E-­‐08	   tsf	   Elongation	  factor	  Ts	   2.07	   3.19E-­‐13	  
glpA	   sn-­‐glycerol-­‐3-­‐phosphate	  dehydrogenase	  subunit	  A	   2.27	   1.72E-­‐05	   -­‐	   Di-­‐	  and	  tricarboxylate	  transporter	   2.04	   0.000678349	  
dmsC	   Anaerobic	  dimethyl	  sulfoxide	  reductase	  subunit	  C	   2.27	   0.039164522	   -­‐	   Transposase	   2.03	   1.29E-­‐07	  
-­‐	   ABC	  transporter	  permease	   2.25	   0.001678	   -­‐	   RarD	  protein	   2.02	   0.00013	  
napC	   Cytochrome	  C-­‐type	  protein	   2.22	   4.79E-­‐20	   -­‐	   ABC	  transporter	  ATP-­‐binding	  protein	   2.02	   0.000419663	  
ccmC	   Haem	  exporter	  protein	  C	   2.22	   0.012288	   -­‐	   Hypothetical	  protein	   2.01	   0.000426	  
-­‐	   Fimbrial	  biogenesis	  and	  twitching	  motility	  protein	   2.21	   2.69E-­‐05	   	   	   	   	  
-­‐	   Serine/threonine	  transporter	  SstT	   2.21	   0.003067276	   	   	   	   	  
-­‐	   Electron	  transport	  complex	  protein	  RnfB	   2.19	   5.71E-­‐19	   	   	   	   	  
comF	   Competence	  protein	  F	   2.18	   0.000276	   	   	   	   	  
-­‐	   Hemoglobin-­‐binding	  protein	   2.17	   0.014907	   	   	   	   	  
dacB	  
D-­‐alanyl-­‐D-­‐alanine	  carboxypeptidase/endopeptidase	   2.17	   2.00E-­‐09	   	   	   	   	  
-­‐	   Hemoglobin-­‐binding	  protein	   2.16	   0.045916	   	   	   	   	  
ygdK	   Putative	  SufE-­‐like	  protein	  YgdK	   2.15	   2.35E-­‐05	   	   	   	   	  
-­‐	   TonB	   2.15	   6.68E-­‐08	   	   	   	   	  
nrfC	   Nitrite	  reductase	  Fe-­‐S	  protein	   2.15	   0.01587	   	   	   	   	  
-­‐	   YcgL	  domain	  protein	   2.15	   8.39E-­‐06	   	   	   	   	  
malQ	   4-­‐alpha-­‐glucanotransferase	   2.14	   5.28E-­‐20	   	   	   	   	  
-­‐	   dsDNA-­‐mimic	  protein	   2.14	   5.04E-­‐14	   	   	   	   	  
-­‐	   Selenium	  metabolism	  protein	  YedF	   2.14	   1.62E-­‐05	   	   	   	   	  
udp	   Uridine	  phosphorylase	   2.12	   6.86E-­‐05	   	   	   	   	  
aspC	   Aromatic	  amino	  acid	  aminotransferase	   2.12	   0.033669452	   	   	   	   	  
glpB	   Anaerobic	  glycerol-­‐3-­‐ 2.11	   0.009098	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Up-­‐regulated	  genes	   	  
ccmH
_1	  
Cytochrome	  C-­‐type	  biogenesis	  protein	   2.11	   1.43E-­‐08	   	   	   	   	  
-­‐	   Long	  chain	  fatty	  acid	  CoA	  ligase	   2.1	   0.034807476	   	   	   	   	  
-­‐	   Amino	  acid	  carrier	  protein	   2.1	   0.001785	   	   	   	   	  
deoD	   Purine	  nucleoside	  phosphorylase	   2.1	   3.76E-­‐12	   	   	   	   	  
-­‐	   Hypothetical	  protein	   2.1	   1.14E-­‐06	   	   	   	   	  
glpC_
1	  
sn-­‐glycerol-­‐3-­‐phosphate	  dehydrogenase	  subunit	  C	   2.09	   0.01752299	   	   	   	   	  
-­‐	   Hemoglobin-­‐binding	  protein	   2.09	   2.26E-­‐08	   	   	   	   	  
kdsB	   3-­‐deoxy-­‐manno-­‐octulosonate	  cytidylyltransferase	   2.08	   5.72E-­‐13	   	   	   	   	  
glpF_
2	  
Glycerol	  uptake	  facilitator	  protein	   2.07	   0.013920544	   	   	   	   	  
oppC	   Oligopeptide	  ABC	  transporter	  permease	   2.06	   1.29E-­‐07	   	   	   	   	  
-­‐	   Aminodeoxychorismate	  lyase	   2.06	   1.36E-­‐07	   	   	   	   	  
rnfG	   Electron	  transport	  complex	  protein	  RnfG	   2.04	   0.000434589	   	   	   	   	  
mnm
C	  
tRNA	  5-­‐methylaminomethyl-­‐2-­‐thiouridine	  biosynthesis	  bifunctional	  protein	  MnmC	   2.04	   2.34E-­‐06	   	   	   	   	  
-­‐	   Hypothetical	  protein	   2.04	   5.18E-­‐06	   	   	   	   	  
-­‐	   Hypothetical	  protein	   2.04	   2.56E-­‐06	   	   	   	   	  
nrdD	   Anaerobic	  ribonucleoside	  triphosphate	  reductase	   2.03	   0.002097318	   	   	   	   	  
-­‐	   Amino-­‐acid	  ABC	  transporter	  ATP-­‐binding	  protein	   2.03	   0.007643933	   	   	   	   	  
-­‐	   Integrase/recombinase	   2.03	   5.87E-­‐08	   	   	   	   	  
pflA_
1	  
Pyruvate	  formate	  lyase-­‐activating	  enzyme	  1	   2.02	   3.01E-­‐07	   	   	   	   	  
oppD	   Oligopeptide	  transporter	  ATP-­‐binding	  protein	   2.02	   6.29E-­‐12	   	   	   	   	  
-­‐	   tRNA-­‐Leu(gag)	   2.02	   1.95E-­‐05	   	   	   	   	  
moeB
_2	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Table	   S8:	   Differentially	   expressed	   genes	   common	   to	   three	   or	   more	  
conditions	  in	  Rd.	  
Gene	   Product	  
Up-­‐regulated	  genes	  
All	  four	  conditions	  
gdhA	   Glutamate	  dehydrogenase	  
Stationary	  phase,	  oxidative	  stress,	  nutritional	  stress	  
-­‐	   Peroxiredoxin	  hybrid	  Prx5	  
dps	   DNA	  protection	  during	  starvation	  protein	  
Stationary	  phase,	  iron	  starvation,	  nutritional	  stress	  
-­‐	   Amino	  acid	  carrier	  protein	  	  comD	  
	  
Competence	  protein	  D	  	  comB	  
	  
Competence	  protein	  B	  	  
Down-­‐regulated	  genes	  
All	  four	  conditions	  
yecK	  
	  
Cytochrome	  C-­‐like	  protein	  	  mtr	  
	  
Tryptophan-­‐specific	  transport	  protein	  	  hslO	  
	  
Hsp33-­‐like	  chaperonin	  	  trpB	  
	  
Tryptophan	  synthase	  subunit	  beta	  	  
Stationary	  phase,	  oxidative	  stress,	  iron	  starvation	  
cydD_1	  
	  
ABC	  transporter	  ATP-­‐binding	  protein	  	  cydD_2	  
	  
ABC	  transporter	  ATP-­‐binding	  protein	  	  -­‐	  
	  
ABC	  transporter	  ATP-­‐binding	  protein	  	  dmsA_3	  
	  
Anaerobic	  dimethyl	  sulfoxide	  reductase	  subunit	  A	  	  nrfB	  
	  
Cytochrome	  c	  nitrite	  reductase	  pentaheme	  subunit	  	  nrfA	  
	  
Cytochrome	  c552	  	  
Stationary	  phase,	  iron	  starvation,	  nutritional	  stress	  
ilvC	  
	  
Ketol-­‐acid	  reductoisomerase	  	  tsf	  
	  
Elongation	  factor	  Ts	  	  infB	  
	  
Translation	  initiation	  factor	  IF-­‐2	  	  potD_2	  
	  
Spermidine/putrescine	  ABC	  transporter	  substrate-­‐binding	  protein	  	  
Stationary	  phase,	  oxidative	  stress,	  nutritional	  stress	  
arcA	  
	  
Two-­‐component	  response	  regulator	  	  artM	  
	  
Arginine	  transporter	  permease	  subunit	  ArtM	  	  artQ	  
	  
Arginine	  transporter	  permease	  subunit	  ArtQ	  	  artI	  
	  
Arginine	  ABC	  transporter	  substrate-­‐binding	  protein	  	  artP	  
	  
Arginine	  transporter	  ATP-­‐binding	  protein	  	  pepT	  
	  
Peptidase	  T	  	  trpE	  
	  
Anthranilate	  synthase	  component	  I	  	  trpG_2	  
	  
Anthranilate	  synthase	  component	  II	  	  -­‐	  
	  
Short	  chain	  dehydrogenase/reductase	  	  argG	  
	  
Argininosuccinate	  synthase	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Table	  S9:	  Differentially	  expressed	  genes	  common	  to	  all	  three	  conditions	  in	  
R2866.	  














GroES,	  chaperone	  Hsp10	  	  GroES,	  chaperone	  Hsp10	  	  hxuA	  	   Haem-­‐hemopexin	  utilization	  protein	  A	  	  hxuB	  
	  
Haem-­‐hemopexin	  utilization	  protein	  B	  	  hxuC	  
	  
Haem-­‐hemopexin	  utilization	  protein	  C	  	  hemR	  
	  
	  
Putative	  TonB-­‐dependent	  haem	  receptor	  	  	  hitA	  	   Iron(III)	  ABC	  transporter	  periplasmic-­‐binding	  protein	  	  dnaK	  
	  
Molecular	  chaperone	  DnaK	  (Hsp70)	  	  msrAB	  
	  
Peptide	  methionine	  sulfoxide	  reductase	  	  ompU1	  
	  
Putative	  outer	  membrane	  protein	  OmpU1	  	  tbp2	  
	  
Transferrin-­‐binding	  protein	  2	  	  tbp1	  
	  




30S	  ribosomal	  subunit	  protein	  S18	  	  tgt	  
	  
tRNA-­‐guanine	  transglycosylase	  	  ahpC	  
	  
Peroxiredoxin	  	  potD	  
	  
Spermidine/putrescine	  ABC	  transporter,	  periplasmic-­‐binding	  protein	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Appendix	  C:	  The	  toRNAdo	  script	  
import	  numpy	  from	  copy	  import	  deepcopy	  import	  os	  from	  sys	  import	  argv	  	  #	  filters	  a	  dictionary	  by	  length	  def	  filter_by_length(unfiltered_list):	  	  	  	  	  	  	  	  	  copy1	  =	  deepcopy(unfiltered_list)	  	  	  	  	  	  	  	  	  for	  nuc1	  in	  copy1:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  count1	  =	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  position1	  =	  nuc1	  +	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  while	  position1	  in	  copy1:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  count1	  +=	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  position1	  +=	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  else:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  count1	  <	  50	  and	  nuc1	  -­‐	  1	  not	  in	  unfiltered_list:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  del	  unfiltered_list[nuc1]	  	  #	  function	  to	  create	  text	  files	  def	  write_to_file(sequences,	  filename):	  	  	  	  	  	  	  	  	  out_file	  =	  open(output_folder	  +	  filename	  +	  '.wig','w')	  	  	  	  	  	  	  	  	  list2	  =	  sorted(sequences.keys())	  	  	  	  	  	  	  	  	  lines1	  =	  ["%s\t%f"	  %	  (g,	  sequences[g])	  for	  g	  in	  list2]	  	  	  	  	  	  	  	  	  lines1.insert(0,	  "variableStep\tchrom=Rd")	  	  	  	  	  	  	  	  	  out_file.write('\n'.join(lines1))	  	  	  	  	  	  	  	  	  out_file.write('\n')	  	  	  	  	  	  	  	  	  out_file.close()	  	  	  	  	  	  #	  function	  to	  find	  ncRNAs	  to	  the	  "right"	  of	  UTR,	  and	  reclassify	  it	  def	  find_RNA_right(UTR_dict):	  	  	  	  	  	  	  	  	  temp_dict	  =	  {}	  	  	  	  	  	  	  	  	  another_temp_dict	  =	  {}	  	  	  	  	  	  	  	  	  copy_UTR	  =	  deepcopy(UTR_dict)	  	  	  	  	  	  	  	  	  for	  nuc	  in	  copy_UTR:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  nuc	  -­‐	  1	  not	  in	  copy_UTR:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  while	  nuc	  +	  1	  in	  copy_UTR	  and	  copy_UTR[nuc	  +	  1]	  <=	  copy_UTR[nuc]:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  nuc	  +=	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  else:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  nuc	  +	  1	  not	  in	  copy_UTR:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  None	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  else:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  temp_thresh	  =	  copy_UTR[nuc]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  temp_dict[nuc]	  =	  copy_UTR[nuc]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  while	  nuc	  +	  1	  in	  copy_UTR:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  temp_dict[nuc	  +	  1]	  =	  copy_UTR[nuc	  +	  1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  nuc	  +=	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  else:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  any((x	  /	  5)	  >	  temp_thresh	  for	  x	  in	  temp_dict.values()):	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  for	  nuc1	  in	  temp_dict:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  UTR_dict	  ==	  UTR5_minus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  RNA_minus[nuc1]	  =	  temp_dict[nuc1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  del	  UTR_dict[nuc1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  UTR_dict	  ==	  UTR3_plus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  RNA_plus[nuc1]	  =	  temp_dict[nuc1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  del	  UTR_dict[nuc1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  else:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  min_key	  =	  min(temp_dict,	  key=lambda	  k:	  temp_dict[k])	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  min_thresh	  =	  temp_dict[min_key]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  pos	  =	  min_key	  +	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  another_temp_dict[min_key]	  =	  temp_dict[min_key]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  while	  pos	  in	  temp_dict:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  another_temp_dict[pos]	  =	  temp_dict[pos]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  pos	  +=	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  else:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  any((x1	  /	  5)	  >	  min_thresh	  for	  x1	  in	  another_temp_dict.values()):	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  for	  nuc2	  in	  another_temp_dict:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  UTR_dict	  ==	  UTR5_minus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  RNA_minus[nuc2]	  =	  another_temp_dict[nuc2]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  del	  UTR_dict[nuc2]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  UTR_dict	  ==	  UTR3_plus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  RNA_plus[nuc2]	  =	  another_temp_dict[nuc2]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  del	  UTR_dict[nuc2]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  another_temp_dict.clear()	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  temp_dict.clear()	  	  #	  function	  to	  find	  ncRNA	  to	  the	  "left"	  of	  UTR,	  and	  reclassify	  it	  def	  find_RNA_left(UTR_dict1):	  	  	  	  	  	  	  	  	  temp_dict	  =	  {}	  	  	  	  	  	  	  	  	  another_temp_dict	  =	  {}	  
	  	   277	  
	  	  	  	  	  	  	  	  copy_UTR	  =	  deepcopy(UTR_dict1)	  	  	  	  	  	  	  	  	  for	  nuc	  in	  copy_UTR:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  nuc	  +	  1	  not	  in	  copy_UTR:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  while	  nuc	  -­‐	  1	  in	  copy_UTR	  and	  copy_UTR[nuc	  -­‐	  1]	  <=	  copy_UTR[nuc]:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  nuc	  -­‐=	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  else:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  nuc	  -­‐	  1	  not	  in	  copy_UTR:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  None	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  else:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  temp_thresh	  =	  copy_UTR[nuc]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  temp_dict[nuc]	  =	  copy_UTR[nuc]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  while	  nuc	  -­‐	  1	  in	  copy_UTR:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  temp_dict[nuc	  -­‐	  1]	  =	  copy_UTR[nuc	  -­‐	  1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  nuc	  -­‐=	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  else:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  any((x	  /	  5)	  >	  temp_thresh	  for	  x	  in	  temp_dict.values()):	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  for	  nuc1	  in	  temp_dict:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  UTR_dict1	  ==	  UTR3_minus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  RNA_minus[nuc1]	  =	  temp_dict[nuc1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  del	  UTR_dict1[nuc1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  UTR_dict1	  ==	  UTR5_plus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  RNA_plus[nuc1]	  =	  temp_dict[nuc1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  del	  UTR_dict1[nuc1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  else:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  min_key	  =	  min(temp_dict,	  key=lambda	  k:	  temp_dict[k])	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  min_thresh	  =	  temp_dict[min_key]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  pos	  =	  min_key	  -­‐	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  another_temp_dict[min_key]	  =	  temp_dict[min_key]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  while	  pos	  in	  temp_dict:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  another_temp_dict[pos]	  =	  temp_dict[pos]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  pos	  -­‐=	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  else:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  any((x1	  /	  5)	  >	  min_thresh	  for	  x1	  in	  another_temp_dict.values()):	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  for	  nuc2	  in	  another_temp_dict:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  UTR_dict1	  ==	  UTR3_minus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  RNA_minus[nuc2]	  =	  another_temp_dict[nuc2]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  del	  UTR_dict1[nuc2]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  UTR_dict1	  ==	  UTR5_plus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  RNA_plus[nuc2]	  =	  another_temp_dict[nuc2]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  del	  UTR_dict1[nuc2]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  another_temp_dict.clear()	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  temp_dict.clear()	  	  #	  function	  to	  find	  ncRNA	  in	  the	  intergenic	  region,	  which	  has	  been	  originally	  classified	  as	  part	  of	  an	  operon	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  def	  find_RNA_operon(operon_dict):	  	  	  	  	  	  	  	  	  temp_dict	  =	  {}	  	  	  	  	  	  	  	  	  temp_dict_right	  =	  {}	  	  	  	  	  	  	  	  	  temp_dict_left	  =	  {}	  	  	  	  	  	  	  	  	  new_left	  =	  {}	  	  	  	  	  	  	  	  	  new_right	  =	  {}	  	  	  	  	  	  	  	  	  copy_operon	  =	  deepcopy(operon_dict)	  	  	  	  	  	  	  	  	  for	  nuc	  in	  copy_operon:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  nuc	  -­‐	  1	  not	  in	  copy_operon:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  while	  nuc	  +	  1	  in	  copy_operon:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  temp_dict[nuc]	  =	  copy_operon[nuc]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  nuc	  +=	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  else:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  temp_dict[nuc]	  =	  copy_operon[nuc]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  min_key	  =	  min(temp_dict,	  key=lambda	  k:	  temp_dict[k])	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  min_thresh	  =	  temp_dict[min_key]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  any((x	  /	  5)	  >	  min_thresh	  for	  x	  in	  temp_dict.values()):	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  while	  min_key	  +	  1	  in	  temp_dict:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  temp_dict_right[min_key	  +	  1]	  =	  temp_dict[min_key	  +	  1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  min_key	  +=	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  else:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  min_key	  =	  min(temp_dict,	  key=lambda	  k:	  temp_dict[k])	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  temp_dict_left[min_key]	  =	  temp_dict[min_key]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  while	  min_key	  -­‐	  1	  in	  temp_dict:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  temp_dict_left[min_key	  -­‐	  1]	  =	  temp_dict[min_key	  -­‐	  1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  min_key	  -­‐=	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  else:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  any((x1	  /	  5)	  >	  min_thresh	  for	  x1	  in	  temp_dict_left.values()):	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  max_key_left	  =	  max(temp_dict_left,	  key=lambda	  k1:	  temp_dict_left[k1])	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  max_key_left_thresh	  =	  temp_dict_left[max_key_left]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  while	  max_key_left	  -­‐	  1	  in	  temp_dict_left:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  new_left[max_key_left	  -­‐	  1]	  =	  temp_dict_left[max_key_left	  -­‐	  1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  max_key_left	  -­‐=	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  else:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  any((max_key_left_thresh	  /	  5)	  >	  x2	  for	  x2	  in	  new_left.values()):	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  min_key_left	  =	  min(new_left,	  key=lambda	  k2:	  new_left[k2])	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  while	  min_key_left	  +	  1	  in	  temp_dict_left:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  operon_dict	  ==	  operon_plus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  RNA_plus[min_key_left	  +	  1]	  =	  temp_dict_left[min_key_left	  +	  1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  del	  operon_dict[min_key_left	  +	  1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  operon_dict	  ==	  operon_minus:	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  RNA_minus[min_key_left	  +	  1]	  =	  temp_dict_left[min_key_left	  +	  1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  del	  operon_dict[min_key_left	  +	  1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  min_key_left	  +=	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  any((x3	  /	  5)	  >	  min_thresh	  for	  x3	  in	  temp_dict_right.values()):	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  max_key_right	  =	  max(temp_dict_right,	  key=lambda	  k3:	  temp_dict_right[k3])	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  max_key_right_thresh	  =	  temp_dict_right[max_key_right]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  while	  max_key_right	  +	  1	  in	  temp_dict_right:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  new_right[max_key_right	  +	  1]	  =	  temp_dict_right[max_key_right	  +	  1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  max_key_right	  +=	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  else:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  any((max_key_right_thresh	  /	  5)	  >	  x4	  for	  x4	  in	  new_right.values()):	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  min_key_right	  =	  min(new_right,	  key=lambda	  k4:	  new_right[k4])	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  while	  min_key_right	  -­‐	  1	  in	  temp_dict_right:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  operon_dict	  ==	  operon_plus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  RNA_plus[min_key_right	  -­‐	  1]	  =	  temp_dict_right[min_key_right	  -­‐	  1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  del	  operon_dict[min_key_right	  -­‐	  1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  operon_dict	  ==	  operon_minus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  RNA_minus[min_key_right	  -­‐	  1]	  =	  temp_dict_right[min_key_right	  -­‐	  1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  del	  operon_dict[min_key_right	  -­‐	  1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  min_key_right	  -­‐=	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  new_left.clear()	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  new_right.clear()	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  temp_dict_right.clear()	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  temp_dict_left.clear()	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  temp_dict.clear()	  	  #	  function	  to	  reclassify	  former	  operon	  regions	  into	  UTRs	  and	  delete	  those	  regions	  from	  the	  operon	  dictionary	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  def	  operon_to_UTR(operon_dict1):	  	  	  	  	  	  	  	  	  temp_dict	  =	  {}	  	  	  	  	  	  	  	  	  operon_copy	  =	  deepcopy(operon_dict1)	  	  	  	  	  	  	  	  	  for	  nuc	  in	  operon_copy:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  nuc	  -­‐	  1	  not	  in	  operon_copy:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  operon_dict1	  ==	  operon_plus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  nuc	  -­‐	  1	  not	  in	  dict_strand:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  UTR5_plus[nuc]	  =	  operon_copy[nuc]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  del	  operon_dict1[nuc]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  while	  nuc	  +	  1	  in	  operon_copy:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  UTR5_plus[nuc	  +	  1]	  =	  operon_copy[nuc	  +	  1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  del	  operon_dict1[nuc	  +	  1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  nuc	  +=	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  else:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  while	  nuc	  +	  1	  in	  operon_copy:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  nuc	  +=	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  else:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  nuc	  +	  1	  not	  in	  dict_strand:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  UTR3_plus[nuc]	  =	  operon_copy[nuc]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  del	  operon_dict1[nuc]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  while	  nuc	  -­‐	  1	  in	  operon_copy:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  UTR3_plus[nuc	  -­‐	  1]	  =	  operon_copy[nuc	  -­‐	  1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  del	  operon_dict1[nuc	  -­‐	  1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  nuc	  -­‐=	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  operon_dict1	  ==	  operon_minus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  nuc	  -­‐	  1	  not	  in	  dict_strand:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  UTR3_minus[nuc]	  =	  operon_copy[nuc]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  del	  operon_dict1[nuc]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  while	  nuc	  +	  1	  in	  operon_copy:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  UTR3_minus[nuc	  +	  1]	  =	  operon_copy[nuc	  +	  1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  del	  operon_dict1[nuc	  +	  1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  nuc	  +=	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  else:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  while	  nuc	  +	  1	  in	  operon_copy:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  nuc	  +=	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  else:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  nuc	  +	  1	  not	  in	  dict_strand:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  UTR5_minus[nuc]	  =	  operon_copy[nuc]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  del	  operon_dict1[nuc]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  while	  nuc	  -­‐	  1	  in	  operon_copy:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  UTR5_minus[nuc	  -­‐	  1]	  =	  operon_copy[nuc	  -­‐	  1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  del	  operon_dict1[nuc	  -­‐	  1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  nuc	  -­‐=	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  #	  function	  to	  correct	  intergenic	  RNA	  into	  antisense	  of	  border	  RNAs	  def	  RNA_to_antisense_border(rna_dict):	  	  	  	  	  	  	  	  	  RNA_copy	  =	  deepcopy(rna_dict)	  	  	  	  	  	  	  	  	  temp_dict	  =	  {}	  	  	  	  	  	  	  	  	  anti_dict	  =	  {}	  	  	  	  	  	  	  	  	  for	  rna	  in	  RNA_copy:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  rna	  -­‐	  1	  not	  in	  RNA_copy:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  temp_dict[rna]	  =	  RNA_copy[rna]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  while	  rna	  +	  1	  in	  RNA_copy:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  temp_dict[rna	  +	  1]	  =	  RNA_copy[rna	  +	  1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  rna	  +=	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  else:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  any(x	  in	  dict_strand	  for	  x	  in	  temp_dict.keys()):	  
	  	   279	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  any(y	  not	  in	  dict_strand	  for	  y	  in	  temp_dict.keys()):	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  for	  rna1	  in	  temp_dict:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  rna_dict	  ==	  RNA_plus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  border_plus[rna1]	  =	  temp_dict[rna1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  del	  RNA_plus[rna1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  rna_dict	  ==	  RNA_minus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  border_minus[rna1]	  =	  temp_dict[rna1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  del	  RNA_minus[rna1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  else:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  for	  rna2	  in	  temp_dict:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  rna_dict	  ==	  RNA_plus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  antisense_of_minus[rna2]	  =	  temp_dict[rna2]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  del	  RNA_plus[rna2]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  rna_dict	  ==	  RNA_minus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  antisense_of_plus[rna2]	  =	  temp_dict[rna2]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  del	  RNA_minus[rna2]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  temp_dict.clear()	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  #	  function	  to	  look	  at	  all	  ncRNA	  dictionaries	  and	  find	  RNAs	  with	  a	  "5x"	  expression	  peak	  def	  find_peaks(RNAdict,	  cooldict):	  	  	  	  	  	  	  	  	  temp_dict	  =	  {}	  	  	  	  	  	  	  	  	  copy_RNAdict	  =	  deepcopy(RNAdict)	  	  	  	  	  	  	  	  	  for	  abc	  in	  copy_RNAdict:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  abc	  -­‐	  1	  not	  in	  copy_RNAdict:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  paul	  =	  abc	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  temp_dict[paul]	  =	  copy_RNAdict[paul]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  while	  paul	  +	  1	  in	  copy_RNAdict:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  temp_dict[paul	  +	  1]	  =	  copy_RNAdict[paul]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  paul	  +=	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  else:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  min_key	  =	  min(temp_dict,	  key=lambda	  k:	  temp_dict[k])	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  min_thresh	  =	  temp_dict[min_key]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  any((x	  /	  5)	  >	  min_thresh	  for	  x	  in	  temp_dict.values()):	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  for	  abcd	  in	  temp_dict:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  cooldict[abcd]	  =	  temp_dict[abcd]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  del	  RNAdict[abcd]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  temp_dict.clear()	  	  #	  file1	  -­‐	  nucleotide	  coverage	  for	  both	  strands;	  file2	  -­‐	  nucleotide	  coverage	  for	  minus	  strand;	  file	  3	  -­‐	  nucleotide	  coverage	  for	  plus	  strand;	  file	  4	  -­‐	  nucleotide	  coverage	  for	  all	  annotated	  genome	  features	  and	  their	  coordinates.	  script,	  file1,	  file2,	  file3,	  file4,	  output_folder	  =	  argv	  	  #	  open	  all	  files	  needed	  for	  analysis	  data_both	  =	  open(file1).readlines()	  data_minus	  =	  open(file2).readlines()	  data_plus	  =	  open(file3).readlines()	  data_genes	  =	  open(file4).readlines()	  	  #	  empty	  lists	  that	  will	  have	  data	  appended	  to	  realdata_minus	  =	  []	  realdata_plus	  =	  []	  realdata_genes	  =	  []	  realdata_both	  =	  []	  gene_ncoverage	  =	  []	  both_ncoverage	  =	  []	  	  #	  loops	  for	  appending	  into	  empty	  lists	  and	  changing	  lists	  of	  strings	  into	  lists	  of	  integers	  for	  line_both	  in	  data_both:	  	  	  	  	  	  	  	  	  realdata_both.append(line_both.strip().split())	  realdata_both	  =	  [[float(ab)	  for	  ab	  in	  bb]	  for	  bb	  in	  realdata_both]	  	  #	  turns	  everything	  in	  a	  list	  of	  lists	  into	  integers	  cov_both_list	  =	  [a[1]	  for	  a	  in	  realdata_both]	  #	  makes	  new	  list	  with	  just	  the	  coverage	  sum_both	  =	  float(sum(cov_both_list))	  #	  produces	  the	  sum	  of	  all	  coverage	  values,	  used	  for	  normalization	  later	  	  for	  line_minus	  in	  data_minus:	  	  	  	  	  	  	  	  	  realdata_minus.append(line_minus.strip().split())	  realdata_minus	  =	  [[float(ab)	  for	  ab	  in	  bb]	  for	  bb	  in	  realdata_minus]	  #	  turns	  everything	  in	  a	  list	  of	  lists	  into	  integers	  for	  i	  in	  realdata_minus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  #	  a	  loop	  to	  normalize	  each	  data	  based	  on	  the	  sum	  of	  coverage	  values	  calculated	  earlier	  	  	  	  	  	  	  	  	  i[1]	  =	  i[1]	  /	  sum_both	  *	  10000000000	  	  for	  line_plus	  in	  data_plus:	  	  	  	  	  	  	  	  	  realdata_plus.append(line_plus.strip().split())	  realdata_plus	  =	  [[float(ab)	  for	  ab	  in	  bb]	  for	  bb	  in	  realdata_plus]	  for	  e	  in	  realdata_plus:	  	  	  	  	  	  	  	  	  e[1]	  =	  e[1]	  /	  sum_both	  *	  10000000000	  	  for	  line_genes	  in	  data_genes:	  	  	  	  	  	  	  	  	  realdata_genes.append(line_genes.strip().split())	  	  	  	  	  	  	  	  	  	  for	  value	  in	  realdata_genes:	  	  	  	  	  	  	  	  	  gene_ncoverage.append(value[3])	  	  	  #	  makes	  a	  new	  list	  with	  just	  the	  gene	  coverage	  values.	  To	  calculate	  mean	  and	  standard	  deviation	  below.	  Not	  really	  used	  here	  yet!!	  gene_ncoverage	  =	  [float(b)	  for	  b	  in	  gene_ncoverage]	  	  threshold	  =	  100.0	  #	  expression	  threshold	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#	  modifies	  a	  list	  of	  gene	  coordinates,	  removing	  the	  nucleotide	  column	  and	  #	  turning	  the	  start	  position	  in	  the	  first	  column	  into	  nucleotide	  coordinate	  for	  f	  in	  realdata_genes:	  	  	  	  	  	  	  	  	  f[0]	  =	  int(f[0])	  	  	  	  	  	  	  	  	  f[2]	  =	  int(f[2])	  	  	  	  	  	  	  	  	  f[3]	  =	  int(f[3])	  	  	  	  	  	  	  	  	  f[0]	  =	  f[0]	  +	  f[2]	  -­‐	  1	  	  	  	  	  	  	  	  	  f.pop(2)	  	  #	  Dictionaries!!	  Easier	  to	  work	  with	  here	  than	  with	  lists...	  dict_minus	  =	  {}	  dict_plus	  =	  {}	  dict_both	  =	  {}	  dict_strand	  =	  {}	  	  #	  Turning	  lists	  into	  dictionaries	  for	  line1	  in	  realdata_minus:	  	  	  	  	  	  	  	  	  dict_minus[line1[0]]	  =	  line1[1]	  for	  line2	  in	  realdata_plus:	  	  	  	  	  	  	  	  	  dict_plus[line2[0]]	  =	  line2[1]	  for	  line3	  in	  realdata_both:	  	  	  	  	  	  	  	  	  dict_both[line3[0]]	  =	  line3[1]	  for	  line4	  in	  realdata_genes:	  	  	  	  	  	  	  	  	  dict_strand[line4[0]]	  =	  line4[1]	  	  #	  empty	  dictionaries	  RNA_minus	  =	  {}	  RNA_plus	  =	  {}	  UTR3_minus	  =	  {}	  UTR5_minus	  =	  {}	  UTR3_plus	  =	  {}	  UTR5_plus	  =	  {}	  antisense_of_minus	  =	  {}	  antisense_of_plus	  =	  {}	  operon_minus	  =	  {}	  operon_plus	  =	  {}	  	  for	  key1	  in	  dict_both:	  	  	  	  	  	  	  	  	  if	  key1	  in	  dict_strand:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  dict_strand[key1]	  ==	  "-­‐":	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  #UTR3_minus	  -­‐	  puts	  all	  3'	  UTR	  regions	  above	  the	  threshold	  on	  a	  minus	  strand	  into	  a	  new	  dictionary	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  key1	  -­‐	  1	  not	  in	  dict_strand	  and	  key1	  -­‐	  1	  in	  dict_both:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  while	  dict_minus[key1	  -­‐	  1]	  >	  threshold	  and	  key1	  -­‐	  1	  not	  in	  dict_strand:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  UTR3_minus[key1	  -­‐	  1]	  =	  dict_minus[key1	  -­‐	  1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  key1	  -­‐=	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  elif	  dict_strand[key1]	  ==	  "+":	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  #UTR5_plus	  -­‐	  puts	  all	  5'	  UTR	  regions	  above	  the	  threshold	  on	  a	  plus	  strand	  into	  a	  new	  dictionary	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  key1	  -­‐	  1	  not	  in	  dict_strand	  and	  key1	  -­‐	  1	  in	  dict_both:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  while	  dict_plus[key1	  -­‐	  1]	  >	  threshold	  and	  key1	  -­‐	  1	  not	  in	  dict_strand:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  UTR5_plus[key1	  -­‐	  1]	  =	  dict_plus[key1	  -­‐	  1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  key1	  -­‐=	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  for	  key11	  in	  dict_both:	  	  	  	  	  	  	  	  	  if	  key11	  in	  dict_strand:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  dict_strand[key11]	  ==	  "-­‐":	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  #UTR5_minus	  -­‐	  puts	  all	  5'	  UTR	  regions	  above	  the	  threshold	  on	  a	  minus	  strand	  into	  a	  new	  dictionary	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  key11	  +	  1	  not	  in	  dict_strand	  and	  key11	  +	  1	  in	  dict_both:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  while	  dict_minus[key11	  +	  1]	  >	  threshold	  and	  key11	  +	  1	  not	  in	  dict_strand:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  UTR5_minus[key11	  +	  1]	  =	  dict_minus[key11	  +	  1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  key11	  +=	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  elif	  dict_strand[key11]	  ==	  "+":	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  #UTR3_plus	  -­‐	  puts	  all	  3'	  UTR	  regions	  above	  the	  threshold	  on	  a	  plus	  strand	  into	  a	  new	  dictionary	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  key11	  +	  1	  not	  in	  dict_strand	  and	  key11	  +	  1	  in	  dict_both:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  while	  dict_plus[key11	  +	  1]	  >	  threshold	  and	  key11	  +	  1	  not	  in	  dict_strand:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  UTR3_plus[key11	  +	  1]	  =	  dict_plus[key11	  +	  1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  key11	  +=	  1	  	  #	  finds	  any	  RNA	  that	  is	  antisense	  to	  a	  coding	  region	  and	  is	  above	  a	  threshold	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  for	  key21	  in	  dict_both:	  	  	  	  	  	  	  	  	  if	  key21	  in	  dict_strand:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  dict_strand[key21]	  ==	  "-­‐":	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  #antisense_minus	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  dict_plus[key21]	  >	  threshold:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  antisense_of_minus[key21]	  =	  dict_plus[key21]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  elif	  dict_strand[key21]	  ==	  "+":	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  #antisense_plus	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  dict_minus[key21]	  >	  threshold:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  antisense_of_plus[key21]	  =	  dict_minus[key21]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  #	  finds	  any	  RNA	  that	  is	  in	  an	  intergenic	  region	  and	  above	  the	  threshold	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  for	  key2	  in	  dict_both:	  	  	  	  	  	  	  	  	  if	  key2	  not	  in	  dict_strand:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  key2	  not	  in	  UTR3_plus	  and	  key2	  not	  in	  UTR5_plus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  dict_plus[key2]	  >	  threshold:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  RNA_plus[key2]	  =	  dict_plus[key2]	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  if	  key2	  not	  in	  UTR3_minus	  and	  key2	  not	  in	  UTR5_minus	  :	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  dict_minus[key2]	  >	  threshold:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  RNA_minus[key2]	  =	  dict_minus[key2]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  #	  creates	  a	  copy	  of	  a	  dictionary	  that	  will	  be	  used	  below.	  This	  is	  done	  so	  that	  I	  can	  modify	  the	  real	  dictionary	  while	  looping	  through	  the	  copy	  copy_UTR3_minus	  =	  deepcopy(UTR3_minus)	  #	  finds	  regions	  betwen	  genes	  that	  are	  likely	  to	  belong	  to	  an	  operon	  for	  key3	  in	  copy_UTR3_minus:	  	  	  	  	  	  	  	  	  if	  key3	  in	  UTR5_minus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  operon_minus[key3]	  =	  UTR3_minus[key3]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  del	  UTR3_minus[key3]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  del	  UTR5_minus[key3]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  copy_UTR3_plus	  =	  deepcopy(UTR3_plus)	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  for	  key4	  in	  copy_UTR3_plus:	  	  	  	  	  	  	  	  	  if	  key4	  in	  UTR5_plus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  operon_plus[key4]	  =	  UTR3_plus[key4]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  del	  UTR3_plus[key4]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  del	  UTR5_plus[key4]	  	  #	  the	  loop	  below	  correctly	  classifies	  UTRs	  that	  have	  been	  misclassified	  as	  antisense	  RNA	  due	  to	  overlapping	  coding	  regions	  cop1_antisense_minus	  =	  deepcopy(antisense_of_minus)	  cop1_antisense_plus	  =	  deepcopy(antisense_of_plus)	  for	  pete	  in	  dict_strand:	  	  	  	  	  	  	  	  	  if	  dict_strand[pete]	  ==	  "+":	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  pete	  +	  1	  in	  cop1_antisense_minus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  pos9	  =	  pete	  +	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  while	  pos9	  in	  cop1_antisense_minus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  UTR3_plus[pos9]	  =	  cop1_antisense_minus[pos9]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  del	  antisense_of_minus[pos9]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  pos9	  +=	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  cop1_antisense_minus	  =	  deepcopy(antisense_of_minus)	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  elif	  pete	  -­‐	  1	  in	  cop1_antisense_minus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  pos10	  =	  pete	  -­‐	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  while	  pos10	  in	  cop1_antisense_minus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  UTR5_plus[pos10]	  =	  cop1_antisense_minus[pos10]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  del	  antisense_of_minus[pos10]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  pos10	  -­‐=	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  cop1_antisense_minus	  =	  deepcopy(antisense_of_minus)	  	  	  	  	  	  	  	  	  elif	  dict_strand[pete]	  ==	  "-­‐":	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  if	  pete	  +	  1	  in	  cop1_antisense_plus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  pos11	  =	  pete	  +	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  while	  pos11	  in	  cop1_antisense_plus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  UTR5_minus[pos11]	  =	  cop1_antisense_plus[pos11]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  del	  antisense_of_plus[pos11]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  pos11	  +=	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  cop1_antisense_plus	  =	  deepcopy(antisense_of_plus)	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  elif	  pete	  -­‐	  1	  in	  cop1_antisense_plus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  pos12	  =	  pete	  -­‐	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  while	  pos12	  in	  cop1_antisense_plus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  UTR3_minus[pos12]	  =	  cop1_antisense_plus[pos12]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  del	  antisense_of_plus[pos12]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  pos12	  -­‐=	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  cop1_antisense_plus	  =	  deepcopy(antisense_of_plus)	  	  #	  joins	  the	  UTR	  region	  with	  antisense	  region	  if	  they	  are	  part	  of	  the	  same	  UTR	  	  temp_UTR5_minus	  =	  {}	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  copy_antisense_of_plus	  =	  deepcopy(antisense_of_plus)	  for	  key51	  in	  UTR5_minus:	  	  	  	  	  	  	  	  	  if	  key51	  +	  1	  in	  copy_antisense_of_plus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  while	  key51	  +	  1	  in	  copy_antisense_of_plus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  temp_UTR5_minus[key51	  +	  1]	  =	  antisense_of_plus[key51	  +	  1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  del	  antisense_of_plus[key51	  +	  1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  key51	  +=	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  #	  merges	  two	  dictionaries	  together:	  will	  update	  the	  first	  dictionary	  with	  the	  second	  one,	  if	  any	  keys	  match	  UTR5_minus.update(temp_UTR5_minus)	  	  temp_UTR3_plus	  =	  {}	  copy_antisense_of_minus	  =	  deepcopy(antisense_of_minus)	  for	  key53	  in	  UTR3_plus:	  	  	  	  	  	  	  	  	  if	  key53	  +	  1	  in	  copy_antisense_of_minus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  while	  key53	  +	  1	  in	  copy_antisense_of_minus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  temp_UTR3_plus[key53	  +	  1]	  =	  antisense_of_minus[key53	  +	  1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  del	  antisense_of_minus[key53	  +	  1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  key53	  +=	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  UTR3_plus.update(temp_UTR3_plus)	  	  temp_UTR5_plus	  =	  {}	  copy1_antisense_of_minus	  =	  deepcopy(antisense_of_minus)	  for	  key54	  in	  UTR5_plus:	  	  	  	  	  	  	  	  	  if	  key54	  -­‐	  1	  in	  copy1_antisense_of_minus:	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  while	  key54	  -­‐	  1	  in	  copy1_antisense_of_minus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  temp_UTR5_plus[key54	  -­‐	  1]	  =	  antisense_of_minus[key54	  -­‐	  1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  del	  antisense_of_minus[key54	  -­‐	  1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  key54	  -­‐=	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  UTR5_plus.update(temp_UTR5_plus)	  	  temp_UTR3_minus	  =	  {}	  copy1_antisense_of_plus	  =	  deepcopy(antisense_of_plus)	  for	  key52	  in	  UTR3_minus:	  	  	  	  	  	  	  	  	  if	  key52	  -­‐	  1	  in	  copy1_antisense_of_plus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  while	  key52	  -­‐	  1	  in	  copy1_antisense_of_plus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  temp_UTR3_minus[key52	  -­‐	  1]	  =	  antisense_of_plus[key52	  -­‐	  1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  del	  antisense_of_plus[key52	  -­‐	  1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  key52	  -­‐=	  1	  	  UTR3_minus.update(temp_UTR3_minus)	  	  #	  loops	  below	  merge	  any	  intergenic	  RNA	  with	  antisense	  RNA	  if	  they	  are	  part	  of	  the	  same	  transcript.	  Calls	  this	  new	  joined	  transcript	  either	  border_plus	  or	  border_minus	  ("mixed"	  ncRNAs)	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  border_minus	  =	  {}	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  for	  key5	  in	  antisense_of_plus:	  	  	  	  	  	  	  	  	  if	  key5	  -­‐	  1	  in	  RNA_minus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  border_minus[key5]	  =	  antisense_of_plus[key5]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  pos1	  =	  key5	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  while	  pos1	  -­‐	  1	  in	  RNA_minus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  border_minus[pos1	  -­‐	  1]	  =	  RNA_minus[pos1	  -­‐	  1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  pos1	  -­‐=	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  pos2	  =	  key5	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  while	  pos2	  +	  1	  in	  antisense_of_plus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  border_minus[pos2	  +	  1]	  =	  antisense_of_plus[pos2	  +	  1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  pos2	  +=	  1	  	  	  	  	  	  	  	  	  elif	  key5	  +	  1	  in	  RNA_minus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  border_minus[key5]	  =	  antisense_of_plus[key5]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  pos3	  =	  key5	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  while	  pos3	  +	  1	  in	  RNA_minus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  border_minus[pos3	  +	  1]	  =	  RNA_minus[pos3	  +	  1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  pos3	  +=	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  pos4	  =	  key5	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  while	  pos4	  -­‐	  1	  in	  antisense_of_plus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  border_minus[pos4	  -­‐	  1]	  =	  antisense_of_plus[pos4	  -­‐	  1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  pos4	  -­‐=	  1	  	  border_plus	  =	  {}	  for	  key7	  in	  antisense_of_minus:	  	  	  	  	  	  	  	  	  if	  key7	  -­‐	  1	  in	  RNA_plus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  border_plus[key7]	  =	  antisense_of_minus[key7]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  pos5	  =	  key7	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  while	  pos5	  -­‐	  1	  in	  RNA_plus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  border_plus[pos5	  -­‐	  1]	  =	  RNA_plus[pos5	  -­‐	  1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  pos5	  -­‐=	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  pos6	  =	  key7	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  while	  pos6	  +	  1	  in	  antisense_of_plus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  border_plus[pos6	  +	  1]	  =	  antisense_of_minus[pos6	  +	  1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  pos6	  +=	  1	  	  	  	  	  	  	  	  	  elif	  key7	  +	  1	  in	  RNA_plus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  border_plus[key7]	  =	  antisense_of_minus[key7]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  pos7	  =	  key7	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  while	  pos7	  +	  1	  in	  RNA_plus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  border_plus[pos7	  +	  1]	  =	  RNA_plus[pos7	  +	  1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  pos7	  +=	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  pos8	  =	  key7	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  while	  pos8	  -­‐	  1	  in	  antisense_of_minus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  border_plus[pos8	  -­‐	  1]	  =	  antisense_of_minus[pos8	  -­‐	  1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  pos8	  -­‐=	  1	  	  #	  these	  loops	  just	  delete	  keys	  from	  antisense	  and	  RNA	  dictionaries	  that	  match	  the	  keys	  from	  border_plus	  or	  border_minus	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  for	  key9	  in	  border_minus:	  	  	  	  	  	  	  	  	  if	  key9	  in	  antisense_of_plus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  del	  antisense_of_plus[key9]	  	  	  	  	  	  	  	  	  if	  key9	  in	  RNA_minus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  del	  RNA_minus[key9]	  	  for	  key10	  in	  border_plus:	  	  	  	  	  	  	  	  	  if	  key10	  in	  antisense_of_minus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  del	  antisense_of_minus[key10]	  	  	  	  	  	  	  	  	  if	  key10	  in	  RNA_plus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  del	  RNA_plus[key10]	  	  #	  the	  following	  two	  loops	  joins	  mixed	  RNAs	  with	  antisense	  RNA	  if	  they	  are	  a	  part	  of	  the	  same	  transcript	  border_plus_temp	  =	  {}	  cop_antisense_minus	  =	  deepcopy(antisense_of_minus)	  for	  a1	  in	  border_plus:	  	  	  	  	  	  	  	  	  if	  a1	  +	  1	  in	  cop_antisense_minus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  apos1	  =	  a1	  
	  	   283	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  while	  apos1	  +	  1	  in	  cop_antisense_minus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  border_plus_temp[apos1	  +	  1]	  =	  cop_antisense_minus[apos1	  +	  1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  del	  antisense_of_minus[apos1	  +	  1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  apos1	  +=	  1	  	  	  	  	  	  	  	  	  elif	  a1	  -­‐	  1	  in	  cop_antisense_minus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  apos2	  =	  a1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  while	  apos2	  -­‐	  1	  in	  cop_antisense_minus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  border_plus_temp[apos2	  -­‐	  1]	  =	  cop_antisense_minus[apos2	  -­‐	  1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  del	  antisense_of_minus[apos2	  -­‐	  1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  apos2	  -­‐=	  1	  	  border_plus.update(border_plus_temp)	  	  border_minus_temp	  =	  {}	  cop_antisense_plus	  =	  deepcopy(antisense_of_plus)	  for	  a2	  in	  border_minus:	  	  	  	  	  	  	  	  	  if	  a2	  +	  1	  in	  cop_antisense_plus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  apos3	  =	  a2	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  while	  apos3	  +	  1	  in	  cop_antisense_plus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  border_minus_temp[apos3	  +	  1]	  =	  cop_antisense_plus[apos3	  +	  1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  del	  antisense_of_plus[apos3	  +	  1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  apos3	  +=	  1	  	  	  	  	  	  	  	  	  elif	  a2	  -­‐	  1	  in	  cop_antisense_plus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  apos4	  =	  a2	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  while	  apos4	  -­‐	  1	  in	  cop_antisense_plus:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  border_minus_temp[apos4	  -­‐	  1]	  =	  cop_antisense_plus[apos4	  -­‐	  1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  del	  antisense_of_plus[apos4	  -­‐	  1]	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  apos4	  -­‐=	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  border_minus.update(border_minus_temp)	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  #	  here	  I	  call	  the	  functions	  to	  find	  ncRNAs	  that	  have	  been	  misclassified	  as	  operon	  or	  UTR	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  find_RNA_right(UTR5_minus)	  find_RNA_right(UTR3_plus)	  find_RNA_left(UTR5_plus)	  find_RNA_left(UTR3_minus)	  find_RNA_operon(operon_minus)	  find_RNA_operon(operon_plus)	  operon_to_UTR(operon_minus)	  operon_to_UTR(operon_plus)	  	  RNA_to_antisense_border(RNA_plus)	  RNA_to_antisense_border(RNA_minus)	  	  #	  here	  I	  call	  the	  function	  which	  filters	  dictionaries	  by	  length	  filter_by_length(antisense_of_minus)	  filter_by_length(antisense_of_plus)	  filter_by_length(RNA_minus)	  filter_by_length(RNA_plus)	  filter_by_length(border_minus)	  filter_by_length(border_plus)	  	  proper_antisense_of_minus	  =	  {}	  proper_antisense_of_plus	  =	  {}	  proper_RNA_minus	  =	  {}	  proper_RNA_plus	  =	  {}	  proper_border_minus	  =	  {}	  proper_border_plus	  =	  {}	  	  find_peaks(antisense_of_minus,	  proper_antisense_of_minus)	  find_peaks(antisense_of_plus,	  proper_antisense_of_plus)	  find_peaks(RNA_minus,	  proper_RNA_minus)	  find_peaks(RNA_plus,	  proper_RNA_plus)	  find_peaks(border_minus,	  proper_border_minus)	  find_peaks(border_plus,	  proper_border_plus)	  	  write_to_file(antisense_of_minus,	  "antisense_of_minus")	  	  write_to_file(antisense_of_plus,	  "antisense_of_plus")	  write_to_file(RNA_minus,	  "intergenic_minus")	  write_to_file(RNA_plus,	  "intergenic_plus")	  write_to_file(operon_minus,	  "operon_minus")	  write_to_file(operon_plus,	  "operon_plus")	  write_to_file(border_minus,	  "mixed_minus")	  write_to_file(border_plus,	  "mixed_plus")	  write_to_file(UTR3_plus,	  "UTR3_plus")	  write_to_file(UTR5_plus,	  "UTR5_plus")	  write_to_file(UTR3_minus,	  "UTR3_minus")	  write_to_file(UTR5_minus,	  "UTR5_minus")	  write_to_file(proper_antisense_of_minus,	  "filtered_antisense_of_minus")	  write_to_file(proper_antisense_of_plus,	  "filtered_antisense_of_plus")	  write_to_file(proper_border_minus,	  "filtered_mixed_minus")	  write_to_file(proper_border_plus,	  "filtered_mixed_plus")	  write_to_file(proper_RNA_minus,	  "filtered_intergenic_minus")	  write_to_file(proper_RNA_plus,	  "filtered_intergenic_plus")	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Appendix	  D:	  Supplementary	  tables	  for	  
Chapter	  5	  
	  
Table	   S10:	   Characteristics	   of	   all	   identified	   putative	   ncRNAs	   in	   Rd	   and	  
R2866	  genomes.	  	  
	  
Name	   Start	  position	  
Stop	  




position	   Length	   Type	  
Rd	   R2866	  Rd_001	   30539	   31309	   771	   mixed	   R2866_001	   9716	   10442	   727	   mixed	  Rd_002	   37519	   37954	   436	   antisense	   R2866_002	   97846	   98356	   511	   mixed	  Rd_003	   73608	   73816	   208	   mixed	   R2866_003	   113760	   114721	   962	   mixed	  Rd_004	   109964	   110715	   752	   mixed	   R2866_004	   132320	   132529	   210	   intergenic	  Rd_005	   127630	   128163	   534	   mixed	   R2866_005	   175384	   175658	   274	   mixed	  Rd_006	   130258	   131358	   1101	   mixed	   R2866_006	   186358	   186567	   210	   intergenic	  Rd_007	   136228	   138127	   1900	   mixed	   R2866_007	   186977	   187800	   824	   mixed	  Rd_008	   154965	   155378	   414	   intergenic	   R2866_008	   194341	   194992	   651	   mixed	  Rd_009	   155135	   155395	   261	   mixed	   R2866_009	   272052	   272292	   241	   intergenic	  Rd_010	   156713	   156995	   283	   mixed	   R2866_010	   289003	   290293	   1291	   mixed	  Rd_011	   169023	   169556	   534	   mixed	   R2866_011	   346335	   346699	   365	   mixed	  Rd_012	   175352	   175818	   467	   antisense	   R2866_012	   347170	   347384	   215	   antisense	  Rd_013	   176336	   176520	   185	   intergenic	   R2866_013	   357196	   358018	   823	   mixed	  Rd_014	   180355	   181025	   671	   antisense	   R2866_014	   357774	   358115	   342	   intergenic	  Rd_015	   184195	   184851	   656	   antisense	   R2866_015	   363380	   363853	   474	   mixed	  Rd_016	   208435	   209046	   612	   antisense	   R2866_016	   390735	   391522	   788	   mixed	  Rd_017	   214643	   214968	   326	   antisense	   R2866_017	   397982	   398500	   519	   intergenic	  Rd_018	   227136	   227665	   530	   intergenic	   R2866_018	   398271	   398538	   268	   intergenic	  Rd_019	   227394	   227616	   223	   intergenic	   R2866_019	   400501	   401715	   1215	   mixed	  Rd_020	   243893	   244749	   857	   mixed	   R2866_020	   406115	   406693	   578	   mixed	  Rd_021	   249824	   250087	   264	   mixed	   R2866_021	   408041	   408417	   377	   mixed	  Rd_022	   256153	   256897	   745	   mixed	   R2866_022	   419392	   419860	   469	   antisense	  Rd_023	   271291	   271628	   338	   mixed	   R2866_023	   429795	   430126	   332	   mixed	  Rd_024	   278059	   279280	   1222	   mixed	   R2866_024	   452241	   452552	   312	   intergenic	  Rd_025	   278913	   279873	   961	   mixed	   R2866_025	   452279	   452786	   508	   intergenic	  Rd_026	   281235	   281514	   280	   intergenic	   R2866_026	   459566	   460100	   535	   mixed	  Rd_027	   281280	   281477	   198	   intergenic	   R2866_027	   471758	   472743	   986	   mixed	  Rd_028	   296327	   296520	   194	   intergenic	   R2866_028	   474416	   474668	   253	   mixed	  Rd_029	   305850	   306227	   378	   mixed	   R2866_029	   474428	   474748	   321	   intergenic	  Rd_030	   308744	   309586	   843	   mixed	   R2866_030	   478478	   479142	   665	   mixed	  Rd_031	   310894	   311696	   803	   mixed	   R2866_031	   492230	   494186	   1957	   mixed	  Rd_032	   312222	   313247	   1025	   mixed	   R2866_032	   495129	   495444	   315	   mixed	  Rd_033	   320793	   321132	   340	   intergenic	   R2866_033	   498570	   498891	   322	   intergenic	  Rd_034	   320889	   321185	   297	   mixed	   R2866_034	   499358	   500645	   1288	   mixed	  Rd_035	   330677	   330927	   251	   antisense	   R2866_035	   502749	   503057	   309	   mixed	  Rd_036	   331381	   331544	   164	   antisense	   R2866_036	   505734	   506225	   492	   antisense	  Rd_037	   339574	   341083	   1510	   antisense	   R2866_037	   524761	   526365	   1605	   mixed	  Rd_038	   354436	   355486	   1051	   mixed	   R2866_038	   528692	   529532	   841	   mixed	  Rd_039	   397157	   398551	   1395	   mixed	   R2866_039	   542421	   543162	   742	   mixed	  Rd_040	   400512	   400738	   227	   intergenic	   R2866_040	   548285	   548624	   340	   intergenic	  Rd_041	   427943	   428118	   176	   intergenic	   R2866_041	   555815	   556104	   290	   mixed	  Rd_042	   435624	   436053	   430	   mixed	   R2866_042	   564343	   565334	   992	   antisense	  Rd_043	   459360	   459961	   602	   antisense	   R2866_043	   569053	   569691	   639	   mixed	  Rd_044	   468285	   469071	   787	   mixed	   R2866_044	   570011	   570339	   329	   intergenic	  Rd_045	   476500	   477190	   691	   mixed	   R2866_045	   570544	   571082	   539	   antisense	  Rd_046	   477271	   477797	   526	   mixed	   R2866_046	   574965	   575734	   770	   mixed	  Rd_047	   484909	   485234	   326	   intergenic	   R2866_047	   586813	   587344	   532	   antisense	  Rd_048	   488999	   490088	   1090	   antisense	   R2866_048	   611151	   611641	   491	   intergenic	  Rd_049	   497643	   499189	   1547	   mixed	   R2866_049	   626576	   627214	   638	   mixed	  Rd_050	   534853	   535313	   460	   antisense	   R2866_050	   642578	   643219	   642	   mixed	  Rd_051	   537894	   538102	   209	   mixed	   R2866_051	   650312	   650559	   247	   mixed	  Rd_052	   544821	   545640	   820	   mixed	   R2866_052	   673871	   674425	   555	   antisense	  Rd_053	   555630	   556800	   1170	   mixed	   R2866_053	   675975	   676626	   652	   mixed	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Name	   Start	  position	   Stop	  position	   Length	   Type	   Name	   Start	  position	   Stop	  position	   Length	   Type	  
Rd	   R2866	  Rd_054	   557547	   558857	   1311	   mixed	   R2866_054	   686375	   686787	   413	   antisense	  Rd_055	   613015	   613361	   346	   mixed	   R2866_055	   692900	   693767	   868	   mixed	  Rd_056	   617165	   618118	   954	   mixed	   R2866_056	   729897	   732565	   2669	   mixed	  Rd_057	   641974	   643467	   1494	   mixed	   R2866_057	   742675	   743213	   539	   mixed	  Rd_058	   659943	   661422	   1479	   antisense	   R2866_058	   758611	   758847	   236	   intergenic	  Rd_059	   662409	   662498	   89	   intergenic	   R2866_059	   766185	   766446	   262	   antisense	  Rd_060	   666223	   666468	   246	   mixed	   R2866_060	   776385	   776842	   458	   antisense	  Rd_061	   673236	   674403	   1168	   mixed	   R2866_061	   781437	   782175	   739	   mixed	  Rd_062	   674424	   674962	   539	   mixed	   R2866_062	   791588	   792501	   914	   mixed	  Rd_063	   692219	   692619	   401	   mixed	   R2866_063	   791708	   792149	   442	   intergenic	  Rd_064	   694639	   695370	   732	   mixed	   R2866_064	   808837	   809046	   210	   mixed	  Rd_065	   708324	   708556	   233	   mixed	   R2866_065	   821541	   822128	   587	   mixed	  Rd_066	   721899	   722015	   116	   intergenic	   R2866_066	   831407	   832623	   1217	   mixed	  Rd_067	   739932	   740404	   473	   antisense	   R2866_067	   834258	   835311	   1054	   antisense	  Rd_068	   740746	   741363	   618	   antisense	   R2866_068	   875603	   876167	   565	   mixed	  Rd_069	   743129	   744301	   1173	   antisense	   R2866_069	   891340	   892159	   820	   intergenic	  Rd_070	   745331	   745785	   454	   mixed	   R2866_070	   892244	   892573	   330	   antisense	  Rd_071	   755770	   755977	   207	   intergenic	   R2866_071	   898563	   898961	   399	   antisense	  Rd_072	   785976	   786677	   702	   antisense	   R2866_072	   904640	   905021	   382	   intergenic	  Rd_073	   787692	   788471	   780	   antisense	   R2866_073	   908067	   909070	   1004	   mixed	  Rd_074	   788487	   789222	   736	   mixed	   R2866_074	   909244	   910626	   1383	   antisense	  Rd_075	   801028	   801557	   530	   mixed	   R2866_075	   949794	   949955	   162	   mixed	  Rd_076	   804927	   805709	   783	   mixed	   R2866_076	   964326	   964722	   397	   mixed	  Rd_077	   808749	   809804	   1056	   mixed	   R2866_077	   973191	   974050	   860	   mixed	  Rd_078	   828325	   829313	   989	   mixed	   R2866_078	   993545	   993783	   238	   intergenic	  Rd_079	   833686	   834447	   762	   mixed	   R2866_079	   995263	   995765	   503	   mixed	  Rd_080	   840869	   841324	   456	   antisense	   R2866_080	   1006041	   1006276	   236	   intergenic	  Rd_081	   876552	   876924	   372	   intergenic	   R2866_081	   1012493	   1013174	   682	   mixed	  Rd_082	   885347	   885661	   315	   intergenic	   R2866_082	   1030821	   1031179	   359	   antisense	  Rd_083	   885469	   885645	   177	   intergenic	   R2866_083	   1037230	   1038444	   1215	   mixed	  Rd_084	   897457	   897766	   310	   intergenic	   R2866_084	   1051711	   1052380	   670	   antisense	  Rd_085	   914086	   914547	   462	   mixed	   R2866_085	   1058738	   1059734	   997	   mixed	  Rd_086	   915521	   915888	   367	   intergenic	   R2866_086	   1103736	   1104765	   1030	   mixed	  Rd_087	   929086	   930970	   1885	   antisense	   R2866_087	   1131442	   1131731	   290	   mixed	  Rd_088	   965560	   966963	   1404	   mixed	   R2866_088	   1132270	   1132860	   591	   mixed	  Rd_089	   992036	   992369	   334	   antisense	   R2866_089	   1150324	   1150566	   242	   intergenic	  Rd_090	   994816	   995745	   930	   mixed	   R2866_090	   1177936	   1178325	   390	   mixed	  Rd_091	   1016881	   1017852	   972	   mixed	   R2866_091	   1178739	   1181057	   2319	   mixed	  Rd_092	   1033013	   1033875	   863	   mixed	   R2866_092	   1191418	   1191868	   451	   mixed	  Rd_093	   1041098	   1041478	   381	   antisense	   R2866_093	   1194076	   1194461	   386	   mixed	  Rd_094	   1052866	   1053413	   548	   antisense	   R2866_094	   1198769	   1198991	   222	   intergenic	  Rd_095	   1068302	   1068890	   589	   mixed	   R2866_095	   1221439	   1221709	   271	   intergenic	  Rd_096	   1071796	   1072503	   708	   antisense	   R2866_096	   1221502	   1222055	   554	   mixed	  Rd_097	   1073701	   1074177	   477	   antisense	   R2866_097	   1242786	   1243183	   398	   intergenic	  Rd_098	   1080264	   1080879	   615	   mixed	   R2866_098	   1245476	   1246096	   621	   mixed	  Rd_099	   1083534	   1084437	   904	   mixed	   R2866_099	   1254839	   1255962	   1124	   mixed	  Rd_100	   1102893	   1104117	   1225	   mixed	   R2866_100	   1256714	   1257862	   1149	   mixed	  Rd_101	   1110417	   1111758	   1342	   mixed	   R2866_101	   1259245	   1259534	   290	   intergenic	  Rd_102	   1113627	   1114077	   451	   antisense	   R2866_102	   1259344	   1259817	   474	   mixed	  Rd_103	   1147693	   1148130	   437	   mixed	   R2866_103	   1264431	   1265888	   1458	   mixed	  Rd_104	   1150191	   1150430	   239	   mixed	   R2866_104	   1269607	   1270022	   416	   antisense	  Rd_105	   1173203	   1173472	   269	   intergenic	   R2866_105	   1277352	   1278405	   1054	   mixed	  Rd_106	   1173213	   1173455	   243	   intergenic	   R2866_106	   1284990	   1286304	   1315	   mixed	  Rd_107	   1179087	   1179305	   219	   antisense	   R2866_107	   1301932	   1302148	   217	   antisense	  Rd_108	   1194933	   1196201	   1269	   mixed	   R2866_108	   1307763	   1308096	   334	   intergenic	  Rd_109	   1203265	   1203822	   558	   mixed	   R2866_109	   1307782	   1308061	   280	   intergenic	  Rd_110	   1217011	   1217468	   458	   mixed	   R2866_110	   1330706	   1330920	   215	   antisense	  Rd_111	   1222538	   1222811	   274	   mixed	   R2866_111	   1356981	   1357494	   514	   mixed	  Rd_112	   1222610	   1222912	   303	   intergenic	   R2866_112	   1367615	   1367940	   326	   mixed	  Rd_113	   1236131	   1236896	   766	   mixed	   R2866_113	   1370928	   1371628	   700	   antisense	  Rd_114	   1239034	   1239442	   409	   intergenic	   R2866_114	   1378432	   1378907	   476	   mixed	  Rd_115	   1255321	   1255696	   376	   antisense	   R2866_115	   1391570	   1393605	   2036	   mixed	  Rd_116	   1260213	   1260718	   506	   mixed	   R2866_116	   1418314	   1418931	   618	   antisense	  Rd_117	   1265023	   1265765	   743	   antisense	   R2866_117	   1454600	   1455239	   640	   mixed	  Rd_118	   1274013	   1276134	   2122	   mixed	   R2866_118	   1473212	   1475161	   1950	   mixed	  Rd_119	   1303104	   1304060	   957	   mixed	   R2866_119	   1476038	   1476384	   347	   mixed	  Rd_120	   1318219	   1318845	   627	   mixed	   R2866_120	   1490768	   1491332	   564	   mixed	  Rd_121	   1323679	   1323971	   293	   intergenic	   R2866_121	   1503072	   1504125	   1053	   mixed	  Rd_122	   1336677	   1337031	   355	   antisense	   R2866_122	   1510202	   1511152	   951	   mixed	  Rd_123	   1348269	   1348666	   398	   intergenic	   R2866_123	   1517911	   1518282	   372	   antisense	  Rd_124	   1372243	   1372984	   742	   antisense	   R2866_124	   1535931	   1536542	   612	   mixed	  Rd_125	   1386245	   1387027	   782	   mixed	   R2866_125	   1554103	   1554489	   386	   intergenic	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Name	   Start	  position	   Stop	  position	   Length	   Type	   Name	   Start	  position	   Stop	  position	   Length	   Type	  
Rd	   R2866	  Rd_126	   1390722	   1392443	   1722	   mixed	   R2866_126	   1555300	   1555903	   604	   mixed	  Rd_127	   1399972	   1400704	   732	   mixed	   R2866_127	   1566085	   1566450	   366	   antisense	  Rd_128	   1419419	   1419850	   431	   antisense	   R2866_128	   1567612	   1567841	   229	   intergenic	  Rd_129	   1421775	   1422207	   433	   antisense	   R2866_129	   1570086	   1570511	   426	   antisense	  Rd_130	   1472704	   1473265	   562	   mixed	   R2866_130	   1571782	   1571932	   150	   antisense	  Rd_131	   1475674	   1475988	   315	   intergenic	   R2866_131	   1572288	   1572544	   257	   intergenic	  Rd_132	   1483534	   1483759	   226	   intergenic	   R2866_132	   1592489	   1592795	   307	   intergenic	  Rd_133	   1505845	   1506661	   817	   mixed	   R2866_133	   1592505	   1592681	   177	   intergenic	  Rd_134	   1515886	   1516381	   496	   mixed	   R2866_134	   1607433	   1607912	   480	   mixed	  Rd_135	   1518769	   1518894	   126	   mixed	   R2866_135	   1643962	   1645106	   1145	   mixed	  Rd_136	   1529438	   1529910	   473	   mixed	   R2866_136	   1649473	   1650470	   998	   mixed	  Rd_137	   1545292	   1545803	   512	   mixed	   R2866_137	   1669077	   1670181	   1105	   mixed	  Rd_138	   1562150	   1562462	   313	   mixed	   R2866_138	   1670185	   1670563	   379	   antisense	  Rd_139	   1576249	   1577329	   1081	   mixed	   R2866_139	   1673212	   1674054	   843	   mixed	  Rd_140	   1578359	   1579198	   840	   antisense	   R2866_140	   1674588	   1675134	   547	   antisense	  Rd_141	   1579222	   1579848	   627	   antisense	   R2866_141	   1677370	   1677857	   487	   mixed	  Rd_142	   1602676	   1602924	   248	   antisense	   R2866_142	   1696211	   1696464	   254	   antisense	  Rd_143	   1605548	   1606363	   816	   mixed	   R2866_143	   1733584	   1734196	   613	   mixed	  Rd_144	   1616521	   1616858	   338	   mixed	   R2866_144	   1743386	   1743894	   508	   mixed	  Rd_145	   1624072	   1624299	   228	   intergenic	   R2866_145	   1744080	   1745121	   1042	   antisense	  Rd_146	   1659756	   1660684	   929	   mixed	   R2866_146	   1757230	   1757710	   481	   antisense	  Rd_147	   1666018	   1666223	   205	   intergenic	   R2866_147	   1780641	   1780933	   292	   intergenic	  Rd_148	   1685708	   1686593	   886	   mixed	   R2866_148	   1804546	   1805373	   828	   mixed	  Rd_149	   1694403	   1694923	   521	   antisense	   R2866_149	   1834710	   1835250	   541	   intergenic	  Rd_150	   1714534	   1714829	   295	   mixed	   R2866_150	   1851986	   1852172	   187	   antisense	  Rd_151	   1714817	   1715360	   544	   intergenic	   R2866_151	   1853122	   1853918	   797	   antisense	  Rd_152	   1714856	   1715470	   615	   mixed	   R2866_152	   1855188	   1855517	   329	   mixed	  Rd_153	   1724508	   1725675	   1168	   mixed	   R2866_153	   1890125	   1891074	   950	   mixed	  Rd_154	   1732610	   1733522	   913	   mixed	   R2866_154	   1899828	   1900062	   234	   intergenic	  Rd_155	   1733417	   1733874	   458	   mixed	   R2866_155	   1902432	   1903046	   615	   intergenic	  Rd_156	   1748493	   1748724	   232	   intergenic	   R2866_156	   1903042	   1904111	   1070	   intergenic	  Rd_157	   1777537	   1779667	   2131	   mixed	   R2866_157	   1904502	   1904767	   266	   mixed	  Rd_158	   1785066	   1785298	   233	   intergenic	   R2866_158	   1906897	   1907094	   197	   antisense	  Rd_159	   1785416	   1785659	   244	   intergenic	   R2866_159	   1907095	   1907225	   131	   antisense	  Rd_160	   1788561	   1789102	   542	   intergenic	   R2866_160	   1907338	   1907455	   118	   antisense	  Rd_161	   1789118	   1789884	   767	   mixed	   R2866_161	   1908114	   1908244	   131	   intergenic	  Rd_162	   1789913	   1790132	   219	   mixed	   R2866_162	   1908264	   1908555	   292	   intergenic	  Rd_163	   1794537	   1795072	   536	   mixed	   R2866_163	   1908916	   1909084	   168	   intergenic	  Rd_164	   1795845	   1796096	   251	   intergenic	   	   	   	   	   	  Rd_165	   1796507	   1796828	   322	   intergenic	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Table	  S11:	  Differentially	  expressed	  ncRNAs	  in	  Rd	  during	  stationary	  phase.	  
ncRNA	   Fold	  change	   Adjusted	  p-­‐value	   ncRNA	   Fold	  change	   Adjusted	  p-­‐value	  
Up-­‐regulated	  ncRNAs	   Down-­‐regulated	  ncRNAs	  Rd_011	   22.31	   1.79E-­‐52	   Rd_164	   13.76	   5.59E-­‐88	  Rd_092	   13.77	   1.59E-­‐32	   Rd_159	   13.19	   4.26E-­‐87	  Rd_010	   13.37	   5.73E-­‐21	   Rd_156	   7.66	   1.74E-­‐30	  Rd_141	   9.59	   8.76E-­‐22	   Rd_160	   4.11	   6.96E-­‐32	  Rd_146	   9.55	   2.83E-­‐51	   Rd_128	   2.14	   5.93E-­‐07	  Rd_120	   9.22	   6.62E-­‐116	   	   	   	  Rd_106	   9.00	   6.07E-­‐13	   	   	   	  Rd_078	   8.79	   1.55E-­‐45	   	   	   	  Rd_082	   8.48	   1.35E-­‐77	   	   	   	  Rd_139	   7.81	   6.73E-­‐27	   	   	   	  Rd_031	   7.74	   7.65E-­‐29	   	   	   	  Rd_036	   7.71	   1.69E-­‐13	   	   	   	  Rd_062	   7.33	   4.66E-­‐43	   	   	   	  Rd_116	   7.21	   1.94E-­‐32	   	   	   	  Rd_153	   6.90	   4.28E-­‐25	   	   	   	  Rd_007	   6.88	   1.65E-­‐30	   	   	   	  Rd_034	   6.80	   3.01E-­‐64	   	   	   	  Rd_030	   6.79	   2.11E-­‐34	   	   	   	  Rd_115	   6.66	   3.13E-­‐19	   	   	   	  Rd_048	   6.28	   3.01E-­‐16	   	   	   	  Rd_107	   6.14	   1.40E-­‐09	   	   	   	  Rd_091	   6.11	   7.55E-­‐33	   	   	   	  Rd_083	   6.02	   8.81E-­‐17	   	   	   	  Rd_157	   5.99	   2.32E-­‐40	   	   	   	  Rd_022	   5.92	   1.68E-­‐18	   	   	   	  Rd_038	   5.88	   1.63E-­‐32	   	   	   	  Rd_009	   5.77	   9.58E-­‐53	   	   	   	  Rd_096	   5.77	   2.79E-­‐22	   	   	   	  Rd_140	   5.73	   1.51E-­‐23	   	   	   	  Rd_109	   5.49	   2.55E-­‐17	   	   	   	  Rd_090	   5.29	   8.87E-­‐51	   	   	   	  Rd_069	   5.26	   1.31E-­‐36	   	   	   	  Rd_068	   5.25	   2.79E-­‐22	   	   	   	  Rd_122	   5.23	   1.09E-­‐20	   	   	   	  Rd_020	   5.20	   9.00E-­‐25	   	   	   	  Rd_095	   5.13	   1.48E-­‐20	   	   	   	  Rd_143	   5.10	   6.00E-­‐23	   	   	   	  Rd_074	   4.94	   2.87E-­‐15	   	   	   	  Rd_023	   4.71	   1.26E-­‐11	   	   	   	  Rd_057	   4.55	   4.69E-­‐28	   	   	   	  Rd_137	   4.47	   3.71E-­‐20	   	   	   	  Rd_012	   4.31	   2.04E-­‐28	   	   	   	  Rd_064	   4.28	   1.40E-­‐14	   	   	   	  Rd_087	   4.20	   1.02E-­‐36	   	   	   	  Rd_056	   4.12	   1.13E-­‐27	   	   	   	  Rd_073	   4.07	   1.62E-­‐13	   	   	   	  Rd_129	   4.03	   7.14E-­‐27	   	   	   	  Rd_054	   3.96	   3.19E-­‐16	   	   	   	  Rd_161	   3.91	   6.61E-­‐36	   	   	   	  Rd_149	   3.87	   1.21E-­‐11	   	   	   	  Rd_032	   3.77	   1.52E-­‐11	   	   	   	  Rd_077	   3.75	   4.51E-­‐31	   	   	   	  Rd_001	   3.62	   7.15E-­‐14	   	   	   	  Rd_131	   3.59	   9.84E-­‐08	   	   	   	  Rd_132	   3.59	   6.37E-­‐20	   	   	   	  Rd_072	   3.55	   4.67E-­‐11	   	   	   	  Rd_052	   3.51	   2.33E-­‐14	   	   	   	  Rd_037	   3.47	   1.03E-­‐15	   	   	   	  Rd_100	   3.43	   6.55E-­‐30	   	   	   	  Rd_051	   3.41	   3.02E-­‐30	   	   	   	  Rd_124	   3.39	   3.56E-­‐08	   	   	   	  Rd_084	   3.35	   2.77E-­‐10	   	   	   	  Rd_061	   3.29	   2.02E-­‐18	   	   	   	  Rd_050	   3.25	   8.34E-­‐09	   	   	   	  Rd_063	   3.21	   2.52E-­‐13	   	   	   	  Rd_110	   3.20	   1.52E-­‐10	   	   	   	  Rd_112	   3.19	   9.72E-­‐39	   	   	   	  Rd_058	   3.15	   8.82E-­‐18	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ncRNA	   Fold	  change	   Adjusted	  p-­‐value	   	   	   	  
Up-­‐regulated	  ncRNAs	   	  Rd_104	   3.11	   3.49E-­‐07	   	   	   	  Rd_126	   3.11	   1.33E-­‐22	   	   	   	  Rd_014	   3.10	   2.75E-­‐21	   	   	   	  Rd_008	   3.08	   3.13E-­‐30	   	   	   	  Rd_080	   3.05	   2.67E-­‐09	   	   	   	  Rd_144	   3.05	   2.80E-­‐07	   	   	   	  Rd_101	   3.02	   3.71E-­‐13	   	   	   	  Rd_119	   3.02	   3.83E-­‐14	   	   	   	  Rd_099	   3.02	   3.17E-­‐21	   	   	   	  Rd_027	   2.97	   2.02E-­‐12	   	   	   	  Rd_043	   2.96	   9.89E-­‐15	   	   	   	  Rd_067	   2.95	   9.68E-­‐08	   	   	   	  Rd_093	   2.92	   2.45E-­‐12	   	   	   	  Rd_039	   2.89	   4.15E-­‐22	   	   	   	  Rd_148	   2.87	   1.44E-­‐14	   	   	   	  Rd_005	   2.73	   2.07E-­‐09	   	   	   	  Rd_089	   2.69	   1.04E-­‐07	   	   	   	  Rd_118	   2.65	   3.73E-­‐18	   	   	   	  Rd_042	   2.64	   4.29E-­‐08	   	   	   	  Rd_088	   2.62	   4.31E-­‐15	   	   	   	  Rd_081	   2.57	   1.11E-­‐17	   	   	   	  Rd_114	   2.56	   5.87E-­‐15	   	   	   	  Rd_111	   2.50	   5.13E-­‐14	   	   	   	  Rd_046	   2.42	   4.23E-­‐08	   	   	   	  Rd_130	   2.41	   6.75E-­‐09	   	   	   	  Rd_085	   2.40	   1.16E-­‐07	   	   	   	  Rd_142	   2.40	   0.000675838	   	   	   	  Rd_079	   2.40	   2.96E-­‐10	   	   	   	  Rd_021	   2.34	   2.09E-­‐06	   	   	   	  Rd_016	   2.33	   7.78E-­‐13	   	   	   	  Rd_113	   2.28	   2.57E-­‐07	   	   	   	  Rd_019	   2.27	   0.000202062	   	   	   	  Rd_108	   2.24	   3.65E-­‐05	   	   	   	  Rd_151	   2.20	   3.07E-­‐07	   	   	   	  Rd_029	   2.18	   0.000321933	   	   	   	  Rd_013	   2.15	   2.46E-­‐06	   	   	   	  Rd_121	   2.11	   0.000178688	   	   	   	  Rd_097	   2.11	   0.003194726	   	   	   	  Rd_152	   2.11	   2.55E-­‐08	   	   	   	  Rd_055	   2.03	   1.45E-­‐06	   	   	   	  Rd_004	   2.00	   3.26E-­‐11	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Table	   S12:	   Differentially	   expressed	   ncRNAs	   in	   R2866	   during	   stationary	  
phase.	  
ncRNA	   Fold	  change	   Adjusted	  p-­‐value	   ncRNA	   Fold	  change	   Adjusted	  p-­‐value	  
Up-­‐regulated	  ncRNAs	   Down-­‐regulated	  ncRNAs	  R2866_112	   14.28	   1.21E-­‐131	   R2866_158	   12.31	   2.82E-­‐65	  R2866_075	   13.45	   1.27E-­‐36	   R2866_154	   9.82	   2.79E-­‐96	  R2866_067	   10.39	   1.46E-­‐60	   R2866_163	   2.74	   6.14E-­‐06	  R2866_132	   8.64	   5.56E-­‐88	   R2866_003	   2.60	   2.24E-­‐35	  R2866_001	   8.12	   1.32E-­‐59	   R2866_058	   2.52	   8.30E-­‐35	  R2866_144	   7.39	   8.78E-­‐143	   R2866_141	   2.51	   2.79E-­‐16	  R2866_031	   7.19	   3.85E-­‐256	   	   	   	  R2866_036	   6.90	   4.58E-­‐27	   	   	   	  R2866_057	   6.57	   6.83E-­‐24	   	   	   	  R2866_050	   6.28	   3.89E-­‐51	   	   	   	  R2866_133	   6.27	   2.85E-­‐28	   	   	   	  R2866_136	   6.09	   1.11E-­‐53	   	   	   	  R2866_101	   5.35	   5.86E-­‐277	   	   	   	  R2866_056	   5.12	   5.31E-­‐124	   	   	   	  R2866_117	   4.99	   1.06E-­‐24	   	   	   	  R2866_142	   4.92	   4.90E-­‐15	   	   	   	  R2866_109	   4.83	   3.62E-­‐15	   	   	   	  R2866_064	   4.56	   7.36E-­‐10	   	   	   	  R2866_046	   4.53	   3.88E-­‐173	   	   	   	  R2866_092	   4.50	   3.28E-­‐72	   	   	   	  R2866_118	   4.43	   4.80E-­‐18	   	   	   	  R2866_083	   4.42	   2.13E-­‐55	   	   	   	  R2866_086	   4.36	   1.76E-­‐51	   	   	   	  R2866_055	   4.34	   4.65E-­‐44	   	   	   	  R2866_028	   4.32	   1.23E-­‐84	   	   	   	  R2866_087	   4.31	   1.39E-­‐20	   	   	   	  R2866_093	   4.28	   9.27E-­‐24	   	   	   	  R2866_070	   4.28	   2.22E-­‐94	   	   	   	  R2866_082	   4.08	   8.45E-­‐19	   	   	   	  R2866_053	   4.01	   4.32E-­‐21	   	   	   	  R2866_103	   3.95	   1.51E-­‐103	   	   	   	  R2866_061	   3.94	   2.66E-­‐32	   	   	   	  R2866_017	   3.73	   1.22E-­‐93	   	   	   	  R2866_119	   3.71	   9.24E-­‐16	   	   	   	  R2866_137	   3.69	   7.03E-­‐176	   	   	   	  R2866_074	   3.68	   1.61E-­‐49	   	   	   	  R2866_068	   3.64	   4.04E-­‐45	   	   	   	  R2866_157	   3.60	   5.73E-­‐23	   	   	   	  R2866_091	   3.60	   3.94E-­‐143	   	   	   	  R2866_066	   3.50	   1.82E-­‐40	   	   	   	  R2866_011	   3.47	   1.45E-­‐11	   	   	   	  R2866_159	   3.40	   2.69E-­‐27	   	   	   	  R2866_027	   3.39	   2.94E-­‐81	   	   	   	  R2866_099	   3.28	   4.76E-­‐33	   	   	   	  R2866_073	   3.22	   2.16E-­‐36	   	   	   	  R2866_026	   3.17	   4.83E-­‐60	   	   	   	  R2866_090	   3.15	   1.01E-­‐13	   	   	   	  R2866_134	   3.12	   3.44E-­‐17	   	   	   	  R2866_088	   3.10	   6.45E-­‐45	   	   	   	  R2866_048	   3.10	   3.07E-­‐141	   	   	   	  R2866_013	   3.08	   8.79E-­‐47	   	   	   	  R2866_060	   3.07	   6.38E-­‐20	   	   	   	  R2866_021	   3.04	   3.62E-­‐12	   	   	   	  R2866_096	   3.03	   2.86E-­‐20	   	   	   	  R2866_033	   3.02	   5.42E-­‐16	   	   	   	  R2866_035	   2.98	   1.99E-­‐22	   	   	   	  R2866_107	   2.90	   8.02E-­‐07	   	   	   	  R2866_161	   2.87	   2.51E-­‐18	   	   	   	  R2866_123	   2.86	   3.78E-­‐23	   	   	   	  R2866_149	   2.85	   3.57E-­‐62	   	   	   	  R2866_140	   2.84	   2.16E-­‐16	   	   	   	  R2866_145	   2.84	   1.33E-­‐24	   	   	   	  R2866_155	   2.82	   2.43E-­‐14	   	   	   	  R2866_084	   2.77	   2.39E-­‐16	   	   	   	  R2866_022	   2.76	   2.49E-­‐18	   	   	   	  
	  	   290	  
ncRNA	   Fold	  change	   Adjusted	  p-­‐value	   	   	   	  
Up-­‐regulated	  ncRNAs	   	  R2866_039	   2.73	   6.76E-­‐55	   	   	   	  R2866_097	   2.72	   4.31E-­‐82	   	   	   	  R2866_023	   2.70	   9.64E-­‐12	   	   	   	  R2866_030	   2.69	   3.29E-­‐18	   	   	   	  R2866_071	   2.66	   2.31E-­‐11	   	   	   	  R2866_146	   2.66	   2.28E-­‐20	   	   	   	  R2866_085	   2.64	   2.45E-­‐35	   	   	   	  R2866_004	   2.61	   1.05E-­‐11	   	   	   	  R2866_160	   2.54	   2.44E-­‐08	   	   	   	  R2866_072	   2.54	   4.80E-­‐28	   	   	   	  R2866_105	   2.51	   1.23E-­‐59	   	   	   	  R2866_135	   2.50	   2.68E-­‐36	   	   	   	  R2866_110	   2.48	   2.07E-­‐11	   	   	   	  R2866_115	   2.41	   3.32E-­‐30	   	   	   	  R2866_122	   2.39	   4.75E-­‐27	   	   	   	  R2866_162	   2.36	   5.67E-­‐11	   	   	   	  R2866_120	   2.34	   2.01E-­‐10	   	   	   	  R2866_045	   2.33	   2.32E-­‐11	   	   	   	  R2866_016	   2.33	   2.03E-­‐12	   	   	   	  R2866_037	   2.28	   2.44E-­‐31	   	   	   	  R2866_042	   2.27	   2.33E-­‐14	   	   	   	  R2866_008	   2.22	   2.38E-­‐18	   	   	   	  R2866_038	   2.22	   5.89E-­‐43	   	   	   	  R2866_111	   2.20	   1.44E-­‐08	   	   	   	  R2866_065	   2.19	   2.39E-­‐09	   	   	   	  R2866_080	   2.18	   3.52E-­‐27	   	   	   	  R2866_131	   2.14	   4.73E-­‐09	   	   	   	  R2866_062	   2.12	   6.60E-­‐37	   	   	   	  R2866_044	   2.11	   1.36E-­‐85	   	   	   	  R2866_106	   2.09	   3.56E-­‐25	   	   	   	  R2866_104	   2.02	   3.16E-­‐05	   	   	   	  R2866_114	   2.02	   2.44E-­‐20	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Table	  S13:	  Differentially	  expressed	  ncRNAs	  in	  Rd	  during	  oxidative	  stress.	  
ncRNA	   Fold	  change	   Adjusted	  p-­‐value	   ncRNA	   Fold	  change	   Adjusted	  p-­‐value	  
Up-­‐regulated	  ncRNAs	   Down-­‐regulated	  ncRNAs	  Rd_116	   3.58	   2.31E-­‐19	   Rd_143	   2.17	   5.20E-­‐09	  Rd_135	   2.46	   2.59E-­‐10	   	   	   	  Rd_027	   2.36	   3.27E-­‐09	   	   	   	  Rd_064	   2.09	   0.000599706	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Table	   S14:	   Differentially	   expressed	   ncRNAs	   in	   R2866	   during	   oxidative	  
stress.	  
ncRNA	   Fold	  change	   Adjusted	  p-­‐value	   ncRNA	   Fold	  change	   Adjusted	  p-­‐value	  
Up-­‐regulated	  ncRNAs	   Down-­‐regulated	  ncRNAs	  R2866_049	   2.90	   1.42E-­‐15	   R2866_076	   2.09	   0.031810371	  R2866_040	   2.30	   3.78E-­‐05	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Table	   S15:	  Differentially	   expressed	   ncRNAs	   in	   Rd	   during	   iron-­‐starvation	  
stress.	  
ncRNA	   Fold	  change	   Adjusted	  p-­‐value	   ncRNA	   Fold	  change	   Adjusted	  p-­‐value	  
Up-­‐regulated	  ncRNAs	   Down-­‐regulated	  ncRNAs	  Rd_114	   4.94	   1.19E-­‐27	   Rd_087	   2.61	   1.88E-­‐11	  Rd_165	   4.86	   1.24E-­‐54	   Rd_032	   2.11	   0.000658856	  Rd_158	   4.18	   1.31E-­‐38	   Rd_050	   2.06	   0.000805925	  Rd_070	   2.61	   1.35E-­‐06	   Rd_161	   2.04	   5.47E-­‐10	  Rd_117	   2.45	   5.86E-­‐11	   	   	   	  Rd_060	   2.30	   7.88E-­‐05	   	   	   	  Rd_002	   2.21	   7.77E-­‐07	   	   	   	  Rd_160	   2.20	   5.31E-­‐16	   	   	   	  Rd_028	   2.15	   9.13E-­‐06	   	   	   	  Rd_030	   2.13	   2.86E-­‐06	   	   	   	  Rd_022	   2.03	   5.10E-­‐07	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Table	   S16:	   Differentially	   expressed	   ncRNAs	   in	   R2866	   during	   iron-­‐
starvation	  stress.	  
ncRNA	   Fold	  change	   Adjusted	  p-­‐value	   ncRNA	   Fold	  change	   Adjusted	  p-­‐value	  
Up-­‐regulated	  ncRNAs	   Down-­‐regulated	  ncRNAs	  R2866_104	   3.19	   1.66E-­‐06	   R2866_154	   5.00	   4.56E-­‐21	  R2866_027	   2.18	   1.28E-­‐08	   R2866_158	   4.26	   1.86E-­‐13	  R2866_071	   2.12	   0.003649679	   R2866_015	   2.85	   1.22E-­‐05	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Table	  S17:	  Differentially	  expressed	  ncRNAs	  in	  Rd	  during	  nutritional	  stress.	  
ncRNA	   Fold	  change	   Adjusted	  p-­‐value	   ncRNA	   Fold	  change	   Adjusted	  p-­‐value	  
Up-­‐regulated	  ncRNAs	   Down-­‐regulated	  ncRNAs	  Rd_098	   2.08	   2.99E-­‐09	   Rd_032	   7.76	   9.76E-­‐35	  
	   	   	   Rd_145	   4.38	   3.98E-­‐19	  
	   	   	   Rd_015	   4.21	   2.54E-­‐11	  
	   	   	   Rd_069	   3.21	   1.16E-­‐08	  
	   	   	   Rd_116	   2.95	   9.68E-­‐06	  
	   	   	   Rd_120	   2.91	   1.64E-­‐09	  
	   	   	   Rd_050	   2.83	   1.66E-­‐09	  
	   	   	   Rd_101	   2.81	   1.19E-­‐06	  
	   	   	   Rd_142	   2.69	   2.21E-­‐05	  
	   	   	   Rd_078	   2.67	   1.29E-­‐05	  
	   	   	   Rd_104	   2.61	   1.26E-­‐05	  
	   	   	   Rd_022	   2.52	   0.000435058	  
	   	   	   Rd_137	   2.47	   5.42E-­‐14	  
	   	   	   Rd_095	   2.39	   3.45E-­‐06	  
	   	   	   Rd_006	   2.28	   0.000124837	  
	   	   	   Rd_052	   2.26	   3.63E-­‐14	  
	   	   	   Rd_124	   2.22	   4.70E-­‐05	  
	   	   	   Rd_156	   2.19	   0.00056713	  
	   	   	   Rd_138	   2.10	   2.02E-­‐08	  
	   	   	   Rd_038	   2.10	   0.000203088	  
	   	   	   Rd_002	   2.09	   1.45E-­‐05	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